data_1o78_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1o78 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.297 0.57 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.07 -131.78 3.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -125.25 106.48 9.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -1.151 . . . . 0.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.14 -31.23 4.98 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.44 168.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 110.629 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.34 105.03 34.08 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.96 139.55 36.29 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.582 1.306 . . . . 0.0 110.762 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 174.3 3.16 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 0.0 110.297 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.18 -53.34 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.722 1.38 . . . . 0.0 110.384 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.84 -49.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.35 177.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.42 -171.06 43.77 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -126.96 104.8 8.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -1.109 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -55.95 155.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -128.14 -40.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -174.0 133.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -98.48 151.13 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.42 -58.76 1.88 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.327 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.61 150.9 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 1.3 mttt -118.17 42.59 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.434 ' CG ' ' HA ' ' A' ' 65' ' ' LYS . 13.3 tm-20 59.77 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.616 0.722 . . . . 0.0 110.698 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.74 20.29 66.1 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.45 136.54 52.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.965 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -71.84 159.57 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 110.106 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -147.01 165.57 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -122.64 177.1 5.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.114 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.96 103.33 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.77 -19.02 9.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.22 112.63 2.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.123 -1.222 . . . . 0.0 110.297 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 89.1 m -52.1 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ILE . 59.8 t -57.77 -37.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.844 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.415 HD21 ' CG1' ' A' ' 43' ' ' VAL . 0.7 OUTLIER -167.11 -160.01 0.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.577 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.03 148.16 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.143 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.22 173.68 13.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.058 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 110.429 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.203 0.525 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.25 109.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 43' ' ' VAL . 48.1 mt -88.82 102.64 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 13.9 p-10 -75.99 138.21 40.77 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.602 0.715 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.23 145.9 33.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.887 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.01 -37.05 3.79 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.593 1.312 . . . . 0.0 110.637 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -155.5 160.91 40.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.5 m-20 -58.49 142.62 48.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.323 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.04 -164.33 37.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -132.03 148.47 52.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -1.133 . . . . 0.0 110.035 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 16.0 t -84.73 138.16 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.51 -25.37 16.88 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.475 -0.766 . . . . 0.0 109.05 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER 179.17 137.47 0.1 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 109.75 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -93.31 130.37 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.438 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.49 -50.79 4.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.047 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.04 163.06 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.209 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -136.15 160.35 38.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.007 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 58.07 28.85 16.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -113.25 112.96 24.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.867 . . . . 0.0 109.824 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -105.09 177.33 4.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 110.602 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 33.6 m 36.84 56.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.294 0.569 . . . . 0.0 111.709 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.405 ' O ' ' CG ' ' A' ' 75' ' ' GLN . 0.5 OUTLIER -136.85 71.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.065 -1.022 . . . . 0.0 110.48 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -116.07 168.85 12.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 -29.61 12.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.77 152.51 21.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -1.059 . . . . 0.0 109.914 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.55 136.66 43.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.3 mt -88.83 -51.09 5.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -1.17 . . . . 0.0 110.058 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.99 139.97 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.099 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -93.5 134.81 35.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.414 ' N ' ' HD2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -145.78 147.15 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.151 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.257 0.551 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.18 158.26 27.17 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.13 -28.05 66.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -1.09 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.03 -24.14 25.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -80.41 150.51 29.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -1.123 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.9 100.1 53.2 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.956 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.42 164.67 34.92 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.676 1.356 . . . . 0.0 110.956 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 119.8 74.5 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.848 . . . . 0.0 109.984 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.94 0.03 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.45 1.237 . . . . 0.0 111.152 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.54 59.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.829 -1.169 . . . . 0.0 110.389 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HA ' ' N ' ' A' ' 76' ' ' GLY . . . 49.87 -167.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 110.568 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.77 156.65 7.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.4 m -103.68 108.29 19.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -1.168 . . . . 0.0 110.29 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.37 125.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.73 -46.25 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 110.569 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.16 152.8 13.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.008 . . . . 0.0 110.137 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.5 pt -118.76 135.35 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.152 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp -92.29 -3.16 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.417 ' CG2' HG23 ' A' ' 63' ' ' VAL . 12.0 p -93.8 151.64 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.79 153.3 44.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.054 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -68.18 131.55 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.132 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.77 16.72 67.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.95 158.7 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -1.2 . . . . 0.0 109.968 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 59.2 m -105.37 129.21 53.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 174.09 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.52 152.6 48.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.52 116.4 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.405 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.94 -24.98 9.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.41 122.66 24.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.436 HG22 ' CB ' ' A' ' 54' ' ' GLU . 5.0 m -59.05 104.59 0.25 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.178 -0.951 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.417 HG12 ' CB ' ' A' ' 57' ' ' ALA . 23.8 m -91.0 -15.09 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.59 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.432 HD13 ' CG2' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -145.14 160.32 41.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.191 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.52 122.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mt -113.89 172.91 6.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 110.373 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.166 0.507 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' CB ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -54.25 129.92 36.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -101.71 90.35 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.36 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 24.6 p-10 -65.38 141.42 58.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 43' ' ' VAL . . . -52.58 150.58 9.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.166 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.31 -31.48 11.56 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.675 1.355 . . . . 0.0 110.497 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 t -174.69 166.25 3.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.04 123.47 18.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.16 170.57 38.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HG2' ' N ' ' A' ' 63' ' ' VAL . 11.1 ttmt -104.93 152.86 22.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.425 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 15.1 t -71.92 143.91 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 110.152 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.05 -17.98 11.32 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.44 117.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.164 -0.96 . . . . 0.0 110.387 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -100.89 132.67 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.117 -0.99 . . . . 0.0 109.852 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.18 -21.81 9.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.045 -1.034 . . . . 0.0 110.723 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 7.5 p -59.86 148.83 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.82 145.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.42 76.13 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 177.83 -45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.305 -0.872 . . . . 0.0 110.1 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -55.3 128.13 32.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.277 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -140.68 164.65 29.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.1 t 56.44 164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.789 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.44 111.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.389 -0.819 . . . . 0.0 110.877 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -101.3 -159.78 27.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.91 -19.2 55.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -92.68 138.51 31.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -1.213 . . . . 0.0 110.421 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.58 177.03 0.36 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -135.5 -65.9 0.59 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.75 142.37 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -100.42 120.83 40.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.86 128.55 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.884 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.336 0.588 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.73 -107.26 3.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.4 tt0 -140.33 104.31 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -1.151 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.93 -39.53 2.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -54.66 157.48 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -1.093 . . . . 0.0 110.476 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.13 104.63 52.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 109.928 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.18 136.74 29.95 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.585 1.308 . . . . 0.0 110.533 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.54 139.2 97.68 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 0.0 110.242 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.76 -24.13 13.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.61 1.321 . . . . 0.0 110.623 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -131.51 166.24 21.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 75' ' ' GLN . . . -75.06 174.92 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.299 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.3 179.36 39.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.1 m -133.42 137.32 45.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 110.156 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.67 118.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.303 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.69 -28.63 19.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.69 126.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -81.48 150.34 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 -38.38 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.171 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.13 176.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.412 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.35 46.01 1.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.321 -0.862 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 1.4 tt0 59.82 155.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.26 28.22 42.09 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.61 124.73 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.164 . . . . 0.0 110.288 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -69.64 149.93 47.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 161.51 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 ttmm -115.48 155.27 27.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.95 109.94 1.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.211 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 28.73 4.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -118.16 115.24 24.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -1.214 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 87.0 m -54.42 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.5 m -69.07 -22.65 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.404 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -161.22 172.3 16.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.493 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.36 130.55 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.034 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 -177.8 3.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.331 0.586 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.7 103.46 14.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 43' ' ' VAL . 41.0 mm -68.85 91.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.553 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -77.24 131.41 38.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.434 -0.791 . . . . 0.0 110.238 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.2 156.41 1.4 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 -37.92 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.694 1.365 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -158.8 178.3 10.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.18 132.12 38.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.85 -135.44 3.09 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -154.41 150.13 27.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.272 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 9.1 t -64.25 142.11 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.053 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -115.6 -18.38 10.91 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.843 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 3.4 tmtm? 179.24 89.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 12.6 p -79.8 117.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.974 . . . . 0.0 110.202 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pp -96.93 -25.71 15.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.79 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.293 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -132.16 160.19 36.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.34 153.58 43.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.917 . . . . 0.0 110.224 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 55.13 21.63 4.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.313 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.05 87.32 2.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.163 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.22 149.09 13.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.0 164.12 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.114 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.412 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -106.15 -179.21 3.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.48 129.56 10.54 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 35.42 2.24 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.19 126.32 26.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -1.148 . . . . 0.0 110.14 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.91 151.17 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -118.58 -64.21 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -1.115 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.31 133.64 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.198 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -82.45 143.66 31.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.403 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.2 tt -164.82 161.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.547 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.222 0.534 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.95 -168.53 17.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.06 78.45 3.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -1.186 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.79 -20.88 1.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.53 170.49 9.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -1.166 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.45 132.14 24.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 109.97 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.36 131.71 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.51 1.268 . . . . 0.0 110.639 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.48 137.27 69.66 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.4 113.93 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.582 1.306 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.5 mm? 49.45 48.95 20.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 -154.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 0.0 110.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.06 172.46 14.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.5 p -112.49 112.22 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.18 112.31 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.982 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.6 -9.25 12.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.715 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -168.46 151.24 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.983 -1.073 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.25 145.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.39 -42.31 4.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.76 165.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -140.92 163.21 33.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 9.3 pt-20 -68.46 135.42 51.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.0 22.69 68.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.21 130.02 55.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.7 m -75.43 118.56 18.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.058 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 p -98.19 151.49 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.437 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 156.07 21.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 109.99 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 121.42 14.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -5.67 44.55 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.496 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ALA . 1.5 tt0 -85.5 123.64 31.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.819 -1.401 . . . . 0.0 110.441 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.2 m -55.68 102.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.285 -0.884 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 57' ' ' ALA . 35.4 m -81.48 -23.0 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -154.2 162.97 40.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.613 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.94 125.26 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.91 168.03 10.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 110.291 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.248 0.547 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' CG ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -95.25 113.58 25.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.25 94.2 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.324 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 3.7 m-20 -66.67 148.79 51.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.407 0.622 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . . . -65.19 146.47 98.93 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.51 -0.744 . . . . 0.0 110.352 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.09 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.703 1.37 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.75 150.5 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.98 147.99 52.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.175 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.5 -164.22 37.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -125.65 142.3 51.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -1.107 . . . . 0.0 110.251 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 18.7 t -80.06 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.019 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.58 -15.11 13.1 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.569 -0.707 . . . . 0.0 109.851 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.09 131.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.104 -0.998 . . . . 0.0 110.163 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.31 150.69 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.12 -58.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' OD2' ' A' ' 72' ' ' ASP . 41.3 t -84.54 154.94 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 71' ' ' ARG . 9.1 mmtt -135.33 166.01 24.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 4.4 mt-10 -63.79 80.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -176.88 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' OD2' ' CG1' ' A' ' 68' ' ' VAL . 15.8 p-10 -52.7 125.03 15.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -122.2 158.68 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.204 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 26.7 m 36.6 42.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 121.285 0.564 . . . . 0.0 111.694 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.883 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.46 150.12 19.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.68 14.88 64.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -99.34 150.25 22.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.287 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 106.28 1.57 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mt -55.73 -79.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -1.156 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.5 mt -144.54 160.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -88.47 132.61 34.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.067 -1.02 . . . . 0.0 110.126 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.78 33.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.594 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.258 0.551 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.72 170.17 13.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.17 107.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.12 -24.73 5.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -94.64 158.2 15.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -1.143 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.54 111.64 27.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.033 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 45.8 Cg_endo -72.42 157.92 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.513 1.27 . . . . 0.0 110.793 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -95.77 112.49 59.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.167 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.92 -3.71 14.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.55 1.289 . . . . 0.0 111.28 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.18 33.2 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 110.725 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.89 -157.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.139 -0.975 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.84 -159.17 20.62 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.23 -146.83 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -1.176 . . . . 0.0 110.115 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 m -47.68 -31.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.049 -1.032 . . . . 0.0 111.147 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p 57.18 39.49 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -66.43 101.15 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.428 ' CG1' HG21 ' A' ' 31' ' ' VAL . 5.5 tt -62.3 115.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.457 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.4 mt -69.9 -26.75 64.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.944 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' CG1' ' A' ' 29' ' ' ILE . 23.4 m -98.98 -158.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.177 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.84 -178.45 6.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.49 151.81 27.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.72 5.13 83.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.49 167.65 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.002 -1.293 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.426 HG21 ' N ' ' A' ' 37' ' ' VAL . 98.9 m -103.75 156.53 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.426 ' N ' HG21 ' A' ' 36' ' ' THR . 7.7 p -137.85 167.76 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.35 160.1 34.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 121.48 15.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.303 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.27 44.95 6.04 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -132.34 110.11 10.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.139 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 93.8 m -53.07 114.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.72 -12.9 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.884 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -132.45 166.35 22.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.848 -1.157 . . . . 0.0 110.909 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.82 103.47 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 110.036 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -138.96 137.0 36.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' LEU . 41.0 m . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 42' ' ' THR . 6.2 mt-10 -56.08 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.098 . . . . 0.0 110.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' THR . 16.9 mm -88.48 102.16 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -78.73 127.3 31.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.427 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.2 14.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 110.083 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -51.47 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.652 1.343 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.6 p -139.71 156.06 47.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 29.2 p-10 -62.28 166.51 4.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.75 -161.91 29.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -134.92 143.88 47.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -1.187 . . . . 0.0 109.936 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.48 134.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 110.329 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.83 -11.87 16.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.69 138.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 109.771 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.44 160.55 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' HG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -126.36 -67.44 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 110.04 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.42 169.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 110.489 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.158 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' CG ' ' HA ' ' A' ' 28' ' ' LYS . 4.1 tt0 -53.88 134.23 42.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.903 . . . . 0.0 110.441 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 55.83 51.4 12.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.473 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -102.51 -26.35 13.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' CG2' ' A' ' 74' ' ' VAL . . . 61.82 142.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.397 -0.815 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 73' ' ' ALA . 14.8 m 34.53 89.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 121.417 0.627 . . . . 0.0 112.139 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.19 64.28 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.102 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.44 154.87 17.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.3 54.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -118.24 163.41 16.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -1.165 . . . . 0.0 110.143 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -58.14 175.81 2.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.7 mt -123.42 -43.03 2.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 tt -175.67 143.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.084 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -98.4 126.35 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.69 113.29 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.525 -179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.119 0.485 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.56 -125.38 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.42 97.15 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -1.12 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.62 1.15 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -118.23 174.86 5.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.317 -1.108 . . . . 0.0 110.343 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 ' O ' ' CG ' ' A' ' 80' ' ' LEU . 15.6 mm -107.97 100.12 34.34 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.179 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.01 45.78 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.638 1.336 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.51 116.1 61.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.94 -8.03 22.19 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.46 1.242 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.6 tp -150.03 126.13 10.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.999 -1.063 . . . . 0.0 110.285 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.421 ' HB2' ' CA ' ' A' ' 75' ' ' GLN . . . -58.74 178.35 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . 151.19 -149.52 21.33 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.066 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.441 ' CA ' ' HB2' ' A' ' 73' ' ' ALA . 31.0 p -137.46 100.01 4.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.442 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 59.1 t -50.28 100.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.013 -1.055 . . . . 0.0 110.291 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 t -57.44 -41.02 79.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -173.12 156.64 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 68' ' ' VAL . 3.6 tt -96.42 136.3 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.348 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -103.43 -25.81 13.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' CG2' HG22 ' A' ' 63' ' ' VAL . 9.2 p -87.15 153.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' HG21 ' A' ' 31' ' ' VAL . 2.8 tptp -123.29 149.21 45.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.208 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -69.85 136.12 50.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.64 24.13 59.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.35 143.43 51.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -1.09 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -85.67 116.8 24.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.1 p -100.96 154.64 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 110.358 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 145.77 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.41 142.12 33.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.303 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.88 -34.59 5.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.22 123.56 20.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -1.201 . . . . 0.0 110.381 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.436 ' O ' ' CG2' ' A' ' 42' ' ' THR . 8.1 t -57.19 101.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.971 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CB ' ' A' ' 57' ' ' ALA . 32.9 m -77.57 -17.39 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 110.449 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HB3' HD11 ' A' ' 55' ' ' ILE . 4.0 mt -152.21 155.61 38.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.077 -1.014 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.83 117.97 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.471 ' CD1' ' CB ' ' A' ' 73' ' ' ALA . 2.4 mm? -102.35 174.56 5.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.457 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.181 0.515 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.27 132.34 53.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.849 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 46' ' ' LEU . 20.8 mt -107.02 99.68 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.45 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 10.6 p-10 -70.86 137.41 49.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.367 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.449 ' CB ' ' CG1' ' A' ' 43' ' ' VAL . . . -56.66 148.32 47.02 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.85 . . . . 0.0 110.068 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.49 -36.11 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.644 1.339 . . . . 0.0 110.504 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -157.31 158.27 35.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 139.23 46.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.18 38.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 139.43 49.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG22 ' CG2' ' A' ' 31' ' ' VAL . 24.5 t -72.43 142.28 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.014 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -105.86 -18.18 14.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.794 . . . . 0.0 109.681 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 156.61 0.55 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -0.976 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 35.8 m -134.63 100.06 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.055 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -15.0 48.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 0.0 110.489 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.402 HG22 ' CD1' ' A' ' 29' ' ' ILE . 30.2 m -46.7 153.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 7.66 8.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.657 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 61.27 143.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.957 . . . . 0.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.7 mtp-105 52.53 39.03 27.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -154.53 42.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 46' ' ' LEU . . . -82.12 -4.92 57.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.002 . . . . 0.0 110.439 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 24' ' ' GLY . 29.9 m -44.29 140.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.367 -0.833 . . . . 0.0 111.155 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.421 ' CA ' ' HB2' ' A' ' 23' ' ' ALA . 20.2 tt0 54.12 100.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.454 -0.778 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -168.6 8.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.91 -24.69 27.28 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -79.11 130.69 35.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -1.075 . . . . 0.0 110.158 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.99 157.44 9.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.406 ' CG ' ' O ' ' A' ' 18' ' ' ILE . 32.3 mt -118.68 -64.96 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -1.179 . . . . 0.0 110.216 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 51.6 mt -126.65 156.36 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 146.55 25.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.006 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 6.5 tt -136.59 25.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.56 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.283 0.564 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.87 -122.0 2.88 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 -57.62 2.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -1.133 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.54 -5.69 89.21 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.1 135.24 37.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.311 . . . . 0.0 110.375 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.48 109.84 34.66 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.351 -0.843 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 44.4 Cg_endo -72.15 152.51 56.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.495 1.261 . . . . 0.0 110.641 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.76 122.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.154 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.87 -17.62 25.32 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.481 1.253 . . . . 0.0 110.43 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.95 138.67 42.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.96 141.24 28.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.106 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.39 158.64 23.51 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 47' ' ' GLU . 1.1 p -121.11 104.83 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -1.132 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 72' ' ' ASP . 7.5 p -47.38 168.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -0.898 . . . . 0.0 110.902 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 25.7 t -149.69 -42.19 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 109.878 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -160.24 119.42 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tt -81.76 151.73 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.76 -38.01 5.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.104 -0.997 . . . . 0.0 110.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' CG2' HG11 ' A' ' 43' ' ' VAL . 35.9 m -123.41 168.35 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.284 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -121.38 -162.58 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -82.99 140.56 32.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 110.28 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.82 49.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 172.38 7.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.093 -1.239 . . . . 0.0 110.41 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.6 m -116.93 133.58 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -125.56 152.56 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 110.273 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -110.78 163.91 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 107.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.257 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.99 -0.72 31.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -90.25 127.26 36.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.334 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 3.4 m -54.13 135.6 43.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 57' ' ' ALA . 97.2 t -118.6 -38.17 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.94 159.34 43.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.792 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.03 116.79 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.954 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.39 153.57 19.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 25' ' ' THR . 17.2 tt0 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.076 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.272 0.558 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.64 128.77 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.8 81.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.246 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 2.0 m120 -72.58 133.93 44.95 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.545 0.688 . . . . 0.0 110.654 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -49.97 143.7 11.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 110.456 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.25 -32.44 6.63 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.655 1.345 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -145.08 162.25 37.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.27 133.5 38.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.42 173.83 35.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -90.99 152.63 20.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -1.131 . . . . 0.0 110.153 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.18 128.67 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -109.25 -1.33 18.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.448 -0.783 . . . . 0.0 110.319 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.86 139.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.01 89.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -58.1 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.509 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.92 137.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -163.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 0.0 109.759 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 8.3 tt0 -91.69 131.63 36.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 110.133 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.437 ' N ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 71.53 2.96 4.48 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.595 -0.69 . . . . 0.0 111.189 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.456 ' N ' HG13 ' A' ' 26' ' ' VAL . 4.6 m-20 -98.39 84.54 3.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.0 109.702 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.34 155.96 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.224 -0.922 . . . . 0.0 110.794 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.51 158.75 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 110.077 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -100.77 152.27 20.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.943 . . . . 0.0 110.398 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.13 138.66 42.46 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.71 -7.37 11.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.91 150.26 38.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.918 -1.343 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -59.09 159.85 17.62 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.422 ' O ' ' CG2' ' A' ' 81' ' ' ILE . 57.5 mt -108.86 -49.68 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.865 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 80' ' ' LEU . 4.8 pt -154.46 150.58 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.835 . . . . 0.0 110.024 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -108.36 139.42 43.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.938 . . . . 0.0 110.368 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 3.7 tt -148.85 44.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.611 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.343 0.592 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.98 -110.59 1.03 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.0 mt-10 -139.45 125.44 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 110.13 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.86 -33.56 5.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -57.23 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.409 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.84 110.75 7.99 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.76 137.01 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.539 1.284 . . . . 0.0 110.355 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.11 136.32 53.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.78 -24.55 13.21 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.462 1.243 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.05 139.9 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.32 178.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.977 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.83 155.84 19.28 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -99.74 121.31 41.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.362 -1.081 . . . . 0.0 109.979 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.42 136.37 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 110.366 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 t -115.62 -31.86 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtmt -172.84 139.94 0.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.083 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.2 tt -101.82 140.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 mt -116.29 -27.14 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.258 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.83 155.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.61 160.37 39.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.888 . . . . 0.0 110.248 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -68.07 122.17 17.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.99 -2.26 55.35 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 126.32 38.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.872 -1.37 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.8 m -64.55 124.03 20.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.46 145.27 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.88 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.47 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.937 . . . . 0.0 110.234 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.16 17.86 23.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 119.55 34.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.149 -1.207 . . . . 0.0 110.189 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 79.5 m -52.65 122.45 9.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.915 . . . . 0.0 110.011 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' CB ' ' A' ' 57' ' ' ALA . 15.4 m -114.33 -23.34 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 171.06 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.977 -1.077 . . . . 0.0 111.058 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.31 117.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 109.397 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.83 149.51 28.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.943 . . . . 0.0 110.815 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.819 . . . . 0.0 109.966 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 55' ' ' ILE . 53.8 m . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.051 0.453 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.46 97.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 111.106 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 53' ' ' THR . 26.7 mm -96.12 90.96 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.012 . . . . 0.0 109.5 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 50.5 m-20 -62.63 138.85 58.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' CB ' HG12 ' A' ' 43' ' ' VAL . . . -54.06 167.81 0.5 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.387 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.02 -35.85 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.822 1.433 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -165.69 -159.41 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.9 147.51 26.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.85 -150.53 22.09 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -129.99 149.06 51.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.94 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.5 110.18 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 110.379 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -78.4 -12.39 60.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.99 174.71 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 34.7 m -123.64 91.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.53 -30.18 69.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -103.81 142.74 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 110.545 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 -171.64 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 109.992 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.6 154.76 21.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.043 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 58.07 30.55 19.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.896 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.95 67.55 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 173.3 0.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.479 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t 53.55 86.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -131.21 28.09 4.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.155 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.38 132.98 11.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.11 44.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.31 150.01 21.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -1.202 . . . . 0.0 110.152 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.12 149.01 35.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.1 mt -96.57 -68.57 0.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 82' ' ' LYS . 6.1 mt -126.85 146.86 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' N ' HG21 ' A' ' 81' ' ' ILE . 6.4 tptm -88.06 118.93 27.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.491 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.5 pt -146.0 153.36 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.506 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.12 -106.23 0.48 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.0 148.47 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.96 58.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.65 166.14 11.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -1.095 . . . . 0.0 110.46 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.67 100.41 19.59 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.858 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.18 121.31 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.742 1.391 . . . . 0.0 110.542 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 80' ' ' LEU . . . -60.79 141.62 92.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -20.56 21.74 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.654 1.344 . . . . 0.0 110.387 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.84 151.43 29.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.66 174.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.304 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.03 153.37 11.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -106.77 135.33 48.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -1.19 . . . . 0.0 110.22 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -89.9 130.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.427 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -101.8 -23.18 14.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -169.63 165.43 10.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 29' ' ' ILE . 9.5 tt -122.43 145.24 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 -54.55 2.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.822 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.2 m -71.53 -171.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.837 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.93 39.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.44 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 17.9 tt0 61.21 142.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.295 -0.878 . . . . 0.0 110.727 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.73 60.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -1.234 . . . . 0.0 109.886 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 m -57.61 178.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 110.047 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 38' ' ' LYS . 13.4 p -171.78 164.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 37' ' ' VAL . 10.1 mtmm -122.69 177.45 5.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.28 125.93 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.464 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.51 -22.34 41.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.01 127.73 33.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 0.0 110.407 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.2 m -52.13 137.95 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.931 . . . . 0.0 110.011 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.452 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 93.7 t -123.49 -36.45 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -142.82 176.28 9.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.135 -0.978 . . . . 0.0 111.076 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.48 145.12 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -149.73 -174.83 4.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.046 . . . . 0.0 110.523 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 54' ' ' GLU . 8.2 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' HG21 ' A' ' 53' ' ' THR . 1.1 mt-10 -37.69 133.79 0.76 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.302 -0.874 . . . . 0.0 112.237 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' LEU . 35.1 mm -125.69 106.71 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.643 -0.661 . . . . 0.0 109.411 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 76.3 m-20 -57.18 144.1 36.41 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.703 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' CB ' ' CG2' ' A' ' 43' ' ' VAL . . . -62.38 152.38 79.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.71 -33.77 7.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.693 1.365 . . . . 0.0 110.389 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -161.51 151.75 17.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.43 158.49 14.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.59 -144.23 12.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -140.33 158.17 44.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -1.158 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 52.5 t -85.19 119.98 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 84' ' ' GLY . 1.2 mm-40 -90.22 -10.49 44.15 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 109.598 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.1 mttm 179.86 163.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -123.72 95.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 -36.48 75.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.15 128.53 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.204 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 -170.9 2.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.109 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 134.7 34.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 52.14 42.17 30.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -104.25 -23.76 13.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.312 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 60.73 117.17 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.04 -177.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.0 . . . . 0.0 110.339 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.08 162.85 21.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.62 146.43 48.5 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.84 37.16 6.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -146.51 132.05 18.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.74 114.74 4.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.427 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 26.1 mt -70.19 -57.89 4.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.296 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.03 168.78 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.3 143.08 42.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.38 162.6 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.305 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 64' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.531 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.195 0.521 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.74 -133.16 4.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.35 132.35 46.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.43 24.75 59.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.21 159.34 32.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -1.188 . . . . 0.0 110.277 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.7 mt -130.94 99.56 18.03 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.967 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.53 130.28 14.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.734 1.386 . . . . 0.0 110.618 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.55 114.18 36.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -18.59 26.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.468 1.247 . . . . 0.0 110.665 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.0 mt -119.97 9.27 11.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.68 -150.32 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 0.0 110.402 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.62 176.69 16.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.406 ' N ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -121.23 108.96 14.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -1.136 . . . . 0.0 110.009 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.3 136.35 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -40.21 3.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.248 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.69 139.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 tt -81.73 149.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.16 -45.57 4.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.152 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.4 m -101.91 -158.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -148.98 179.25 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 146.41 53.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.37 87.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.12 146.48 26.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.3 . . . . 0.0 110.163 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.7 m -97.83 107.26 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -81.25 158.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.86 155.42 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . . . -60.34 109.43 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.8 34.43 5.73 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -125.04 114.52 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.153 . . . . 0.0 110.084 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 90.7 m -49.16 113.77 0.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.221 -0.924 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 44' ' ' LEU . 12.0 p -107.95 -26.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.838 . . . . 0.0 110.625 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' N ' HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -142.78 175.44 9.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.137 -0.977 . . . . 0.0 111.163 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 53' ' ' THR . 57.5 t -116.17 142.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.948 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 47' ' ' GLU . 21.7 tp -134.72 159.22 41.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.015 . . . . 0.0 110.731 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 34.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.979 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 54.6 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.9 105.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.717 -1.24 . . . . 0.0 110.949 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 46' ' ' LEU . 26.2 mm -103.76 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 18.4 p-10 -69.81 135.38 49.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.638 -0.664 . . . . 0.0 110.726 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.43 175.3 0.13 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 110.175 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' O ' ' CG2' ' A' ' 59' ' ' THR . 49.0 Cg_endo -76.51 -48.99 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.762 1.401 . . . . 0.0 110.768 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -163.42 -167.66 1.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 124.86 26.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.412 ' HA2' ' CG2' ' A' ' 83' ' ' ILE . . . -179.87 169.9 40.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -107.62 151.43 25.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.84 106.85 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.997 . . . . 0.0 110.453 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -84.33 -10.79 57.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt 178.19 157.3 0.43 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.119 -0.988 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.39 94.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -70.37 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.498 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.48 166.12 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -118.5 -176.25 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.52 145.5 26.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 57.89 33.62 23.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.64 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 145.74 8.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.226 -0.922 . . . . 0.0 110.48 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.09 158.59 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 110.094 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -98.8 24.79 7.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.912 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.52 172.1 37.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.19 34.33 88.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.47 130.03 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -1.117 . . . . 0.0 110.157 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.33 111.25 2.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.1 mt -67.9 -70.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.333 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 44' ' ' LEU . 72.3 mt -132.5 160.61 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -102.35 117.92 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.412 ' CG2' ' HA2' ' A' ' 61' ' ' GLY . 70.8 mt -118.88 38.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.221 0.534 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.4 -179.19 26.89 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.4 141.53 51.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -1.175 . . . . 0.0 110.231 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.59 -51.59 4.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.02 132.63 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.341 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.97 120.07 51.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 154.27 53.22 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.409 1.215 . . . . 0.0 110.672 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 94.52 11.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.54 -5.63 17.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.735 1.387 . . . . 0.0 111.056 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.09 3.24 35.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.064 -1.023 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.11 178.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.936 -1.103 . . . . 0.0 110.188 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.51 172.06 31.51 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -101.14 112.73 25.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -1.123 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.63 97.51 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.857 . . . . 0.0 109.983 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -41.76 11.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.298 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.28 170.87 4.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.26 124.03 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.127 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.78 -60.73 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.52 -115.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.097 -1.002 . . . . 0.0 109.812 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tttp 53.96 50.45 16.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.401 -1.437 . . . . 0.0 110.196 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.05 103.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -0.82 . . . . 0.0 109.803 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.6 22.11 61.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 140.04 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 110.12 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 51.7 m -76.95 88.28 3.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 27.7 m -67.04 -171.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 15.7 ttpp -147.64 155.87 42.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.053 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.15 93.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -0.958 . . . . 0.0 110.397 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.45 34.07 1.65 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -115.18 109.04 17.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 110.362 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.437 HG22 ' CB ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -52.22 109.8 0.42 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.02 -4.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 111.226 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -131.05 164.21 25.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 110.658 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' CG1' HG21 ' A' ' 53' ' ' THR . 81.7 t -123.33 108.16 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 55' ' ' ILE . 1.4 mm? -125.15 154.63 41.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.301 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.428 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 121.164 0.507 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' CB ' HG22 ' A' ' 42' ' ' THR . 2.9 mp0 -56.57 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 111.08 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 46' ' ' LEU . 20.8 mm -99.63 98.43 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.185 -0.947 . . . . 0.0 109.755 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 73.0 m-80 -69.98 131.71 44.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.837 . . . . 0.0 110.136 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 156.07 2.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.39 -49.03 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.701 1.369 . . . . 0.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.5 p -138.97 -172.5 3.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 110.202 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.429 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 6.3 p-10 -101.56 152.44 20.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 159.88 9.04 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 17.4 tttt -85.69 121.09 27.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.129 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 t -54.34 159.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.803 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -118.39 -14.87 9.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.438 -0.789 . . . . 0.0 110.123 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 tttt 179.97 149.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.73 159.5 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 109.558 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.27 -68.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.7 m -48.55 155.12 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.175 -0.953 . . . . 0.0 110.63 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -124.31 148.46 47.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.237 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.0 72.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.39 145.22 11.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -135.91 135.18 39.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.491 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 73' ' ' ALA . 14.5 p 36.91 48.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.883 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.33 97.87 6.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.09 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.96 156.31 19.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.43 18.27 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.71 155.94 17.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -1.213 . . . . 0.0 110.241 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.97 161.9 23.53 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mt -109.18 -68.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 81' ' ' ILE . 36.3 mm -140.8 148.42 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 91.28 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 pt -125.45 45.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.224 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.571 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.13 0.491 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.0 25.88 5.16 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 53.24 25.32 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -1.132 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.79 49.85 0.09 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.48 -176.94 5.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 110.187 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.51 91.51 49.67 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.115 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.41 134.55 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.704 1.371 . . . . 0.0 110.709 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.81 142.62 69.95 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.54 -32.35 9.89 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.609 1.32 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.8 tt -118.73 157.16 28.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HA ' ' N ' ' A' ' 76' ' ' GLY . . . -61.1 176.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 110.546 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -153.52 146.85 15.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.32 -141.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -1.125 . . . . 0.0 110.584 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 71' ' ' ARG . 19.1 m -38.47 -46.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.518 -0.739 . . . . 0.0 112.539 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER 61.01 40.82 14.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.748 -1.22 . . . . 0.0 110.016 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 108.39 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 12.2 tt -62.05 120.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.475 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.2 -18.23 29.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.175 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.27 169.77 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.331 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -123.7 159.55 29.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.72 142.49 53.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.9 . . . . 0.0 110.171 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.45 73.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -110.69 154.72 23.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.102 -1.234 . . . . 0.0 109.874 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 1.4 m -96.73 110.67 23.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.308 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' GLY . 34.5 m -81.92 157.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -120.06 160.44 22.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.294 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . -69.12 99.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.02 46.92 0.85 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -135.34 114.44 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -1.167 . . . . 0.0 109.809 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' CG2' ' A' ' 42' ' ' THR . 12.6 t -55.25 105.12 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.575 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.52 0.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.942 -1.099 . . . . 0.0 110.227 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.81 156.82 42.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.952 -1.093 . . . . 0.0 110.472 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' SER . 93.5 t -119.23 99.84 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 tt -105.83 151.0 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.897 -179.943 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.204 0.526 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.1 pt-20 -65.41 103.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' CB ' ' HB3' ' A' ' 44' ' ' LEU . 48.6 mm -77.37 94.05 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 67.3 m-20 -77.31 133.16 38.85 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.629 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.77 170.09 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.29 -54.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.762 1.401 . . . . 0.0 110.812 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 39' ' ' ALA . 1.3 p -153.26 -166.12 2.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.361 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -78.56 123.59 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.395 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' VAL . . . -173.42 -165.95 31.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.8 ttpt -133.27 153.48 51.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.131 -1.217 . . . . 0.0 110.384 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -80.19 125.14 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -88.64 -14.09 38.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.76 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.5 169.06 0.84 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.63 144.91 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -52.62 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 109.95 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.05 154.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 18.0 mttt -94.28 -10.87 31.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -0.976 . . . . 0.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 4.8 tt0 61.61 135.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.21 22.38 7.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.07 . . . . 0.0 109.949 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -115.86 120.62 39.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 109.821 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 168.7 11.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' GLY . 19.5 t 60.86 139.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.488 0.661 . . . . 0.0 110.648 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.04 43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.012 -1.055 . . . . 0.0 110.338 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -101.08 130.89 10.38 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.82 19.37 63.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -131.37 139.83 49.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -1.179 . . . . 0.0 110.14 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.75 140.85 29.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.1 mt -92.1 -47.71 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -1.188 . . . . 0.0 110.002 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 81' ' ' ILE . 98.2 mt -137.2 151.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -97.31 145.97 25.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.116 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -147.46 159.08 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.615 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.96 -106.93 0.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -119.18 -49.36 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.159 . . . . 0.0 109.893 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' CA ' ' HG2' ' A' ' 82' ' ' LYS . . . -95.58 85.28 0.92 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.461 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.7 pm0 -157.96 150.78 22.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -1.079 . . . . 0.0 110.236 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 78.5 mt -111.85 99.38 45.13 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.9 128.35 14.87 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.702 1.369 . . . . 0.0 110.472 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.84 138.05 87.82 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.079 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.46 -13.31 25.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.558 1.294 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.04 153.15 41.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.249 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.03 162.09 9.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.139 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.37 -165.04 34.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.55 149.23 29.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.295 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.69 132.89 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.57 -28.6 12.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 109.923 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.42 153.52 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 tt -112.46 149.56 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.478 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' CG2' ' A' ' 42' ' ' THR . 0.5 OUTLIER -114.4 -36.0 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.009 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 32' ' ' LYS . 59.6 t -110.04 157.24 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.05 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' N ' HG11 ' A' ' 31' ' ' VAL . 21.2 mmtt -119.83 178.71 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -77.28 131.5 38.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.85 70.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.58 157.02 18.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.317 . . . . 0.0 110.421 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.69 174.7 8.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.919 . . . . 0.0 109.971 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -157.61 166.28 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 110.212 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -122.06 169.57 10.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.42 114.6 18.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.5 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -109.46 119.67 40.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -1.224 . . . . 0.0 110.006 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.429 ' CG2' HD12 ' A' ' 30' ' ' LEU . 88.6 m -53.19 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.374 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' ILE . 41.5 t -64.73 -33.49 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 0.0 109.776 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.03 -177.74 6.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.627 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.94 125.67 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.053 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.74 177.67 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.242 0.544 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.79 112.69 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.444 ' O ' ' N ' ' A' ' 43' ' ' VAL . 98.1 mt -82.61 89.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 70.1 m-80 -72.57 135.12 45.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.549 -0.719 . . . . 0.0 110.797 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.441 ' CA ' HG22 ' A' ' 43' ' ' VAL . . . -56.43 154.17 17.57 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.297 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 -46.19 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.746 1.393 . . . . 0.0 110.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 m -155.82 169.98 23.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.66 145.08 56.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.47 28.17 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -132.2 150.96 52.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.434 HG12 ' CG2' ' A' ' 66' ' ' VAL . 30.2 t -71.87 132.86 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -9.43 20.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.517 -0.739 . . . . 0.0 110.081 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 140.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.06 . . . . 0.0 109.837 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 63' ' ' VAL . 64.3 t -123.67 95.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.463 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.26 -18.07 59.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.103 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.67 143.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 110.342 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.99 15.87 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 110.349 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 61.97 135.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.324 -0.86 . . . . 0.0 110.586 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 32.75 17.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -127.59 116.85 20.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.52 146.21 54.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.16 122.71 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 160.4 30.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.68 51.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 -2.76 30.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -97.79 123.73 41.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.363 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.5 137.68 48.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.5 mt -107.43 -57.87 2.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -1.193 . . . . 0.0 110.352 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 43' ' ' VAL . 16.4 tt -143.19 170.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 17' ' ' GLU . 8.0 tptp -143.02 172.26 12.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.448 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 3.3 pt -153.39 131.89 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.668 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.242 0.544 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.39 -115.08 3.63 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -120.65 -35.01 3.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.65 15.42 11.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -97.09 124.24 41.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.255 . . . . 0.0 109.991 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.19 117.2 67.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.357 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.89 134.33 19.68 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.386 1.203 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' CA ' HD13 ' A' ' 80' ' ' LEU . . . -80.19 125.88 80.49 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.14 141.12 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.441 1.232 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.52 127.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.397 -0.814 . . . . 0.0 110.523 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.93 170.59 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 0.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.41 -177.8 47.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.2 m -133.99 147.16 50.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.85 134.52 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.1 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 p -110.16 -20.67 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.952 . . . . 0.0 110.141 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.93 122.8 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.311 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -83.39 144.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.082 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -119.31 -24.8 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.917 . . . . 0.0 110.632 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -108.12 165.02 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.307 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 169.06 18.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 110.322 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 156.98 38.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 23.32 70.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.13 166.14 12.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -1.14 . . . . 0.0 110.075 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -109.11 128.12 54.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.19 158.96 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.402 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' CG ' ' OD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -110.94 179.71 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.87 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.425 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . . . -90.1 124.55 34.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.098 -1.001 . . . . 0.0 110.33 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.33 29.55 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -113.82 122.31 46.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -1.174 . . . . 0.0 110.316 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 24.2 m -56.6 109.91 0.7 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG21 ' N ' ' A' ' 44' ' ' LEU . 34.3 m -95.81 -21.14 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -147.93 173.94 12.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.992 -1.067 . . . . 0.0 111.348 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' THR . 45.7 t -126.2 113.33 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 109.251 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.35 165.46 11.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.01 -1.056 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.58 -0.7 . . . . 0.0 109.707 179.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 51.9 m . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.94 102.11 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 111.076 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 55' ' ' ILE . 32.1 mm -103.94 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.941 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 31.3 m120 -73.89 135.28 43.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.42 0.628 . . . . 0.0 110.694 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.35 167.81 0.67 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.09 -52.47 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.761 1.4 . . . . 0.0 110.523 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.28 170.27 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.098 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' CB ' ' A' ' 39' ' ' ALA . 3.6 m-20 -57.88 139.01 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.4 172.35 35.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -109.86 150.06 28.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -1.14 . . . . 0.0 109.974 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -77.81 124.42 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.368 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.39 -6.81 23.56 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 110.003 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -177.87 150.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 109.92 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.62 146.28 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.92 -69.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.46 158.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.051 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -129.69 -165.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 155.26 20.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 55.53 25.86 8.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.27 105.61 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.245 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 137.55 50.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.004 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 p -130.23 132.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.74 -177.45 6.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.304 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.07 125.72 7.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.29 0.69 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.15 128.71 9.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.419 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.01 130.55 36.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.419 HD13 ' CA ' ' A' ' 20' ' ' ALA . 10.9 mt -92.21 -70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -1.099 . . . . 0.0 109.698 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.3 mm -134.64 145.04 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 0.0 109.833 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.72 137.96 31.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.182 -0.949 . . . . 0.0 110.493 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.95 146.2 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.305 0.574 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.5 -173.71 44.11 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 135.72 56.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -1.147 . . . . 0.0 110.17 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -19.12 48.76 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' OE2' ' CD ' ' A' ' 82' ' ' LYS . 1.1 mp0 -110.04 127.7 54.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.248 . . . . 0.0 110.508 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.38 111.93 32.24 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.793 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.88 143.35 45.19 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.41 1.216 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 80' ' ' LEU . . . -85.86 135.73 37.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.123 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.58 133.81 17.74 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.592 1.312 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.36 -166.87 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.55 137.88 38.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.254 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.77 169.13 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 132.58 54.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.32 141.32 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 110.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -113.18 -24.45 9.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.52 140.78 0.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.855 . . . . 0.0 110.088 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 tt -100.06 134.45 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.343 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.48 -56.18 3.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 m -81.02 -177.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.364 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -145.93 52.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.028 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER 59.85 157.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.08 55.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -106.93 147.92 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.233 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 93.9 m -108.75 123.3 48.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.275 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.81 -175.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.086 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 3.0 ttpt -142.7 49.58 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . 54.75 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.76 -13.32 7.7 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.339 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.59 119.94 21.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.05 -1.264 . . . . 0.0 110.555 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.3 m -61.71 103.3 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.035 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 44' ' ' LEU . 34.7 m -86.78 -21.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -151.18 176.84 10.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.26 117.98 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.07 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -99.23 157.4 16.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.248 0.547 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.39 149.58 42.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.91 86.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.965 . . . . 0.0 110.613 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.2 m-20 -84.31 127.59 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.273 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.01 145.32 5.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 110.277 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -45.22 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.65 1.342 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 39' ' ' ALA . 8.9 t -137.41 158.09 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 110.419 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 4.6 p30 -56.83 160.22 3.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 168.76 14.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 21.9 ttpt -109.53 139.56 44.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 16.7 t -64.66 135.45 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.03 . . . . 0.0 109.94 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.19 -17.66 16.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.83 156.06 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.008 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 81' ' ' ILE . 23.9 m -126.72 127.29 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.81 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 68' ' ' VAL . 1.8 pp -104.79 -26.27 12.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.305 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.429 ' CG2' HD13 ' A' ' 67' ' ' LEU . 84.3 t -98.97 150.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -164.87 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -79.75 151.38 30.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 110.148 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.52 39.11 27.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -100.79 -19.47 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.315 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 72' ' ' ASP . . . 56.33 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.547 -0.721 . . . . 0.0 110.904 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.96 145.33 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.392 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.4 171.53 8.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.24 119.83 18.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 44.51 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 125.35 27.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.78 139.49 39.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 HD12 ' CB ' ' A' ' 20' ' ' ALA . 8.6 mt -107.64 -61.01 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.203 -1.175 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 66' ' ' VAL . 11.8 tt -143.56 151.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' CD ' ' OE2' ' A' ' 17' ' ' GLU . 4.5 ttpt -95.23 143.81 26.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.072 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.8 tt -136.07 151.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.888 -1.507 . . . . 0.0 109.573 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.262 0.553 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.67 -106.74 1.08 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -129.82 158.89 38.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.009 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.06 39.79 92.55 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -135.15 161.33 35.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -1.117 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.14 102.69 50.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.12 156.6 55.47 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.656 1.345 . . . . 0.0 110.527 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.23 138.64 34.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.316 -0.865 . . . . 0.0 110.081 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.88 -27.37 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.609 1.321 . . . . 0.0 110.506 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.78 165.69 23.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.08 156.34 21.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.28 -177.42 14.93 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -122.99 -133.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -1.198 . . . . 0.0 110.142 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 71' ' ' ARG . 15.7 m -36.8 -46.32 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.472 -0.768 . . . . 0.0 112.276 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 29' ' ' ILE . 1.3 t 54.95 42.41 31.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 0.0 109.918 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 27' ' ' SER . 13.6 tt -68.09 86.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.04 -41.87 68.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.002 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 32' ' ' LYS . 9.9 p -62.03 164.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.5 ttmt -123.57 169.31 11.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 110.27 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.73 134.39 34.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.51 19.13 57.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.62 179.42 4.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.924 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -122.12 140.25 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.75 175.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.46 161.2 27.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.367 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.38 127.93 33.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.89 . . . . 0.0 110.084 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.56 19.13 45.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -109.36 111.65 23.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.243 . . . . 0.0 109.992 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 54.2 m -51.08 116.09 1.84 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.541 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 44' ' ' LEU . 30.2 m -115.44 -22.56 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.842 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -131.16 154.77 48.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.2 109.76 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.215 -0.928 . . . . 0.0 110.818 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.33 147.33 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 0.0 109.953 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.716 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.247 0.546 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.408 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -77.85 118.58 20.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 30.7 mm -88.75 90.07 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.575 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.0 p-10 -73.45 132.36 42.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 110.064 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.37 1.93 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.362 -0.836 . . . . 0.0 110.665 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.88 -40.22 1.97 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.569 1.299 . . . . 0.0 110.644 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.4 m -156.09 153.4 29.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.255 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.79 140.94 40.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.45 177.8 39.73 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.19 142.29 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -1.141 . . . . 0.0 110.045 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.8 129.73 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.95 -6.66 35.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 110.362 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -174.84 148.14 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 110.204 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.415 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 7.1 p -105.14 144.49 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.97 -53.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.5 t -53.46 128.21 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 110.061 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -80.15 1.75 26.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 61.95 132.39 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.64 26.38 12.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.077 . . . . 0.0 110.136 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -126.41 120.63 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.18 142.95 24.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.66 171.39 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.967 -1.083 . . . . 0.0 110.426 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -113.34 -179.23 3.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.79 140.78 15.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.22 20.62 10.9 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -125.97 143.85 50.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.164 . . . . 0.0 110.111 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.04 144.48 49.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 mt -104.85 -42.73 5.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 110.25 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 tp -167.72 143.51 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -92.46 147.95 22.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.957 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 83' ' ' ILE . 29.3 pt -133.76 158.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.467 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.28 0.562 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.33 59.6 0.53 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 53.65 79.03 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.23 -56.49 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -53.1 143.62 17.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.126 . . . . 0.0 110.362 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.3 mp -113.33 131.87 22.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.34 144.7 37.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.524 1.276 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.25 74.34 1.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.959 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.54 61.84 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.772 1.406 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.01 -12.46 13.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.62 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 55.01 -174.16 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.054 -1.029 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 -162.48 12.35 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 10.4 p -130.46 101.0 5.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.254 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -55.05 137.01 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.171 -0.956 . . . . 0.0 109.802 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -22.62 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.958 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.32 166.12 1.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.989 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -114.16 145.85 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.0 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.403 ' N ' HG13 ' A' ' 29' ' ' ILE . 3.3 mm? -117.59 -15.77 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.75 140.0 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 178.79 4.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.887 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.79 143.47 28.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 110.183 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.9 21.64 65.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.41 158.28 25.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -1.167 . . . . 0.0 110.118 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 134.56 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.06 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -138.64 146.91 42.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.9 103.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 -7.31 8.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.33 121.8 36.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.855 -1.379 . . . . 0.0 110.376 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.409 HG22 ' CB ' ' A' ' 54' ' ' GLU . 1.3 m -51.11 129.6 24.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.155 -0.966 . . . . 0.0 110.012 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG21 ' N ' ' A' ' 44' ' ' LEU . 31.1 m -124.91 -24.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 111.191 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -139.93 167.53 21.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.883 -1.136 . . . . 0.0 111.091 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 53' ' ' THR . 85.5 t -123.64 121.18 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 109.678 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tt -151.41 140.87 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.0 110.523 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' OG1' ' A' ' 25' ' ' THR . 4.4 pt-20 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' HG12 ' A' ' 55' ' ' ILE . 24.9 p . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.798 0.333 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.409 ' CB ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -52.14 104.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.632 -1.292 . . . . 0.0 110.79 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 53' ' ' THR . 24.3 mm -94.01 90.96 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 37.8 p-10 -49.38 147.04 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.502 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.79 151.68 41.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.979 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' O ' ' CG2' ' A' ' 59' ' ' THR . 45.1 Cg_endo -72.66 -27.85 14.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.164 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -170.62 -171.86 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.948 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -103.6 144.05 31.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.52 -155.23 26.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -127.49 144.35 51.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.093 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 39.4 t -76.18 100.88 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 110.111 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.73 -15.37 63.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.743 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER 177.24 161.1 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' CG2' HG12 ' A' ' 63' ' ' VAL . 92.5 t -131.51 129.44 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD13 ' CG1' ' A' ' 68' ' ' VAL . 3.1 pp -109.9 -28.04 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.979 . . . . 0.0 110.641 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 67' ' ' LEU . 35.4 m -78.84 -176.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.051 -1.031 . . . . 0.0 110.306 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.2 155.53 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -50.95 165.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER 74.09 -42.63 0.51 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.538 -0.726 . . . . 0.0 111.949 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.41 129.06 30.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 25' ' ' THR . . . -165.12 -156.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.377 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 84.6 t 57.4 115.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.607 0.718 . . . . 0.0 111.196 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 51.88 93.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.622 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.05 -136.34 0.25 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.12 7.07 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.46 140.54 33.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.184 . . . . 0.0 110.015 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.19 148.07 5.54 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mt -91.51 -70.76 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -1.107 . . . . 0.0 110.268 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -152.29 154.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 110.099 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.61 130.27 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.18 22.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 17' ' ' GLU . . . -64.56 -124.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -120.61 -25.85 5.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.15 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.79 64.93 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLY . 1.8 pm0 -129.59 166.95 18.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.47 104.55 47.51 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.92 138.23 30.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.587 1.309 . . . . 0.0 110.27 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.17 148.69 35.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 110.33 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.43 -24.09 19.63 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.679 1.358 . . . . 0.0 110.171 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.79 96.64 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 109.911 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.95 -62.41 1.59 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.209 -0.932 . . . . 0.0 110.004 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.89 -170.02 34.34 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 80.34 8.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.33 114.48 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.3 m -111.58 -36.46 5.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 142.85 31.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -107.26 113.4 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 110.051 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.33 -25.49 42.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.537 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.3 161.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.421 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -134.82 -167.89 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -94.66 133.73 38.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.048 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.41 -1.61 88.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.51 137.4 32.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.33 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -85.93 124.47 32.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.547 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 m -102.55 -175.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.937 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 16.6 mmtt -139.45 164.72 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.8 98.8 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.86 19.31 6.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -106.18 118.94 37.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.1 -1.235 . . . . 0.0 109.902 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -49.08 128.12 15.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.972 -1.08 . . . . 0.0 110.659 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' N ' ' A' ' 44' ' ' LEU . 17.9 m -128.76 -31.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.717 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -125.57 161.34 27.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 0.0 110.733 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' THR . 41.4 t -132.07 126.36 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.264 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -134.07 167.36 20.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 88.6 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.622 0.248 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' N ' HG21 ' A' ' 53' ' ' THR . 33.6 mt-10 -50.53 114.42 1.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.586 -1.321 . . . . 0.0 111.303 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.447 ' CD1' HD22 ' A' ' 46' ' ' LEU . 13.7 mm -106.79 99.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.81 134.57 55.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.565 -0.709 . . . . 0.0 110.458 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 154.96 4.54 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.04 -38.9 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.693 1.365 . . . . 0.0 110.539 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.73 149.68 28.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.4 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.435 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 2.6 p30 -65.49 153.1 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.68 161.54 10.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -84.3 142.52 30.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -1.084 . . . . 0.0 110.205 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.73 131.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.213 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -91.45 -15.32 29.05 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.457 -0.777 . . . . 0.0 109.801 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt 179.55 166.64 1.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.214 -0.929 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.1 105.9 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.29 -28.13 14.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.962 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.59 155.26 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -135.17 159.62 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.633 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.7 74.33 6.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.92 -36.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.818 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -51.96 107.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.29 124.63 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.689 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 57.43 113.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.702 -0.624 . . . . 0.0 110.78 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -153.68 -77.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.988 -1.07 . . . . 0.0 111.298 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.3 132.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.85 2.22 39.66 Favored Glycine 0 N--CA 1.491 2.306 0 O-C-N 121.09 -1.241 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.95 146.59 50.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.804 -1.41 . . . . 0.0 110.244 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.39 141.45 45.94 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.85 -48.86 8.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.325 -1.103 . . . . 0.0 110.002 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.6 pt -149.07 152.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 110.173 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 157.87 36.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.9 tt -162.88 149.78 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.16 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.24 0.543 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.25 -155.49 6.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.13 127.94 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -1.108 . . . . 0.0 110.236 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.34 -57.23 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.75 162.12 19.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -1.205 . . . . 0.0 110.197 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 pt -133.19 135.56 25.82 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.42 155.97 54.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.615 1.324 . . . . 0.0 110.688 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 131.24 52.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.09 -19.9 17.21 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.54 1.284 . . . . 0.0 110.625 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -129.79 148.76 51.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -85.44 166.11 16.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -179.89 40.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 m -113.62 127.36 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.17 139.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 109.891 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 m -134.98 -39.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.7 148.46 45.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.37 151.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.414 ' CD1' HG22 ' A' ' 45' ' ' VAL . 2.4 mp -129.37 -49.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.499 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.45 143.76 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.272 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -103.85 157.84 16.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.006 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 5.4 pt-20 -83.66 146.6 28.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.12 58.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.15 173.99 6.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.296 . . . . 0.0 110.052 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 7.5 m -106.47 110.22 22.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.45 145.07 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.86 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -100.9 152.66 20.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.206 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 130.68 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.59 21.39 29.13 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.44 121.77 42.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -1.212 . . . . 0.0 110.29 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.9 m -53.57 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' N ' ' A' ' 44' ' ' LEU . 33.8 m -86.07 -21.7 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -149.77 171.27 16.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 30' ' ' LEU . 97.5 t -136.74 140.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.99 170.32 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 110.19 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.5 132.41 49.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 110.217 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -98.9 87.08 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.189 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.6 m-20 -74.09 129.37 37.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.555 -0.716 . . . . 0.0 110.35 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.55 138.99 11.43 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.436 -0.79 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.93 -37.61 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.595 1.313 . . . . 0.0 110.82 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -144.67 149.34 35.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 110.549 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.16 153.0 31.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.21 -166.55 39.75 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.7 tttp -127.61 143.03 51.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 12.8 t -84.06 141.92 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -0.886 . . . . 0.0 110.274 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.4 -11.3 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.571 -0.706 . . . . 0.0 110.263 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.19 107.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 110.079 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -97.6 143.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -118.62 -23.91 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.053 -1.029 . . . . 0.0 110.544 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 80' ' ' LEU . 35.2 m -61.97 163.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 110.166 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -157.63 158.71 36.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.99 68.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -173.62 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.81 149.16 27.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.419 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -127.57 179.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.0 109.874 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 29.2 m 36.22 68.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -75.44 -0.82 21.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -54.97 104.62 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.01 57.53 1.9 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -163.24 138.33 6.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -1.127 . . . . 0.0 110.15 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.13 136.45 34.45 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.447 ' HA ' ' CG1' ' A' ' 68' ' ' VAL . 10.8 mt -102.15 -71.52 0.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.315 -1.109 . . . . 0.0 109.952 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -148.64 152.43 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.79 123.63 34.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.079 -1.013 . . . . 0.0 110.487 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.3 tt -129.74 142.22 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.507 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.266 0.555 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.26 156.02 21.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -54.06 134.59 43.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -1.168 . . . . 0.0 110.314 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 -23.07 37.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -91.87 155.96 17.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.348 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.58 104.71 55.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.4 164.11 35.99 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.567 1.298 . . . . 0.0 110.766 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.56 156.11 70.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.849 . . . . 0.0 110.335 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.51 -36.97 3.45 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.716 1.377 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.26 -53.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.972 . . . . 0.0 110.325 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.62 179.19 4.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . 177.43 160.46 24.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.8 p -115.96 90.83 3.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.174 . . . . 0.0 110.439 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.421 HG23 ' CG2' ' A' ' 68' ' ' VAL . 41.4 t -63.81 136.23 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 109.667 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.4 m -127.39 -30.67 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.013 -1.054 . . . . 0.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.83 159.12 41.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.21 135.26 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.35 -40.2 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.942 . . . . 0.0 109.987 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.02 -170.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 109.804 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -165.78 -45.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.655 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.0 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.15 31.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -54.71 115.32 2.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -1.17 . . . . 0.0 109.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -75.86 95.84 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.17 165.27 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 4.1 mttp -124.42 165.01 18.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.33 110.59 2.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.5 36.9 11.36 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -116.25 114.26 24.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -1.103 . . . . 0.0 110.073 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.4 m -52.58 118.58 3.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.16 -10.5 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.915 . . . . 0.0 110.943 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 160.37 42.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' THR . 89.2 t -109.68 117.19 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.617 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.424 HD21 ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -150.37 134.89 17.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.408 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' N ' HD21 ' A' ' 46' ' ' LEU . 17.9 mt-10 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 110.115 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 120.942 0.401 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.44 98.93 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.892 -1.13 . . . . 0.0 110.552 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -105.54 98.6 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 11.6 m-20 -74.31 133.34 42.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.649 -0.657 . . . . 0.0 110.123 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.84 166.21 0.21 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.369 -0.832 . . . . 0.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -32.89 8.92 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.734 1.386 . . . . 0.0 110.526 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 t -173.39 171.08 4.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.7 p-10 -65.09 131.71 47.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.17 -176.59 43.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.61 142.3 35.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -1.099 . . . . 0.0 110.208 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.13 109.49 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.56 -17.66 60.7 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.704 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 176.87 164.65 0.49 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.257 -0.902 . . . . 0.0 109.998 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.99 88.51 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -42.03 70.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.022 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' CG2' HG23 ' A' ' 26' ' ' VAL . 14.7 p -80.92 147.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -146.38 174.9 10.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.65 76.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.298 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER 179.9 -51.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 110.131 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.66 138.83 40.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.872 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -158.56 158.82 34.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 23.1 m 36.73 49.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.257 0.551 . . . . 0.0 111.7 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -154.03 85.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.72 -172.97 41.13 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.84 -25.75 25.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.25 160.46 14.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -1.155 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.66 171.2 5.81 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -131.84 -58.02 0.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.24 -1.153 . . . . 0.0 110.04 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mp -136.88 146.38 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.192 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -106.15 131.91 52.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.875 . . . . 0.0 110.141 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.62 35.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.234 0.54 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.78 168.17 20.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt -137.15 154.99 50.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 110.268 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -121.02 120.57 35.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.43 38.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 59.06 159.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -137.76 68.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -111.1 132.11 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.167 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.48 -29.27 3.65 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.03 -172.87 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 0.0 110.205 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.32 -127.84 4.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -134.36 28.4 3.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -1.166 . . . . 0.0 110.179 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.43 122.18 11.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 110.193 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.07 -131.78 3.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -125.25 106.48 9.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -1.151 . . . . 0.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.14 -31.23 4.98 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.44 168.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 110.629 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.34 105.03 34.08 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.96 139.55 36.29 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.582 1.306 . . . . 0.0 110.762 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 174.3 3.16 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 0.0 110.297 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.18 -53.34 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.722 1.38 . . . . 0.0 110.384 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 mt -151.84 -49.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -175.35 177.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 48' ' ' ALA . . . 177.42 -171.06 43.77 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -126.96 104.8 8.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -1.109 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.4 t -55.95 155.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -128.14 -40.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -174.0 133.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.3 tt -98.48 151.13 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -106.42 -58.76 1.88 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.327 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -70.61 150.9 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 1.3 mttt -118.17 42.59 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.434 ' CG ' ' HA ' ' A' ' 65' ' ' LYS . 13.3 tm-20 59.77 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.616 0.722 . . . . 0.0 110.698 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.74 20.29 66.1 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.45 136.54 52.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.965 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -71.84 159.57 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 110.106 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 p -147.01 165.57 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 0.9 OUTLIER -122.64 177.1 5.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.114 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.96 103.33 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.77 -19.02 9.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.22 112.63 2.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.123 -1.222 . . . . 0.0 110.297 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 89.1 m -52.1 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ILE . 59.8 t -57.77 -37.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.844 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.415 HD21 ' CG1' ' A' ' 43' ' ' VAL . 0.7 OUTLIER -167.11 -160.01 0.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.577 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.03 148.16 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.143 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.22 173.68 13.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.058 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -161.79 100.14 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' CB ' ' HA3' ' A' ' 24' ' ' GLY . . . -118.39 -52.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 49.57 0.92 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.43 48.76 16.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 110.0 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.6 ttm -152.33 27.32 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.06 -81.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.965 . . . . 0.0 110.454 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.92 -152.44 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.157 -0.964 . . . . 0.0 110.254 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.25 109.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.211 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 43' ' ' VAL . 48.1 mt -88.82 102.64 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 13.9 p-10 -75.99 138.21 40.77 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.602 0.715 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.23 145.9 33.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.887 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.01 -37.05 3.79 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.593 1.312 . . . . 0.0 110.637 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -155.5 160.91 40.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.5 m-20 -58.49 142.62 48.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.323 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.04 -164.33 37.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -132.03 148.47 52.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -1.133 . . . . 0.0 110.035 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 16.0 t -84.73 138.16 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.51 -25.37 16.88 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.475 -0.766 . . . . 0.0 109.05 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER 179.17 137.47 0.1 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 109.75 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p -93.31 130.37 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.438 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.49 -50.79 4.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.047 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -58.04 163.06 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.209 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -136.15 160.35 38.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.007 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 58.07 28.85 16.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -113.25 112.96 24.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.867 . . . . 0.0 109.824 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -105.09 177.33 4.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 110.602 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 33.6 m 36.84 56.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.294 0.569 . . . . 0.0 111.709 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.405 ' O ' ' CG ' ' A' ' 75' ' ' GLN . 0.5 OUTLIER -136.85 71.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.065 -1.022 . . . . 0.0 110.48 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -116.07 168.85 12.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 -29.61 12.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -102.77 152.51 21.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -1.059 . . . . 0.0 109.914 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.55 136.66 43.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.3 mt -88.83 -51.09 5.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -1.17 . . . . 0.0 110.058 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.99 139.97 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.099 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -93.5 134.81 35.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.414 ' N ' ' HD2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -145.78 147.15 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.151 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.247 0.546 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.44 40.47 3.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 85.73 5.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.81 -178.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.254 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.71 125.27 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.1 p -127.66 -70.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.134 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.44 148.18 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -133.73 131.62 39.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.158 -0.964 . . . . 0.0 110.316 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.46 155.14 24.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 51.38 84.1 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -1.11 . . . . 0.0 110.444 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 57.42 0.09 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -122.21 22.29 10.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -1.157 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.71 -168.63 1.33 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 110.129 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.18 158.26 27.17 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.13 -28.05 66.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -1.09 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.03 -24.14 25.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -80.41 150.51 29.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -1.123 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.9 100.1 53.2 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.956 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.42 164.67 34.92 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.676 1.356 . . . . 0.0 110.956 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 119.8 74.5 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.848 . . . . 0.0 109.984 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.94 0.03 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.45 1.237 . . . . 0.0 111.152 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.54 59.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.829 -1.169 . . . . 0.0 110.389 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' HA ' ' N ' ' A' ' 76' ' ' GLY . . . 49.87 -167.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 110.568 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.77 156.65 7.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.4 m -103.68 108.29 19.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -1.168 . . . . 0.0 110.29 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.37 125.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.73 -46.25 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 110.569 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.16 152.8 13.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.008 . . . . 0.0 110.137 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' CG2' HD13 ' A' ' 44' ' ' LEU . 21.5 pt -118.76 135.35 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.152 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 mp -92.29 -3.16 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.417 ' CG2' HG23 ' A' ' 63' ' ' VAL . 12.0 p -93.8 151.64 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.79 153.3 44.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.054 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -68.18 131.55 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.132 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.77 16.72 67.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.95 158.7 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -1.2 . . . . 0.0 109.968 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 59.2 m -105.37 129.21 53.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 174.09 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.52 152.6 48.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.52 116.4 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.405 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.94 -24.98 9.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.41 122.66 24.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.436 HG22 ' CB ' ' A' ' 54' ' ' GLU . 5.0 m -59.05 104.59 0.25 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.178 -0.951 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.417 HG12 ' CB ' ' A' ' 57' ' ' ALA . 23.8 m -91.0 -15.09 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.59 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.432 HD13 ' CG2' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -145.14 160.32 41.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.191 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.52 122.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 mt -113.89 172.91 6.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -139.54 129.32 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 110.373 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.95 139.83 22.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.82 39.73 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 tttt 52.96 46.82 26.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.73 -179.69 5.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.3 136.66 44.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.145 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -126.29 74.68 1.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.408 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' CB ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -54.25 129.92 36.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -101.71 90.35 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.36 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 24.6 p-10 -65.38 141.42 58.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 43' ' ' VAL . . . -52.58 150.58 9.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.166 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.31 -31.48 11.56 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.675 1.355 . . . . 0.0 110.497 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 t -174.69 166.25 3.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.04 123.47 18.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.16 170.57 38.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HG2' ' N ' ' A' ' 63' ' ' VAL . 11.1 ttmt -104.93 152.86 22.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 ' N ' ' HG2' ' A' ' 62' ' ' LYS . 15.1 t -71.92 143.91 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 110.152 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.05 -17.98 11.32 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.44 117.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.164 -0.96 . . . . 0.0 110.387 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -100.89 132.67 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.117 -0.99 . . . . 0.0 109.852 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.18 -21.81 9.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.045 -1.034 . . . . 0.0 110.723 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 7.5 p -59.86 148.83 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.82 145.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.42 76.13 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 177.83 -45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.305 -0.872 . . . . 0.0 110.1 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -55.3 128.13 32.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.277 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -140.68 164.65 29.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 85.1 t 56.44 164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.789 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.44 111.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.389 -0.819 . . . . 0.0 110.877 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -101.3 -159.78 27.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.91 -19.2 55.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -92.68 138.51 31.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -1.213 . . . . 0.0 110.421 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.58 177.03 0.36 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -135.5 -65.9 0.59 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.75 142.37 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -100.42 120.83 40.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.86 128.55 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.884 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.309 0.576 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 59.67 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.25 -50.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.96 . . . . 0.0 110.309 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -117.48 124.13 48.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.8 -61.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.1 m -159.54 31.2 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.2 m -119.93 -20.45 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 54.83 77.56 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.53 -174.44 43.85 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.51 -55.13 2.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 135.69 0.14 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -88.04 88.4 7.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.163 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.77 161.9 28.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.73 -107.26 3.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.4 tt0 -140.33 104.31 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -1.151 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.93 -39.53 2.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -54.66 157.48 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -1.093 . . . . 0.0 110.476 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.13 104.63 52.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 109.928 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.18 136.74 29.95 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.585 1.308 . . . . 0.0 110.533 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.54 139.2 97.68 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 0.0 110.242 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.76 -24.13 13.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.61 1.321 . . . . 0.0 110.623 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -131.51 166.24 21.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 75' ' ' GLN . . . -75.06 174.92 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.299 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.3 179.36 39.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.1 m -133.42 137.32 45.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 110.156 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.9 t -69.67 118.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.303 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.69 -28.63 19.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.69 126.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tt -81.48 150.34 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 -38.38 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.171 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.13 176.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.412 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.35 46.01 1.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.321 -0.862 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 1.4 tt0 59.82 155.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.26 28.22 42.09 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.61 124.73 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.164 . . . . 0.0 110.288 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.8 m -69.64 149.93 47.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.7 161.51 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 ttmm -115.48 155.27 27.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.95 109.94 1.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.211 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 28.73 4.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -118.16 115.24 24.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -1.214 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 87.0 m -54.42 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 55' ' ' ILE . 20.5 m -69.07 -22.65 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -161.22 172.3 16.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.493 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.36 130.55 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.034 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 -177.8 3.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 50' ' ' LYS . 1.0 OUTLIER 52.82 -176.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.3 -62.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.318 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -30.72 16.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HB2' ' CG ' ' A' ' 47' ' ' GLU . 37.4 mttt -69.87 -52.64 23.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.162 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.4 tpp -175.79 117.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.111 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.12 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.0 110.07 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.4 m -80.26 134.8 36.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.373 -0.829 . . . . 0.0 110.471 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.7 103.46 14.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 43' ' ' VAL . 41.0 mm -68.85 91.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.553 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -77.24 131.41 38.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.434 -0.791 . . . . 0.0 110.238 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.2 156.41 1.4 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 -37.92 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.694 1.365 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -158.8 178.3 10.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.18 132.12 38.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.85 -135.44 3.09 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -154.41 150.13 27.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.272 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 9.1 t -64.25 142.11 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.053 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -115.6 -18.38 10.91 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.843 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 3.4 tmtm? 179.24 89.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 12.6 p -79.8 117.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.974 . . . . 0.0 110.202 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pp -96.93 -25.71 15.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.79 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.293 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -132.16 160.19 36.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.34 153.58 43.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.917 . . . . 0.0 110.224 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 55.13 21.63 4.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.313 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.05 87.32 2.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.163 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.22 149.09 13.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.0 164.12 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.114 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.412 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -106.15 -179.21 3.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.48 129.56 10.54 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 35.42 2.24 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.19 126.32 26.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -1.148 . . . . 0.0 110.14 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.91 151.17 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.8 mt -118.58 -64.21 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -1.115 . . . . 0.0 110.203 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.31 133.64 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.198 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -82.45 143.66 31.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.403 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.2 tt -164.82 161.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.547 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -74.86 -59.09 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.196 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 mt -111.7 -171.03 1.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 110.332 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -132.18 -54.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.904 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t 61.14 137.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.525 0.678 . . . . 0.0 110.571 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.5 p -99.14 37.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 110.018 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.46 19.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.43 146.12 23.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 110.157 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.25 155.35 6.81 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.66 131.66 52.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 110.202 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.59 -75.41 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.39 177.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -1.213 . . . . 0.0 110.106 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.54 -168.86 1.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 110.545 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.95 -168.53 17.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.06 78.45 3.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -1.186 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.79 -20.88 1.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.53 170.49 9.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -1.166 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.45 132.14 24.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 109.97 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.36 131.71 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.51 1.268 . . . . 0.0 110.639 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.48 137.27 69.66 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.4 113.93 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.582 1.306 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 4.5 mm? 49.45 48.95 20.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 -154.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 0.0 110.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.06 172.46 14.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.5 p -112.49 112.22 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.18 112.31 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.982 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.6 -9.25 12.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.715 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -168.46 151.24 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.983 -1.073 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.25 145.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.39 -42.31 4.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.118 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.6 p -71.76 165.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.204 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -140.92 163.21 33.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 9.3 pt-20 -68.46 135.42 51.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.0 22.69 68.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.21 130.02 55.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.7 m -75.43 118.56 18.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.058 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.5 p -98.19 151.49 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.437 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 156.07 21.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 109.99 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 121.42 14.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -5.67 44.55 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.496 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ALA . 1.5 tt0 -85.5 123.64 31.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.819 -1.401 . . . . 0.0 110.441 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.2 m -55.68 102.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.285 -0.884 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 57' ' ' ALA . 35.4 m -81.48 -23.0 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -154.2 162.97 40.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.613 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.94 125.26 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.91 168.03 10.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 82.14 1.98 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 110.291 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.07 -157.92 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 0.0 110.113 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -57.81 -23.05 50.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -67.19 -14.63 63.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.887 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 57.3 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.074 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 57.16 74.31 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -96.23 132.08 42.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.248 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' CG ' HG22 ' A' ' 42' ' ' THR . 0.8 OUTLIER -95.25 113.58 25.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.25 94.2 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.324 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 3.7 m-20 -66.67 148.79 51.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.407 0.622 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . . . -65.19 146.47 98.93 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.51 -0.744 . . . . 0.0 110.352 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.09 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.703 1.37 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.75 150.5 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.98 147.99 52.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.175 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.5 -164.22 37.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -125.65 142.3 51.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -1.107 . . . . 0.0 110.251 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 18.7 t -80.06 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.019 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.58 -15.11 13.1 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.569 -0.707 . . . . 0.0 109.851 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.09 131.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.104 -0.998 . . . . 0.0 110.163 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.31 150.69 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.12 -58.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' OD2' ' A' ' 72' ' ' ASP . 41.3 t -84.54 154.94 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 71' ' ' ARG . 9.1 mmtt -135.33 166.01 24.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 4.4 mt-10 -63.79 80.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -176.88 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' OD2' ' CG1' ' A' ' 68' ' ' VAL . 15.8 p-10 -52.7 125.03 15.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -122.2 158.68 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.204 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 26.7 m 36.6 42.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 121.285 0.564 . . . . 0.0 111.694 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.883 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.46 150.12 19.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.68 14.88 64.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -99.34 150.25 22.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.287 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.47 106.28 1.57 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mt -55.73 -79.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -1.156 . . . . 0.0 110.126 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.5 mt -144.54 160.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -88.47 132.61 34.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.067 -1.02 . . . . 0.0 110.126 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.78 33.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.594 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.329 0.585 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -125.78 147.28 49.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.03 -177.78 3.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.136 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 147.02 23.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.86 103.28 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.8 m -88.09 -25.42 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 p -91.35 163.84 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -91.45 156.38 17.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 110.313 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.2 -157.8 10.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 54.65 -160.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -1.195 . . . . 0.0 110.152 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' ALA . . . 110.45 74.81 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 tptt 55.24 -88.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.483 -1.01 . . . . 0.0 110.384 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . -158.3 152.82 24.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.253 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.72 170.17 13.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.17 107.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.12 -24.73 5.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -94.64 158.2 15.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -1.143 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.54 111.64 27.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.033 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 45.8 Cg_endo -72.42 157.92 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.513 1.27 . . . . 0.0 110.793 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -95.77 112.49 59.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.167 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.92 -3.71 14.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.55 1.289 . . . . 0.0 111.28 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.18 33.2 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 110.725 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.89 -157.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.139 -0.975 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.84 -159.17 20.62 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.23 -146.83 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -1.176 . . . . 0.0 110.115 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 m -47.68 -31.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.049 -1.032 . . . . 0.0 111.147 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p 57.18 39.49 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -66.43 101.15 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.428 ' CG1' HG21 ' A' ' 31' ' ' VAL . 5.5 tt -62.3 115.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.457 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.4 mt -69.9 -26.75 64.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.944 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' CG1' ' A' ' 29' ' ' ILE . 23.4 m -98.98 -158.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.177 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.84 -178.45 6.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.49 151.81 27.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 110.075 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.72 5.13 83.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.49 167.65 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.002 -1.293 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.426 HG21 ' N ' ' A' ' 37' ' ' VAL . 98.9 m -103.75 156.53 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.327 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.426 ' N ' HG21 ' A' ' 36' ' ' THR . 7.7 p -137.85 167.76 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.35 160.1 34.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 121.48 15.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.303 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.27 44.95 6.04 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -132.34 110.11 10.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.139 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 93.8 m -53.07 114.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.72 -12.9 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.884 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' CD1' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -132.45 166.35 22.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.848 -1.157 . . . . 0.0 110.909 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.4 t -117.82 103.47 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 110.036 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -138.96 137.0 36.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -127.23 106.87 9.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 50' ' ' LYS . . . -144.81 71.14 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 59.04 -83.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.465 -0.772 . . . . 0.0 110.438 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -60.07 -38.34 82.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.503 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 17.6 mmt -88.14 159.64 18.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.176 -0.953 . . . . 0.0 110.34 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -143.17 68.85 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -0.982 . . . . 0.0 110.299 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 52' ' ' GLU . 41.0 m 61.0 -74.74 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.712 -0.618 . . . . 0.0 111.188 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 52' ' ' GLU . 6.2 mt-10 -56.08 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.098 . . . . 0.0 110.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' THR . 16.9 mm -88.48 102.16 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -78.73 127.3 31.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.427 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.2 14.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 110.083 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -51.47 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.652 1.343 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.6 p -139.71 156.06 47.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 29.2 p-10 -62.28 166.51 4.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.75 -161.91 29.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -134.92 143.88 47.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -1.187 . . . . 0.0 109.936 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.48 134.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 110.329 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.83 -11.87 16.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.69 138.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 109.771 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.44 160.55 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' HG ' ' HA2' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -126.36 -67.44 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 110.04 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.42 169.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 110.489 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.158 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' CG ' ' HA ' ' A' ' 28' ' ' LYS . 4.1 tt0 -53.88 134.23 42.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.903 . . . . 0.0 110.441 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 55.83 51.4 12.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.473 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -102.51 -26.35 13.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' C ' ' CG2' ' A' ' 74' ' ' VAL . . . 61.82 142.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.397 -0.815 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 73' ' ' ALA . 14.8 m 34.53 89.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 121.417 0.627 . . . . 0.0 112.139 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.19 64.28 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.102 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.44 154.87 17.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.3 54.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -118.24 163.41 16.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -1.165 . . . . 0.0 110.143 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -58.14 175.81 2.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.7 mt -123.42 -43.03 2.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.5 tt -175.67 143.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.084 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -98.4 126.35 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.69 113.29 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.525 -179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.224 0.535 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -70.3 62.07 0.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.14 172.56 18.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.255 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -122.6 171.48 9.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.248 -0.908 . . . . 0.0 110.299 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 6' ' ' THR . 92.7 t -115.85 81.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 15.1 t 37.99 30.53 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.232 0.539 . . . . 0.0 111.702 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 5' ' ' VAL . 27.7 t 49.17 61.23 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.49 -172.48 3.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.62 -138.16 14.03 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.81 -175.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.254 -1.145 . . . . 0.0 110.384 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.61 24.06 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -151.29 141.62 22.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -1.158 . . . . 0.0 110.308 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.24 169.81 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.56 -125.38 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.42 97.15 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -1.12 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.62 1.15 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -118.23 174.86 5.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.317 -1.108 . . . . 0.0 110.343 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 ' O ' ' CG ' ' A' ' 80' ' ' LEU . 15.6 mm -107.97 100.12 34.34 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.179 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.01 45.78 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.638 1.336 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.51 116.1 61.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.94 -8.03 22.19 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.46 1.242 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.6 tp -150.03 126.13 10.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.999 -1.063 . . . . 0.0 110.285 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.421 ' HB2' ' CA ' ' A' ' 75' ' ' GLN . . . -58.74 178.35 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . 151.19 -149.52 21.33 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.066 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.441 ' CA ' ' HB2' ' A' ' 73' ' ' ALA . 31.0 p -137.46 100.01 4.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.442 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 59.1 t -50.28 100.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.013 -1.055 . . . . 0.0 110.291 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 t -57.44 -41.02 79.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -173.12 156.64 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 68' ' ' VAL . 3.6 tt -96.42 136.3 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.348 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -103.43 -25.81 13.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' CG2' HG22 ' A' ' 63' ' ' VAL . 9.2 p -87.15 153.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' N ' HG21 ' A' ' 31' ' ' VAL . 2.8 tptp -123.29 149.21 45.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.208 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -69.85 136.12 50.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.64 24.13 59.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.35 143.43 51.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -1.09 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -85.67 116.8 24.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.1 p -100.96 154.64 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 110.358 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 145.77 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.41 142.12 33.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.303 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.88 -34.59 5.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.22 123.56 20.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -1.201 . . . . 0.0 110.381 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.436 ' O ' ' CG2' ' A' ' 42' ' ' THR . 8.1 t -57.19 101.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.971 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.449 ' CG1' ' CB ' ' A' ' 57' ' ' ALA . 32.9 m -77.57 -17.39 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 110.449 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HB3' HD11 ' A' ' 55' ' ' ILE . 4.0 mt -152.21 155.61 38.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.077 -1.014 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.83 117.97 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.471 ' CD1' ' CB ' ' A' ' 73' ' ' ALA . 2.4 mm? -102.35 174.56 5.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.457 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.74 117.59 3.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.098 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.36 -80.34 0.56 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.0 ttp -85.38 56.95 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.313 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.53 38.33 27.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -139.35 105.57 5.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.59 109.11 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m -89.87 87.61 7.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.27 132.34 53.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.849 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 46' ' ' LEU . 20.8 mt -107.02 99.68 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.45 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 10.6 p-10 -70.86 137.41 49.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.367 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' CB ' ' CG1' ' A' ' 43' ' ' VAL . . . -56.66 148.32 47.02 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.85 . . . . 0.0 110.068 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.49 -36.11 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.644 1.339 . . . . 0.0 110.504 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -157.31 158.27 35.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 139.23 46.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.18 38.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 139.43 49.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG22 ' CG2' ' A' ' 31' ' ' VAL . 24.5 t -72.43 142.28 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.014 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -105.86 -18.18 14.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.794 . . . . 0.0 109.681 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 156.61 0.55 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -0.976 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 35.8 m -134.63 100.06 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.055 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.08 -15.0 48.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 0.0 110.489 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.402 HG22 ' CD1' ' A' ' 29' ' ' ILE . 30.2 m -46.7 153.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 7.66 8.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.657 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 61.27 143.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.957 . . . . 0.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.7 mtp-105 52.53 39.03 27.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -154.53 42.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 46' ' ' LEU . . . -82.12 -4.92 57.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.002 . . . . 0.0 110.439 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 24' ' ' GLY . 29.9 m -44.29 140.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.367 -0.833 . . . . 0.0 111.155 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.421 ' CA ' ' HB2' ' A' ' 23' ' ' ALA . 20.2 tt0 54.12 100.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.454 -0.778 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -168.6 8.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.91 -24.69 27.28 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -79.11 130.69 35.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -1.075 . . . . 0.0 110.158 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.99 157.44 9.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.406 ' CG ' ' O ' ' A' ' 18' ' ' ILE . 32.3 mt -118.68 -64.96 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -1.179 . . . . 0.0 110.216 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 51.6 mt -126.65 156.36 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 146.55 25.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.006 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 6.5 tt -136.59 25.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.56 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.269 0.557 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.96 17.09 24.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.397 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 51.87 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.407 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -92.35 136.97 32.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 35.2 m -143.9 104.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -122.07 36.42 4.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.156 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 8' ' ' ASN . 37.8 t 57.75 160.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.55 -0.719 . . . . 0.0 110.471 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' N ' HG11 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -106.99 102.33 11.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.63 -152.4 0.19 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.16 -158.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 110.225 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.95 54.02 0.46 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.44 -54.78 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -1.153 . . . . 0.0 110.302 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -155.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.87 -122.0 2.88 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 -57.62 2.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -1.133 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.54 -5.69 89.21 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -78.1 135.24 37.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.311 . . . . 0.0 110.375 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.48 109.84 34.66 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.351 -0.843 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HA ' ' HA3' ' A' ' 79' ' ' GLY . 44.4 Cg_endo -72.15 152.51 56.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.495 1.261 . . . . 0.0 110.641 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.76 122.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.154 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.87 -17.62 25.32 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.481 1.253 . . . . 0.0 110.43 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.95 138.67 42.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.96 141.24 28.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.106 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.39 158.64 23.51 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 47' ' ' GLU . 1.1 p -121.11 104.83 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -1.132 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 72' ' ' ASP . 7.5 p -47.38 168.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -0.898 . . . . 0.0 110.902 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' A' ' 26' ' ' VAL . 25.7 t -149.69 -42.19 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 109.878 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -160.24 119.42 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tt -81.76 151.73 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.76 -38.01 5.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.104 -0.997 . . . . 0.0 110.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' CG2' HG11 ' A' ' 43' ' ' VAL . 35.9 m -123.41 168.35 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.284 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -121.38 -162.58 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -82.99 140.56 32.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 110.28 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.82 49.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 172.38 7.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.093 -1.239 . . . . 0.0 110.41 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.6 m -116.93 133.58 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -125.56 152.56 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 110.273 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -110.78 163.91 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.386 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 107.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.257 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.99 -0.72 31.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -90.25 127.26 36.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.334 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 3.4 m -54.13 135.6 43.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 57' ' ' ALA . 97.2 t -118.6 -38.17 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.94 159.34 43.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.792 . . . . 0.0 110.544 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.03 116.79 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.954 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.39 153.57 19.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 25' ' ' THR . 17.2 tt0 -106.77 141.02 38.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.076 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.64 -157.24 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.9 mtp -52.59 -26.98 14.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -6.48 57.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.864 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.9 ttp 56.33 19.57 4.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.036 -1.04 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.49 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 109.931 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 m -121.1 98.45 5.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 110.481 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.64 128.77 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.8 81.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.246 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 2.0 m120 -72.58 133.93 44.95 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.545 0.688 . . . . 0.0 110.654 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 43' ' ' VAL . . . -49.97 143.7 11.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 110.456 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.25 -32.44 6.63 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.655 1.345 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -145.08 162.25 37.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.27 133.5 38.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.42 173.83 35.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -90.99 152.63 20.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -1.131 . . . . 0.0 110.153 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.18 128.67 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -109.25 -1.33 18.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.448 -0.783 . . . . 0.0 110.319 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.86 139.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.01 89.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -58.1 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.509 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.92 137.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -163.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 0.0 109.759 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 8.3 tt0 -91.69 131.63 36.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 110.133 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.437 ' N ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 71.53 2.96 4.48 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.595 -0.69 . . . . 0.0 111.189 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.456 ' N ' HG13 ' A' ' 26' ' ' VAL . 4.6 m-20 -98.39 84.54 3.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.0 109.702 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.34 155.96 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.224 -0.922 . . . . 0.0 110.794 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.51 158.75 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 110.077 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -100.77 152.27 20.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.943 . . . . 0.0 110.398 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.13 138.66 42.46 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.71 -7.37 11.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.91 150.26 38.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.918 -1.343 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -59.09 159.85 17.62 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.422 ' O ' ' CG2' ' A' ' 81' ' ' ILE . 57.5 mt -108.86 -49.68 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.865 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 80' ' ' LEU . 4.8 pt -154.46 150.58 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.835 . . . . 0.0 110.024 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -108.36 139.42 43.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.938 . . . . 0.0 110.368 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 3.7 tt -148.85 44.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.611 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.176 0.512 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -156.22 143.59 19.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.44 54.06 0.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -156.59 120.93 4.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.302 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.07 170.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.264 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 m 53.99 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 110.438 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.7 75.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.152 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -95.82 73.64 3.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.1 -146.6 13.18 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 178.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -1.158 . . . . 0.0 110.392 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.27 34.16 1.09 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -125.86 24.11 7.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 110.226 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -123.9 157.72 33.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.98 -110.59 1.03 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.0 mt-10 -139.45 125.44 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 110.13 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.86 -33.56 5.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -57.23 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.409 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.9 mp -138.84 110.75 7.99 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.079 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.76 137.01 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.539 1.284 . . . . 0.0 110.355 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.11 136.32 53.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.78 -24.55 13.21 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.462 1.243 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.05 139.9 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.32 178.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.977 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -176.83 155.84 19.28 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -99.74 121.31 41.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.362 -1.081 . . . . 0.0 109.979 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.42 136.37 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 110.366 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.5 t -115.62 -31.86 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtmt -172.84 139.94 0.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.083 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.2 tt -101.82 140.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 mt -116.29 -27.14 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.258 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.83 155.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.61 160.37 39.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.888 . . . . 0.0 110.248 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -68.07 122.17 17.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.99 -2.26 55.35 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 126.32 38.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.872 -1.37 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.8 m -64.55 124.03 20.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.46 145.27 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.88 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.47 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.937 . . . . 0.0 110.234 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.16 17.86 23.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 119.55 34.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.149 -1.207 . . . . 0.0 110.189 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 79.5 m -52.65 122.45 9.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.915 . . . . 0.0 110.011 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' CB ' ' A' ' 57' ' ' ALA . 15.4 m -114.33 -23.34 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 171.06 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.977 -1.077 . . . . 0.0 111.058 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.31 117.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 109.397 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.83 149.51 28.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.943 . . . . 0.0 110.815 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -131.62 53.47 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.819 . . . . 0.0 109.966 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.74 -166.4 1.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.888 . . . . 0.0 110.41 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.4 mtt -63.35 -39.8 95.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.416 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -14.83 61.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.6 ttp 54.63 75.52 0.29 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.109 -0.995 . . . . 0.0 110.122 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.4 tp10 -92.27 -34.51 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 52' ' ' GLU . 53.8 m 56.81 -83.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.585 -0.697 . . . . 0.0 111.002 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' GLU . 29.0 mt-10 -58.46 97.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 111.106 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 53' ' ' THR . 26.7 mm -96.12 90.96 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.012 . . . . 0.0 109.5 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 50.5 m-20 -62.63 138.85 58.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' CB ' HG12 ' A' ' 43' ' ' VAL . . . -54.06 167.81 0.5 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.387 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.02 -35.85 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.822 1.433 . . . . 0.0 110.446 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -165.69 -159.41 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.9 147.51 26.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.85 -150.53 22.09 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -129.99 149.06 51.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.94 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.6 t -80.5 110.18 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 110.379 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -78.4 -12.39 60.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.99 174.71 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' A' ' 66' ' ' VAL . 34.7 m -123.64 91.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.53 -30.18 69.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -103.81 142.74 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 110.545 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 -171.64 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 109.992 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.6 154.76 21.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.043 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 58.07 30.55 19.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.896 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.95 67.55 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 173.3 0.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.479 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t 53.55 86.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -131.21 28.09 4.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.155 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.38 132.98 11.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.11 44.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.31 150.01 21.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -1.202 . . . . 0.0 110.152 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.12 149.01 35.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.1 mt -96.57 -68.57 0.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 82' ' ' LYS . 6.1 mt -126.85 146.86 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' N ' HG21 ' A' ' 81' ' ' ILE . 6.4 tptm -88.06 118.93 27.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.491 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.5 pt -146.0 153.36 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.506 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.998 0.427 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 62.94 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.716 -0.615 . . . . 0.0 110.664 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.15 121.66 41.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.052 . . . . 0.0 109.98 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 176.41 6.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.183 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.38 -32.6 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.1 t -60.1 167.53 2.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 110.199 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.52 109.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -59.54 -166.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.119 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.02 -31.15 0.31 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.79 83.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.197 -1.178 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.78 -66.35 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.73 176.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -1.145 . . . . 0.0 110.153 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.39 162.29 14.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.12 -106.23 0.48 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.0 148.47 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.96 58.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.65 166.14 11.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -1.095 . . . . 0.0 110.46 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.67 100.41 19.59 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.858 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.18 121.31 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.742 1.391 . . . . 0.0 110.542 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 80' ' ' LEU . . . -60.79 141.62 92.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -20.56 21.74 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.654 1.344 . . . . 0.0 110.387 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.84 151.43 29.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.66 174.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.304 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.03 153.37 11.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.2 p -106.77 135.33 48.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -1.19 . . . . 0.0 110.22 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -89.9 130.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.427 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -101.8 -23.18 14.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -169.63 165.43 10.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 29' ' ' ILE . 9.5 tt -122.43 145.24 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.01 -54.55 2.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.822 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.2 m -71.53 -171.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.837 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.93 39.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.44 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 17.9 tt0 61.21 142.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.295 -0.878 . . . . 0.0 110.727 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.73 60.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -1.234 . . . . 0.0 109.886 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.7 m -57.61 178.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 110.047 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 38' ' ' LYS . 13.4 p -171.78 164.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 37' ' ' VAL . 10.1 mtmm -122.69 177.45 5.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.28 125.93 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.464 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.51 -22.34 41.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.01 127.73 33.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 0.0 110.407 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.2 m -52.13 137.95 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.931 . . . . 0.0 110.011 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.452 ' CG2' ' CB ' ' A' ' 57' ' ' ALA . 93.7 t -123.49 -36.45 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -142.82 176.28 9.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.135 -0.978 . . . . 0.0 111.076 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.1 t -124.48 145.12 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -149.73 -174.83 4.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.046 . . . . 0.0 110.523 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -168.13 109.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.3 -165.32 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.101 -0.999 . . . . 0.0 110.394 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -35.34 80.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.441 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.99 12.98 13.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.713 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.11 153.23 36.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.791 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -149.48 92.74 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 0.0 111.088 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.457 HG21 ' N ' ' A' ' 54' ' ' GLU . 8.2 t 36.5 -127.61 0.15 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.989 -0.444 . . . . 0.0 111.989 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' HG21 ' A' ' 53' ' ' THR . 1.1 mt-10 -37.69 133.79 0.76 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.302 -0.874 . . . . 0.0 112.237 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' LEU . 35.1 mm -125.69 106.71 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.643 -0.661 . . . . 0.0 109.411 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 76.3 m-20 -57.18 144.1 36.41 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.703 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' CB ' ' CG2' ' A' ' 43' ' ' VAL . . . -62.38 152.38 79.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.71 -33.77 7.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.693 1.365 . . . . 0.0 110.389 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -161.51 151.75 17.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.43 158.49 14.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.59 -144.23 12.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -140.33 158.17 44.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -1.158 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 52.5 t -85.19 119.98 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 84' ' ' GLY . 1.2 mm-40 -90.22 -10.49 44.15 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 109.598 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.1 mttm 179.86 163.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -123.72 95.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 -36.48 75.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.1 t -96.15 128.53 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.204 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 -170.9 2.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.109 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 134.7 34.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 52.14 42.17 30.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -104.25 -23.76 13.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.312 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 60.73 117.17 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.04 -177.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.0 . . . . 0.0 110.339 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.08 162.85 21.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.62 146.43 48.5 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.84 37.16 6.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -146.51 132.05 18.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.74 114.74 4.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.427 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 26.1 mt -70.19 -57.89 4.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.296 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.03 168.78 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.3 143.08 42.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.38 162.6 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.305 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 64' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.531 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.203 0.525 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -81.41 173.0 12.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.51 -173.11 4.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 110.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.63 63.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.084 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.65 90.0 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -153.85 38.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.37 -0.831 . . . . 0.0 110.065 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.55 101.19 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -122.23 -61.08 1.51 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.09 -166.58 15.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 52.95 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.97 -45.12 1.35 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 124.32 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.113 . . . . 0.0 110.259 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.27 -150.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.198 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.74 -133.16 4.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.35 132.35 46.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.43 24.75 59.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.21 159.34 32.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -1.188 . . . . 0.0 110.277 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.7 mt -130.94 99.56 18.03 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.967 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.53 130.28 14.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.734 1.386 . . . . 0.0 110.618 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.55 114.18 36.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -18.59 26.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.468 1.247 . . . . 0.0 110.665 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.0 mt -119.97 9.27 11.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.68 -150.32 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 0.0 110.402 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.62 176.69 16.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.406 ' N ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -121.23 108.96 14.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -1.136 . . . . 0.0 110.009 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.3 136.35 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -40.21 3.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.248 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.69 139.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 tt -81.73 149.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.16 -45.57 4.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.152 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.4 m -101.91 -158.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -148.98 179.25 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 146.41 53.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.37 87.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.12 146.48 26.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.3 . . . . 0.0 110.163 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.7 m -97.83 107.26 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -81.25 158.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.86 155.42 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' THR . . . -60.34 109.43 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.371 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.8 34.43 5.73 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -125.04 114.52 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.153 . . . . 0.0 110.084 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 90.7 m -49.16 113.77 0.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.221 -0.924 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 44' ' ' LEU . 12.0 p -107.95 -26.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.838 . . . . 0.0 110.625 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' N ' HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -142.78 175.44 9.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.137 -0.977 . . . . 0.0 111.163 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 53' ' ' THR . 57.5 t -116.17 142.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.948 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 47' ' ' GLU . 21.7 tp -134.72 159.22 41.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.015 . . . . 0.0 110.731 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 34.8 tt0 -154.47 72.6 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.979 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.04 69.7 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp 59.0 16.64 4.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.303 -0.873 . . . . 0.0 110.562 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -126.89 -11.55 5.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.783 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.7 ttt 53.56 23.85 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.038 -1.038 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -40.94 64.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 109.616 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 54.6 m 52.1 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.558 -0.714 . . . . 0.0 110.773 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.9 105.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.717 -1.24 . . . . 0.0 110.949 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 46' ' ' LEU . 26.2 mm -103.76 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 18.4 p-10 -69.81 135.38 49.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.638 -0.664 . . . . 0.0 110.726 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.43 175.3 0.13 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 110.175 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' O ' ' CG2' ' A' ' 59' ' ' THR . 49.0 Cg_endo -76.51 -48.99 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.762 1.401 . . . . 0.0 110.768 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -163.42 -167.66 1.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 124.86 26.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.412 ' HA2' ' CG2' ' A' ' 83' ' ' ILE . . . -179.87 169.9 40.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -107.62 151.43 25.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.84 106.85 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.997 . . . . 0.0 110.453 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -84.33 -10.79 57.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt 178.19 157.3 0.43 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.119 -0.988 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.39 94.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -70.37 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.498 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.48 166.12 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -118.5 -176.25 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.52 145.5 26.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 57.89 33.62 23.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.64 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.38 145.74 8.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.226 -0.922 . . . . 0.0 110.48 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.09 158.59 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 110.094 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -98.8 24.79 7.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.912 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.52 172.1 37.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.19 34.33 88.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.47 130.03 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -1.117 . . . . 0.0 110.157 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.33 111.25 2.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.1 mt -67.9 -70.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.333 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 44' ' ' LEU . 72.3 mt -132.5 160.61 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -102.35 117.92 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.412 ' CG2' ' HA2' ' A' ' 61' ' ' GLY . 70.8 mt -118.88 38.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.219 0.533 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -137.9 49.06 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 110.153 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -102.4 -28.56 12.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.357 -0.84 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm 54.91 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 110.307 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 3' ' ' LEU . 29.4 m -137.02 28.67 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.938 -1.101 . . . . 0.0 110.05 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -100.39 145.54 28.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.174 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.84 147.5 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -155.63 90.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 110.364 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.6 127.68 4.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 165.96 17.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.109 . . . . 0.0 110.107 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.49 -95.28 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -131.52 121.21 24.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -1.113 . . . . 0.0 110.223 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.54 155.89 6.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.4 -179.19 26.89 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.4 141.53 51.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -1.175 . . . . 0.0 110.231 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.59 -51.59 4.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.02 132.63 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.341 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.97 120.07 51.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 154.27 53.22 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.409 1.215 . . . . 0.0 110.672 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.5 94.52 11.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.54 -5.63 17.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.735 1.387 . . . . 0.0 111.056 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.09 3.24 35.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.064 -1.023 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.11 178.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.936 -1.103 . . . . 0.0 110.188 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.51 172.06 31.51 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.6 p -101.14 112.73 25.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -1.123 . . . . 0.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -80.63 97.51 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.857 . . . . 0.0 109.983 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -41.76 11.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.298 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.28 170.87 4.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.26 124.03 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.127 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.78 -60.73 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.52 -115.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.097 -1.002 . . . . 0.0 109.812 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 tttp 53.96 50.45 16.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.401 -1.437 . . . . 0.0 110.196 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.05 103.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -0.82 . . . . 0.0 109.803 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.6 22.11 61.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 140.04 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 110.12 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 51.7 m -76.95 88.28 3.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' HA ' ' NE2' ' A' ' 41' ' ' GLN . 27.7 m -67.04 -171.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 15.7 ttpp -147.64 155.87 42.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.053 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.15 93.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -0.958 . . . . 0.0 110.397 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.45 34.07 1.65 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -115.18 109.04 17.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 110.362 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.437 HG22 ' CB ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -52.22 109.8 0.42 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.02 -4.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 111.226 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -131.05 164.21 25.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 110.658 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' CG1' HG21 ' A' ' 53' ' ' THR . 81.7 t -123.33 108.16 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.441 ' HB2' ' CG1' ' A' ' 55' ' ' ILE . 1.4 mm? -125.15 154.63 41.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -144.12 69.24 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.301 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.32 139.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -0.937 . . . . 0.0 110.423 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.5 78.32 0.17 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.328 -0.858 . . . . 0.0 110.865 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptt 51.64 61.71 3.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.27 -0.894 . . . . 0.0 111.015 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.26 95.4 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.737 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 mt-10 -87.14 53.88 2.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.812 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.428 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.4 m 65.7 -64.99 0.18 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.37 -0.831 . . . . 0.0 111.046 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' CB ' HG22 ' A' ' 42' ' ' THR . 2.9 mp0 -56.57 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 111.08 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 46' ' ' LEU . 20.8 mm -99.63 98.43 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.185 -0.947 . . . . 0.0 109.755 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 73.0 m-80 -69.98 131.71 44.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.837 . . . . 0.0 110.136 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 156.07 2.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.39 -49.03 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.701 1.369 . . . . 0.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.5 p -138.97 -172.5 3.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 110.202 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.429 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 6.3 p-10 -101.56 152.44 20.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 159.88 9.04 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 17.4 tttt -85.69 121.09 27.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.129 . . . . 0.0 110.356 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.4 t -54.34 159.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.803 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -118.39 -14.87 9.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.438 -0.789 . . . . 0.0 110.123 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 tttt 179.97 149.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.73 159.5 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 109.558 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.27 -68.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.7 m -48.55 155.12 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.175 -0.953 . . . . 0.0 110.63 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -124.31 148.46 47.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.237 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.0 72.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.79 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.39 145.22 11.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -135.91 135.18 39.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.491 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 73' ' ' ALA . 14.5 p 36.91 48.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.883 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.33 97.87 6.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.09 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.96 156.31 19.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.43 18.27 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.71 155.94 17.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -1.213 . . . . 0.0 110.241 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.97 161.9 23.53 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mt -109.18 -68.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 110.258 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 81' ' ' ILE . 36.3 mm -140.8 148.42 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 91.28 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 pt -125.45 45.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.224 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.571 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.24 0.543 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.39 156.27 19.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.21 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 -25.62 14.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.01 105.42 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -137.27 132.43 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -149.42 129.41 13.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.45 148.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.167 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -102.52 43.99 1.04 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.055 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.51 32.31 1.64 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.75 47.18 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -1.147 . . . . 0.0 110.275 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.98 121.68 4.17 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -162.56 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -1.155 . . . . 0.0 110.467 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.12 -166.24 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.153 -0.967 . . . . 0.0 109.964 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.0 25.88 5.16 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 53.24 25.32 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -1.132 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.79 49.85 0.09 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.48 -176.94 5.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 110.187 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.51 91.51 49.67 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.115 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.41 134.55 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.704 1.371 . . . . 0.0 110.709 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.81 142.62 69.95 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.54 -32.35 9.89 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.609 1.32 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.8 tt -118.73 157.16 28.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HA ' ' N ' ' A' ' 76' ' ' GLY . . . -61.1 176.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 110.546 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -153.52 146.85 15.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.32 -141.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -1.125 . . . . 0.0 110.584 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 71' ' ' ARG . 19.1 m -38.47 -46.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.518 -0.739 . . . . 0.0 112.539 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER 61.01 40.82 14.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.748 -1.22 . . . . 0.0 110.016 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.95 108.39 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 12.2 tt -62.05 120.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.475 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.2 -18.23 29.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.175 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.0 p -91.27 169.77 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.331 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -123.7 159.55 29.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.144 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.72 142.49 53.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.9 . . . . 0.0 110.171 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.45 73.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -110.69 154.72 23.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.102 -1.234 . . . . 0.0 109.874 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 1.4 m -96.73 110.67 23.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.308 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' GLY . 34.5 m -81.92 157.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -120.06 160.44 22.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.294 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . -69.12 99.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.02 46.92 0.85 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -135.34 114.44 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -1.167 . . . . 0.0 109.809 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' CG2' ' A' ' 42' ' ' THR . 12.6 t -55.25 105.12 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.575 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.52 0.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.942 -1.099 . . . . 0.0 110.227 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.81 156.82 42.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.952 -1.093 . . . . 0.0 110.472 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' SER . 93.5 t -119.23 99.84 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.8 tt -105.83 151.0 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' A' ' 48' ' ' ALA . 2.6 tt0 -124.55 159.16 31.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.897 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 47' ' ' GLU . . . -176.42 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.69 52.41 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mttm 49.19 38.35 13.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.171 -0.956 . . . . 0.0 110.583 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.93 134.34 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 110.247 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.52 128.34 36.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.217 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.8 m -102.97 107.64 18.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.1 pt-20 -65.41 103.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' CB ' ' HB3' ' A' ' 44' ' ' LEU . 48.6 mm -77.37 94.05 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 67.3 m-20 -77.31 133.16 38.85 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.629 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.77 170.09 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.29 -54.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.762 1.401 . . . . 0.0 110.812 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 39' ' ' ALA . 1.3 p -153.26 -166.12 2.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.361 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -78.56 123.59 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.395 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 37' ' ' VAL . . . -173.42 -165.95 31.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.8 ttpt -133.27 153.48 51.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.131 -1.217 . . . . 0.0 110.384 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -80.19 125.14 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -88.64 -14.09 38.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.76 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.5 169.06 0.84 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.63 144.91 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -52.62 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 109.95 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.05 154.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 18.0 mttt -94.28 -10.87 31.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -0.976 . . . . 0.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 4.8 tt0 61.61 135.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.21 22.38 7.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.07 . . . . 0.0 109.949 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -115.86 120.62 39.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 109.821 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.87 168.7 11.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' GLY . 19.5 t 60.86 139.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.488 0.661 . . . . 0.0 110.648 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.04 43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.012 -1.055 . . . . 0.0 110.338 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 23' ' ' ALA . . . -101.08 130.89 10.38 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.82 19.37 63.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -131.37 139.83 49.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -1.179 . . . . 0.0 110.14 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.75 140.85 29.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.1 mt -92.1 -47.71 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -1.188 . . . . 0.0 110.002 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.434 HG23 HD11 ' A' ' 81' ' ' ILE . 98.2 mt -137.2 151.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -97.31 145.97 25.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.116 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -147.46 159.08 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.615 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -119.47 -50.47 2.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.282 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.57 147.59 51.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.877 . . . . 0.0 110.286 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.2 -155.94 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 110.019 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -134.41 86.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.0 t -161.78 -40.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.398 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.44 178.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.372 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -160.45 -50.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.63 -156.44 15.82 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.13 -60.63 1.68 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 110.119 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.39 132.25 0.56 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -74.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -1.108 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 53.73 79.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.918 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.96 -106.93 0.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -119.18 -49.36 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.159 . . . . 0.0 109.893 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' CA ' ' HG2' ' A' ' 82' ' ' LYS . . . -95.58 85.28 0.92 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.461 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.7 pm0 -157.96 150.78 22.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -1.079 . . . . 0.0 110.236 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 78.5 mt -111.85 99.38 45.13 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.9 128.35 14.87 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.702 1.369 . . . . 0.0 110.472 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.84 138.05 87.82 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.079 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.46 -13.31 25.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.558 1.294 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.04 153.15 41.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.249 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.03 162.09 9.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.139 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.37 -165.04 34.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.55 149.23 29.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.295 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.0 t -88.69 132.89 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.57 -28.6 12.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 109.923 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.42 153.52 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.8 tt -112.46 149.56 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.478 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.429 HD12 ' CG2' ' A' ' 42' ' ' THR . 0.5 OUTLIER -114.4 -36.0 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.009 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 32' ' ' LYS . 59.6 t -110.04 157.24 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.05 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' N ' HG11 ' A' ' 31' ' ' VAL . 21.2 mmtt -119.83 178.71 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -77.28 131.5 38.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.85 70.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.58 157.02 18.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.317 . . . . 0.0 110.421 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.69 174.7 8.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.919 . . . . 0.0 109.971 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -157.61 166.28 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 110.212 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -122.06 169.57 10.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.42 114.6 18.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.5 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -109.46 119.67 40.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -1.224 . . . . 0.0 110.006 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.429 ' CG2' HD12 ' A' ' 30' ' ' LEU . 88.6 m -53.19 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.374 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 55' ' ' ILE . 41.5 t -64.73 -33.49 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 0.0 109.776 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.03 -177.74 6.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.627 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.94 125.67 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.053 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.74 177.67 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.21 97.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.5 -51.47 2.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mmt -96.78 42.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 110.219 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm 53.23 38.17 26.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 110.206 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.4 ttm -138.99 117.83 12.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -56.91 102.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -91.49 129.8 37.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 110.321 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.79 112.69 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.444 ' O ' ' N ' ' A' ' 43' ' ' VAL . 98.1 mt -82.61 89.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 70.1 m-80 -72.57 135.12 45.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.549 -0.719 . . . . 0.0 110.797 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.441 ' CA ' HG22 ' A' ' 43' ' ' VAL . . . -56.43 154.17 17.57 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.297 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 -46.19 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.746 1.393 . . . . 0.0 110.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.4 m -155.82 169.98 23.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.265 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.66 145.08 56.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 162.66 -156.47 28.17 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -132.2 150.96 52.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.434 HG12 ' CG2' ' A' ' 66' ' ' VAL . 30.2 t -71.87 132.86 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -9.43 20.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.517 -0.739 . . . . 0.0 110.081 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 140.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.06 . . . . 0.0 109.837 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 63' ' ' VAL . 64.3 t -123.67 95.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.463 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.26 -18.07 59.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.103 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.6 t -69.67 143.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 110.342 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.99 15.87 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 110.349 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 61.97 135.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.324 -0.86 . . . . 0.0 110.586 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 32.75 17.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -127.59 116.85 20.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.52 146.21 54.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.16 122.71 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 160.4 30.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.68 51.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 -2.76 30.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -97.79 123.73 41.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.363 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.5 137.68 48.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.5 mt -107.43 -57.87 2.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -1.193 . . . . 0.0 110.352 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.435 ' CD1' HG13 ' A' ' 43' ' ' VAL . 16.4 tt -143.19 170.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 17' ' ' GLU . 8.0 tptp -143.02 172.26 12.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.448 ' N ' ' HG3' ' A' ' 82' ' ' LYS . 3.3 pt -153.39 131.89 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.668 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.213 0.53 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -61.84 -50.95 70.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.53 -25.01 20.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.326 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 tttt 59.94 155.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.347 -0.845 . . . . 0.0 110.267 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.64 123.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p -83.77 144.72 29.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.17 136.7 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 110.142 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -164.05 37.36 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.79 179.88 37.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 150.67 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.76 -74.51 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.66 -58.86 6.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.318 -1.107 . . . . 0.0 110.272 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.86 138.85 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.915 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.39 -115.08 3.63 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -120.65 -35.01 3.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.65 15.42 11.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -97.09 124.24 41.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.255 . . . . 0.0 109.991 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.19 117.2 67.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.357 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.89 134.33 19.68 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.386 1.203 . . . . 0.0 110.385 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' CA ' HD13 ' A' ' 80' ' ' LEU . . . -80.19 125.88 80.49 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.14 141.12 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.441 1.232 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.52 127.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.397 -0.814 . . . . 0.0 110.523 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.93 170.59 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 0.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.41 -177.8 47.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.2 m -133.99 147.16 50.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.85 134.52 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.1 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 p -110.16 -20.67 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.952 . . . . 0.0 110.141 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.93 122.8 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.311 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -83.39 144.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.082 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -119.31 -24.8 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.917 . . . . 0.0 110.632 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -108.12 165.02 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.307 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 169.06 18.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 110.322 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.09 156.98 38.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 23.32 70.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.13 166.14 12.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -1.14 . . . . 0.0 110.075 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -109.11 128.12 54.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.19 158.96 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.402 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' CG ' ' OD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -110.94 179.71 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.87 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.425 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . . . -90.1 124.55 34.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.098 -1.001 . . . . 0.0 110.33 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.33 29.55 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -113.82 122.31 46.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -1.174 . . . . 0.0 110.316 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 24.2 m -56.6 109.91 0.7 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG21 ' N ' ' A' ' 44' ' ' LEU . 34.3 m -95.81 -21.14 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -147.93 173.94 12.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.992 -1.067 . . . . 0.0 111.348 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' THR . 45.7 t -126.2 113.33 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 109.251 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.35 165.46 11.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.01 -1.056 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -144.67 80.05 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.58 -0.7 . . . . 0.0 109.707 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.23 -163.49 0.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 110.264 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.95 52.59 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -168.91 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.342 -0.849 . . . . 0.0 110.009 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 174.44 -73.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.188 -0.945 . . . . 0.0 110.445 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.7 mm-40 54.08 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.897 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 51.9 m 51.67 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.987 . . . . 0.0 111.082 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 52' ' ' GLU . 4.9 tt0 -60.94 102.11 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 111.076 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 55' ' ' ILE . 32.1 mm -103.94 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.941 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 31.3 m120 -73.89 135.28 43.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.42 0.628 . . . . 0.0 110.694 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.35 167.81 0.67 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.09 -52.47 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.761 1.4 . . . . 0.0 110.523 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.28 170.27 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.098 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' CB ' ' A' ' 39' ' ' ALA . 3.6 m-20 -57.88 139.01 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.4 172.35 35.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -109.86 150.06 28.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -1.14 . . . . 0.0 109.974 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -77.81 124.42 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.368 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.39 -6.81 23.56 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 110.003 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -177.87 150.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 109.92 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.62 146.28 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.92 -69.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.5 m -75.46 158.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.051 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -129.69 -165.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 155.26 20.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 55.53 25.86 8.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.27 105.61 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.245 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 137.55 50.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.004 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.9 p -130.23 132.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.74 -177.45 6.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.304 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.07 125.72 7.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.29 0.69 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.15 128.71 9.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.419 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.01 130.55 36.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD13 ' CA ' ' A' ' 20' ' ' ALA . 10.9 mt -92.21 -70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -1.099 . . . . 0.0 109.698 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.3 mm -134.64 145.04 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 0.0 109.833 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.72 137.96 31.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.182 -0.949 . . . . 0.0 110.493 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.95 146.2 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.234 0.54 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 52.74 -166.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.964 . . . . 0.0 110.233 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.18 51.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.3 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.67 96.98 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.2 t -108.47 147.8 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.927 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.6 p 44.26 -153.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.544 -0.723 . . . . 0.0 110.881 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.23 58.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 110.173 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -132.24 126.01 32.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.03 111.24 0.55 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.21 42.48 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -1.109 . . . . 0.0 110.134 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.26 92.55 0.76 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.11 75.24 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.29 154.12 20.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 110.154 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.5 -173.71 44.11 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 135.72 56.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -1.147 . . . . 0.0 110.17 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.61 -19.12 48.76 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' OE2' ' CD ' ' A' ' 82' ' ' LYS . 1.1 mp0 -110.04 127.7 54.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.248 . . . . 0.0 110.508 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.38 111.93 32.24 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.793 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.88 143.35 45.19 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.41 1.216 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 80' ' ' LEU . . . -85.86 135.73 37.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.123 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.58 133.81 17.74 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.592 1.312 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.36 -166.87 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.55 137.88 38.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.254 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.77 169.13 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 132.58 54.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.32 141.32 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 110.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -113.18 -24.45 9.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.52 140.78 0.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.855 . . . . 0.0 110.088 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.0 tt -100.06 134.45 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.343 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.48 -56.18 3.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 m -81.02 -177.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.364 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -145.93 52.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.028 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER 59.85 157.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.08 55.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -106.93 147.92 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.233 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 93.9 m -108.75 123.3 48.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.275 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.81 -175.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.086 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 3.0 ttpt -142.7 49.58 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . 54.75 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.76 -13.32 7.7 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.339 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -77.59 119.94 21.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.05 -1.264 . . . . 0.0 110.555 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.3 m -61.71 103.3 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.035 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 44' ' ' LEU . 34.7 m -86.78 -21.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.3 OUTLIER -151.18 176.84 10.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 67.8 t -134.26 117.98 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.07 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -99.23 157.4 16.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -155.1 115.11 3.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.07 120.54 20.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.5 52.13 10.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.158 -0.964 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.25 55.03 10.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.825 . . . . 0.0 110.781 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -34.62 5.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 55.33 100.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m -130.21 107.33 9.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.39 149.58 42.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.91 86.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.965 . . . . 0.0 110.613 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.2 m-20 -84.31 127.59 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.273 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.01 145.32 5.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 110.277 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -45.22 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.65 1.342 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.437 ' HA ' ' CB ' ' A' ' 39' ' ' ALA . 8.9 t -137.41 158.09 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 110.419 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 4.6 p30 -56.83 160.22 3.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.71 168.76 14.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 21.9 ttpt -109.53 139.56 44.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 16.7 t -64.66 135.45 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.03 . . . . 0.0 109.94 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.19 -17.66 16.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.83 156.06 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.008 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 81' ' ' ILE . 23.9 m -126.72 127.29 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.81 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD13 ' CG2' ' A' ' 68' ' ' VAL . 1.8 pp -104.79 -26.27 12.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.305 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.429 ' CG2' HD13 ' A' ' 67' ' ' LEU . 84.3 t -98.97 150.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -164.87 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -79.75 151.38 30.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 110.148 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.52 39.11 27.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.416 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -100.79 -19.47 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.315 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 72' ' ' ASP . . . 56.33 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.547 -0.721 . . . . 0.0 110.904 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.96 145.33 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.392 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.4 171.53 8.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.24 119.83 18.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 44.51 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 125.35 27.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.78 139.49 39.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 HD12 ' CB ' ' A' ' 20' ' ' ALA . 8.6 mt -107.64 -61.01 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.203 -1.175 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CD1' HG13 ' A' ' 66' ' ' VAL . 11.8 tt -143.56 151.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' CD ' ' OE2' ' A' ' 17' ' ' GLU . 4.5 ttpt -95.23 143.81 26.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.072 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.8 tt -136.07 151.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.888 -1.507 . . . . 0.0 109.573 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -100.94 120.34 40.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.197 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.17 166.78 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.11 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 24.51 1.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.37 119.66 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.153 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.9 p -69.4 105.11 2.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 p -165.22 58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -140.89 -170.15 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.66 -46.23 93.61 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 55.71 -174.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -1.175 . . . . 0.0 110.247 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.17 -61.36 5.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 56.36 70.93 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.287 -1.125 . . . . 0.0 110.481 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 50.5 -164.27 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.312 -0.868 . . . . 0.0 110.537 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.67 -106.74 1.08 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -129.82 158.89 38.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.009 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.06 39.79 92.55 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -135.15 161.33 35.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -1.117 . . . . 0.0 110.335 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mp -118.14 102.69 50.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.12 156.6 55.47 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.656 1.345 . . . . 0.0 110.527 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.23 138.64 34.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.316 -0.865 . . . . 0.0 110.081 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.88 -27.37 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.609 1.321 . . . . 0.0 110.506 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.78 165.69 23.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.08 156.34 21.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.28 -177.42 14.93 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -122.99 -133.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -1.198 . . . . 0.0 110.142 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 71' ' ' ARG . 15.7 m -36.8 -46.32 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.472 -0.768 . . . . 0.0 112.276 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 29' ' ' ILE . 1.3 t 54.95 42.41 31.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 0.0 109.918 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 27' ' ' SER . 13.6 tt -68.09 86.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.04 -41.87 68.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.002 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 32' ' ' LYS . 9.9 p -62.03 164.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.5 ttmt -123.57 169.31 11.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 110.27 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.73 134.39 34.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.51 19.13 57.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.62 179.42 4.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.924 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -122.12 140.25 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.75 175.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.46 161.2 27.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.367 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.38 127.93 33.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.89 . . . . 0.0 110.084 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.56 19.13 45.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -109.36 111.65 23.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.243 . . . . 0.0 109.992 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 54.2 m -51.08 116.09 1.84 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.541 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 44' ' ' LEU . 30.2 m -115.44 -22.56 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.842 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.43 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -131.16 154.77 48.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.2 109.76 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.215 -0.928 . . . . 0.0 110.818 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.5 mt -98.33 147.33 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 0.0 109.953 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.65 59.61 1.45 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.69 110.72 5.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 109.909 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.32 43.64 26.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 110.044 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt 52.94 47.83 23.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.144 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 9.6 mtt -94.39 -18.8 21.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 0.0 110.506 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 53.17 88.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.047 -1.033 . . . . 0.0 109.912 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.1 m -120.32 114.72 22.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.903 . . . . 0.0 110.436 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.408 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -77.85 118.58 20.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 30.7 mm -88.75 90.07 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.575 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.0 p-10 -73.45 132.36 42.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 110.064 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.37 1.93 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.362 -0.836 . . . . 0.0 110.665 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.88 -40.22 1.97 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.569 1.299 . . . . 0.0 110.644 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.4 m -156.09 153.4 29.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.255 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.79 140.94 40.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.45 177.8 39.73 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.19 142.29 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -1.141 . . . . 0.0 110.045 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.8 129.73 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.95 -6.66 35.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 110.362 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -174.84 148.14 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 110.204 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.415 ' N ' ' HG3' ' A' ' 33' ' ' GLU . 7.1 p -105.14 144.49 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.97 -53.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.5 t -53.46 128.21 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 110.061 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -80.15 1.75 26.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 61.95 132.39 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.64 26.38 12.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.077 . . . . 0.0 110.136 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -126.41 120.63 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.18 142.95 24.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.963 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.66 171.39 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.967 -1.083 . . . . 0.0 110.426 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -113.34 -179.23 3.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.79 140.78 15.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.22 20.62 10.9 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -125.97 143.85 50.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.164 . . . . 0.0 110.111 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.04 144.48 49.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.9 mt -104.85 -42.73 5.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 110.25 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 tp -167.72 143.51 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -92.46 147.95 22.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.957 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 83' ' ' ILE . 29.3 pt -133.76 158.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.467 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.257 0.551 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -62.27 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.319 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tt -140.01 101.92 4.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -119.83 -66.53 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.346 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 m -137.67 132.23 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.303 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m 52.93 82.33 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.309 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.4 148.68 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.215 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.38 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.146 -0.971 . . . . 0.0 110.522 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.7 40.82 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.66 104.53 5.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.95 -69.02 0.57 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? 54.0 -160.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -1.127 . . . . 0.0 110.066 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.9 -161.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.988 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.33 59.6 0.53 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 53.65 79.03 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.23 -56.49 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -53.1 143.62 17.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.126 . . . . 0.0 110.362 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.3 mp -113.33 131.87 22.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.34 144.7 37.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.524 1.276 . . . . 0.0 110.577 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.25 74.34 1.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.959 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.54 61.84 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.772 1.406 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.01 -12.46 13.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.62 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 55.01 -174.16 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.054 -1.029 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 -162.48 12.35 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.446 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 10.4 p -130.46 101.0 5.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.254 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.5 m -55.05 137.01 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.171 -0.956 . . . . 0.0 109.802 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -22.62 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.958 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.32 166.12 1.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.989 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -114.16 145.85 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.0 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.403 ' N ' HG13 ' A' ' 29' ' ' ILE . 3.3 mm? -117.59 -15.77 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.75 140.0 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 178.79 4.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.887 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.79 143.47 28.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 110.183 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.9 21.64 65.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.41 158.28 25.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -1.167 . . . . 0.0 110.118 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 134.56 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.06 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -138.64 146.91 42.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.9 103.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 -7.31 8.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.33 121.8 36.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.855 -1.379 . . . . 0.0 110.376 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.409 HG22 ' CB ' ' A' ' 54' ' ' GLU . 1.3 m -51.11 129.6 24.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.155 -0.966 . . . . 0.0 110.012 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG21 ' N ' ' A' ' 44' ' ' LEU . 31.1 m -124.91 -24.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 111.191 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -139.93 167.53 21.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.883 -1.136 . . . . 0.0 111.091 -179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 53' ' ' THR . 85.5 t -123.64 121.18 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 109.678 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tt -151.41 140.87 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.0 110.523 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' OG1' ' A' ' 25' ' ' THR . 4.4 pt-20 -119.56 154.41 33.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.098 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.93 73.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 110.489 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.96 26.35 2.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.376 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' GLU . 6.2 tttt -160.73 29.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 53' ' ' THR . 3.5 mtt 57.04 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.536 -0.727 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' LYS . 1.1 mt-10 62.86 -77.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 51' ' ' MET . 24.9 p 44.77 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.655 -0.653 . . . . 0.0 111.109 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 52' ' ' GLU . 0.8 OUTLIER -52.14 104.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.632 -1.292 . . . . 0.0 110.79 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 53' ' ' THR . 24.3 mm -94.01 90.96 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 37.8 p-10 -49.38 147.04 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.502 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.79 151.68 41.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.979 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' O ' ' CG2' ' A' ' 59' ' ' THR . 45.1 Cg_endo -72.66 -27.85 14.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.164 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -170.62 -171.86 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.948 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -103.6 144.05 31.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.52 -155.23 26.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -127.49 144.35 51.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.093 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 39.4 t -76.18 100.88 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 110.111 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.73 -15.37 63.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.743 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER 177.24 161.1 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' CG2' HG12 ' A' ' 63' ' ' VAL . 92.5 t -131.51 129.44 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD13 ' CG1' ' A' ' 68' ' ' VAL . 3.1 pp -109.9 -28.04 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.979 . . . . 0.0 110.641 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 67' ' ' LEU . 35.4 m -78.84 -176.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.051 -1.031 . . . . 0.0 110.306 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.2 155.53 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -50.95 165.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER 74.09 -42.63 0.51 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.538 -0.726 . . . . 0.0 111.949 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.41 129.06 30.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 25' ' ' THR . . . -165.12 -156.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.377 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 84.6 t 57.4 115.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.607 0.718 . . . . 0.0 111.196 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 51.88 93.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.622 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.05 -136.34 0.25 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.12 7.07 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.46 140.54 33.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.184 . . . . 0.0 110.015 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.19 148.07 5.54 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mt -91.51 -70.76 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -1.107 . . . . 0.0 110.268 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -152.29 154.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 110.099 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.61 130.27 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.18 22.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 tttt 52.97 53.91 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -60.13 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.089 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 130.67 5.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.31 125.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.559 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 p -123.18 169.97 10.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 t 60.05 151.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.426 -0.796 . . . . 0.0 110.406 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 53.35 75.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.06 -108.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.5 170.61 7.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -1.127 . . . . 0.0 110.292 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.09 -154.59 6.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -115.1 37.85 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -1.118 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.5 113.51 25.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 17' ' ' GLU . . . -64.56 -124.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -120.61 -25.85 5.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.15 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.79 64.93 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLY . 1.8 pm0 -129.59 166.95 18.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.47 104.55 47.51 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.291 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.92 138.23 30.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.587 1.309 . . . . 0.0 110.27 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.17 148.69 35.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 110.33 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.43 -24.09 19.63 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.679 1.358 . . . . 0.0 110.171 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.79 96.64 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 109.911 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -49.95 -62.41 1.59 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.209 -0.932 . . . . 0.0 110.004 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.89 -170.02 34.34 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 80.34 8.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.33 114.48 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.3 m -111.58 -36.46 5.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 142.85 31.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -107.26 113.4 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 110.051 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.33 -25.49 42.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.537 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.3 161.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.421 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -134.82 -167.89 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.901 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -94.66 133.73 38.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.048 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.41 -1.61 88.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.51 137.4 32.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.33 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -85.93 124.47 32.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.547 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 m -102.55 -175.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.937 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 16.6 mmtt -139.45 164.72 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.8 98.8 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.86 19.31 6.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -106.18 118.94 37.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.1 -1.235 . . . . 0.0 109.902 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -49.08 128.12 15.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.972 -1.08 . . . . 0.0 110.659 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' N ' ' A' ' 44' ' ' LEU . 17.9 m -128.76 -31.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.717 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -125.57 161.34 27.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 0.0 110.733 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' THR . 41.4 t -132.07 126.36 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.264 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.447 HD22 ' CD1' ' A' ' 55' ' ' ILE . 1.0 OUTLIER -134.07 167.36 20.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.4 88.2 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.87 155.16 0.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -0.923 . . . . 0.0 109.694 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.2 mmt 51.56 90.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' GLU . 21.9 mtmt 56.58 26.19 10.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 50' ' ' LYS . 0.8 OUTLIER 65.58 -63.28 0.21 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.707 -0.62 . . . . 0.0 110.935 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' LYS . 1.1 tp10 67.76 -65.15 0.25 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.24 -0.913 . . . . 0.0 109.88 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 88.6 m 52.45 -103.46 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 110.585 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' N ' HG21 ' A' ' 53' ' ' THR . 33.6 mt-10 -50.53 114.42 1.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.586 -1.321 . . . . 0.0 111.303 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.447 ' CD1' HD22 ' A' ' 46' ' ' LEU . 13.7 mm -106.79 99.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.81 134.57 55.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.565 -0.709 . . . . 0.0 110.458 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 154.96 4.54 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.04 -38.9 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.693 1.365 . . . . 0.0 110.539 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.73 149.68 28.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.4 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.435 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 2.6 p30 -65.49 153.1 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.68 161.54 10.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -84.3 142.52 30.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -1.084 . . . . 0.0 110.205 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.73 131.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.213 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -91.45 -15.32 29.05 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.457 -0.777 . . . . 0.0 109.801 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt 179.55 166.64 1.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.214 -0.929 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.1 105.9 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 109.909 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.29 -28.13 14.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.962 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.59 155.26 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -135.17 159.62 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.633 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.7 74.33 6.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.92 -36.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.818 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -51.96 107.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.29 124.63 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.689 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 57.43 113.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.702 -0.624 . . . . 0.0 110.78 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -153.68 -77.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.988 -1.07 . . . . 0.0 111.298 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.3 132.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.85 2.22 39.66 Favored Glycine 0 N--CA 1.491 2.306 0 O-C-N 121.09 -1.241 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -127.95 146.59 50.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.804 -1.41 . . . . 0.0 110.244 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.39 141.45 45.94 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.85 -48.86 8.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.325 -1.103 . . . . 0.0 110.002 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.6 pt -149.07 152.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 110.173 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 157.87 36.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.9 tt -162.88 149.78 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.16 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.251 0.548 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 146.92 49.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 110.174 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.68 171.88 10.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 179.59 7.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.222 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 m -98.45 145.81 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 110.257 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -64.29 127.51 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.897 . . . . 0.0 110.136 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 86.3 t -117.1 -77.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.269 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.35 35.35 13.68 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.98 166.26 11.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.17 41.98 32.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -1.066 . . . . 0.0 110.366 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.84 157.18 8.37 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.38 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.384 -1.068 . . . . 0.0 110.411 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.53 -155.95 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.065 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.25 -155.49 6.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.13 127.94 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -1.108 . . . . 0.0 110.236 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.34 -57.23 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.75 162.12 19.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -1.205 . . . . 0.0 110.197 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 pt -133.19 135.56 25.82 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.42 155.97 54.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.615 1.324 . . . . 0.0 110.688 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.71 131.24 52.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.09 -19.9 17.21 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.54 1.284 . . . . 0.0 110.625 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -129.79 148.76 51.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -85.44 166.11 16.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -179.89 40.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.6 m -113.62 127.36 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 0.0 110.361 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.17 139.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 109.891 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 m -134.98 -39.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.7 148.46 45.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.37 151.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.414 ' CD1' HG22 ' A' ' 45' ' ' VAL . 2.4 mp -129.37 -49.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.499 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.45 143.76 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.272 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -103.85 157.84 16.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.006 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 5.4 pt-20 -83.66 146.6 28.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.12 58.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.15 173.99 6.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.296 . . . . 0.0 110.052 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 7.5 m -106.47 110.22 22.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.086 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.9 p -87.45 145.07 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.86 . . . . 0.0 110.134 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -100.9 152.66 20.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.206 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 130.68 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.59 21.39 29.13 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.44 121.77 42.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -1.212 . . . . 0.0 110.29 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.9 m -53.57 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 ' N ' ' A' ' 44' ' ' LEU . 33.8 m -86.07 -21.7 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' N ' HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -149.77 171.27 16.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.414 HG22 ' CD1' ' A' ' 30' ' ' LEU . 97.5 t -136.74 140.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.99 170.32 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 110.19 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -152.59 127.09 9.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.21 -156.45 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.2 tpt -92.73 39.82 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.396 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -153.04 -47.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -173.93 1.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -106.68 138.4 42.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.148 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.2 m -109.16 150.23 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.091 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.5 132.41 49.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 110.217 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.8 mt -98.9 87.08 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.189 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.6 m-20 -74.09 129.37 37.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.555 -0.716 . . . . 0.0 110.35 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.55 138.99 11.43 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.436 -0.79 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.93 -37.61 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.595 1.313 . . . . 0.0 110.82 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -144.67 149.34 35.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 110.549 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.16 153.0 31.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.21 -166.55 39.75 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.7 tttp -127.61 143.03 51.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 12.8 t -84.06 141.92 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -0.886 . . . . 0.0 110.274 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.4 -11.3 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.571 -0.706 . . . . 0.0 110.263 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.19 107.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 110.079 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -97.6 143.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -118.62 -23.91 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.053 -1.029 . . . . 0.0 110.544 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.447 ' CG1' ' HA ' ' A' ' 80' ' ' LEU . 35.2 m -61.97 163.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 110.166 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -157.63 158.71 36.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.99 68.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -173.62 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.81 149.16 27.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.419 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -127.57 179.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.0 109.874 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 29.2 m 36.22 68.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -75.44 -0.82 21.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.881 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -54.97 104.62 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.01 57.53 1.9 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -163.24 138.33 6.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -1.127 . . . . 0.0 110.15 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.13 136.45 34.45 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.447 ' HA ' ' CG1' ' A' ' 68' ' ' VAL . 10.8 mt -102.15 -71.52 0.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.315 -1.109 . . . . 0.0 109.952 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -148.64 152.43 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.79 123.63 34.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.079 -1.013 . . . . 0.0 110.487 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.3 tt -129.74 142.22 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.507 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.242 0.544 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.72 43.08 3.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mt -66.51 93.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 9.2 pttt -69.66 -25.83 64.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 110.35 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' N ' ' HG3' ' A' ' 4' ' ' LYS . 9.0 p -58.47 152.74 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.955 . . . . 0.0 110.15 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 p -89.21 161.72 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 110.246 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.01 117.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -100.14 83.32 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.266 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -133.2 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -168.39 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -1.143 . . . . 0.0 110.235 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.71 -78.05 0.38 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.13 156.94 40.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -1.148 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.69 -165.75 1.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.26 156.02 21.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -54.06 134.59 43.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -1.168 . . . . 0.0 110.314 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 -23.07 37.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -91.87 155.96 17.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.348 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.58 104.71 55.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.4 164.11 35.99 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.567 1.298 . . . . 0.0 110.766 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.56 156.11 70.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.849 . . . . 0.0 110.335 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.51 -36.97 3.45 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.716 1.377 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.26 -53.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.972 . . . . 0.0 110.325 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.62 179.19 4.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . 177.43 160.46 24.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.8 p -115.96 90.83 3.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.174 . . . . 0.0 110.439 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.421 HG23 ' CG2' ' A' ' 68' ' ' VAL . 41.4 t -63.81 136.23 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 109.667 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.4 m -127.39 -30.67 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.013 -1.054 . . . . 0.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.83 159.12 41.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.21 135.26 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.35 -40.2 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.942 . . . . 0.0 109.987 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.6 m -91.02 -170.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 109.804 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -165.78 -45.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.655 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.0 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.15 31.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -54.71 115.32 2.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -1.17 . . . . 0.0 109.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -75.86 95.84 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.17 165.27 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 4.1 mttp -124.42 165.01 18.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.33 110.59 2.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.5 36.9 11.36 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -116.25 114.26 24.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -1.103 . . . . 0.0 110.073 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.4 m -52.58 118.58 3.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.16 -10.5 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.915 . . . . 0.0 110.943 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 160.37 42.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 110.738 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' THR . 89.2 t -109.68 117.19 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.617 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.424 HD21 ' N ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -150.37 134.89 17.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.408 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' N ' HD21 ' A' ' 46' ' ' LEU . 17.9 mt-10 -117.47 104.0 10.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 110.115 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.02 -160.24 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.361 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 ttm -76.26 -29.03 57.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.925 . . . . 0.0 110.348 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -113.26 11.52 18.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.695 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 mtt -135.68 168.94 18.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 109.976 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 tt0 -154.1 73.37 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.04 -1.038 . . . . 0.0 110.978 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER 66.84 -59.96 0.36 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -71.44 98.93 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.892 -1.13 . . . . 0.0 110.552 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.5 mm -105.54 98.6 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 11.6 m-20 -74.31 133.34 42.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.649 -0.657 . . . . 0.0 110.123 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.84 166.21 0.21 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.369 -0.832 . . . . 0.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.69 -32.89 8.92 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.734 1.386 . . . . 0.0 110.526 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 t -173.39 171.08 4.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.7 p-10 -65.09 131.71 47.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.17 -176.59 43.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.61 142.3 35.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -1.099 . . . . 0.0 110.208 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.13 109.49 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.56 -17.66 60.7 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.704 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 176.87 164.65 0.49 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.257 -0.902 . . . . 0.0 109.998 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -123.99 88.51 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -42.03 70.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.022 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' CG2' HG23 ' A' ' 26' ' ' VAL . 14.7 p -80.92 147.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -146.38 174.9 10.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.65 76.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.298 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER 179.9 -51.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 110.131 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.66 138.83 40.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.872 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -158.56 158.82 34.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 73' ' ' ALA . 23.1 m 36.73 49.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.257 0.551 . . . . 0.0 111.7 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -154.03 85.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.72 -172.97 41.13 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.84 -25.75 25.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.25 160.46 14.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -1.155 . . . . 0.0 110.301 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.66 171.2 5.81 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -131.84 -58.02 0.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.24 -1.153 . . . . 0.0 110.04 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mp -136.88 146.38 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.192 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -106.15 131.91 52.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.875 . . . . 0.0 110.141 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.62 35.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.297 0.57 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.07 -131.78 3.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -125.25 106.48 9.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -1.151 . . . . 0.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.14 -31.23 4.98 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.44 168.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 110.629 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.34 105.03 34.08 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.0 Cg_endo -70.96 139.55 36.29 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.582 1.306 . . . . 0.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.737 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -69.55 174.3 3.16 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 0.0 110.297 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 47.7 Cg_endo -74.18 -53.34 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.722 1.38 . . . . 0.0 110.384 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 22' ' ' LEU . 5.5 mt -151.84 -49.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.922 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -175.35 177.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 73' ' ' ALA . . . 177.42 -171.06 43.77 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -126.96 104.8 8.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -1.109 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.651 HG22 HD11 ' A' ' 46' ' ' LEU . 64.4 t -55.95 155.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -128.14 -40.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -174.0 133.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG22 ' A' ' 29' ' ' ILE . 15.3 tt -98.48 151.13 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.9 mm? -106.42 -58.76 1.88 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.327 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 33' ' ' GLU . 95.6 t -70.61 150.9 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 1.3 mttt -118.17 42.59 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HA ' HG11 ' A' ' 63' ' ' VAL . 13.3 tm-20 59.77 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.616 0.722 . . . . 0.0 110.698 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.74 20.29 66.1 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.45 136.54 52.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.965 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -71.84 159.57 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 110.106 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 57' ' ' ALA . 9.2 p -147.01 165.57 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -122.64 177.1 5.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.114 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.96 103.33 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.77 -19.02 9.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.22 112.63 2.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.123 -1.222 . . . . 0.0 110.297 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 89.1 m -52.1 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 HD23 ' A' ' 44' ' ' LEU . 59.8 t -57.77 -37.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.844 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.928 HD11 HD12 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -167.11 -160.01 0.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.577 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 46' ' ' LEU . 39.9 t -143.03 148.16 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -150.22 173.68 13.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.058 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 110.429 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.203 0.525 . . . . 0.0 110.254 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER -54.25 109.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.211 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.928 HD12 HD11 ' A' ' 44' ' ' LEU . 48.1 mt -88.82 102.64 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 13.9 p-10 -75.99 138.21 40.77 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.602 0.715 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 37' ' ' VAL . . . -54.23 145.9 33.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.887 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.01 -37.05 3.79 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.593 1.312 . . . . 0.0 110.637 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -155.5 160.91 40.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.49 142.62 48.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.04 -164.33 37.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -132.03 148.47 52.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -1.133 . . . . 0.0 110.035 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.0 t -84.73 138.16 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.51 -25.37 16.88 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.475 -0.766 . . . . 0.0 109.05 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.17 137.47 0.1 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 109.75 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.4 p -93.31 130.37 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.438 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.49 -50.79 4.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.047 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 69' ' ' LYS . 11.4 p -58.04 163.06 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 68' ' ' VAL . 7.9 ttmt -136.15 160.35 38.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.007 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 58.07 28.85 16.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HG23 ' A' ' 26' ' ' VAL . 46.3 t0 -113.25 112.96 24.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.867 . . . . 0.0 109.824 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -105.09 177.33 4.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 110.602 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.922 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 33.6 m 36.84 56.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.294 0.569 . . . . 0.0 111.709 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.523 ' NE2' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -136.85 71.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.065 -1.022 . . . . 0.0 110.48 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -116.07 168.85 12.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 -29.61 12.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -102.77 152.51 21.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -1.059 . . . . 0.0 109.914 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.55 136.66 43.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.3 mt -88.83 -51.09 5.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -1.17 . . . . 0.0 110.058 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.99 139.97 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.099 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -93.5 134.81 35.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -145.78 147.15 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.151 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.257 0.551 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.18 158.26 27.17 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.13 -28.05 66.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -1.09 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.03 -24.14 25.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -80.41 150.51 29.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -1.123 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.9 100.1 53.2 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.956 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -72.42 164.67 34.92 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.676 1.356 . . . . 0.0 110.956 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 119.8 74.5 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.848 . . . . 0.0 109.984 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.94 0.03 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.45 1.237 . . . . 0.0 111.152 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.54 59.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.829 -1.169 . . . . 0.0 110.389 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.87 -167.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.77 156.65 7.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.463 ' C ' HD23 ' A' ' 46' ' ' LEU . 92.4 m -103.68 108.29 19.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -1.168 . . . . 0.0 110.29 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 72' ' ' ASP . 44.9 t -72.37 125.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.73 -46.25 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 110.569 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.16 152.8 13.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.008 . . . . 0.0 110.137 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 44' ' ' LEU . 21.5 pt -118.76 135.35 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.152 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.1 mp -92.29 -3.16 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 63' ' ' VAL . 12.0 p -93.8 151.64 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.79 153.3 44.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.054 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -68.18 131.55 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.132 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.77 16.72 67.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.95 158.7 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -1.2 . . . . 0.0 109.968 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 59.2 m -105.37 129.21 53.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.3 m -113.75 174.09 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 6.1 mtpm? -128.52 152.6 48.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -62.52 116.4 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.94 -24.98 9.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 tt0 -76.41 122.66 24.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 55' ' ' ILE . 5.0 m -59.05 104.59 0.25 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.178 -0.951 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 41' ' ' GLN . 23.8 m -91.0 -15.09 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.59 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -145.14 160.32 41.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.191 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.52 122.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 25' ' ' THR . 1.9 mt -113.89 172.91 6.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 110.373 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.166 0.507 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -54.25 129.92 36.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 42' ' ' THR . 37.9 mm -101.71 90.35 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.36 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -65.38 141.42 58.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -52.58 150.58 9.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.166 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.31 -31.48 11.56 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.675 1.355 . . . . 0.0 110.497 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.631 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 7.3 t -174.69 166.25 3.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.04 123.47 18.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 175.16 170.57 38.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 63' ' ' VAL . 11.1 ttmt -104.93 152.86 22.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 31' ' ' VAL . 15.1 t -71.92 143.91 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 110.152 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.05 -17.98 11.32 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.44 117.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.164 -0.96 . . . . 0.0 110.387 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -100.89 132.67 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.117 -0.99 . . . . 0.0 109.852 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.18 -21.81 9.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.045 -1.034 . . . . 0.0 110.723 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 7.5 p -59.86 148.83 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.82 145.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.42 76.13 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 177.83 -45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.305 -0.872 . . . . 0.0 110.1 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 23.6 t0 -55.3 128.13 32.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.277 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -140.68 164.65 29.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 75' ' ' GLN . 85.1 t 56.44 164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.789 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 57.44 111.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.389 -0.819 . . . . 0.0 110.877 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.3 -159.78 27.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.91 -19.2 55.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 6.2 mt-30 -92.68 138.51 31.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -1.213 . . . . 0.0 110.421 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.58 177.03 0.36 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -135.5 -65.9 0.59 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.75 142.37 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -100.42 120.83 40.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.86 128.55 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.884 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.336 0.588 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.73 -107.26 3.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.4 tt0 -140.33 104.31 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -1.151 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.93 -39.53 2.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -54.66 157.48 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -1.093 . . . . 0.0 110.476 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 18' ' ' ILE . 5.1 mp -116.13 104.63 52.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 109.928 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 43.7 Cg_endo -71.18 136.74 29.95 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.585 1.308 . . . . 0.0 110.533 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -64.54 139.2 97.68 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.76 -24.13 13.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.61 1.321 . . . . 0.0 110.623 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -131.51 166.24 21.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 75' ' ' GLN . . . -75.06 174.92 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.299 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.3 179.36 39.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.1 m -133.42 137.32 45.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 110.156 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 41.9 t -69.67 118.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.69 -28.63 19.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.69 126.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.868 HD12 HD21 ' A' ' 44' ' ' LEU . 1.4 tt -81.48 150.34 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 -38.38 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.171 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.13 176.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.412 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.35 46.01 1.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.321 -0.862 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.746 ' HA ' HG11 ' A' ' 63' ' ' VAL . 1.4 tt0 59.82 155.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.26 28.22 42.09 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.61 124.73 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.164 . . . . 0.0 110.288 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 61' ' ' GLY . 25.8 m -69.64 149.93 47.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 57' ' ' ALA . 7.2 p -136.7 161.51 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 37' ' ' VAL . 3.7 ttmm -115.48 155.27 27.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.95 109.94 1.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.211 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 28.73 4.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -118.16 115.24 24.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -1.214 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 87.0 m -54.42 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 55' ' ' ILE . 20.5 m -69.07 -22.65 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.22 172.3 16.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.493 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 97.1 t -119.36 130.55 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.034 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 -177.8 3.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.331 0.586 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.7 103.46 14.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.675 ' O ' HG22 ' A' ' 43' ' ' VAL . 41.0 mm -68.85 91.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.553 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -77.24 131.41 38.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.434 -0.791 . . . . 0.0 110.238 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -50.2 156.41 1.4 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 -37.92 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.694 1.365 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -158.8 178.3 10.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.18 132.12 38.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 36' ' ' THR . . . 174.85 -135.44 3.09 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -154.41 150.13 27.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.272 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 33' ' ' GLU . 9.1 t -64.25 142.11 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.053 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -115.6 -18.38 10.91 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.843 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 3.4 tmtm? 179.24 89.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.6 p -79.8 117.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.974 . . . . 0.0 110.202 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.753 HD11 ' O ' ' A' ' 79' ' ' GLY . 2.7 pp -96.93 -25.71 15.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.79 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.293 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -132.16 160.19 36.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.34 153.58 43.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.917 . . . . 0.0 110.224 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 55.13 21.63 4.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.313 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.05 87.32 2.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.163 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.22 149.09 13.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 75' ' ' GLN . 13.2 p -153.0 164.12 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.114 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -106.15 -179.21 3.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.48 129.56 10.54 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 35.42 2.24 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -136.19 126.32 26.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -1.148 . . . . 0.0 110.14 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.753 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.91 151.17 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 20' ' ' ALA . 67.8 mt -118.58 -64.21 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -1.115 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 66' ' ' VAL . 1.8 pp -135.31 133.64 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.198 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -82.45 143.66 31.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.403 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.2 tt -164.82 161.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.547 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.222 0.534 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.95 -168.53 17.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.06 78.45 3.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -1.186 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.79 -20.88 1.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.53 170.49 9.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -1.166 . . . . 0.0 110.234 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.45 132.14 24.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 109.97 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.9 Cg_endo -74.36 131.71 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.51 1.268 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -55.48 137.27 69.66 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.4 113.93 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.582 1.306 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.5 mm? 49.45 48.95 20.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 -154.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 0.0 110.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.732 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 143.06 172.46 14.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.5 p -112.49 112.22 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.481 HG21 ' OD2' ' A' ' 72' ' ' ASP . 38.8 t -76.18 112.31 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.982 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.6 -9.25 12.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.715 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -168.46 151.24 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.983 -1.073 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.25 145.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 30' ' ' LEU . 2.2 mm? -107.39 -42.31 4.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.118 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 43' ' ' VAL . 7.6 p -71.76 165.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.204 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 31' ' ' VAL . 25.7 tttt -140.92 163.21 33.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HB3' HG13 ' A' ' 66' ' ' VAL . 9.3 pt-20 -68.46 135.42 51.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.0 22.69 68.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.21 130.02 55.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.7 m -75.43 118.56 18.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.058 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.5 p -98.19 151.49 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.66 156.07 21.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 109.99 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 121.42 14.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -5.67 44.55 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.496 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ALA . 1.5 tt0 -85.5 123.64 31.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.819 -1.401 . . . . 0.0 110.441 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.2 m -55.68 102.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.285 -0.884 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.4 m -81.48 -23.0 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -154.2 162.97 40.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.613 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.94 125.26 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.732 HD21 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -98.91 168.03 10.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 110.291 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.248 0.547 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.25 113.58 25.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' HB3' ' A' ' 44' ' ' LEU . 49.7 mt -81.25 94.2 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.324 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 3.7 m-20 -66.67 148.79 51.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.407 0.622 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -65.19 146.47 98.93 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.51 -0.744 . . . . 0.0 110.352 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.09 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.703 1.37 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.75 150.5 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.98 147.99 52.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.175 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.5 -164.22 37.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -125.65 142.3 51.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -1.107 . . . . 0.0 110.251 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 18.7 t -80.06 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.019 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.58 -15.11 13.1 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.569 -0.707 . . . . 0.0 109.851 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.09 131.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.104 -0.998 . . . . 0.0 110.163 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 33' ' ' GLU . 32.5 m -73.31 150.69 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 79' ' ' GLY . 0.5 OUTLIER -125.12 -58.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' OD2' ' A' ' 72' ' ' ASP . 41.3 t -84.54 154.94 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 71' ' ' ARG . 9.1 mmtt -135.33 166.01 24.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 4.4 mt-10 -63.79 80.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -176.88 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.481 ' OD2' HG21 ' A' ' 26' ' ' VAL . 15.8 p-10 -52.7 125.03 15.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -122.2 158.68 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.204 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 73' ' ' ALA . 26.7 m 36.6 42.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 121.285 0.564 . . . . 0.0 111.694 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.883 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -99.46 150.12 19.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.68 14.88 64.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 24.8 tt0 -99.34 150.25 22.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.287 . . . . 0.0 110.119 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.532 ' O ' HD13 ' A' ' 67' ' ' LEU . . . -66.47 106.28 1.57 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 2.7 mt -55.73 -79.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -1.156 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.5 mt -144.54 160.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -88.47 132.61 34.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.067 -1.02 . . . . 0.0 110.126 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.78 33.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.594 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.258 0.551 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.72 170.17 13.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.17 107.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.12 -24.73 5.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -94.64 158.2 15.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -1.143 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -124.54 111.64 27.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.8 Cg_endo -72.42 157.92 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.513 1.27 . . . . 0.0 110.793 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -95.77 112.49 59.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.92 -3.71 14.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.55 1.289 . . . . 0.0 111.28 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -142.18 33.2 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 110.725 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.89 -157.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.139 -0.975 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.84 -159.17 20.62 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.23 -146.83 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -1.176 . . . . 0.0 110.115 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 m -47.68 -31.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.049 -1.032 . . . . 0.0 111.147 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p 57.18 39.49 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -66.43 101.15 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 29' ' ' ILE . 5.5 tt -62.3 115.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.457 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 45' ' ' VAL . 28.4 mt -69.9 -26.75 64.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.944 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 31' ' ' VAL . 23.4 m -98.98 -158.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.177 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.84 -178.45 6.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -81.49 151.81 27.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 110.075 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.72 5.13 83.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.49 167.65 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.002 -1.293 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -103.75 156.53 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.327 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 38' ' ' LYS . 7.7 p -137.85 167.76 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -129.35 160.1 34.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 121.48 15.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.303 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.27 44.95 6.04 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.814 ' O ' HG13 ' A' ' 43' ' ' VAL . 3.4 tt0 -132.34 110.11 10.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 54' ' ' GLU . 93.8 m -53.07 114.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -124.72 -12.9 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.884 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.531 HD12 HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -132.45 166.35 22.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.848 -1.157 . . . . 0.0 110.909 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG13 HG23 ' A' ' 53' ' ' THR . 92.4 t -117.82 103.47 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 110.036 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -138.96 137.0 36.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.829 HG23 HG13 ' A' ' 45' ' ' VAL . 41.0 m . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 42' ' ' THR . 6.2 mt-10 -56.08 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.098 . . . . 0.0 110.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.9 mm -88.48 102.16 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -78.73 127.3 31.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.427 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.2 14.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 110.083 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -51.47 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.652 1.343 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.6 p -139.71 156.06 47.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 29.2 p-10 -62.28 166.51 4.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.75 -161.91 29.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -134.92 143.88 47.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -1.187 . . . . 0.0 109.936 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.48 134.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 110.329 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.83 -11.87 16.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.69 138.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 109.771 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 33' ' ' GLU . 34.1 m -86.44 160.55 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.36 -67.44 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' LYS . 13.3 p -62.42 169.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 110.489 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.2 mmmt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.158 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 28' ' ' LYS . 4.1 tt0 -53.88 134.23 42.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.903 . . . . 0.0 110.441 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 55.83 51.4 12.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.473 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.2 t0 -102.51 -26.35 13.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 61.82 142.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.397 -0.815 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.466 HG22 ' C ' ' A' ' 73' ' ' ALA . 14.8 m 34.53 89.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 121.417 0.627 . . . . 0.0 112.139 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.19 64.28 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.102 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -104.44 154.87 17.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.3 54.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.7 tt0 -118.24 163.41 16.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -1.165 . . . . 0.0 110.143 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.14 175.81 2.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 20' ' ' ALA . 65.7 mt -123.42 -43.03 2.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 81' ' ' ILE . 8.5 tt -175.67 143.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.084 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -98.4 126.35 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.69 113.29 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.525 -179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.119 0.485 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.56 -125.38 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.42 97.15 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -1.12 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.62 1.15 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -118.23 174.86 5.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.317 -1.108 . . . . 0.0 110.343 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' LEU . 15.6 mm -107.97 100.12 34.34 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.179 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.01 45.78 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.638 1.336 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.51 116.1 61.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.94 -8.03 22.19 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.46 1.242 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 22' ' ' LEU . 14.6 tp -150.03 126.13 10.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.999 -1.063 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB1' ' H ' ' A' ' 75' ' ' GLN . . . -58.74 178.35 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.751 ' C ' ' HB3' ' A' ' 73' ' ' ALA . . . 151.19 -149.52 21.33 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.066 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.547 ' N ' ' HB3' ' A' ' 73' ' ' ALA . 31.0 p -137.46 100.01 4.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.898 HG23 ' HB2' ' A' ' 73' ' ' ALA . 59.1 t -50.28 100.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.013 -1.055 . . . . 0.0 110.291 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 t -57.44 -41.02 79.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -173.12 156.64 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.721 HD12 HG21 ' A' ' 68' ' ' VAL . 3.6 tt -96.42 136.3 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.348 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 30' ' ' LEU . 1.2 mm? -103.43 -25.81 13.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 81' ' ' ILE . 9.2 p -87.15 153.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -123.29 149.21 45.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.208 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -69.85 136.12 50.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.64 24.13 59.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.35 143.43 51.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -1.09 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -85.67 116.8 24.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 43' ' ' VAL . 13.1 p -100.96 154.64 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 145.77 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -55.41 142.12 33.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.303 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.88 -34.59 5.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.22 123.56 20.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -1.201 . . . . 0.0 110.381 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 42' ' ' THR . 8.1 t -57.19 101.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.971 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.889 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 32.9 m -77.57 -17.39 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 110.449 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 55' ' ' ILE . 4.0 mt -152.21 155.61 38.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.077 -1.014 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.83 117.97 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.842 HD11 ' CB ' ' A' ' 73' ' ' ALA . 2.4 mm? -102.35 174.56 5.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.457 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.181 0.515 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.27 132.34 53.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.849 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.754 HD11 HD23 ' A' ' 46' ' ' LEU . 20.8 mt -107.02 99.68 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.45 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 10.6 p-10 -70.86 137.41 49.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.367 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.889 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -56.66 148.32 47.02 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.85 . . . . 0.0 110.068 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.49 -36.11 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.644 1.339 . . . . 0.0 110.504 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 2.6 m -157.31 158.27 35.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 139.23 46.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.18 38.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 139.43 49.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 31' ' ' VAL . 24.5 t -72.43 142.28 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.014 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -105.86 -18.18 14.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.794 . . . . 0.0 109.681 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 156.61 0.55 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -0.976 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 66' ' ' VAL . 35.8 m -134.63 100.06 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.055 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -84.08 -15.0 48.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 0.0 110.489 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.721 HG21 HD12 ' A' ' 29' ' ' ILE . 30.2 m -46.7 153.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 7.66 8.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.657 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 61.27 143.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.957 . . . . 0.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.7 mtp-105 52.53 39.03 27.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -154.53 42.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.898 ' HB2' HG23 ' A' ' 26' ' ' VAL . . . -82.12 -4.92 57.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.002 . . . . 0.0 110.439 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 24' ' ' GLY . 29.9 m -44.29 140.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.367 -0.833 . . . . 0.0 111.155 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.609 ' H ' ' HB1' ' A' ' 23' ' ' ALA . 20.2 tt0 54.12 100.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.454 -0.778 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -168.6 8.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.91 -24.69 27.28 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -79.11 130.69 35.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -1.075 . . . . 0.0 110.158 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.939 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -55.99 157.44 9.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 68' ' ' VAL . 32.3 mt -118.68 -64.96 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -1.179 . . . . 0.0 110.216 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.649 HD13 HG11 ' A' ' 31' ' ' VAL . 51.6 mt -126.65 156.36 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 146.55 25.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.006 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 6.5 tt -136.59 25.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.56 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.283 0.564 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.87 -122.0 2.88 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 -57.62 2.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -1.133 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.54 -5.69 89.21 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' OE1' HD21 ' A' ' 67' ' ' LEU . 42.2 mt-10 -78.1 135.24 37.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.311 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.48 109.84 34.66 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.351 -0.843 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.15 152.51 56.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.495 1.261 . . . . 0.0 110.641 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -100.76 122.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.87 -17.62 25.32 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.481 1.253 . . . . 0.0 110.43 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.95 138.67 42.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.96 141.24 28.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.106 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -134.39 158.64 23.51 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -121.11 104.83 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -1.132 . . . . 0.0 110.04 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 27' ' ' SER . 7.5 p -47.38 168.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -0.898 . . . . 0.0 110.902 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 26' ' ' VAL . 25.7 t -149.69 -42.19 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 109.878 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -160.24 119.42 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 44' ' ' LEU . 1.2 tt -81.76 151.73 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.76 -38.01 5.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.104 -0.997 . . . . 0.0 110.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.813 HG21 HG13 ' A' ' 43' ' ' VAL . 35.9 m -123.41 168.35 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.284 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -121.38 -162.58 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -82.99 140.56 32.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 110.28 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.82 49.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 172.38 7.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.093 -1.239 . . . . 0.0 110.41 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.6 m -116.93 133.58 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 61' ' ' GLY . 34.8 m -125.56 152.56 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 14.0 tttt -110.78 163.91 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.386 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 107.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.257 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.99 -0.72 31.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -90.25 127.26 36.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.334 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 3.4 m -54.13 135.6 43.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 31' ' ' VAL . 97.2 t -118.6 -38.17 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -147.94 159.34 43.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.792 . . . . 0.0 110.544 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.03 116.79 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.954 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.458 HD11 ' HA3' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -101.39 153.57 19.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.076 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.272 0.558 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.64 128.77 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.8 81.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.246 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 2.0 m120 -72.58 133.93 44.95 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.545 0.688 . . . . 0.0 110.654 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 43' ' ' VAL . . . -49.97 143.7 11.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 110.456 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.25 -32.44 6.63 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.655 1.345 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -145.08 162.25 37.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.1 p-10 -77.27 133.5 38.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 166.42 173.83 35.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -90.99 152.63 20.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -1.131 . . . . 0.0 110.153 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.18 128.67 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -109.25 -1.33 18.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.448 -0.783 . . . . 0.0 110.319 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -177.86 139.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.01 89.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.522 HD21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -52.31 -58.1 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.509 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.677 HG22 HG11 ' A' ' 74' ' ' VAL . 57.9 t -95.92 137.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -163.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 0.0 109.759 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HA ' HG21 ' A' ' 26' ' ' VAL . 8.3 tt0 -91.69 131.63 36.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 110.133 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 71.53 2.96 4.48 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.595 -0.69 . . . . 0.0 111.189 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.455 ' N ' HG11 ' A' ' 26' ' ' VAL . 4.6 m-20 -98.39 84.54 3.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.0 109.702 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.34 155.96 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.224 -0.922 . . . . 0.0 110.794 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HG22 ' A' ' 68' ' ' VAL . 26.4 m -142.51 158.75 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 110.077 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -100.77 152.27 20.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.943 . . . . 0.0 110.398 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.13 138.66 42.46 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.71 -7.37 11.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.91 150.26 38.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.918 -1.343 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.09 159.85 17.62 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 20' ' ' ALA . 57.5 mt -108.86 -49.68 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.865 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' C ' ' A' ' 80' ' ' LEU . 4.8 pt -154.46 150.58 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.835 . . . . 0.0 110.024 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 65' ' ' LYS . 37.2 tttt -108.36 139.42 43.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.938 . . . . 0.0 110.368 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 3.7 tt -148.85 44.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.611 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.581 ' HB1' ' CG ' ' A' ' 17' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.343 0.592 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.98 -110.59 1.03 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.0 mt-10 -139.45 125.44 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 110.13 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.86 -33.56 5.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -57.23 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.409 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG12 ' A' ' 83' ' ' ILE . 3.9 mp -138.84 110.75 7.99 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.079 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.76 137.01 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.539 1.284 . . . . 0.0 110.355 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.11 136.32 53.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.78 -24.55 13.21 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.462 1.243 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -134.05 139.9 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.32 178.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.977 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -176.83 155.84 19.28 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -99.74 121.31 41.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.362 -1.081 . . . . 0.0 109.979 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.42 136.37 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 110.366 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 45' ' ' VAL . 44.5 t -115.62 -31.86 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 109.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtmt -172.84 139.94 0.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.083 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.437 ' H ' HG22 ' A' ' 29' ' ' ILE . 8.2 tt -101.82 140.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 mt -116.29 -27.14 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.258 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.634 ' CG2' HG21 ' A' ' 63' ' ' VAL . 9.2 p -82.83 155.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.61 160.37 39.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.888 . . . . 0.0 110.248 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -68.07 122.17 17.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.99 -2.26 55.35 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 126.32 38.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.872 -1.37 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.8 m -64.55 124.03 20.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.7 p -99.46 145.27 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.88 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.47 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.937 . . . . 0.0 110.234 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.16 17.86 23.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -118.45 119.55 34.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.149 -1.207 . . . . 0.0 110.189 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 79.5 m -52.65 122.45 9.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.915 . . . . 0.0 110.011 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -114.33 -23.34 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 171.06 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.977 -1.077 . . . . 0.0 111.058 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 27' ' ' SER . 50.4 t -121.31 117.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 109.397 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 24' ' ' GLY . 3.2 tp -107.83 149.51 28.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.943 . . . . 0.0 110.815 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.819 . . . . 0.0 109.966 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 53.8 m . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.051 0.453 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.46 97.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 111.106 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 43' ' ' VAL . 26.7 mm -96.12 90.96 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.012 . . . . 0.0 109.5 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -62.63 138.85 58.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.582 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -54.06 167.81 0.5 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.387 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.53 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 48.6 Cg_endo -75.02 -35.85 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.822 1.433 . . . . 0.0 110.446 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -165.69 -159.41 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.9 147.51 26.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.85 -150.53 22.09 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -129.99 149.06 51.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.94 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 31' ' ' VAL . 38.6 t -80.5 110.18 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 110.379 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -78.4 -12.39 60.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.99 174.71 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 66' ' ' VAL . 34.7 m -123.64 91.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.742 HD13 ' HA3' ' A' ' 79' ' ' GLY . 1.1 mt -60.53 -30.18 69.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -103.81 142.74 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 110.545 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 -171.64 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 109.992 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.6 154.76 21.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.043 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 58.07 30.55 19.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.896 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.95 67.55 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 173.3 0.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.479 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t 53.55 86.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -131.21 28.09 4.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.155 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.38 132.98 11.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.11 44.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.31 150.01 21.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -1.202 . . . . 0.0 110.152 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.742 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -58.12 149.01 35.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.1 mt -96.57 -68.57 0.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 6.1 mt -126.85 146.86 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -88.06 118.93 27.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.491 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 18' ' ' ILE . 4.5 pt -146.0 153.36 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.506 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.716 ' HB1' ' OE2' ' A' ' 17' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.12 -106.23 0.48 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.0 148.47 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.96 58.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.716 ' OE2' ' HB1' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -111.65 166.14 11.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -1.095 . . . . 0.0 110.46 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.67 100.41 19.59 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.858 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.2 Cg_endo -71.18 121.31 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.742 1.391 . . . . 0.0 110.542 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -60.79 141.62 92.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -20.56 21.74 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.654 1.344 . . . . 0.0 110.387 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.84 151.43 29.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.66 174.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.304 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.03 153.37 11.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 46' ' ' LEU . 21.2 p -106.77 135.33 48.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -1.19 . . . . 0.0 110.22 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 68' ' ' VAL . 43.1 t -89.9 130.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -101.8 -23.18 14.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -169.63 165.43 10.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.5 tt -122.43 145.24 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -103.01 -54.55 2.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.822 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 HG13 ' A' ' 43' ' ' VAL . 29.2 m -71.53 -171.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.837 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.93 39.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 17.9 tt0 61.21 142.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.295 -0.878 . . . . 0.0 110.727 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.73 60.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -1.234 . . . . 0.0 109.886 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' VAL . 3.7 m -57.61 178.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 110.047 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 36' ' ' THR . 13.4 p -171.78 164.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' HG22 ' A' ' 37' ' ' VAL . 10.1 mtmm -122.69 177.45 5.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.28 125.93 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.464 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.51 -22.34 41.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 43' ' ' VAL . 49.0 tt0 -70.01 127.73 33.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 0.0 110.407 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.587 HG22 HD22 ' A' ' 30' ' ' LEU . 69.2 m -52.13 137.95 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.931 . . . . 0.0 110.011 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.878 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 93.7 t -123.49 -36.45 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -142.82 176.28 9.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.135 -0.978 . . . . 0.0 111.076 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 53' ' ' THR . 42.1 t -124.48 145.12 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -174.83 4.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.046 . . . . 0.0 110.523 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.47 HG23 ' N ' ' A' ' 54' ' ' GLU . 8.2 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' THR . 1.1 mt-10 -37.69 133.79 0.76 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.302 -0.874 . . . . 0.0 112.237 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.663 HG13 HD12 ' A' ' 46' ' ' LEU . 35.1 mm -125.69 106.71 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.643 -0.661 . . . . 0.0 109.411 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 76.3 m-20 -57.18 144.1 36.41 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.703 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.878 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -62.38 152.38 79.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.71 -33.77 7.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.693 1.365 . . . . 0.0 110.389 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -161.51 151.75 17.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.43 158.49 14.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 145.59 -144.23 12.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -140.33 158.17 44.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -1.158 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 52.5 t -85.19 119.98 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 84' ' ' GLY . 1.2 mm-40 -90.22 -10.49 44.15 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 109.598 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.1 mttm 179.86 163.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -123.72 95.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 -36.48 75.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.741 HG21 HD23 ' A' ' 80' ' ' LEU . 45.1 t -96.15 128.53 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 -170.9 2.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.109 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 134.7 34.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 52.14 42.17 30.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.7 t70 -104.25 -23.76 13.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.312 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 60.73 117.17 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.04 -177.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.0 . . . . 0.0 110.339 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.08 162.85 21.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.62 146.43 48.5 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.84 37.16 6.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.7 tt0 -146.51 132.05 18.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.74 114.74 4.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 68' ' ' VAL . 26.1 mt -70.19 -57.89 4.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.296 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.03 168.78 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.3 143.08 42.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.38 162.6 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.305 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 64' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.531 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.195 0.521 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.74 -133.16 4.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.35 132.35 46.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.43 24.75 59.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.21 159.34 32.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -1.188 . . . . 0.0 110.277 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 83' ' ' ILE . 67.7 mt -130.94 99.56 18.03 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.967 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.5 Cg_endo -73.53 130.28 14.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.734 1.386 . . . . 0.0 110.618 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.55 114.18 36.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -18.59 26.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.468 1.247 . . . . 0.0 110.665 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.0 mt -119.97 9.27 11.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' ' N ' ' A' ' 76' ' ' GLY . . . 51.68 -150.32 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 0.0 110.402 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.62 176.69 16.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -121.23 108.96 14.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -1.136 . . . . 0.0 110.009 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.3 136.35 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -40.21 3.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.248 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.69 139.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.5 tt -81.73 149.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -105.16 -45.57 4.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.152 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 HG23 ' A' ' 43' ' ' VAL . 24.4 m -101.91 -158.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -148.98 179.25 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 146.41 53.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.37 87.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.12 146.48 26.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.3 . . . . 0.0 110.163 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.7 m -97.83 107.26 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 61' ' ' GLY . 31.3 m -81.25 158.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.86 155.42 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.34 109.43 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.371 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.8 34.43 5.73 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -125.04 114.52 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.153 . . . . 0.0 110.084 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -49.16 113.77 0.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.221 -0.924 . . . . 0.0 110.412 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 31' ' ' VAL . 12.0 p -107.95 -26.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.838 . . . . 0.0 110.625 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.758 ' CD1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -142.78 175.44 9.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.137 -0.977 . . . . 0.0 111.163 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' THR . 57.5 t -116.17 142.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.948 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HB2' HG13 ' A' ' 55' ' ' ILE . 21.7 tp -134.72 159.22 41.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.015 . . . . 0.0 110.731 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 34.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.979 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 54' ' ' GLU . 54.6 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 53' ' ' THR . 7.4 mt-10 -59.9 105.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.717 -1.24 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 46' ' ' LEU . 26.2 mm -103.76 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 18.4 p-10 -69.81 135.38 49.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.638 -0.664 . . . . 0.0 110.726 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.43 175.3 0.13 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 110.175 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.761 ' O ' HG23 ' A' ' 59' ' ' THR . 49.0 Cg_endo -76.51 -48.99 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.762 1.401 . . . . 0.0 110.768 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -163.42 -167.66 1.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 124.86 26.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 37' ' ' VAL . . . -179.87 169.9 40.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -107.62 151.43 25.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.84 106.85 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.997 . . . . 0.0 110.453 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -84.33 -10.79 57.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt 178.19 157.3 0.43 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.119 -0.988 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' VAL . 19.2 m -112.39 94.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -70.37 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.498 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.48 166.12 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -118.5 -176.25 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.52 145.5 26.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 57.89 33.62 23.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.64 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' THR . . . -51.38 145.74 8.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.226 -0.922 . . . . 0.0 110.48 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.09 158.59 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 110.094 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -98.8 24.79 7.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.912 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . 77.52 172.1 37.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.19 34.33 88.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -128.47 130.03 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -1.117 . . . . 0.0 110.157 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.33 111.25 2.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.1 mt -67.9 -70.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.333 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.758 HD11 ' CD1' ' A' ' 44' ' ' LEU . 72.3 mt -132.5 160.61 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -102.35 117.92 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 83' ' ' ILE . 70.8 mt -118.88 38.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.221 0.534 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.4 -179.19 26.89 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.4 141.53 51.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -1.175 . . . . 0.0 110.231 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.59 -51.59 4.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.02 132.63 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.341 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.97 120.07 51.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 154.27 53.22 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.409 1.215 . . . . 0.0 110.672 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.76 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -107.5 94.52 11.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.54 -5.63 17.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.735 1.387 . . . . 0.0 111.056 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.09 3.24 35.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.064 -1.023 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.11 178.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.936 -1.103 . . . . 0.0 110.188 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.51 172.06 31.51 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.635 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.6 p -101.14 112.73 25.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -1.123 . . . . 0.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 69' ' ' LYS . 96.8 t -80.63 97.51 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.857 . . . . 0.0 109.983 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -41.76 11.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.298 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.28 170.87 4.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' ILE . 20.4 tt -133.26 124.03 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 4.7 mp -68.78 -60.73 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 32' ' ' LYS . 21.3 t -131.52 -115.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.097 -1.002 . . . . 0.0 109.812 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.608 ' C ' HG21 ' A' ' 63' ' ' VAL . 3.9 tttp 53.96 50.45 16.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.401 -1.437 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -170.05 103.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -0.82 . . . . 0.0 109.803 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.6 22.11 61.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 140.04 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 110.12 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 m -76.95 88.28 3.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.7 m -67.04 -171.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 15.7 ttpp -147.64 155.87 42.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.053 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.15 93.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -0.958 . . . . 0.0 110.397 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.45 34.07 1.65 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.808 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -115.18 109.04 17.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 110.362 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.591 HG21 ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -52.22 109.8 0.42 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -130.02 -4.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 111.226 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.437 HD23 HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -131.05 164.21 25.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 110.658 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.811 HG13 ' CG2' ' A' ' 53' ' ' THR . 81.7 t -123.33 108.16 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 25' ' ' THR . 1.4 mm? -125.15 154.63 41.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.301 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.811 ' CG2' HG13 ' A' ' 45' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 121.164 0.507 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.591 ' HG3' HG21 ' A' ' 42' ' ' THR . 2.9 mp0 -56.57 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 111.08 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -99.63 98.43 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.185 -0.947 . . . . 0.0 109.755 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.98 131.71 44.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.837 . . . . 0.0 110.136 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 156.07 2.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.39 -49.03 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.701 1.369 . . . . 0.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.5 p -138.97 -172.5 3.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 110.202 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.457 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 6.3 p-10 -101.56 152.44 20.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 150.69 159.88 9.04 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -85.69 121.09 27.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.129 . . . . 0.0 110.356 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.608 HG21 ' C ' ' A' ' 32' ' ' LYS . 27.4 t -54.34 159.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -118.39 -14.87 9.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.438 -0.789 . . . . 0.0 110.123 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 tttt 179.97 149.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.73 159.5 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 109.558 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -138.27 -68.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.538 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.676 HG11 HD23 ' A' ' 80' ' ' LEU . 23.7 m -48.55 155.12 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.175 -0.953 . . . . 0.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' O ' HG11 ' A' ' 26' ' ' VAL . 9.5 mtmt -124.31 148.46 47.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.237 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.0 72.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -176.79 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.39 145.22 11.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' C ' HG12 ' A' ' 74' ' ' VAL . . . -135.91 135.18 39.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.491 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.5 p 36.91 48.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.883 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.33 97.87 6.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.09 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.96 156.31 19.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.43 18.27 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.71 155.94 17.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -1.213 . . . . 0.0 110.241 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.97 161.9 23.53 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 20' ' ' ALA . 9.4 mt -109.18 -68.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.736 HG22 HG23 ' A' ' 83' ' ' ILE . 36.3 mm -140.8 148.42 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 91.28 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.736 HG23 HG22 ' A' ' 81' ' ' ILE . 46.6 pt -125.45 45.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.224 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.571 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.13 0.491 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.0 25.88 5.16 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 53.24 25.32 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -1.132 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.79 49.85 0.09 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.48 -176.94 5.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 110.187 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.51 91.51 49.67 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.115 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.41 134.55 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.704 1.371 . . . . 0.0 110.709 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.81 142.62 69.95 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.54 -32.35 9.89 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.609 1.32 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 23' ' ' ALA . 5.8 tt -118.73 157.16 28.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -61.1 176.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 110.546 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -153.52 146.85 15.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -68.32 -141.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -1.125 . . . . 0.0 110.584 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 27' ' ' SER . 19.1 m -38.47 -46.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.518 -0.739 . . . . 0.0 112.539 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER 61.01 40.82 14.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.748 -1.22 . . . . 0.0 110.016 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -54.95 108.39 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 29' ' ' ILE . 12.2 tt -62.05 120.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.475 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.506 HD23 ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -88.2 -18.23 29.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.175 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.629 HG11 HD13 ' A' ' 81' ' ' ILE . 14.0 p -91.27 169.77 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 31' ' ' VAL . 23.9 tttt -123.7 159.55 29.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.72 142.49 53.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.9 . . . . 0.0 110.171 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.45 73.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -110.69 154.72 23.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.102 -1.234 . . . . 0.0 109.874 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 1.4 m -96.73 110.67 23.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.308 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' GLY . 34.5 m -81.92 157.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 25.1 tttt -120.06 160.44 22.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.294 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . -69.12 99.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.02 46.92 0.85 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 43' ' ' VAL . 38.7 tt0 -135.34 114.44 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -1.167 . . . . 0.0 109.809 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 42' ' ' THR . 12.6 t -55.25 105.12 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.575 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.1 m -104.52 0.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.942 -1.099 . . . . 0.0 110.227 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.81 156.82 42.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.952 -1.093 . . . . 0.0 110.472 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 30' ' ' LEU . 93.5 t -119.23 99.84 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.582 ' HB3' HD11 ' A' ' 55' ' ' ILE . 7.8 tt -105.83 151.0 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' N ' HD23 ' A' ' 46' ' ' LEU . 2.6 tt0 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.897 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.204 0.526 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.1 pt-20 -65.41 103.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 46' ' ' LEU . 48.6 mm -77.37 94.05 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 67.3 m-20 -77.31 133.16 38.85 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.629 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.77 170.09 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 49.9 Cg_endo -77.29 -54.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.762 1.401 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 58' ' ' PRO . 1.3 p -153.26 -166.12 2.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.361 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 52.3 t0 -78.56 123.59 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.395 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' HA3' HD11 ' A' ' 83' ' ' ILE . . . -173.42 -165.95 31.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.8 ttpt -133.27 153.48 51.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.131 -1.217 . . . . 0.0 110.384 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.709 HG22 ' CG2' ' A' ' 81' ' ' ILE . 37.9 t -80.19 125.14 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -88.64 -14.09 38.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.76 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.5 169.06 0.84 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.63 144.91 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -52.62 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 109.95 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 70' ' ' GLU . 11.3 p -53.05 154.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 18.0 mttt -94.28 -10.87 31.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -0.976 . . . . 0.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.797 ' H ' HG22 ' A' ' 68' ' ' VAL . 4.8 tt0 61.61 135.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.21 22.38 7.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.07 . . . . 0.0 109.949 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 69' ' ' LYS . 22.9 t70 -115.86 120.62 39.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 109.821 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -67.87 168.7 11.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 19.5 t 60.86 139.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.488 0.661 . . . . 0.0 110.648 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.04 43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.012 -1.055 . . . . 0.0 110.338 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.08 130.89 10.38 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.82 19.37 63.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 16.1 mt-30 -131.37 139.83 49.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -1.179 . . . . 0.0 110.14 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.75 140.85 29.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.1 mt -92.1 -47.71 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -1.188 . . . . 0.0 110.002 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.709 ' CG2' HG22 ' A' ' 63' ' ' VAL . 98.2 mt -137.2 151.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.2 ttmt -97.31 145.97 25.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.464 HD11 ' HA3' ' A' ' 61' ' ' GLY . 10.7 tt -147.46 159.08 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.615 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.96 -106.93 0.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -119.18 -49.36 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.159 . . . . 0.0 109.893 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' CA ' ' HG2' ' A' ' 82' ' ' LYS . . . -95.58 85.28 0.92 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.7 pm0 -157.96 150.78 22.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -1.079 . . . . 0.0 110.236 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 81' ' ' ILE . 78.5 mt -111.85 99.38 45.13 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.9 128.35 14.87 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.702 1.369 . . . . 0.0 110.472 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -69.84 138.05 87.82 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.079 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.46 -13.31 25.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.558 1.294 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.04 153.15 41.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.249 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.03 162.09 9.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.139 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.37 -165.04 34.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -150.55 149.23 29.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.295 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.879 HG21 HG13 ' A' ' 68' ' ' VAL . 90.0 t -88.69 132.89 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.57 -28.6 12.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 109.923 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.42 153.52 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.441 HG22 ' OE2' ' A' ' 70' ' ' GLU . 3.8 tt -112.46 149.56 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.478 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.696 HD13 HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -114.4 -36.0 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.009 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 43' ' ' VAL . 59.6 t -110.04 157.24 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.05 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -119.83 178.71 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -77.28 131.5 38.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.85 70.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.58 157.02 18.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.317 . . . . 0.0 110.421 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.69 174.7 8.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.919 . . . . 0.0 109.971 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 61' ' ' GLY . 11.4 p -157.61 166.28 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 110.212 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 37' ' ' VAL . 1.3 mtpm? -122.06 169.57 10.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -79.42 114.6 18.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.5 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -109.46 119.67 40.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -1.224 . . . . 0.0 110.006 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.696 HG22 HD13 ' A' ' 30' ' ' LEU . 88.6 m -53.19 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.374 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 41.5 t -64.73 -33.49 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 0.0 109.776 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -155.03 -177.74 6.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.627 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.94 125.67 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.053 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -100.74 177.67 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.242 0.544 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.79 112.69 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 46' ' ' LEU . 98.1 mt -82.61 89.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 70.1 m-80 -72.57 135.12 45.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.549 -0.719 . . . . 0.0 110.797 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.702 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -56.43 154.17 17.57 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.297 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 -46.19 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.746 1.393 . . . . 0.0 110.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.578 HG22 ' OD1' ' A' ' 60' ' ' ASP . 4.4 m -155.82 169.98 23.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.265 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.578 ' OD1' HG22 ' A' ' 59' ' ' THR . 9.5 p-10 -64.66 145.08 56.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 162.66 -156.47 28.17 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -132.2 150.96 52.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 66' ' ' VAL . 30.2 t -71.87 132.86 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -9.43 20.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.517 -0.739 . . . . 0.0 110.081 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 140.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.06 . . . . 0.0 109.837 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 63' ' ' VAL . 64.3 t -123.67 95.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.463 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.26 -18.07 59.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.103 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.879 HG13 HG21 ' A' ' 26' ' ' VAL . 39.6 t -69.67 143.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 110.342 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.99 15.87 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 110.349 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.1 tt0 61.97 135.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.324 -0.86 . . . . 0.0 110.586 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 32.75 17.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -127.59 116.85 20.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 25' ' ' THR . . . -64.52 146.21 54.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 80' ' ' LEU . 26.6 m -136.16 122.71 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 160.4 30.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.68 51.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 -2.76 30.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -97.79 123.73 41.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.363 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.5 137.68 48.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 20' ' ' ALA . 51.5 mt -107.43 -57.87 2.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -1.193 . . . . 0.0 110.352 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.57 HD13 HG11 ' A' ' 43' ' ' VAL . 16.4 tt -143.19 170.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.476 ' O ' HG23 ' A' ' 83' ' ' ILE . 8.0 tptp -143.02 172.26 12.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' LYS . 3.3 pt -153.39 131.89 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.668 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.242 0.544 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.39 -115.08 3.63 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -120.65 -35.01 3.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.65 15.42 11.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -97.09 124.24 41.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.255 . . . . 0.0 109.991 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.19 117.2 67.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.357 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.7 Cg_endo -73.89 134.33 19.68 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.386 1.203 . . . . 0.0 110.385 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -80.19 125.88 80.49 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.14 141.12 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.441 1.232 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.52 127.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.397 -0.814 . . . . 0.0 110.523 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.93 170.59 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 0.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.41 -177.8 47.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.2 m -133.99 147.16 50.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.85 134.52 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.1 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 p -110.16 -20.67 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.952 . . . . 0.0 110.141 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.93 122.8 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.311 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.494 ' O ' HD22 ' A' ' 30' ' ' LEU . 1.1 tt -83.39 144.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.082 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 29' ' ' ILE . 2.3 mm? -119.31 -24.8 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.917 . . . . 0.0 110.632 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.5 p -108.12 165.02 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.307 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -136.13 169.06 18.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 110.322 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -73.09 156.98 38.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 23.32 70.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.13 166.14 12.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -1.14 . . . . 0.0 110.075 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -109.11 128.12 54.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 61' ' ' GLY . 7.6 p -109.19 158.96 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' CG ' ' OD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -110.94 179.71 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.87 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . . . -90.1 124.55 34.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.098 -1.001 . . . . 0.0 110.33 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.33 29.55 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 43' ' ' VAL . 20.3 tt0 -113.82 122.31 46.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -1.174 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 24.2 m -56.6 109.91 0.7 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 57' ' ' ALA . 34.3 m -95.81 -21.14 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -147.93 173.94 12.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.992 -1.067 . . . . 0.0 111.348 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.491 HG23 HD23 ' A' ' 30' ' ' LEU . 45.7 t -126.2 113.33 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 109.251 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.35 165.46 11.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.01 -1.056 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.58 -0.7 . . . . 0.0 109.707 179.805 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 51.9 m . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 53' ' ' THR . 4.9 tt0 -60.94 102.11 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 111.076 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 43' ' ' VAL . 32.1 mm -103.94 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.941 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 56.8 m-80 -73.89 135.28 43.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.42 0.628 . . . . 0.0 110.694 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -55.35 167.81 0.67 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.547 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.0 Cg_endo -74.09 -52.47 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.761 1.4 . . . . 0.0 110.523 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.28 170.27 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.098 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 39' ' ' ALA . 3.6 m-20 -57.88 139.01 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 169.4 172.35 35.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -109.86 150.06 28.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -1.14 . . . . 0.0 109.974 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 33' ' ' GLU . 31.5 t -77.81 124.42 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.39 -6.81 23.56 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 110.003 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -177.87 150.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 109.92 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.62 146.28 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -119.92 -69.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.65 HG21 HD23 ' A' ' 80' ' ' LEU . 33.5 m -75.46 158.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -129.69 -165.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 155.26 20.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 55.53 25.86 8.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.27 105.61 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.245 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 137.55 50.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.004 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.9 p -130.23 132.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.74 -177.45 6.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.304 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.07 125.72 7.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.29 0.69 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -154.15 128.71 9.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.419 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.01 130.55 36.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 20' ' ' ALA . 10.9 mt -92.21 -70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -1.099 . . . . 0.0 109.698 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.3 mm -134.64 145.04 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 0.0 109.833 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.72 137.96 31.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.182 -0.949 . . . . 0.0 110.493 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.95 146.2 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.305 0.574 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.5 -173.71 44.11 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 135.72 56.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -1.147 . . . . 0.0 110.17 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . 102.61 -19.12 48.76 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' OE2' ' CD ' ' A' ' 82' ' ' LYS . 1.1 mp0 -110.04 127.7 54.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.248 . . . . 0.0 110.508 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.7 mp -82.38 111.93 32.24 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.793 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.88 143.35 45.19 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.41 1.216 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 1.014 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -85.86 135.73 37.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.123 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.58 133.81 17.74 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.592 1.312 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.36 -166.87 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.55 137.88 38.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.254 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.77 169.13 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 132.58 54.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.32 141.32 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 110.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -113.18 -24.45 9.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.52 140.78 0.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.855 . . . . 0.0 110.088 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 29' ' ' ILE . 11.0 tt -100.06 134.45 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.343 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -85.48 -56.18 3.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 43' ' ' VAL . 19.5 m -81.02 -177.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.364 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -145.93 52.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.028 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.622 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER 59.85 157.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.08 55.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 4.2 p30 -106.93 147.92 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.233 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.9 m -108.75 123.3 48.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.275 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 61' ' ' GLY . 35.6 m -108.81 -175.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.086 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 3.0 ttpt -142.7 49.58 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . 54.75 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.76 -13.32 7.7 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.339 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.8 tt0 -77.59 119.94 21.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.05 -1.264 . . . . 0.0 110.555 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.3 m -61.71 103.3 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.035 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 31' ' ' VAL . 34.7 m -86.78 -21.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -151.18 176.84 10.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG23 HD23 ' A' ' 30' ' ' LEU . 67.8 t -134.26 117.98 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.07 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -99.23 157.4 16.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.248 0.547 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 42' ' ' THR . 16.1 mt-10 -62.39 149.58 42.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 44' ' ' LEU . 64.6 mt -111.91 86.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.965 . . . . 0.0 110.613 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.2 m-20 -84.31 127.59 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.273 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.01 145.32 5.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 110.277 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -45.22 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.65 1.342 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.723 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 8.9 t -137.41 158.09 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 110.419 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 4.6 p30 -56.83 160.22 3.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 148.71 168.76 14.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 21.9 ttpt -109.53 139.56 44.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.7 t -64.66 135.45 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.03 . . . . 0.0 109.94 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.19 -17.66 16.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.83 156.06 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.008 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 81' ' ' ILE . 23.9 m -126.72 127.29 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.81 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.693 ' CD1' HG23 ' A' ' 68' ' ' VAL . 1.8 pp -104.79 -26.27 12.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.305 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 67' ' ' LEU . 84.3 t -98.97 150.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -164.87 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -79.75 151.38 30.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 110.148 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.52 39.11 27.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.79 -19.47 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.315 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.33 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.547 -0.721 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.96 145.33 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.392 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.4 171.53 8.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.24 119.83 18.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 44.51 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 125.35 27.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -54.78 139.49 39.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.014 HD11 ' HB2' ' A' ' 20' ' ' ALA . 8.6 mt -107.64 -61.01 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.203 -1.175 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.562 ' CD1' HG12 ' A' ' 66' ' ' VAL . 11.8 tt -143.56 151.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' CD ' ' OE2' ' A' ' 17' ' ' GLU . 4.5 ttpt -95.23 143.81 26.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.072 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.8 tt -136.07 151.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.888 -1.507 . . . . 0.0 109.573 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' N ' ' A' ' 79' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.262 0.553 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.67 -106.74 1.08 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -129.82 158.89 38.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.009 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.06 39.79 92.55 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 13' ' ' ALA . 2.0 pp20? -135.15 161.33 35.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -1.117 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.622 ' N ' HD12 ' A' ' 18' ' ' ILE . 4.7 mp -118.14 102.69 50.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.9 Cg_endo -72.12 156.6 55.47 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.656 1.345 . . . . 0.0 110.527 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -86.23 138.64 34.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.316 -0.865 . . . . 0.0 110.081 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.88 -27.37 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.609 1.321 . . . . 0.0 110.506 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.78 165.69 23.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.08 156.34 21.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . -134.28 -177.42 14.93 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 1.5 m -122.99 -133.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -1.198 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' SER . 15.7 m -36.8 -46.32 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.472 -0.768 . . . . 0.0 112.276 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t 54.95 42.41 31.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 0.0 109.918 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -51.93 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 29' ' ' ILE . 13.6 tt -68.09 86.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.5 mm? -54.04 -41.87 68.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.002 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.9 p -62.03 164.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 31' ' ' VAL . 5.5 ttmt -123.57 169.31 11.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 110.27 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.73 134.39 34.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.51 19.13 57.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.62 179.42 4.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.924 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -122.12 140.25 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.75 175.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -125.46 161.2 27.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -63.38 127.93 33.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.89 . . . . 0.0 110.084 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.56 19.13 45.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.719 ' O ' HG13 ' A' ' 43' ' ' VAL . 37.1 tt0 -109.36 111.65 23.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.243 . . . . 0.0 109.992 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 54.2 m -51.08 116.09 1.84 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.541 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.027 HG23 HD12 ' A' ' 44' ' ' LEU . 30.2 m -115.44 -22.56 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.842 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.027 HD12 HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -131.16 154.77 48.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 28' ' ' LYS . 98.6 t -128.2 109.76 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.215 -0.928 . . . . 0.0 110.818 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.653 HD22 ' HA3' ' A' ' 24' ' ' GLY . 30.5 mt -98.33 147.33 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 0.0 109.953 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.716 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.247 0.546 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.4 OUTLIER -77.85 118.58 20.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 46' ' ' LEU . 30.7 mm -88.75 90.07 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.575 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.0 p-10 -73.45 132.36 42.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 110.064 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.37 1.93 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.362 -0.836 . . . . 0.0 110.665 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.88 -40.22 1.97 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.569 1.299 . . . . 0.0 110.644 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 79.4 m -156.09 153.4 29.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.255 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 24.7 t70 -55.79 140.94 40.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.45 177.8 39.73 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.19 142.29 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -1.141 . . . . 0.0 110.045 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 81' ' ' ILE . 41.9 t -71.8 129.73 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.95 -6.66 35.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 110.362 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -174.84 148.14 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 110.204 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 81' ' ' ILE . 7.1 p -105.14 144.49 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.97 -53.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 70' ' ' GLU . 92.5 t -53.46 128.21 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -80.15 1.75 26.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 68' ' ' VAL . 18.8 tt0 61.95 132.39 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.64 26.38 12.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.077 . . . . 0.0 110.136 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.1 t0 -126.41 120.63 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' THR . . . -54.18 142.95 24.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.963 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 72' ' ' ASP . 35.9 m -136.66 171.39 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.967 -1.083 . . . . 0.0 110.426 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -113.34 -179.23 3.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.79 140.78 15.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.22 20.62 10.9 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.2 mm-40 -125.97 143.85 50.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.164 . . . . 0.0 110.111 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.04 144.48 49.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 48.9 mt -104.85 -42.73 5.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 66' ' ' VAL . 1.9 tp -167.72 143.51 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -92.46 147.95 22.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.957 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.3 pt -133.76 158.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.467 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.28 0.562 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.33 59.6 0.53 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 53.65 79.03 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.23 -56.49 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -53.1 143.62 17.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.126 . . . . 0.0 110.362 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -113.33 131.87 22.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -73.34 144.7 37.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.524 1.276 . . . . 0.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -113.25 74.34 1.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.959 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.54 61.84 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.772 1.406 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 22' ' ' LEU . 1.7 mm? -113.01 -12.46 13.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.62 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 46' ' ' LEU . . . 55.01 -174.16 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.054 -1.029 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . 113.29 -162.48 12.35 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.483 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 10.4 p -130.46 101.0 5.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.254 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.547 ' H ' ' HB2' ' A' ' 73' ' ' ALA . 34.5 m -55.05 137.01 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.171 -0.956 . . . . 0.0 109.802 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -22.62 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.958 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -178.32 166.12 1.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.989 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.492 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -114.16 145.85 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.0 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 29' ' ' ILE . 3.3 mm? -117.59 -15.77 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.75 140.0 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 178.79 4.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.887 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.79 143.47 28.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 110.183 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.9 21.64 65.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.41 158.28 25.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -1.167 . . . . 0.0 110.118 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 134.56 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.06 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 2.0 ttpm? -138.64 146.91 42.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -58.9 103.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 -7.31 8.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -94.33 121.8 36.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.855 -1.379 . . . . 0.0 110.376 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.54 HG21 ' CG ' ' A' ' 54' ' ' GLU . 1.3 m -51.11 129.6 24.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.155 -0.966 . . . . 0.0 110.012 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 55' ' ' ILE . 31.1 m -124.91 -24.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 111.191 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.93 167.53 21.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.883 -1.136 . . . . 0.0 111.091 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 53' ' ' THR . 85.5 t -123.64 121.18 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 109.678 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 23' ' ' ALA . 8.8 tt -151.41 140.87 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.0 110.523 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' OG1' ' A' ' 25' ' ' THR . 4.4 pt-20 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 55' ' ' ILE . 24.9 p . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.798 0.333 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -52.14 104.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.632 -1.292 . . . . 0.0 110.79 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 43' ' ' VAL . 24.3 mm -94.01 90.96 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 37.8 p-10 -49.38 147.04 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.502 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 38' ' ' LYS . . . -57.79 151.68 41.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.979 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 59' ' ' THR . 45.1 Cg_endo -72.66 -27.85 14.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.164 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -170.62 -171.86 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.948 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -103.6 144.05 31.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.52 -155.23 26.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -127.49 144.35 51.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.093 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 81' ' ' ILE . 39.4 t -76.18 100.88 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 110.111 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.73 -15.37 63.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.743 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER 177.24 161.1 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 81' ' ' ILE . 92.5 t -131.51 129.44 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.587 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.1 pp -109.9 -28.04 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.979 . . . . 0.0 110.641 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 80' ' ' LEU . 35.4 m -78.84 -176.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.051 -1.031 . . . . 0.0 110.306 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.2 155.53 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -50.95 165.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER 74.09 -42.63 0.51 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.538 -0.726 . . . . 0.0 111.949 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.41 129.06 30.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' GLY . . . -165.12 -156.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.377 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 84.6 t 57.4 115.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.607 0.718 . . . . 0.0 111.196 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 51.88 93.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.622 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.05 -136.34 0.25 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.12 7.07 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -141.46 140.54 33.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.184 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.587 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.19 148.07 5.54 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 20' ' ' ALA . 4.1 mt -91.51 -70.76 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -1.107 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.698 HD13 HG22 ' A' ' 63' ' ' VAL . 2.7 pp -152.29 154.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 110.099 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.61 130.27 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.18 22.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.944 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 17' ' ' GLU . . . -64.56 -124.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -120.61 -25.85 5.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.15 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.79 64.93 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLY . 1.8 pm0 -129.59 166.95 18.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 83' ' ' ILE . 2.7 mp -118.47 104.55 47.51 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.92 138.23 30.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.587 1.309 . . . . 0.0 110.27 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -101.17 148.69 35.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 110.33 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.43 -24.09 19.63 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.679 1.358 . . . . 0.0 110.171 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.79 96.64 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 109.911 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' H ' ' A' ' 76' ' ' GLY . . . -49.95 -62.41 1.59 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.209 -0.932 . . . . 0.0 110.004 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' HD13 ' A' ' 46' ' ' LEU . . . 90.89 -170.02 34.34 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 80.34 8.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.33 114.48 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.3 m -111.58 -36.46 5.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 142.85 31.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -107.26 113.4 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 110.051 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 45' ' ' VAL . 2.8 mm? -79.33 -25.49 42.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.537 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 32' ' ' LYS . 8.6 p -90.3 161.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.421 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' HG22 ' A' ' 31' ' ' VAL . 3.5 ttpt -134.82 -167.89 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.901 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -94.66 133.73 38.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.048 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.41 -1.61 88.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.51 137.4 32.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.33 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -85.93 124.47 32.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.547 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 61' ' ' GLY . 25.5 m -102.55 -175.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.937 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 16.6 mmtt -139.45 164.72 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.8 98.8 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.86 19.31 6.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.687 ' O ' HG13 ' A' ' 43' ' ' VAL . 15.4 tt0 -106.18 118.94 37.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.1 -1.235 . . . . 0.0 109.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -49.08 128.12 15.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.972 -1.08 . . . . 0.0 110.659 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 41' ' ' GLN . 17.9 m -128.76 -31.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.717 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.57 161.34 27.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 53' ' ' THR . 41.4 t -132.07 126.36 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.264 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -134.07 167.36 20.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 54' ' ' GLU . 88.6 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.622 0.248 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 53' ' ' THR . 33.6 mt-10 -50.53 114.42 1.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.586 -1.321 . . . . 0.0 111.303 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 46' ' ' LEU . 13.7 mm -106.79 99.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.81 134.57 55.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.565 -0.709 . . . . 0.0 110.458 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -52.89 154.96 4.54 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.701 ' HG3' HG21 ' A' ' 18' ' ' ILE . 50.8 Cg_endo -77.04 -38.9 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.693 1.365 . . . . 0.0 110.539 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.73 149.68 28.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.4 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 2.6 p30 -65.49 153.1 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.647 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 151.68 161.54 10.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -84.3 142.52 30.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -1.084 . . . . 0.0 110.205 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.73 131.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.213 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -91.45 -15.32 29.05 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.457 -0.777 . . . . 0.0 109.801 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt 179.55 166.64 1.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.214 -0.929 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 66' ' ' VAL . 11.8 m -131.1 105.9 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 109.909 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.3 pp -96.29 -28.13 14.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.962 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.59 155.26 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -135.17 159.62 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.633 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.7 74.33 6.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.92 -36.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.818 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -51.96 107.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.29 124.63 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.689 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 57.43 113.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.702 -0.624 . . . . 0.0 110.78 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.4 tt0 -153.68 -77.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.988 -1.07 . . . . 0.0 111.298 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 23' ' ' ALA . . . 64.3 132.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.85 2.22 39.66 Favored Glycine 0 N--CA 1.491 2.306 0 O-C-N 121.09 -1.241 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -127.95 146.59 50.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.804 -1.41 . . . . 0.0 110.244 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.651 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -63.39 141.45 45.94 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 20' ' ' ALA . 23.0 mt -84.85 -48.86 8.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.325 -1.103 . . . . 0.0 110.002 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.438 HG23 ' C ' ' A' ' 80' ' ' LEU . 29.6 pt -149.07 152.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 110.173 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 157.87 36.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 18' ' ' ILE . 1.9 tt -162.88 149.78 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.16 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' ' CA ' ' A' ' 79' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.24 0.543 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.25 -155.49 6.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.13 127.94 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -1.108 . . . . 0.0 110.236 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.34 -57.23 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.75 162.12 19.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -1.205 . . . . 0.0 110.197 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 pt -133.19 135.56 25.82 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.0 Cg_endo -72.42 155.97 54.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.615 1.324 . . . . 0.0 110.688 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 75' ' ' GLN . . . -83.71 131.24 52.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.09 -19.9 17.21 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.54 1.284 . . . . 0.0 110.625 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -129.79 148.76 51.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' H ' HD13 ' A' ' 22' ' ' LEU . . . -85.44 166.11 16.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.546 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . 166.23 -179.89 40.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 46' ' ' LEU . 14.6 m -113.62 127.36 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.17 139.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 109.891 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 m -134.98 -39.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.7 148.46 45.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.37 151.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 HG22 ' A' ' 42' ' ' THR . 2.4 mp -129.37 -49.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.499 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 43' ' ' VAL . 9.3 p -51.45 143.76 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.272 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -103.85 157.84 16.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.006 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 63' ' ' VAL . 5.4 pt-20 -83.66 146.6 28.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.12 58.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.15 173.99 6.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.296 . . . . 0.0 110.052 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.5 m -106.47 110.22 22.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.086 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 ' CG1' ' A' ' 43' ' ' VAL . 14.9 p -87.45 145.07 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.86 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -100.9 152.66 20.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.206 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 130.68 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.59 21.39 29.13 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 43' ' ' VAL . 1.6 tt0 -116.44 121.77 42.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -1.212 . . . . 0.0 110.29 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.9 m -53.57 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 33.8 m -86.07 -21.7 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.77 171.27 16.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -136.74 140.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.586 ' HG ' HD11 ' A' ' 55' ' ' ILE . 11.8 mt -110.99 170.32 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 110.19 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.5 132.41 49.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 110.217 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 44' ' ' LEU . 85.8 mt -98.9 87.08 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.6 m-20 -74.09 129.37 37.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.555 -0.716 . . . . 0.0 110.35 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.716 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -48.55 138.99 11.43 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.436 -0.79 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.93 -37.61 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.595 1.313 . . . . 0.0 110.82 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -144.67 149.34 35.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 110.549 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.16 153.0 31.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.21 -166.55 39.75 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -127.61 143.03 51.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 33' ' ' GLU . 12.8 t -84.06 141.92 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -0.886 . . . . 0.0 110.274 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.4 -11.3 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.571 -0.706 . . . . 0.0 110.263 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 178.19 107.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 110.079 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -97.6 143.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.874 HD11 ' O ' ' A' ' 79' ' ' GLY . 1.4 pp -118.62 -23.91 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.053 -1.029 . . . . 0.0 110.544 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 80' ' ' LEU . 35.2 m -61.97 163.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 110.166 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 71' ' ' ARG . 13.7 mtmt -157.63 158.71 36.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.99 68.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -173.62 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.81 149.16 27.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.525 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -127.57 179.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.0 109.874 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' C ' ' A' ' 73' ' ' ALA . 29.2 m 36.22 68.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 65.9 mm-40 -75.44 -0.82 21.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -54.97 104.62 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.01 57.53 1.9 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.3 tt0 -163.24 138.33 6.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -1.127 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.874 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -52.13 136.45 34.45 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.856 ' O ' HG13 ' A' ' 68' ' ' VAL . 10.8 mt -102.15 -71.52 0.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.315 -1.109 . . . . 0.0 109.952 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.423 HG23 ' C ' ' A' ' 80' ' ' LEU . 26.4 pt -148.64 152.43 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -90.79 123.63 34.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.079 -1.013 . . . . 0.0 110.487 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.3 tt -129.74 142.22 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.507 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.266 0.555 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.26 156.02 21.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -54.06 134.59 43.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -1.168 . . . . 0.0 110.314 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 -23.07 37.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CG ' ' HD2' ' A' ' 82' ' ' LYS . 15.2 mt-10 -91.87 155.96 17.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.58 104.71 55.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.5 Cg_endo -73.4 164.11 35.99 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.567 1.298 . . . . 0.0 110.766 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -81.56 156.11 70.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.849 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.51 -36.97 3.45 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.716 1.377 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.26 -53.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.972 . . . . 0.0 110.325 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -167.62 179.19 4.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.378 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 177.43 160.46 24.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.8 p -115.96 90.83 3.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.174 . . . . 0.0 110.439 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.715 HG21 ' CG2' ' A' ' 68' ' ' VAL . 41.4 t -63.81 136.23 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 109.667 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.4 m -127.39 -30.67 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.013 -1.054 . . . . 0.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.83 159.12 41.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.604 ' CD1' HG11 ' A' ' 66' ' ' VAL . 6.2 tt -129.21 135.26 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.7 mm? -93.35 -40.2 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.942 . . . . 0.0 109.987 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 31' ' ' VAL . 35.6 m -91.02 -170.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 109.804 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -165.78 -45.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.655 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.0 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.15 31.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -54.71 115.32 2.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -1.17 . . . . 0.0 109.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 19.0 m -75.86 95.84 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.17 165.27 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 4.1 mttp -124.42 165.01 18.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.33 110.59 2.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.5 36.9 11.36 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.833 ' O ' HG13 ' A' ' 43' ' ' VAL . 5.5 tt0 -116.25 114.26 24.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -1.103 . . . . 0.0 110.073 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 54' ' ' GLU . 1.4 m -52.58 118.58 3.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 41' ' ' GLN . 35.3 m -124.16 -10.5 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.915 . . . . 0.0 110.943 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.39 160.37 42.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 110.738 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' THR . 89.2 t -109.68 117.19 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.617 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -150.37 134.89 17.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.408 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 110.115 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 120.942 0.401 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.1 OUTLIER -71.44 98.93 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.892 -1.13 . . . . 0.0 110.552 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 53' ' ' THR . 29.5 mm -105.54 98.6 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 11.6 m-20 -74.31 133.34 42.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.649 -0.657 . . . . 0.0 110.123 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -47.84 166.21 0.21 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.369 -0.832 . . . . 0.0 110.468 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.9 Cg_endo -72.69 -32.89 8.92 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.734 1.386 . . . . 0.0 110.526 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 t -173.39 171.08 4.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.7 p-10 -65.09 131.71 47.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' THR . . . 170.17 -176.59 43.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.61 142.3 35.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -1.099 . . . . 0.0 110.208 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.13 109.49 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.56 -17.66 60.7 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.704 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 176.87 164.65 0.49 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.257 -0.902 . . . . 0.0 109.998 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 68' ' ' VAL . 48.8 t -123.99 88.51 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -42.03 70.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.022 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.746 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 p -80.92 147.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -146.38 174.9 10.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.65 76.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.298 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER 179.9 -51.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 110.131 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.66 138.83 40.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.872 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -158.56 158.82 34.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.536 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 23.1 m 36.73 49.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.257 0.551 . . . . 0.0 111.7 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -154.03 85.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -92.72 -172.97 41.13 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.84 -25.75 25.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -101.25 160.46 14.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -1.155 . . . . 0.0 110.301 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.66 171.2 5.81 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -131.84 -58.02 0.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.24 -1.153 . . . . 0.0 110.04 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 44' ' ' LEU . 2.7 mp -136.88 146.38 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.192 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 17' ' ' GLU . 2.5 tttm -106.15 131.91 52.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.875 . . . . 0.0 110.141 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.62 35.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB3' ' HD2' ' A' ' 2' ' ' LYS . 1.3 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.234 0.54 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -143.78 168.17 20.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt -137.15 154.99 50.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 110.268 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -121.02 120.57 35.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.43 38.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 59.06 159.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -137.76 68.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -111.1 132.11 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.167 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.48 -29.27 3.65 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.03 -172.87 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 0.0 110.205 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.32 -127.84 4.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -134.36 28.4 3.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -1.166 . . . . 0.0 110.179 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.43 122.18 11.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 110.193 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.07 -131.78 3.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -125.25 106.48 9.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -1.151 . . . . 0.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.14 -31.23 4.98 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.44 168.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 110.629 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.34 105.03 34.08 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.0 Cg_endo -70.96 139.55 36.29 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.582 1.306 . . . . 0.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.737 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -69.55 174.3 3.16 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 0.0 110.297 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 47.7 Cg_endo -74.18 -53.34 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.722 1.38 . . . . 0.0 110.384 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 22' ' ' LEU . 5.5 mt -151.84 -49.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.922 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -175.35 177.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 48' ' ' ALA . . . 177.42 -171.06 43.77 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -126.96 104.8 8.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -1.109 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.651 HG22 HD11 ' A' ' 46' ' ' LEU . 64.4 t -55.95 155.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -128.14 -40.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -174.0 133.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG22 ' A' ' 29' ' ' ILE . 15.3 tt -98.48 151.13 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.9 mm? -106.42 -58.76 1.88 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.327 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 33' ' ' GLU . 95.6 t -70.61 150.9 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 1.3 mttt -118.17 42.59 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HA ' HG11 ' A' ' 63' ' ' VAL . 13.3 tm-20 59.77 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.616 0.722 . . . . 0.0 110.698 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.74 20.29 66.1 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.45 136.54 52.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.965 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -71.84 159.57 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 110.106 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 57' ' ' ALA . 9.2 p -147.01 165.57 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -122.64 177.1 5.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.114 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.96 103.33 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.77 -19.02 9.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.22 112.63 2.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.123 -1.222 . . . . 0.0 110.297 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 89.1 m -52.1 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 HD23 ' A' ' 44' ' ' LEU . 59.8 t -57.77 -37.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.844 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.928 HD11 HD12 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -167.11 -160.01 0.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.577 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 46' ' ' LEU . 39.9 t -143.03 148.16 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -150.22 173.68 13.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.058 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -161.79 100.14 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HB2' ' HA3' ' A' ' 24' ' ' GLY . . . -118.39 -52.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 49.57 0.92 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.43 48.76 16.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 110.0 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.6 ttm -152.33 27.32 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -143.06 -81.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.965 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER 51.92 -152.44 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.157 -0.964 . . . . 0.0 110.254 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER -54.25 109.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.211 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.928 HD12 HD11 ' A' ' 44' ' ' LEU . 48.1 mt -88.82 102.64 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 13.9 p-10 -75.99 138.21 40.77 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.602 0.715 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 37' ' ' VAL . . . -54.23 145.9 33.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.887 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.01 -37.05 3.79 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.593 1.312 . . . . 0.0 110.637 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -155.5 160.91 40.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.49 142.62 48.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.04 -164.33 37.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -132.03 148.47 52.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -1.133 . . . . 0.0 110.035 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.0 t -84.73 138.16 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.51 -25.37 16.88 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.475 -0.766 . . . . 0.0 109.05 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.17 137.47 0.1 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 109.75 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.4 p -93.31 130.37 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.438 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.49 -50.79 4.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.047 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 69' ' ' LYS . 11.4 p -58.04 163.06 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 68' ' ' VAL . 7.9 ttmt -136.15 160.35 38.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.007 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 58.07 28.85 16.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HG23 ' A' ' 26' ' ' VAL . 46.3 t0 -113.25 112.96 24.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.867 . . . . 0.0 109.824 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -105.09 177.33 4.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 110.602 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.922 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 33.6 m 36.84 56.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.294 0.569 . . . . 0.0 111.709 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.523 ' NE2' ' OD2' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -136.85 71.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.065 -1.022 . . . . 0.0 110.48 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -116.07 168.85 12.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 -29.61 12.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -102.77 152.51 21.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -1.059 . . . . 0.0 109.914 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.55 136.66 43.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.3 mt -88.83 -51.09 5.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -1.17 . . . . 0.0 110.058 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.99 139.97 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.099 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -93.5 134.81 35.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -145.78 147.15 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.151 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.247 0.546 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.44 40.47 3.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 85.73 5.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.81 -178.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.254 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.6 p -71.71 125.27 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.1 p -127.66 -70.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.134 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.44 148.18 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -133.73 131.62 39.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.158 -0.964 . . . . 0.0 110.316 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.46 155.14 24.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 51.38 84.1 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -1.11 . . . . 0.0 110.444 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 57.42 0.09 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -122.21 22.29 10.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -1.157 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.71 -168.63 1.33 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 110.129 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.18 158.26 27.17 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.13 -28.05 66.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -1.09 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.03 -24.14 25.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -80.41 150.51 29.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -1.123 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.9 100.1 53.2 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.956 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -72.42 164.67 34.92 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.676 1.356 . . . . 0.0 110.956 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 119.8 74.5 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.848 . . . . 0.0 109.984 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.94 0.03 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.45 1.237 . . . . 0.0 111.152 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.54 59.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.829 -1.169 . . . . 0.0 110.389 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.87 -167.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.77 156.65 7.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.463 ' C ' HD23 ' A' ' 46' ' ' LEU . 92.4 m -103.68 108.29 19.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -1.168 . . . . 0.0 110.29 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 72' ' ' ASP . 44.9 t -72.37 125.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.73 -46.25 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 110.569 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.16 152.8 13.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.008 . . . . 0.0 110.137 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 44' ' ' LEU . 21.5 pt -118.76 135.35 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.152 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.1 mp -92.29 -3.16 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 63' ' ' VAL . 12.0 p -93.8 151.64 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.79 153.3 44.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.054 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -68.18 131.55 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.132 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.77 16.72 67.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.95 158.7 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -1.2 . . . . 0.0 109.968 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 59.2 m -105.37 129.21 53.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.3 m -113.75 174.09 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 6.1 mtpm? -128.52 152.6 48.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -62.52 116.4 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.94 -24.98 9.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 tt0 -76.41 122.66 24.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 55' ' ' ILE . 5.0 m -59.05 104.59 0.25 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.178 -0.951 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 41' ' ' GLN . 23.8 m -91.0 -15.09 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.59 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -145.14 160.32 41.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.191 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.52 122.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 25' ' ' THR . 1.9 mt -113.89 172.91 6.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -139.54 129.32 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 110.373 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.95 139.83 22.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.82 39.73 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 tttt 52.96 46.82 26.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.73 -179.69 5.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.3 136.66 44.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.145 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -126.29 74.68 1.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.408 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -54.25 129.92 36.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 42' ' ' THR . 37.9 mm -101.71 90.35 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.36 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -65.38 141.42 58.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -52.58 150.58 9.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.166 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.31 -31.48 11.56 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.675 1.355 . . . . 0.0 110.497 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.631 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 7.3 t -174.69 166.25 3.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.04 123.47 18.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 175.16 170.57 38.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 63' ' ' VAL . 11.1 ttmt -104.93 152.86 22.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 31' ' ' VAL . 15.1 t -71.92 143.91 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 110.152 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.05 -17.98 11.32 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.44 117.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.164 -0.96 . . . . 0.0 110.387 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -100.89 132.67 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.117 -0.99 . . . . 0.0 109.852 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.18 -21.81 9.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.045 -1.034 . . . . 0.0 110.723 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 7.5 p -59.86 148.83 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.82 145.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.42 76.13 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 177.83 -45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.305 -0.872 . . . . 0.0 110.1 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 23.6 t0 -55.3 128.13 32.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.277 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -140.68 164.65 29.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 75' ' ' GLN . 85.1 t 56.44 164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.789 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 57.44 111.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.389 -0.819 . . . . 0.0 110.877 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.3 -159.78 27.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.91 -19.2 55.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 6.2 mt-30 -92.68 138.51 31.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -1.213 . . . . 0.0 110.421 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.58 177.03 0.36 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -135.5 -65.9 0.59 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.75 142.37 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -100.42 120.83 40.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.86 128.55 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.884 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.309 0.576 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 59.67 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -162.25 -50.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.96 . . . . 0.0 110.309 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -117.48 124.13 48.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.8 -61.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 6' ' ' THR . 45.1 m -159.54 31.2 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.2 m -119.93 -20.45 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 54.83 77.56 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.53 -174.44 43.85 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.51 -55.13 2.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 135.69 0.14 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -88.04 88.4 7.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.163 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.77 161.9 28.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.73 -107.26 3.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.4 tt0 -140.33 104.31 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -1.151 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.93 -39.53 2.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -54.66 157.48 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -1.093 . . . . 0.0 110.476 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 18' ' ' ILE . 5.1 mp -116.13 104.63 52.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 109.928 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 43.7 Cg_endo -71.18 136.74 29.95 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.585 1.308 . . . . 0.0 110.533 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -64.54 139.2 97.68 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.76 -24.13 13.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.61 1.321 . . . . 0.0 110.623 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -131.51 166.24 21.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 75' ' ' GLN . . . -75.06 174.92 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.299 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.3 179.36 39.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.1 m -133.42 137.32 45.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 110.156 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 41.9 t -69.67 118.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.69 -28.63 19.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.69 126.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.868 HD12 HD21 ' A' ' 44' ' ' LEU . 1.4 tt -81.48 150.34 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 -38.38 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.171 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.13 176.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.412 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.35 46.01 1.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.321 -0.862 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.746 ' HA ' HG11 ' A' ' 63' ' ' VAL . 1.4 tt0 59.82 155.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.26 28.22 42.09 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.61 124.73 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.164 . . . . 0.0 110.288 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 61' ' ' GLY . 25.8 m -69.64 149.93 47.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 57' ' ' ALA . 7.2 p -136.7 161.51 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 37' ' ' VAL . 3.7 ttmm -115.48 155.27 27.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.95 109.94 1.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.211 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 28.73 4.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -118.16 115.24 24.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -1.214 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 87.0 m -54.42 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 55' ' ' ILE . 20.5 m -69.07 -22.65 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.22 172.3 16.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.493 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 97.1 t -119.36 130.55 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.034 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 -177.8 3.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' CG ' ' HB2' ' A' ' 50' ' ' LYS . 1.0 OUTLIER 52.82 -176.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.3 -62.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.318 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -30.72 16.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 47' ' ' GLU . 37.4 mttt -69.87 -52.64 23.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.162 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.4 tpp -175.79 117.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.111 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.12 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.0 110.07 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.4 m -80.26 134.8 36.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.373 -0.829 . . . . 0.0 110.471 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.7 103.46 14.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.675 ' O ' HG22 ' A' ' 43' ' ' VAL . 41.0 mm -68.85 91.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.553 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -77.24 131.41 38.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.434 -0.791 . . . . 0.0 110.238 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -50.2 156.41 1.4 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 -37.92 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.694 1.365 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -158.8 178.3 10.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.18 132.12 38.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 36' ' ' THR . . . 174.85 -135.44 3.09 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -154.41 150.13 27.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.272 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 33' ' ' GLU . 9.1 t -64.25 142.11 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.053 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -115.6 -18.38 10.91 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.843 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 3.4 tmtm? 179.24 89.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.6 p -79.8 117.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.974 . . . . 0.0 110.202 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.753 HD11 ' O ' ' A' ' 79' ' ' GLY . 2.7 pp -96.93 -25.71 15.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.79 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.293 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -132.16 160.19 36.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.34 153.58 43.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.917 . . . . 0.0 110.224 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 55.13 21.63 4.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.313 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.05 87.32 2.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.163 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.22 149.09 13.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 75' ' ' GLN . 13.2 p -153.0 164.12 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.114 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -106.15 -179.21 3.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.48 129.56 10.54 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 35.42 2.24 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -136.19 126.32 26.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -1.148 . . . . 0.0 110.14 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.753 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.91 151.17 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 20' ' ' ALA . 67.8 mt -118.58 -64.21 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -1.115 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 66' ' ' VAL . 1.8 pp -135.31 133.64 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.198 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -82.45 143.66 31.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.403 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.2 tt -164.82 161.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.547 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -74.86 -59.09 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.196 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 mt -111.7 -171.03 1.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 110.332 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 16.9 tptp -132.18 -54.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.904 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 16.0 t 61.14 137.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.525 0.678 . . . . 0.0 110.571 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.5 p -99.14 37.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 110.018 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 7' ' ' VAL . 46.7 t -128.46 19.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.43 146.12 23.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 110.157 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.25 155.35 6.81 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.66 131.66 52.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 110.202 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.59 -75.41 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.39 177.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -1.213 . . . . 0.0 110.106 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.54 -168.86 1.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 110.545 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.95 -168.53 17.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.06 78.45 3.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -1.186 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.79 -20.88 1.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.53 170.49 9.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -1.166 . . . . 0.0 110.234 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.45 132.14 24.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 109.97 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.9 Cg_endo -74.36 131.71 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.51 1.268 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -55.48 137.27 69.66 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.4 113.93 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.582 1.306 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.5 mm? 49.45 48.95 20.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 -154.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 0.0 110.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.732 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 143.06 172.46 14.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.5 p -112.49 112.22 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.481 HG21 ' OD2' ' A' ' 72' ' ' ASP . 38.8 t -76.18 112.31 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.982 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.6 -9.25 12.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.715 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -168.46 151.24 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.983 -1.073 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.25 145.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 30' ' ' LEU . 2.2 mm? -107.39 -42.31 4.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.118 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 43' ' ' VAL . 7.6 p -71.76 165.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.204 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 31' ' ' VAL . 25.7 tttt -140.92 163.21 33.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HB3' HG13 ' A' ' 66' ' ' VAL . 9.3 pt-20 -68.46 135.42 51.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.0 22.69 68.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.21 130.02 55.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.7 m -75.43 118.56 18.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.058 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.5 p -98.19 151.49 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.66 156.07 21.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 109.99 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 121.42 14.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -5.67 44.55 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.496 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ALA . 1.5 tt0 -85.5 123.64 31.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.819 -1.401 . . . . 0.0 110.441 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.2 m -55.68 102.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.285 -0.884 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.4 m -81.48 -23.0 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -154.2 162.97 40.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.613 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.94 125.26 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.732 HD21 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -98.91 168.03 10.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 82.14 1.98 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 110.291 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.07 -157.92 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 0.0 110.113 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -57.81 -23.05 50.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -67.19 -14.63 63.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.887 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 57.3 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.074 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 57.16 74.31 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -96.23 132.08 42.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.248 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.25 113.58 25.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' HB3' ' A' ' 44' ' ' LEU . 49.7 mt -81.25 94.2 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.324 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 3.7 m-20 -66.67 148.79 51.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.407 0.622 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -65.19 146.47 98.93 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.51 -0.744 . . . . 0.0 110.352 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.09 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.703 1.37 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.75 150.5 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.98 147.99 52.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.175 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.5 -164.22 37.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -125.65 142.3 51.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -1.107 . . . . 0.0 110.251 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 18.7 t -80.06 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.019 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.58 -15.11 13.1 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.569 -0.707 . . . . 0.0 109.851 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.09 131.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.104 -0.998 . . . . 0.0 110.163 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 33' ' ' GLU . 32.5 m -73.31 150.69 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 79' ' ' GLY . 0.5 OUTLIER -125.12 -58.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' OD2' ' A' ' 72' ' ' ASP . 41.3 t -84.54 154.94 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 71' ' ' ARG . 9.1 mmtt -135.33 166.01 24.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 4.4 mt-10 -63.79 80.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -176.88 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.481 ' OD2' HG21 ' A' ' 26' ' ' VAL . 15.8 p-10 -52.7 125.03 15.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -122.2 158.68 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.204 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 73' ' ' ALA . 26.7 m 36.6 42.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 121.285 0.564 . . . . 0.0 111.694 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.883 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -99.46 150.12 19.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.68 14.88 64.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 24.8 tt0 -99.34 150.25 22.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.287 . . . . 0.0 110.119 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.532 ' O ' HD13 ' A' ' 67' ' ' LEU . . . -66.47 106.28 1.57 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 2.7 mt -55.73 -79.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -1.156 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.5 mt -144.54 160.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -88.47 132.61 34.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.067 -1.02 . . . . 0.0 110.126 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.78 33.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.594 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.329 0.585 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -125.78 147.28 49.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.03 -177.78 3.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.136 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 147.02 23.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.86 103.28 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.8 m -88.09 -25.42 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 8' ' ' ASN . 14.2 p -91.35 163.84 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' N ' HG22 ' A' ' 7' ' ' VAL . 8.4 t-20 -91.45 156.38 17.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -166.2 -157.8 10.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 9' ' ' GLY . . . 54.65 -160.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -1.195 . . . . 0.0 110.152 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' ALA . . . 110.45 74.81 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 tptt 55.24 -88.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.483 -1.01 . . . . 0.0 110.384 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . -158.3 152.82 24.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.253 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.72 170.17 13.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.17 107.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.12 -24.73 5.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -94.64 158.2 15.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -1.143 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -124.54 111.64 27.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.8 Cg_endo -72.42 157.92 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.513 1.27 . . . . 0.0 110.793 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -95.77 112.49 59.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.92 -3.71 14.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.55 1.289 . . . . 0.0 111.28 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -142.18 33.2 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 110.725 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.89 -157.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.139 -0.975 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.84 -159.17 20.62 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.23 -146.83 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -1.176 . . . . 0.0 110.115 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 m -47.68 -31.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.049 -1.032 . . . . 0.0 111.147 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p 57.18 39.49 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -66.43 101.15 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 29' ' ' ILE . 5.5 tt -62.3 115.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.457 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 45' ' ' VAL . 28.4 mt -69.9 -26.75 64.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.944 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 31' ' ' VAL . 23.4 m -98.98 -158.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.177 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.84 -178.45 6.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -81.49 151.81 27.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 110.075 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.72 5.13 83.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.49 167.65 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.002 -1.293 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -103.75 156.53 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.327 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 38' ' ' LYS . 7.7 p -137.85 167.76 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -129.35 160.1 34.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 121.48 15.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.303 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.27 44.95 6.04 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.814 ' O ' HG13 ' A' ' 43' ' ' VAL . 3.4 tt0 -132.34 110.11 10.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 54' ' ' GLU . 93.8 m -53.07 114.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -124.72 -12.9 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.884 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 HD12 HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -132.45 166.35 22.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.848 -1.157 . . . . 0.0 110.909 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG13 HG23 ' A' ' 53' ' ' THR . 92.4 t -117.82 103.47 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 110.036 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -138.96 137.0 36.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -127.23 106.87 9.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 50' ' ' LYS . . . -144.81 71.14 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 59.04 -83.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.465 -0.772 . . . . 0.0 110.438 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -60.07 -38.34 82.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.503 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 17.6 mmt -88.14 159.64 18.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.176 -0.953 . . . . 0.0 110.34 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -143.17 68.85 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -0.982 . . . . 0.0 110.299 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.829 HG23 HG13 ' A' ' 45' ' ' VAL . 41.0 m 61.0 -74.74 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.712 -0.618 . . . . 0.0 111.188 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 42' ' ' THR . 6.2 mt-10 -56.08 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.098 . . . . 0.0 110.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.9 mm -88.48 102.16 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -78.73 127.3 31.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.427 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.2 14.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 110.083 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -51.47 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.652 1.343 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.6 p -139.71 156.06 47.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 29.2 p-10 -62.28 166.51 4.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.75 -161.91 29.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -134.92 143.88 47.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -1.187 . . . . 0.0 109.936 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.48 134.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 110.329 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.83 -11.87 16.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.69 138.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 109.771 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 33' ' ' GLU . 34.1 m -86.44 160.55 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.36 -67.44 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' LYS . 13.3 p -62.42 169.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 110.489 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.2 mmmt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.158 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 28' ' ' LYS . 4.1 tt0 -53.88 134.23 42.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.903 . . . . 0.0 110.441 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 55.83 51.4 12.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.473 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.2 t0 -102.51 -26.35 13.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 61.82 142.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.397 -0.815 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.466 HG22 ' C ' ' A' ' 73' ' ' ALA . 14.8 m 34.53 89.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 121.417 0.627 . . . . 0.0 112.139 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.19 64.28 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.102 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -104.44 154.87 17.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.3 54.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.7 tt0 -118.24 163.41 16.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -1.165 . . . . 0.0 110.143 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.14 175.81 2.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 20' ' ' ALA . 65.7 mt -123.42 -43.03 2.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 81' ' ' ILE . 8.5 tt -175.67 143.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.084 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -98.4 126.35 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.69 113.29 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.525 -179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.224 0.535 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -70.3 62.07 0.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.14 172.56 18.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.255 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -122.6 171.48 9.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.248 -0.908 . . . . 0.0 110.299 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 6' ' ' THR . 92.7 t -115.85 81.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 5' ' ' VAL . 15.1 t 37.99 30.53 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.232 0.539 . . . . 0.0 111.702 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 5' ' ' VAL . 27.7 t 49.17 61.23 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.49 -172.48 3.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.62 -138.16 14.03 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.81 -175.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.254 -1.145 . . . . 0.0 110.384 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.61 24.06 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -151.29 141.62 22.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -1.158 . . . . 0.0 110.308 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.24 169.81 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.56 -125.38 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.42 97.15 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -1.12 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.62 1.15 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -118.23 174.86 5.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.317 -1.108 . . . . 0.0 110.343 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' LEU . 15.6 mm -107.97 100.12 34.34 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.179 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.01 45.78 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.638 1.336 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.51 116.1 61.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.94 -8.03 22.19 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.46 1.242 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 22' ' ' LEU . 14.6 tp -150.03 126.13 10.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.999 -1.063 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB1' ' H ' ' A' ' 75' ' ' GLN . . . -58.74 178.35 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.751 ' C ' ' HB3' ' A' ' 73' ' ' ALA . . . 151.19 -149.52 21.33 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.066 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.547 ' N ' ' HB3' ' A' ' 73' ' ' ALA . 31.0 p -137.46 100.01 4.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.898 HG23 ' HB2' ' A' ' 73' ' ' ALA . 59.1 t -50.28 100.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.013 -1.055 . . . . 0.0 110.291 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 t -57.44 -41.02 79.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -173.12 156.64 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.721 HD12 HG21 ' A' ' 68' ' ' VAL . 3.6 tt -96.42 136.3 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.348 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 30' ' ' LEU . 1.2 mm? -103.43 -25.81 13.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 81' ' ' ILE . 9.2 p -87.15 153.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -123.29 149.21 45.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.208 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -69.85 136.12 50.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.64 24.13 59.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.35 143.43 51.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -1.09 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -85.67 116.8 24.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 43' ' ' VAL . 13.1 p -100.96 154.64 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 145.77 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -55.41 142.12 33.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.303 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.88 -34.59 5.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.22 123.56 20.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -1.201 . . . . 0.0 110.381 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 42' ' ' THR . 8.1 t -57.19 101.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.971 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.889 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 32.9 m -77.57 -17.39 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 110.449 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 55' ' ' ILE . 4.0 mt -152.21 155.61 38.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.077 -1.014 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.83 117.97 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.842 HD11 ' CB ' ' A' ' 73' ' ' ALA . 2.4 mm? -102.35 174.56 5.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.457 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.74 117.59 3.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.098 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.36 -80.34 0.56 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.0 ttp -85.38 56.95 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.313 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.53 38.33 27.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -139.35 105.57 5.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.59 109.11 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m -89.87 87.61 7.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.27 132.34 53.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.849 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.754 HD11 HD23 ' A' ' 46' ' ' LEU . 20.8 mt -107.02 99.68 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.45 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 10.6 p-10 -70.86 137.41 49.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.367 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.889 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -56.66 148.32 47.02 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.85 . . . . 0.0 110.068 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.49 -36.11 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.644 1.339 . . . . 0.0 110.504 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 2.6 m -157.31 158.27 35.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 139.23 46.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.18 38.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 139.43 49.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 31' ' ' VAL . 24.5 t -72.43 142.28 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.014 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -105.86 -18.18 14.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.794 . . . . 0.0 109.681 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 156.61 0.55 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -0.976 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 66' ' ' VAL . 35.8 m -134.63 100.06 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.055 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -84.08 -15.0 48.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 0.0 110.489 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.721 HG21 HD12 ' A' ' 29' ' ' ILE . 30.2 m -46.7 153.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 7.66 8.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.657 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 61.27 143.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.957 . . . . 0.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.7 mtp-105 52.53 39.03 27.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -154.53 42.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.898 ' HB2' HG23 ' A' ' 26' ' ' VAL . . . -82.12 -4.92 57.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.002 . . . . 0.0 110.439 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 24' ' ' GLY . 29.9 m -44.29 140.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.367 -0.833 . . . . 0.0 111.155 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.609 ' H ' ' HB1' ' A' ' 23' ' ' ALA . 20.2 tt0 54.12 100.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.454 -0.778 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -168.6 8.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.91 -24.69 27.28 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -79.11 130.69 35.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -1.075 . . . . 0.0 110.158 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.939 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -55.99 157.44 9.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 68' ' ' VAL . 32.3 mt -118.68 -64.96 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -1.179 . . . . 0.0 110.216 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.649 HD13 HG11 ' A' ' 31' ' ' VAL . 51.6 mt -126.65 156.36 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 146.55 25.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.006 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 6.5 tt -136.59 25.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.56 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.269 0.557 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.96 17.09 24.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.397 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 3' ' ' LEU . 2.2 mm? 51.87 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.407 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -92.35 136.97 32.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.2 m -143.9 104.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -122.07 36.42 4.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.156 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.8 t 57.75 160.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.55 -0.719 . . . . 0.0 110.471 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.99 102.33 11.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.63 -152.4 0.19 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.16 -158.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 110.225 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.95 54.02 0.46 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.44 -54.78 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -1.153 . . . . 0.0 110.302 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -155.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.87 -122.0 2.88 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 -57.62 2.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -1.133 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.54 -5.69 89.21 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' OE1' HD21 ' A' ' 67' ' ' LEU . 42.2 mt-10 -78.1 135.24 37.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.311 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.48 109.84 34.66 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.351 -0.843 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.15 152.51 56.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.495 1.261 . . . . 0.0 110.641 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -100.76 122.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.87 -17.62 25.32 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.481 1.253 . . . . 0.0 110.43 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.95 138.67 42.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.96 141.24 28.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.106 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -134.39 158.64 23.51 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -121.11 104.83 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -1.132 . . . . 0.0 110.04 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 27' ' ' SER . 7.5 p -47.38 168.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -0.898 . . . . 0.0 110.902 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 26' ' ' VAL . 25.7 t -149.69 -42.19 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 109.878 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -160.24 119.42 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 44' ' ' LEU . 1.2 tt -81.76 151.73 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.76 -38.01 5.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.104 -0.997 . . . . 0.0 110.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.813 HG21 HG13 ' A' ' 43' ' ' VAL . 35.9 m -123.41 168.35 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.284 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -121.38 -162.58 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -82.99 140.56 32.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 110.28 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.82 49.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 172.38 7.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.093 -1.239 . . . . 0.0 110.41 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.6 m -116.93 133.58 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 61' ' ' GLY . 34.8 m -125.56 152.56 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 14.0 tttt -110.78 163.91 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.386 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 107.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.257 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.99 -0.72 31.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -90.25 127.26 36.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.334 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 3.4 m -54.13 135.6 43.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 31' ' ' VAL . 97.2 t -118.6 -38.17 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -147.94 159.34 43.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.792 . . . . 0.0 110.544 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.03 116.79 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.954 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.458 HD11 ' HA3' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -101.39 153.57 19.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -106.77 141.02 38.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.076 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.64 -157.24 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.9 mtp -52.59 -26.98 14.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -6.48 57.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.864 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.9 ttp 56.33 19.57 4.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.036 -1.04 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.49 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 109.931 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 m -121.1 98.45 5.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 110.481 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.64 128.77 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.8 81.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.246 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 2.0 m120 -72.58 133.93 44.95 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.545 0.688 . . . . 0.0 110.654 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 43' ' ' VAL . . . -49.97 143.7 11.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 110.456 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.25 -32.44 6.63 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.655 1.345 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -145.08 162.25 37.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.1 p-10 -77.27 133.5 38.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 166.42 173.83 35.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -90.99 152.63 20.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -1.131 . . . . 0.0 110.153 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.18 128.67 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -109.25 -1.33 18.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.448 -0.783 . . . . 0.0 110.319 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -177.86 139.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.01 89.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.522 HD21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -52.31 -58.1 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.509 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.677 HG22 HG11 ' A' ' 74' ' ' VAL . 57.9 t -95.92 137.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -163.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 0.0 109.759 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HA ' HG21 ' A' ' 26' ' ' VAL . 8.3 tt0 -91.69 131.63 36.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 110.133 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 71.53 2.96 4.48 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.595 -0.69 . . . . 0.0 111.189 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.455 ' N ' HG11 ' A' ' 26' ' ' VAL . 4.6 m-20 -98.39 84.54 3.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.0 109.702 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.34 155.96 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.224 -0.922 . . . . 0.0 110.794 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HG22 ' A' ' 68' ' ' VAL . 26.4 m -142.51 158.75 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 110.077 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -100.77 152.27 20.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.943 . . . . 0.0 110.398 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.13 138.66 42.46 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.71 -7.37 11.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.91 150.26 38.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.918 -1.343 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.09 159.85 17.62 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 20' ' ' ALA . 57.5 mt -108.86 -49.68 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.865 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' C ' ' A' ' 80' ' ' LEU . 4.8 pt -154.46 150.58 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.835 . . . . 0.0 110.024 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 65' ' ' LYS . 37.2 tttt -108.36 139.42 43.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.938 . . . . 0.0 110.368 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 3.7 tt -148.85 44.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.611 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.176 0.512 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -156.22 143.59 19.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.44 54.06 0.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -156.59 120.93 4.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.302 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 6' ' ' THR . 12.5 p -54.07 170.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.264 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' HG22 ' A' ' 5' ' ' VAL . 10.4 m 53.99 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 110.438 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.7 75.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.152 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -95.82 73.64 3.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.1 -146.6 13.18 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 178.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -1.158 . . . . 0.0 110.392 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.27 34.16 1.09 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -125.86 24.11 7.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 110.226 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.581 ' HB1' ' CG ' ' A' ' 17' ' ' GLU . . . -123.9 157.72 33.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.98 -110.59 1.03 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.0 mt-10 -139.45 125.44 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 110.13 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.86 -33.56 5.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -57.23 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.409 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG12 ' A' ' 83' ' ' ILE . 3.9 mp -138.84 110.75 7.99 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.079 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.76 137.01 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.539 1.284 . . . . 0.0 110.355 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.11 136.32 53.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.78 -24.55 13.21 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.462 1.243 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -134.05 139.9 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.32 178.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.977 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -176.83 155.84 19.28 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -99.74 121.31 41.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.362 -1.081 . . . . 0.0 109.979 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.42 136.37 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 110.366 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 45' ' ' VAL . 44.5 t -115.62 -31.86 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 109.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtmt -172.84 139.94 0.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.083 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.437 ' H ' HG22 ' A' ' 29' ' ' ILE . 8.2 tt -101.82 140.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 mt -116.29 -27.14 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.258 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.634 ' CG2' HG21 ' A' ' 63' ' ' VAL . 9.2 p -82.83 155.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.61 160.37 39.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.888 . . . . 0.0 110.248 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -68.07 122.17 17.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.99 -2.26 55.35 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 126.32 38.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.872 -1.37 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.8 m -64.55 124.03 20.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.7 p -99.46 145.27 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.88 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.47 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.937 . . . . 0.0 110.234 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.16 17.86 23.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -118.45 119.55 34.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.149 -1.207 . . . . 0.0 110.189 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 79.5 m -52.65 122.45 9.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.915 . . . . 0.0 110.011 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -114.33 -23.34 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 171.06 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.977 -1.077 . . . . 0.0 111.058 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 27' ' ' SER . 50.4 t -121.31 117.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 109.397 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 24' ' ' GLY . 3.2 tp -107.83 149.51 28.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.943 . . . . 0.0 110.815 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -131.62 53.47 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.819 . . . . 0.0 109.966 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.74 -166.4 1.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.888 . . . . 0.0 110.41 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.4 mtt -63.35 -39.8 95.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.416 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -14.83 61.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.6 ttp 54.63 75.52 0.29 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.109 -0.995 . . . . 0.0 110.122 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.4 tp10 -92.27 -34.51 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 53.8 m 56.81 -83.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.585 -0.697 . . . . 0.0 111.002 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' GLU . 29.0 mt-10 -58.46 97.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 111.106 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 43' ' ' VAL . 26.7 mm -96.12 90.96 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.012 . . . . 0.0 109.5 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -62.63 138.85 58.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.582 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -54.06 167.81 0.5 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.387 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.53 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 48.6 Cg_endo -75.02 -35.85 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.822 1.433 . . . . 0.0 110.446 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -165.69 -159.41 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.9 147.51 26.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.85 -150.53 22.09 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -129.99 149.06 51.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.94 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 31' ' ' VAL . 38.6 t -80.5 110.18 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 110.379 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -78.4 -12.39 60.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.99 174.71 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 66' ' ' VAL . 34.7 m -123.64 91.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.742 HD13 ' HA3' ' A' ' 79' ' ' GLY . 1.1 mt -60.53 -30.18 69.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -103.81 142.74 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 110.545 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 -171.64 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 109.992 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.6 154.76 21.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.043 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 58.07 30.55 19.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.896 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.95 67.55 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 173.3 0.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.479 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t 53.55 86.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -131.21 28.09 4.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.155 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.38 132.98 11.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.11 44.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.31 150.01 21.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -1.202 . . . . 0.0 110.152 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.742 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -58.12 149.01 35.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.1 mt -96.57 -68.57 0.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 6.1 mt -126.85 146.86 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -88.06 118.93 27.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.491 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 18' ' ' ILE . 4.5 pt -146.0 153.36 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.506 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.998 0.427 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 62.94 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.716 -0.615 . . . . 0.0 110.664 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.15 121.66 41.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.052 . . . . 0.0 109.98 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.609 ' HB3' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -90.51 176.41 6.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.183 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.38 -32.6 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.609 HG22 ' HB3' ' A' ' 4' ' ' LYS . 5.1 t -60.1 167.53 2.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 110.199 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.52 109.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -59.54 -166.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.119 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.02 -31.15 0.31 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.79 83.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.197 -1.178 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.78 -66.35 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.73 176.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -1.145 . . . . 0.0 110.153 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.716 ' HB1' ' OE2' ' A' ' 17' ' ' GLU . . . -107.39 162.29 14.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.12 -106.23 0.48 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.0 148.47 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.96 58.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.716 ' OE2' ' HB1' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -111.65 166.14 11.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -1.095 . . . . 0.0 110.46 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.67 100.41 19.59 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.858 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.2 Cg_endo -71.18 121.31 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.742 1.391 . . . . 0.0 110.542 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -60.79 141.62 92.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -20.56 21.74 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.654 1.344 . . . . 0.0 110.387 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -153.84 151.43 29.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.66 174.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.304 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.03 153.37 11.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 46' ' ' LEU . 21.2 p -106.77 135.33 48.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -1.19 . . . . 0.0 110.22 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 68' ' ' VAL . 43.1 t -89.9 130.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -101.8 -23.18 14.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -169.63 165.43 10.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.5 tt -122.43 145.24 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -103.01 -54.55 2.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.822 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 HG13 ' A' ' 43' ' ' VAL . 29.2 m -71.53 -171.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.837 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.93 39.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 17.9 tt0 61.21 142.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.295 -0.878 . . . . 0.0 110.727 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.73 60.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -1.234 . . . . 0.0 109.886 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' VAL . 3.7 m -57.61 178.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 110.047 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 36' ' ' THR . 13.4 p -171.78 164.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' HG22 ' A' ' 37' ' ' VAL . 10.1 mtmm -122.69 177.45 5.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.28 125.93 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.464 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.51 -22.34 41.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 43' ' ' VAL . 49.0 tt0 -70.01 127.73 33.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 0.0 110.407 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.587 HG22 HD22 ' A' ' 30' ' ' LEU . 69.2 m -52.13 137.95 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.931 . . . . 0.0 110.011 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.878 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 93.7 t -123.49 -36.45 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -142.82 176.28 9.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.135 -0.978 . . . . 0.0 111.076 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 53' ' ' THR . 42.1 t -124.48 145.12 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -174.83 4.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.046 . . . . 0.0 110.523 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -168.13 109.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 51' ' ' MET . . . -168.3 -165.32 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.101 -0.999 . . . . 0.0 110.394 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -35.34 80.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.441 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.727 ' HD3' HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.99 12.98 13.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.713 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.658 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -120.11 153.23 36.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.791 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' C ' HG22 ' A' ' 53' ' ' THR . 0.0 OUTLIER -149.48 92.74 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 0.0 111.088 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.553 HG22 ' C ' ' A' ' 52' ' ' GLU . 8.2 t 36.5 -127.61 0.15 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.989 -0.444 . . . . 0.0 111.989 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' THR . 1.1 mt-10 -37.69 133.79 0.76 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.302 -0.874 . . . . 0.0 112.237 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.663 HG13 HD12 ' A' ' 46' ' ' LEU . 35.1 mm -125.69 106.71 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.643 -0.661 . . . . 0.0 109.411 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 76.3 m-20 -57.18 144.1 36.41 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.703 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.878 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -62.38 152.38 79.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.71 -33.77 7.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.693 1.365 . . . . 0.0 110.389 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -161.51 151.75 17.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.43 158.49 14.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 145.59 -144.23 12.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -140.33 158.17 44.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -1.158 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 52.5 t -85.19 119.98 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 84' ' ' GLY . 1.2 mm-40 -90.22 -10.49 44.15 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 109.598 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.1 mttm 179.86 163.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -123.72 95.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 -36.48 75.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.741 HG21 HD23 ' A' ' 80' ' ' LEU . 45.1 t -96.15 128.53 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 -170.9 2.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.109 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 134.7 34.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 52.14 42.17 30.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.7 t70 -104.25 -23.76 13.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.312 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 60.73 117.17 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.04 -177.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.0 . . . . 0.0 110.339 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.08 162.85 21.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.62 146.43 48.5 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.84 37.16 6.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.7 tt0 -146.51 132.05 18.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.74 114.74 4.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 68' ' ' VAL . 26.1 mt -70.19 -57.89 4.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.296 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.03 168.78 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.3 143.08 42.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.38 162.6 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.305 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 64' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.531 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.203 0.525 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -81.41 173.0 12.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.51 -173.11 4.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 110.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.63 63.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.084 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.65 90.0 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -153.85 38.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.37 -0.831 . . . . 0.0 110.065 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.55 101.19 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -122.23 -61.08 1.51 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.09 -166.58 15.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 52.95 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.97 -45.12 1.35 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 124.32 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.113 . . . . 0.0 110.259 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.27 -150.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.198 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.74 -133.16 4.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.35 132.35 46.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.43 24.75 59.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.21 159.34 32.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -1.188 . . . . 0.0 110.277 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 83' ' ' ILE . 67.7 mt -130.94 99.56 18.03 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.967 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.5 Cg_endo -73.53 130.28 14.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.734 1.386 . . . . 0.0 110.618 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.55 114.18 36.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -18.59 26.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.468 1.247 . . . . 0.0 110.665 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.0 mt -119.97 9.27 11.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' ' N ' ' A' ' 76' ' ' GLY . . . 51.68 -150.32 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 0.0 110.402 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 48' ' ' ALA . . . 141.62 176.69 16.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -121.23 108.96 14.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -1.136 . . . . 0.0 110.009 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.3 136.35 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -40.21 3.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.248 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.69 139.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.5 tt -81.73 149.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -105.16 -45.57 4.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.152 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 HG23 ' A' ' 43' ' ' VAL . 24.4 m -101.91 -158.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -148.98 179.25 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 146.41 53.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.37 87.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.12 146.48 26.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.3 . . . . 0.0 110.163 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.7 m -97.83 107.26 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 61' ' ' GLY . 31.3 m -81.25 158.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.86 155.42 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.34 109.43 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.371 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.8 34.43 5.73 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -125.04 114.52 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.153 . . . . 0.0 110.084 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -49.16 113.77 0.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.221 -0.924 . . . . 0.0 110.412 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 31' ' ' VAL . 12.0 p -107.95 -26.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.838 . . . . 0.0 110.625 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.758 ' CD1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -142.78 175.44 9.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.137 -0.977 . . . . 0.0 111.163 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' THR . 57.5 t -116.17 142.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.948 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HB2' HG13 ' A' ' 55' ' ' ILE . 21.7 tp -134.72 159.22 41.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.015 . . . . 0.0 110.731 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 34.8 tt0 -154.47 72.6 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.979 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . . . -114.04 69.7 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp 59.0 16.64 4.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.303 -0.873 . . . . 0.0 110.562 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -126.89 -11.55 5.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.783 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.7 ttt 53.56 23.85 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.038 -1.038 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -40.94 64.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 109.616 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 54' ' ' GLU . 54.6 m 52.1 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.558 -0.714 . . . . 0.0 110.773 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 53' ' ' THR . 7.4 mt-10 -59.9 105.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.717 -1.24 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 46' ' ' LEU . 26.2 mm -103.76 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 18.4 p-10 -69.81 135.38 49.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.638 -0.664 . . . . 0.0 110.726 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.43 175.3 0.13 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 110.175 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.761 ' O ' HG23 ' A' ' 59' ' ' THR . 49.0 Cg_endo -76.51 -48.99 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.762 1.401 . . . . 0.0 110.768 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -163.42 -167.66 1.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 124.86 26.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 37' ' ' VAL . . . -179.87 169.9 40.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -107.62 151.43 25.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.84 106.85 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.997 . . . . 0.0 110.453 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -84.33 -10.79 57.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt 178.19 157.3 0.43 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.119 -0.988 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' VAL . 19.2 m -112.39 94.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -70.37 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.498 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.48 166.12 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -118.5 -176.25 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.52 145.5 26.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 57.89 33.62 23.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.64 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' THR . . . -51.38 145.74 8.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.226 -0.922 . . . . 0.0 110.48 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.09 158.59 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 110.094 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -98.8 24.79 7.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.912 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . 77.52 172.1 37.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.19 34.33 88.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -128.47 130.03 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -1.117 . . . . 0.0 110.157 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.33 111.25 2.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.1 mt -67.9 -70.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.333 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.758 HD11 ' CD1' ' A' ' 44' ' ' LEU . 72.3 mt -132.5 160.61 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -102.35 117.92 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 83' ' ' ILE . 70.8 mt -118.88 38.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.219 0.533 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -137.9 49.06 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 110.153 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -102.4 -28.56 12.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.357 -0.84 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm 54.91 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 110.307 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 3' ' ' LEU . 29.4 m -137.02 28.67 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.938 -1.101 . . . . 0.0 110.05 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' HD23 ' A' ' 3' ' ' LEU . 3.1 m -100.39 145.54 28.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.174 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.84 147.5 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -155.63 90.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 110.364 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.6 127.68 4.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 165.96 17.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.109 . . . . 0.0 110.107 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.49 -95.28 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -131.52 121.21 24.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -1.113 . . . . 0.0 110.223 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.54 155.89 6.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.4 -179.19 26.89 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.4 141.53 51.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -1.175 . . . . 0.0 110.231 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.59 -51.59 4.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.02 132.63 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.341 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.97 120.07 51.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 154.27 53.22 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.409 1.215 . . . . 0.0 110.672 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.76 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -107.5 94.52 11.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.54 -5.63 17.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.735 1.387 . . . . 0.0 111.056 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.09 3.24 35.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.064 -1.023 . . . . 0.0 110.8 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.11 178.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.936 -1.103 . . . . 0.0 110.188 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.51 172.06 31.51 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.635 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.6 p -101.14 112.73 25.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -1.123 . . . . 0.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 69' ' ' LYS . 96.8 t -80.63 97.51 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.857 . . . . 0.0 109.983 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -41.76 11.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.298 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.28 170.87 4.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' ILE . 20.4 tt -133.26 124.03 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 4.7 mp -68.78 -60.73 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 32' ' ' LYS . 21.3 t -131.52 -115.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.097 -1.002 . . . . 0.0 109.812 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.608 ' C ' HG21 ' A' ' 63' ' ' VAL . 3.9 tttp 53.96 50.45 16.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.401 -1.437 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -170.05 103.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -0.82 . . . . 0.0 109.803 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.6 22.11 61.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 140.04 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 110.12 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 m -76.95 88.28 3.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.7 m -67.04 -171.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 15.7 ttpp -147.64 155.87 42.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.053 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.15 93.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -0.958 . . . . 0.0 110.397 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.45 34.07 1.65 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.808 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -115.18 109.04 17.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 110.362 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.591 HG21 ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -52.22 109.8 0.42 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -130.02 -4.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 111.226 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.437 HD23 HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -131.05 164.21 25.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 110.658 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.811 HG13 ' CG2' ' A' ' 53' ' ' THR . 81.7 t -123.33 108.16 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 25' ' ' THR . 1.4 mm? -125.15 154.63 41.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 5.0 tt0 -144.12 69.24 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' GLU . . . -179.32 139.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -0.937 . . . . 0.0 110.423 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.411 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 54.5 78.32 0.17 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.328 -0.858 . . . . 0.0 110.865 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptt 51.64 61.71 3.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.27 -0.894 . . . . 0.0 111.015 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.443 ' HG2' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -149.26 95.4 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.737 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 mt-10 -87.14 53.88 2.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.812 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.811 ' CG2' HG13 ' A' ' 45' ' ' VAL . 1.4 m 65.7 -64.99 0.18 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.37 -0.831 . . . . 0.0 111.046 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.591 ' HG3' HG21 ' A' ' 42' ' ' THR . 2.9 mp0 -56.57 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 111.08 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -99.63 98.43 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.185 -0.947 . . . . 0.0 109.755 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.98 131.71 44.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.837 . . . . 0.0 110.136 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 156.07 2.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.39 -49.03 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.701 1.369 . . . . 0.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.5 p -138.97 -172.5 3.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 110.202 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.457 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 6.3 p-10 -101.56 152.44 20.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 150.69 159.88 9.04 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -85.69 121.09 27.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.129 . . . . 0.0 110.356 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.608 HG21 ' C ' ' A' ' 32' ' ' LYS . 27.4 t -54.34 159.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -118.39 -14.87 9.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.438 -0.789 . . . . 0.0 110.123 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 tttt 179.97 149.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.73 159.5 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 109.558 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -138.27 -68.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.538 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.676 HG11 HD23 ' A' ' 80' ' ' LEU . 23.7 m -48.55 155.12 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.175 -0.953 . . . . 0.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' O ' HG11 ' A' ' 26' ' ' VAL . 9.5 mtmt -124.31 148.46 47.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.237 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.0 72.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -176.79 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.39 145.22 11.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' C ' HG12 ' A' ' 74' ' ' VAL . . . -135.91 135.18 39.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.491 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.5 p 36.91 48.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.883 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.33 97.87 6.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.09 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.96 156.31 19.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.43 18.27 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.71 155.94 17.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -1.213 . . . . 0.0 110.241 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.97 161.9 23.53 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 20' ' ' ALA . 9.4 mt -109.18 -68.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.736 HG22 HG23 ' A' ' 83' ' ' ILE . 36.3 mm -140.8 148.42 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 91.28 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.736 HG23 HG22 ' A' ' 81' ' ' ILE . 46.6 pt -125.45 45.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.224 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.571 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.24 0.543 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.39 156.27 19.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.21 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 -25.62 14.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.01 105.42 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 5' ' ' VAL . 13.9 p -137.27 132.43 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -149.42 129.41 13.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.868 HG21 ' O ' ' A' ' 11' ' ' GLY . 34.3 m -79.45 148.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.167 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -102.52 43.99 1.04 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.055 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.51 32.31 1.64 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.75 47.18 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -1.147 . . . . 0.0 110.275 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.868 ' O ' HG21 ' A' ' 7' ' ' VAL . . . 96.98 121.68 4.17 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -162.56 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -1.155 . . . . 0.0 110.467 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . 55.12 -166.24 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.153 -0.967 . . . . 0.0 109.964 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.0 25.88 5.16 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 53.24 25.32 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -1.132 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.79 49.85 0.09 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.48 -176.94 5.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 110.187 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.51 91.51 49.67 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.115 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.41 134.55 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.704 1.371 . . . . 0.0 110.709 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.81 142.62 69.95 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.54 -32.35 9.89 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.609 1.32 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 23' ' ' ALA . 5.8 tt -118.73 157.16 28.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -61.1 176.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 110.546 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -153.52 146.85 15.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -68.32 -141.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -1.125 . . . . 0.0 110.584 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 27' ' ' SER . 19.1 m -38.47 -46.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.518 -0.739 . . . . 0.0 112.539 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER 61.01 40.82 14.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.748 -1.22 . . . . 0.0 110.016 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -54.95 108.39 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 29' ' ' ILE . 12.2 tt -62.05 120.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.475 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD23 ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -88.2 -18.23 29.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.175 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.629 HG11 HD13 ' A' ' 81' ' ' ILE . 14.0 p -91.27 169.77 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 31' ' ' VAL . 23.9 tttt -123.7 159.55 29.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.72 142.49 53.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.9 . . . . 0.0 110.171 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.45 73.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -110.69 154.72 23.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.102 -1.234 . . . . 0.0 109.874 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 1.4 m -96.73 110.67 23.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.308 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' GLY . 34.5 m -81.92 157.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 25.1 tttt -120.06 160.44 22.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.294 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . -69.12 99.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.02 46.92 0.85 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 43' ' ' VAL . 38.7 tt0 -135.34 114.44 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -1.167 . . . . 0.0 109.809 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 42' ' ' THR . 12.6 t -55.25 105.12 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.575 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.1 m -104.52 0.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.942 -1.099 . . . . 0.0 110.227 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.81 156.82 42.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.952 -1.093 . . . . 0.0 110.472 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 30' ' ' LEU . 93.5 t -119.23 99.84 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.582 ' HB3' HD11 ' A' ' 55' ' ' ILE . 7.8 tt -105.83 151.0 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 2.6 tt0 -124.55 159.16 31.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.897 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLU . . . -176.42 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.69 52.41 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mttm 49.19 38.35 13.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.171 -0.956 . . . . 0.0 110.583 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.93 134.34 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 110.247 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.52 128.34 36.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.217 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.8 m -102.97 107.64 18.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.1 pt-20 -65.41 103.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 46' ' ' LEU . 48.6 mm -77.37 94.05 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 67.3 m-20 -77.31 133.16 38.85 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.629 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.77 170.09 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 49.9 Cg_endo -77.29 -54.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.762 1.401 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 58' ' ' PRO . 1.3 p -153.26 -166.12 2.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.361 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 52.3 t0 -78.56 123.59 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.395 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' HA3' HD11 ' A' ' 83' ' ' ILE . . . -173.42 -165.95 31.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.8 ttpt -133.27 153.48 51.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.131 -1.217 . . . . 0.0 110.384 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.709 HG22 ' CG2' ' A' ' 81' ' ' ILE . 37.9 t -80.19 125.14 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -88.64 -14.09 38.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.76 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.5 169.06 0.84 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.63 144.91 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -52.62 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 109.95 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 70' ' ' GLU . 11.3 p -53.05 154.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 18.0 mttt -94.28 -10.87 31.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -0.976 . . . . 0.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.797 ' H ' HG22 ' A' ' 68' ' ' VAL . 4.8 tt0 61.61 135.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.21 22.38 7.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.07 . . . . 0.0 109.949 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 69' ' ' LYS . 22.9 t70 -115.86 120.62 39.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 109.821 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -67.87 168.7 11.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 19.5 t 60.86 139.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.488 0.661 . . . . 0.0 110.648 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.04 43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.012 -1.055 . . . . 0.0 110.338 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.08 130.89 10.38 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.82 19.37 63.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 16.1 mt-30 -131.37 139.83 49.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -1.179 . . . . 0.0 110.14 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.75 140.85 29.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.1 mt -92.1 -47.71 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -1.188 . . . . 0.0 110.002 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.709 ' CG2' HG22 ' A' ' 63' ' ' VAL . 98.2 mt -137.2 151.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.2 ttmt -97.31 145.97 25.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.464 HD11 ' HA3' ' A' ' 61' ' ' GLY . 10.7 tt -147.46 159.08 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.615 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -119.47 -50.47 2.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.282 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.57 147.59 51.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.877 . . . . 0.0 110.286 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.2 -155.94 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 110.019 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -134.41 86.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.653 HG23 HG13 ' A' ' 7' ' ' VAL . 7.0 t -161.78 -40.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.653 HG13 HG23 ' A' ' 6' ' ' THR . 34.0 m -118.44 178.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.372 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -160.45 -50.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.63 -156.44 15.82 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.13 -60.63 1.68 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 110.119 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.39 132.25 0.56 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -74.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -1.108 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . . . 53.73 79.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.918 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.96 -106.93 0.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -119.18 -49.36 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.159 . . . . 0.0 109.893 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' CA ' ' HG2' ' A' ' 82' ' ' LYS . . . -95.58 85.28 0.92 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.7 pm0 -157.96 150.78 22.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -1.079 . . . . 0.0 110.236 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 81' ' ' ILE . 78.5 mt -111.85 99.38 45.13 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.9 128.35 14.87 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.702 1.369 . . . . 0.0 110.472 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -69.84 138.05 87.82 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.079 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.46 -13.31 25.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.558 1.294 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.04 153.15 41.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.249 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.03 162.09 9.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.139 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.37 -165.04 34.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -150.55 149.23 29.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.295 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.879 HG21 HG13 ' A' ' 68' ' ' VAL . 90.0 t -88.69 132.89 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.57 -28.6 12.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 109.923 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.42 153.52 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.441 HG22 ' OE2' ' A' ' 70' ' ' GLU . 3.8 tt -112.46 149.56 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.478 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.696 HD13 HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -114.4 -36.0 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.009 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 43' ' ' VAL . 59.6 t -110.04 157.24 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.05 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -119.83 178.71 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -77.28 131.5 38.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.85 70.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.58 157.02 18.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.317 . . . . 0.0 110.421 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.69 174.7 8.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.919 . . . . 0.0 109.971 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 61' ' ' GLY . 11.4 p -157.61 166.28 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 110.212 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 37' ' ' VAL . 1.3 mtpm? -122.06 169.57 10.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -79.42 114.6 18.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.5 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -109.46 119.67 40.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -1.224 . . . . 0.0 110.006 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.696 HG22 HD13 ' A' ' 30' ' ' LEU . 88.6 m -53.19 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.374 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 41.5 t -64.73 -33.49 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 0.0 109.776 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -155.03 -177.74 6.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.627 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.94 125.67 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.053 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -100.74 177.67 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.21 97.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.5 -51.47 2.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mmt -96.78 42.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 110.219 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm 53.23 38.17 26.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 110.206 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.4 ttm -138.99 117.83 12.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -56.91 102.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -91.49 129.8 37.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 110.321 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.79 112.69 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 46' ' ' LEU . 98.1 mt -82.61 89.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 70.1 m-80 -72.57 135.12 45.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.549 -0.719 . . . . 0.0 110.797 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.702 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -56.43 154.17 17.57 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.297 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 -46.19 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.746 1.393 . . . . 0.0 110.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.578 HG22 ' OD1' ' A' ' 60' ' ' ASP . 4.4 m -155.82 169.98 23.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.265 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.578 ' OD1' HG22 ' A' ' 59' ' ' THR . 9.5 p-10 -64.66 145.08 56.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 162.66 -156.47 28.17 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -132.2 150.96 52.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 66' ' ' VAL . 30.2 t -71.87 132.86 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -9.43 20.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.517 -0.739 . . . . 0.0 110.081 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 140.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.06 . . . . 0.0 109.837 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 63' ' ' VAL . 64.3 t -123.67 95.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.463 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.26 -18.07 59.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.103 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.879 HG13 HG21 ' A' ' 26' ' ' VAL . 39.6 t -69.67 143.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 110.342 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.99 15.87 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 110.349 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.1 tt0 61.97 135.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.324 -0.86 . . . . 0.0 110.586 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 32.75 17.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -127.59 116.85 20.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 25' ' ' THR . . . -64.52 146.21 54.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 80' ' ' LEU . 26.6 m -136.16 122.71 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 160.4 30.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.68 51.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 -2.76 30.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -97.79 123.73 41.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.363 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.5 137.68 48.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 20' ' ' ALA . 51.5 mt -107.43 -57.87 2.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -1.193 . . . . 0.0 110.352 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.57 HD13 HG11 ' A' ' 43' ' ' VAL . 16.4 tt -143.19 170.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.476 ' O ' HG23 ' A' ' 83' ' ' ILE . 8.0 tptp -143.02 172.26 12.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' LYS . 3.3 pt -153.39 131.89 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.668 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.213 0.53 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -61.84 -50.95 70.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 3' ' ' LEU . 1.3 mm? -90.53 -25.01 20.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 tttt 59.94 155.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.347 -0.845 . . . . 0.0 110.267 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.0 p -60.64 123.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.453 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 1.6 p -83.77 144.72 29.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.17 136.7 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 110.142 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 6' ' ' THR . 12.3 p30 -164.05 37.36 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.79 179.88 37.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 150.67 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.76 -74.51 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.66 -58.86 6.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.318 -1.107 . . . . 0.0 110.272 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.86 138.85 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.915 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.39 -115.08 3.63 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -120.65 -35.01 3.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.65 15.42 11.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -97.09 124.24 41.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.255 . . . . 0.0 109.991 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.19 117.2 67.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.357 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.7 Cg_endo -73.89 134.33 19.68 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.386 1.203 . . . . 0.0 110.385 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -80.19 125.88 80.49 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.14 141.12 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.441 1.232 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.52 127.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.397 -0.814 . . . . 0.0 110.523 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.93 170.59 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 0.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.41 -177.8 47.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.2 m -133.99 147.16 50.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.85 134.52 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.1 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 p -110.16 -20.67 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.952 . . . . 0.0 110.141 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.93 122.8 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.311 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.494 ' O ' HD22 ' A' ' 30' ' ' LEU . 1.1 tt -83.39 144.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.082 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 29' ' ' ILE . 2.3 mm? -119.31 -24.8 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.917 . . . . 0.0 110.632 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.5 p -108.12 165.02 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.307 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -136.13 169.06 18.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 110.322 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -73.09 156.98 38.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 23.32 70.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.13 166.14 12.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -1.14 . . . . 0.0 110.075 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -109.11 128.12 54.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 61' ' ' GLY . 7.6 p -109.19 158.96 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' CG ' ' OD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -110.94 179.71 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.87 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . . . -90.1 124.55 34.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.098 -1.001 . . . . 0.0 110.33 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.33 29.55 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 43' ' ' VAL . 20.3 tt0 -113.82 122.31 46.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -1.174 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 24.2 m -56.6 109.91 0.7 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 57' ' ' ALA . 34.3 m -95.81 -21.14 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -147.93 173.94 12.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.992 -1.067 . . . . 0.0 111.348 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.491 HG23 HD23 ' A' ' 30' ' ' LEU . 45.7 t -126.2 113.33 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 109.251 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.35 165.46 11.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.01 -1.056 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -144.67 80.05 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.58 -0.7 . . . . 0.0 109.707 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.23 -163.49 0.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 110.264 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.95 52.59 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -168.91 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.342 -0.849 . . . . 0.0 110.009 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 174.44 -73.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.188 -0.945 . . . . 0.0 110.445 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.7 mm-40 54.08 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.897 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 51.9 m 51.67 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.987 . . . . 0.0 111.082 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 53' ' ' THR . 4.9 tt0 -60.94 102.11 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 111.076 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 43' ' ' VAL . 32.1 mm -103.94 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.941 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 56.8 m-80 -73.89 135.28 43.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.42 0.628 . . . . 0.0 110.694 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -55.35 167.81 0.67 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.547 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.0 Cg_endo -74.09 -52.47 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.761 1.4 . . . . 0.0 110.523 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.28 170.27 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.098 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 39' ' ' ALA . 3.6 m-20 -57.88 139.01 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 169.4 172.35 35.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -109.86 150.06 28.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -1.14 . . . . 0.0 109.974 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 33' ' ' GLU . 31.5 t -77.81 124.42 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.39 -6.81 23.56 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 110.003 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -177.87 150.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 109.92 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.62 146.28 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -119.92 -69.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.65 HG21 HD23 ' A' ' 80' ' ' LEU . 33.5 m -75.46 158.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -129.69 -165.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 155.26 20.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 55.53 25.86 8.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.27 105.61 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.245 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 137.55 50.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.004 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.9 p -130.23 132.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.74 -177.45 6.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.304 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.07 125.72 7.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.29 0.69 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -154.15 128.71 9.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.419 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.01 130.55 36.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 20' ' ' ALA . 10.9 mt -92.21 -70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -1.099 . . . . 0.0 109.698 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.3 mm -134.64 145.04 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 0.0 109.833 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.72 137.96 31.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.182 -0.949 . . . . 0.0 110.493 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.95 146.2 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.234 0.54 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' C ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER 52.74 -166.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.964 . . . . 0.0 110.233 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.548 HD23 ' C ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -168.18 51.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.67 96.98 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.885 HG12 HG23 ' A' ' 6' ' ' THR . 32.2 t -108.47 147.8 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.885 HG23 HG12 ' A' ' 5' ' ' VAL . 48.6 p 44.26 -153.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.544 -0.723 . . . . 0.0 110.881 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 7' ' ' VAL . 27.0 m -123.23 58.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -132.24 126.01 32.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.03 111.24 0.55 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.21 42.48 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -1.109 . . . . 0.0 110.134 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.26 92.55 0.76 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.11 75.24 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.29 154.12 20.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 110.154 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.5 -173.71 44.11 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 135.72 56.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -1.147 . . . . 0.0 110.17 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . 102.61 -19.12 48.76 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' OE2' ' CD ' ' A' ' 82' ' ' LYS . 1.1 mp0 -110.04 127.7 54.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.248 . . . . 0.0 110.508 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.7 mp -82.38 111.93 32.24 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.793 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.88 143.35 45.19 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.41 1.216 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 1.014 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -85.86 135.73 37.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.123 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.58 133.81 17.74 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.592 1.312 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.36 -166.87 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.55 137.88 38.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.254 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.77 169.13 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 132.58 54.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.32 141.32 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 110.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -113.18 -24.45 9.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.52 140.78 0.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.855 . . . . 0.0 110.088 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 29' ' ' ILE . 11.0 tt -100.06 134.45 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.343 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -85.48 -56.18 3.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 43' ' ' VAL . 19.5 m -81.02 -177.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.364 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -145.93 52.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.028 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.622 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER 59.85 157.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.08 55.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 4.2 p30 -106.93 147.92 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.233 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.9 m -108.75 123.3 48.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.275 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 61' ' ' GLY . 35.6 m -108.81 -175.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.086 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 3.0 ttpt -142.7 49.58 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . 54.75 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.76 -13.32 7.7 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.339 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.8 tt0 -77.59 119.94 21.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.05 -1.264 . . . . 0.0 110.555 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.3 m -61.71 103.3 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.035 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 31' ' ' VAL . 34.7 m -86.78 -21.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -151.18 176.84 10.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG23 HD23 ' A' ' 30' ' ' LEU . 67.8 t -134.26 117.98 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.07 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -99.23 157.4 16.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -155.1 115.11 3.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.07 120.54 20.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.5 52.13 10.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.158 -0.964 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.25 55.03 10.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.825 . . . . 0.0 110.781 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -34.62 5.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 55.33 100.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m -130.21 107.33 9.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 42' ' ' THR . 16.1 mt-10 -62.39 149.58 42.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 44' ' ' LEU . 64.6 mt -111.91 86.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.965 . . . . 0.0 110.613 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.2 m-20 -84.31 127.59 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.273 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.01 145.32 5.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 110.277 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -45.22 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.65 1.342 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.723 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 8.9 t -137.41 158.09 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 110.419 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 4.6 p30 -56.83 160.22 3.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 148.71 168.76 14.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 21.9 ttpt -109.53 139.56 44.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.7 t -64.66 135.45 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.03 . . . . 0.0 109.94 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.19 -17.66 16.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.83 156.06 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.008 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 81' ' ' ILE . 23.9 m -126.72 127.29 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.81 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.693 ' CD1' HG23 ' A' ' 68' ' ' VAL . 1.8 pp -104.79 -26.27 12.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.305 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 67' ' ' LEU . 84.3 t -98.97 150.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -164.87 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -79.75 151.38 30.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 110.148 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.52 39.11 27.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.79 -19.47 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.315 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.33 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.547 -0.721 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.96 145.33 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.392 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.4 171.53 8.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.24 119.83 18.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 44.51 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 125.35 27.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -54.78 139.49 39.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.014 HD11 ' HB2' ' A' ' 20' ' ' ALA . 8.6 mt -107.64 -61.01 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.203 -1.175 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.562 ' CD1' HG12 ' A' ' 66' ' ' VAL . 11.8 tt -143.56 151.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' CD ' ' OE2' ' A' ' 17' ' ' GLU . 4.5 ttpt -95.23 143.81 26.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.072 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.8 tt -136.07 151.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.888 -1.507 . . . . 0.0 109.573 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -100.94 120.34 40.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.197 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.17 166.78 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.11 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 24.51 1.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.37 119.66 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.153 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.9 p -69.4 105.11 2.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 7' ' ' VAL . 14.9 p -165.22 58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -140.89 -170.15 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -58.66 -46.23 93.61 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 9' ' ' GLY . . . 55.71 -174.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -1.175 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.17 -61.36 5.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 56.36 70.93 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.287 -1.125 . . . . 0.0 110.481 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' N ' ' A' ' 79' ' ' GLY . . . 50.5 -164.27 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.312 -0.868 . . . . 0.0 110.537 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.67 -106.74 1.08 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -129.82 158.89 38.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.009 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.06 39.79 92.55 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 13' ' ' ALA . 2.0 pp20? -135.15 161.33 35.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -1.117 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.622 ' N ' HD12 ' A' ' 18' ' ' ILE . 4.7 mp -118.14 102.69 50.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.9 Cg_endo -72.12 156.6 55.47 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.656 1.345 . . . . 0.0 110.527 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -86.23 138.64 34.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.316 -0.865 . . . . 0.0 110.081 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.88 -27.37 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.609 1.321 . . . . 0.0 110.506 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.78 165.69 23.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.08 156.34 21.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . -134.28 -177.42 14.93 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 1.5 m -122.99 -133.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -1.198 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' SER . 15.7 m -36.8 -46.32 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.472 -0.768 . . . . 0.0 112.276 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t 54.95 42.41 31.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 0.0 109.918 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -51.93 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 29' ' ' ILE . 13.6 tt -68.09 86.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.5 mm? -54.04 -41.87 68.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.002 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.9 p -62.03 164.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 31' ' ' VAL . 5.5 ttmt -123.57 169.31 11.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 110.27 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.73 134.39 34.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.51 19.13 57.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.62 179.42 4.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.924 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -122.12 140.25 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.75 175.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -125.46 161.2 27.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -63.38 127.93 33.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.89 . . . . 0.0 110.084 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.56 19.13 45.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.719 ' O ' HG13 ' A' ' 43' ' ' VAL . 37.1 tt0 -109.36 111.65 23.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.243 . . . . 0.0 109.992 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 54.2 m -51.08 116.09 1.84 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.541 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.027 HG23 HD12 ' A' ' 44' ' ' LEU . 30.2 m -115.44 -22.56 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.842 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.027 HD12 HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -131.16 154.77 48.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 28' ' ' LYS . 98.6 t -128.2 109.76 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.215 -0.928 . . . . 0.0 110.818 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.653 HD22 ' HA3' ' A' ' 24' ' ' GLY . 30.5 mt -98.33 147.33 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 0.0 109.953 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.65 59.61 1.45 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.69 110.72 5.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 109.909 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.32 43.64 26.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 110.044 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt 52.94 47.83 23.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.144 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 9.6 mtt -94.39 -18.8 21.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 0.0 110.506 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 53.17 88.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.047 -1.033 . . . . 0.0 109.912 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.1 m -120.32 114.72 22.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.903 . . . . 0.0 110.436 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.4 OUTLIER -77.85 118.58 20.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 46' ' ' LEU . 30.7 mm -88.75 90.07 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.575 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.0 p-10 -73.45 132.36 42.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 110.064 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.37 1.93 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.362 -0.836 . . . . 0.0 110.665 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.88 -40.22 1.97 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.569 1.299 . . . . 0.0 110.644 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 79.4 m -156.09 153.4 29.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.255 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 24.7 t70 -55.79 140.94 40.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.45 177.8 39.73 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.19 142.29 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -1.141 . . . . 0.0 110.045 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 81' ' ' ILE . 41.9 t -71.8 129.73 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.95 -6.66 35.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 110.362 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -174.84 148.14 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 110.204 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 81' ' ' ILE . 7.1 p -105.14 144.49 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.97 -53.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 70' ' ' GLU . 92.5 t -53.46 128.21 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -80.15 1.75 26.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 68' ' ' VAL . 18.8 tt0 61.95 132.39 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.64 26.38 12.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.077 . . . . 0.0 110.136 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.1 t0 -126.41 120.63 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' THR . . . -54.18 142.95 24.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.963 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 72' ' ' ASP . 35.9 m -136.66 171.39 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.967 -1.083 . . . . 0.0 110.426 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -113.34 -179.23 3.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.79 140.78 15.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.22 20.62 10.9 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.2 mm-40 -125.97 143.85 50.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.164 . . . . 0.0 110.111 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.04 144.48 49.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 48.9 mt -104.85 -42.73 5.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 66' ' ' VAL . 1.9 tp -167.72 143.51 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -92.46 147.95 22.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.957 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.3 pt -133.76 158.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.467 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.257 0.551 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -62.27 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.319 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.708 ' O ' HD23 ' A' ' 3' ' ' LEU . 6.3 tt -140.01 101.92 4.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -119.83 -66.53 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.346 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 5' ' ' VAL . 31.6 m -137.67 132.23 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.303 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m 52.93 82.33 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.309 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.4 148.68 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.215 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.38 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.146 -0.971 . . . . 0.0 110.522 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.7 40.82 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.66 104.53 5.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.95 -69.02 0.57 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? 54.0 -160.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -1.127 . . . . 0.0 110.066 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.9 -161.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.988 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.33 59.6 0.53 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 53.65 79.03 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.23 -56.49 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -53.1 143.62 17.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.126 . . . . 0.0 110.362 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -113.33 131.87 22.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -73.34 144.7 37.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.524 1.276 . . . . 0.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -113.25 74.34 1.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.959 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.54 61.84 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.772 1.406 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 22' ' ' LEU . 1.7 mm? -113.01 -12.46 13.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.62 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 46' ' ' LEU . . . 55.01 -174.16 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.054 -1.029 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . 113.29 -162.48 12.35 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.483 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 10.4 p -130.46 101.0 5.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.254 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.547 ' H ' ' HB2' ' A' ' 73' ' ' ALA . 34.5 m -55.05 137.01 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.171 -0.956 . . . . 0.0 109.802 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -22.62 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.958 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -178.32 166.12 1.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.989 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.492 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -114.16 145.85 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.0 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 29' ' ' ILE . 3.3 mm? -117.59 -15.77 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.75 140.0 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 178.79 4.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.887 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.79 143.47 28.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 110.183 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.9 21.64 65.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.41 158.28 25.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -1.167 . . . . 0.0 110.118 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 134.56 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.06 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 2.0 ttpm? -138.64 146.91 42.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -58.9 103.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 -7.31 8.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -94.33 121.8 36.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.855 -1.379 . . . . 0.0 110.376 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.54 HG21 ' CG ' ' A' ' 54' ' ' GLU . 1.3 m -51.11 129.6 24.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.155 -0.966 . . . . 0.0 110.012 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 55' ' ' ILE . 31.1 m -124.91 -24.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 111.191 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.93 167.53 21.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.883 -1.136 . . . . 0.0 111.091 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 53' ' ' THR . 85.5 t -123.64 121.18 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 109.678 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 23' ' ' ALA . 8.8 tt -151.41 140.87 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.0 110.523 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' OG1' ' A' ' 25' ' ' THR . 4.4 pt-20 -119.56 154.41 33.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.098 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.93 73.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 110.489 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.96 26.35 2.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.376 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' GLU . 6.2 tttt -160.73 29.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 53' ' ' THR . 3.5 mtt 57.04 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.536 -0.727 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.537 ' OE1' HD11 ' A' ' 55' ' ' ILE . 1.1 mt-10 62.86 -77.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 55' ' ' ILE . 24.9 p 44.77 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.655 -0.653 . . . . 0.0 111.109 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -52.14 104.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.632 -1.292 . . . . 0.0 110.79 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 43' ' ' VAL . 24.3 mm -94.01 90.96 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 37.8 p-10 -49.38 147.04 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.502 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 38' ' ' LYS . . . -57.79 151.68 41.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.979 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 59' ' ' THR . 45.1 Cg_endo -72.66 -27.85 14.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.164 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -170.62 -171.86 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.948 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -103.6 144.05 31.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.52 -155.23 26.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -127.49 144.35 51.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.093 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 81' ' ' ILE . 39.4 t -76.18 100.88 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 110.111 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.73 -15.37 63.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.743 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER 177.24 161.1 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 81' ' ' ILE . 92.5 t -131.51 129.44 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.587 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.1 pp -109.9 -28.04 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.979 . . . . 0.0 110.641 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 80' ' ' LEU . 35.4 m -78.84 -176.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.051 -1.031 . . . . 0.0 110.306 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.2 155.53 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -50.95 165.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER 74.09 -42.63 0.51 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.538 -0.726 . . . . 0.0 111.949 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.41 129.06 30.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' GLY . . . -165.12 -156.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.377 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 84.6 t 57.4 115.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.607 0.718 . . . . 0.0 111.196 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 51.88 93.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.622 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.05 -136.34 0.25 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.12 7.07 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -141.46 140.54 33.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.184 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.587 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.19 148.07 5.54 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 20' ' ' ALA . 4.1 mt -91.51 -70.76 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -1.107 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.698 HD13 HG22 ' A' ' 63' ' ' VAL . 2.7 pp -152.29 154.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 110.099 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.61 130.27 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.18 22.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.944 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 tttt 52.97 53.91 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -60.13 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.089 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 130.67 5.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.31 125.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.559 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 p -123.18 169.97 10.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 t 60.05 151.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.426 -0.796 . . . . 0.0 110.406 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 53.35 75.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.06 -108.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.5 170.61 7.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -1.127 . . . . 0.0 110.292 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.09 -154.59 6.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -115.1 37.85 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -1.118 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.5 113.51 25.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 17' ' ' GLU . . . -64.56 -124.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -120.61 -25.85 5.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.15 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.79 64.93 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLY . 1.8 pm0 -129.59 166.95 18.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 83' ' ' ILE . 2.7 mp -118.47 104.55 47.51 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.92 138.23 30.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.587 1.309 . . . . 0.0 110.27 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -101.17 148.69 35.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 110.33 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.43 -24.09 19.63 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.679 1.358 . . . . 0.0 110.171 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.79 96.64 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 109.911 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' H ' ' A' ' 76' ' ' GLY . . . -49.95 -62.41 1.59 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.209 -0.932 . . . . 0.0 110.004 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' HD13 ' A' ' 46' ' ' LEU . . . 90.89 -170.02 34.34 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 80.34 8.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.33 114.48 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.3 m -111.58 -36.46 5.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 142.85 31.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -107.26 113.4 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 110.051 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 45' ' ' VAL . 2.8 mm? -79.33 -25.49 42.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.537 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 32' ' ' LYS . 8.6 p -90.3 161.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.421 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' HG22 ' A' ' 31' ' ' VAL . 3.5 ttpt -134.82 -167.89 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.901 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -94.66 133.73 38.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.048 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.41 -1.61 88.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.51 137.4 32.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.33 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -85.93 124.47 32.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.547 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 61' ' ' GLY . 25.5 m -102.55 -175.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.937 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 16.6 mmtt -139.45 164.72 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.8 98.8 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.86 19.31 6.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.687 ' O ' HG13 ' A' ' 43' ' ' VAL . 15.4 tt0 -106.18 118.94 37.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.1 -1.235 . . . . 0.0 109.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -49.08 128.12 15.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.972 -1.08 . . . . 0.0 110.659 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 41' ' ' GLN . 17.9 m -128.76 -31.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.717 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.57 161.34 27.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 53' ' ' THR . 41.4 t -132.07 126.36 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.264 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -134.07 167.36 20.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -130.4 88.2 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' GLU . . . -179.87 155.16 0.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -0.923 . . . . 0.0 109.694 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.2 mmt 51.56 90.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' GLU . 21.9 mtmt 56.58 26.19 10.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.8 OUTLIER 65.58 -63.28 0.21 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.707 -0.62 . . . . 0.0 110.935 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' LYS . 1.1 tp10 67.76 -65.15 0.25 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.24 -0.913 . . . . 0.0 109.88 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 54' ' ' GLU . 88.6 m 52.45 -103.46 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 110.585 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 53' ' ' THR . 33.6 mt-10 -50.53 114.42 1.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.586 -1.321 . . . . 0.0 111.303 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 46' ' ' LEU . 13.7 mm -106.79 99.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.81 134.57 55.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.565 -0.709 . . . . 0.0 110.458 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -52.89 154.96 4.54 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.701 ' HG3' HG21 ' A' ' 18' ' ' ILE . 50.8 Cg_endo -77.04 -38.9 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.693 1.365 . . . . 0.0 110.539 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.73 149.68 28.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.4 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 2.6 p30 -65.49 153.1 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.647 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 151.68 161.54 10.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -84.3 142.52 30.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -1.084 . . . . 0.0 110.205 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.73 131.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.213 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -91.45 -15.32 29.05 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.457 -0.777 . . . . 0.0 109.801 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt 179.55 166.64 1.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.214 -0.929 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 66' ' ' VAL . 11.8 m -131.1 105.9 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 109.909 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.3 pp -96.29 -28.13 14.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.962 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.59 155.26 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -135.17 159.62 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.633 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.7 74.33 6.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.92 -36.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.818 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -51.96 107.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.29 124.63 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.689 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 57.43 113.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.702 -0.624 . . . . 0.0 110.78 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.4 tt0 -153.68 -77.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.988 -1.07 . . . . 0.0 111.298 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 23' ' ' ALA . . . 64.3 132.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.85 2.22 39.66 Favored Glycine 0 N--CA 1.491 2.306 0 O-C-N 121.09 -1.241 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -127.95 146.59 50.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.804 -1.41 . . . . 0.0 110.244 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.651 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -63.39 141.45 45.94 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 20' ' ' ALA . 23.0 mt -84.85 -48.86 8.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.325 -1.103 . . . . 0.0 110.002 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.438 HG23 ' C ' ' A' ' 80' ' ' LEU . 29.6 pt -149.07 152.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 110.173 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 157.87 36.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 18' ' ' ILE . 1.9 tt -162.88 149.78 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.16 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.251 0.548 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 146.92 49.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 110.174 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.68 171.88 10.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 179.59 7.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.222 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 m -98.45 145.81 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 110.257 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -64.29 127.51 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.897 . . . . 0.0 110.136 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 9' ' ' GLY . 86.3 t -117.1 -77.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.35 35.35 13.68 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.606 ' H ' HG12 ' A' ' 7' ' ' VAL . . . 134.98 166.26 11.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.17 41.98 32.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -1.066 . . . . 0.0 110.366 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.84 157.18 8.37 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.38 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.384 -1.068 . . . . 0.0 110.411 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' ' CA ' ' A' ' 79' ' ' GLY . . . -92.53 -155.95 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.065 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.25 -155.49 6.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.13 127.94 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -1.108 . . . . 0.0 110.236 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.34 -57.23 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.75 162.12 19.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -1.205 . . . . 0.0 110.197 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 pt -133.19 135.56 25.82 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.0 Cg_endo -72.42 155.97 54.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.615 1.324 . . . . 0.0 110.688 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 75' ' ' GLN . . . -83.71 131.24 52.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.09 -19.9 17.21 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.54 1.284 . . . . 0.0 110.625 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -129.79 148.76 51.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' H ' HD13 ' A' ' 22' ' ' LEU . . . -85.44 166.11 16.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.546 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . 166.23 -179.89 40.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 46' ' ' LEU . 14.6 m -113.62 127.36 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.17 139.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 109.891 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 m -134.98 -39.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.7 148.46 45.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.37 151.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 HG22 ' A' ' 42' ' ' THR . 2.4 mp -129.37 -49.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.499 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 43' ' ' VAL . 9.3 p -51.45 143.76 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.272 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -103.85 157.84 16.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.006 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 63' ' ' VAL . 5.4 pt-20 -83.66 146.6 28.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.12 58.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.15 173.99 6.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.296 . . . . 0.0 110.052 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.5 m -106.47 110.22 22.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.086 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 ' CG1' ' A' ' 43' ' ' VAL . 14.9 p -87.45 145.07 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.86 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -100.9 152.66 20.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.206 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 130.68 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.59 21.39 29.13 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 43' ' ' VAL . 1.6 tt0 -116.44 121.77 42.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -1.212 . . . . 0.0 110.29 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.9 m -53.57 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 33.8 m -86.07 -21.7 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.77 171.27 16.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -136.74 140.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.586 ' HG ' HD11 ' A' ' 55' ' ' ILE . 11.8 mt -110.99 170.32 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 110.19 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -152.59 127.09 9.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.21 -156.45 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.2 tpt -92.73 39.82 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.396 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -153.04 -47.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -173.93 1.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -106.68 138.4 42.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.148 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.2 m -109.16 150.23 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.091 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.5 132.41 49.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 110.217 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 44' ' ' LEU . 85.8 mt -98.9 87.08 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.6 m-20 -74.09 129.37 37.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.555 -0.716 . . . . 0.0 110.35 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.716 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -48.55 138.99 11.43 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.436 -0.79 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.93 -37.61 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.595 1.313 . . . . 0.0 110.82 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -144.67 149.34 35.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 110.549 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.16 153.0 31.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.21 -166.55 39.75 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -127.61 143.03 51.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 33' ' ' GLU . 12.8 t -84.06 141.92 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -0.886 . . . . 0.0 110.274 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.4 -11.3 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.571 -0.706 . . . . 0.0 110.263 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 178.19 107.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 110.079 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -97.6 143.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.874 HD11 ' O ' ' A' ' 79' ' ' GLY . 1.4 pp -118.62 -23.91 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.053 -1.029 . . . . 0.0 110.544 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 80' ' ' LEU . 35.2 m -61.97 163.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 110.166 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 71' ' ' ARG . 13.7 mtmt -157.63 158.71 36.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.99 68.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -173.62 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.81 149.16 27.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -127.57 179.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.0 109.874 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' C ' ' A' ' 73' ' ' ALA . 29.2 m 36.22 68.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 65.9 mm-40 -75.44 -0.82 21.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -54.97 104.62 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.01 57.53 1.9 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.3 tt0 -163.24 138.33 6.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -1.127 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.874 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -52.13 136.45 34.45 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.856 ' O ' HG13 ' A' ' 68' ' ' VAL . 10.8 mt -102.15 -71.52 0.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.315 -1.109 . . . . 0.0 109.952 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.423 HG23 ' C ' ' A' ' 80' ' ' LEU . 26.4 pt -148.64 152.43 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -90.79 123.63 34.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.079 -1.013 . . . . 0.0 110.487 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.3 tt -129.74 142.22 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.507 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.242 0.544 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.72 43.08 3.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mt -66.51 93.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 9.2 pttt -69.66 -25.83 64.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 110.35 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' N ' ' HG3' ' A' ' 4' ' ' LYS . 9.0 p -58.47 152.74 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.955 . . . . 0.0 110.15 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 p -89.21 161.72 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 110.246 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.01 117.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -100.14 83.32 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.266 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -133.2 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -168.39 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -1.143 . . . . 0.0 110.235 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.71 -78.05 0.38 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.13 156.94 40.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -1.148 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.69 -165.75 1.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.26 156.02 21.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -54.06 134.59 43.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -1.168 . . . . 0.0 110.314 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 -23.07 37.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CG ' ' HD2' ' A' ' 82' ' ' LYS . 15.2 mt-10 -91.87 155.96 17.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.58 104.71 55.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.5 Cg_endo -73.4 164.11 35.99 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.567 1.298 . . . . 0.0 110.766 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -81.56 156.11 70.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.849 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.51 -36.97 3.45 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.716 1.377 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.26 -53.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.972 . . . . 0.0 110.325 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -167.62 179.19 4.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.378 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 177.43 160.46 24.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.8 p -115.96 90.83 3.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.174 . . . . 0.0 110.439 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.715 HG21 ' CG2' ' A' ' 68' ' ' VAL . 41.4 t -63.81 136.23 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 109.667 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.4 m -127.39 -30.67 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.013 -1.054 . . . . 0.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.83 159.12 41.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.604 ' CD1' HG11 ' A' ' 66' ' ' VAL . 6.2 tt -129.21 135.26 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.7 mm? -93.35 -40.2 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.942 . . . . 0.0 109.987 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 31' ' ' VAL . 35.6 m -91.02 -170.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 109.804 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -165.78 -45.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.655 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.0 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.15 31.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -54.71 115.32 2.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -1.17 . . . . 0.0 109.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 19.0 m -75.86 95.84 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.17 165.27 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 4.1 mttp -124.42 165.01 18.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.33 110.59 2.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.5 36.9 11.36 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.833 ' O ' HG13 ' A' ' 43' ' ' VAL . 5.5 tt0 -116.25 114.26 24.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -1.103 . . . . 0.0 110.073 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 54' ' ' GLU . 1.4 m -52.58 118.58 3.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 41' ' ' GLN . 35.3 m -124.16 -10.5 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.915 . . . . 0.0 110.943 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.39 160.37 42.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 110.738 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' THR . 89.2 t -109.68 117.19 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.617 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -150.37 134.89 17.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.408 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -117.47 104.0 10.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 110.115 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.02 -160.24 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.361 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 ttm -76.26 -29.03 57.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.925 . . . . 0.0 110.348 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -113.26 11.52 18.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.695 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 mtt -135.68 168.94 18.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 109.976 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 tt0 -154.1 73.37 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.04 -1.038 . . . . 0.0 110.978 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER 66.84 -59.96 0.36 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.1 OUTLIER -71.44 98.93 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.892 -1.13 . . . . 0.0 110.552 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 53' ' ' THR . 29.5 mm -105.54 98.6 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 11.6 m-20 -74.31 133.34 42.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.649 -0.657 . . . . 0.0 110.123 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -47.84 166.21 0.21 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.369 -0.832 . . . . 0.0 110.468 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.9 Cg_endo -72.69 -32.89 8.92 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.734 1.386 . . . . 0.0 110.526 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 t -173.39 171.08 4.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.7 p-10 -65.09 131.71 47.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' THR . . . 170.17 -176.59 43.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.61 142.3 35.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -1.099 . . . . 0.0 110.208 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.13 109.49 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.56 -17.66 60.7 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.704 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 176.87 164.65 0.49 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.257 -0.902 . . . . 0.0 109.998 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 68' ' ' VAL . 48.8 t -123.99 88.51 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -42.03 70.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.022 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.746 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 p -80.92 147.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -146.38 174.9 10.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.65 76.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.298 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER 179.9 -51.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 110.131 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.66 138.83 40.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.872 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -158.56 158.82 34.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.536 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 23.1 m 36.73 49.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.257 0.551 . . . . 0.0 111.7 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -154.03 85.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -92.72 -172.97 41.13 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.84 -25.75 25.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -101.25 160.46 14.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -1.155 . . . . 0.0 110.301 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.66 171.2 5.81 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -131.84 -58.02 0.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.24 -1.153 . . . . 0.0 110.04 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 44' ' ' LEU . 2.7 mp -136.88 146.38 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.192 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 17' ' ' GLU . 2.5 tttm -106.15 131.91 52.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.875 . . . . 0.0 110.141 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.62 35.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.297 0.57 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.07 -131.78 3.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -125.25 106.48 9.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -1.151 . . . . 0.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.14 -31.23 4.98 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.44 168.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 110.629 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.34 105.03 34.08 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.0 Cg_endo -70.96 139.55 36.29 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.582 1.306 . . . . 0.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.737 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -69.55 174.3 3.16 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 0.0 110.297 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 47.7 Cg_endo -74.18 -53.34 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.722 1.38 . . . . 0.0 110.384 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 22' ' ' LEU . 5.5 mt -151.84 -49.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.922 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -175.35 177.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 73' ' ' ALA . . . 177.42 -171.06 43.77 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -126.96 104.8 8.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -1.109 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.651 HG22 HD11 ' A' ' 46' ' ' LEU . 64.4 t -55.95 155.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -128.14 -40.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -174.0 133.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG22 ' A' ' 29' ' ' ILE . 15.3 tt -98.48 151.13 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.9 mm? -106.42 -58.76 1.88 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.327 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 33' ' ' GLU . 95.6 t -70.61 150.9 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 1.3 mttt -118.17 42.59 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HA ' HG11 ' A' ' 63' ' ' VAL . 13.3 tm-20 59.77 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.616 0.722 . . . . 0.0 110.698 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.74 20.29 66.1 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.45 136.54 52.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.965 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -71.84 159.57 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 110.106 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 57' ' ' ALA . 9.2 p -147.01 165.57 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -122.64 177.1 5.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.114 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.96 103.33 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.77 -19.02 9.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.22 112.63 2.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.123 -1.222 . . . . 0.0 110.297 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 89.1 m -52.1 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 HD23 ' A' ' 44' ' ' LEU . 59.8 t -57.77 -37.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.844 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.928 HD11 HD12 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -167.11 -160.01 0.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.577 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 46' ' ' LEU . 39.9 t -143.03 148.16 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -150.22 173.68 13.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.058 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 110.429 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.203 0.525 . . . . 0.0 110.254 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER -54.25 109.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.211 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.928 HD12 HD11 ' A' ' 44' ' ' LEU . 48.1 mt -88.82 102.64 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 13.9 p-10 -75.99 138.21 40.77 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.602 0.715 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 37' ' ' VAL . . . -54.23 145.9 33.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.887 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.01 -37.05 3.79 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.593 1.312 . . . . 0.0 110.637 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -155.5 160.91 40.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.49 142.62 48.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.04 -164.33 37.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -132.03 148.47 52.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -1.133 . . . . 0.0 110.035 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.0 t -84.73 138.16 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.51 -25.37 16.88 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.475 -0.766 . . . . 0.0 109.05 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.17 137.47 0.1 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 109.75 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.4 p -93.31 130.37 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.438 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.49 -50.79 4.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.047 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 69' ' ' LYS . 11.4 p -58.04 163.06 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 68' ' ' VAL . 7.9 ttmt -136.15 160.35 38.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.007 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 58.07 28.85 16.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HG23 ' A' ' 26' ' ' VAL . 46.3 t0 -113.25 112.96 24.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.867 . . . . 0.0 109.824 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -105.09 177.33 4.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 110.602 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.922 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 33.6 m 36.84 56.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.294 0.569 . . . . 0.0 111.709 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.405 ' O ' ' CG ' ' A' ' 75' ' ' GLN . 0.5 OUTLIER -136.85 71.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.065 -1.022 . . . . 0.0 110.48 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -116.07 168.85 12.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 -29.61 12.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -102.77 152.51 21.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -1.059 . . . . 0.0 109.914 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.55 136.66 43.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.3 mt -88.83 -51.09 5.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -1.17 . . . . 0.0 110.058 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.99 139.97 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.099 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -93.5 134.81 35.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -145.78 147.15 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.151 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.257 0.551 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.18 158.26 27.17 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.13 -28.05 66.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -1.09 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.03 -24.14 25.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -80.41 150.51 29.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -1.123 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.9 100.1 53.2 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.956 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -72.42 164.67 34.92 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.676 1.356 . . . . 0.0 110.956 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 119.8 74.5 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.848 . . . . 0.0 109.984 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.94 0.03 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.45 1.237 . . . . 0.0 111.152 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.54 59.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.829 -1.169 . . . . 0.0 110.389 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.87 -167.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.77 156.65 7.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.463 ' C ' HD23 ' A' ' 46' ' ' LEU . 92.4 m -103.68 108.29 19.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -1.168 . . . . 0.0 110.29 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 72' ' ' ASP . 44.9 t -72.37 125.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.73 -46.25 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 110.569 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.16 152.8 13.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.008 . . . . 0.0 110.137 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 44' ' ' LEU . 21.5 pt -118.76 135.35 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.152 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.1 mp -92.29 -3.16 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 63' ' ' VAL . 12.0 p -93.8 151.64 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.79 153.3 44.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.054 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -68.18 131.55 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.132 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.77 16.72 67.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.95 158.7 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -1.2 . . . . 0.0 109.968 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 59.2 m -105.37 129.21 53.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.3 m -113.75 174.09 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 6.1 mtpm? -128.52 152.6 48.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -62.52 116.4 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.94 -24.98 9.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 tt0 -76.41 122.66 24.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 55' ' ' ILE . 5.0 m -59.05 104.59 0.25 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.178 -0.951 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 41' ' ' GLN . 23.8 m -91.0 -15.09 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.59 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -145.14 160.32 41.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.191 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.52 122.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 25' ' ' THR . 1.9 mt -113.89 172.91 6.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 110.373 -179.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.166 0.507 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -54.25 129.92 36.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 42' ' ' THR . 37.9 mm -101.71 90.35 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.36 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -65.38 141.42 58.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -52.58 150.58 9.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.166 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.31 -31.48 11.56 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.675 1.355 . . . . 0.0 110.497 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.631 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 7.3 t -174.69 166.25 3.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.04 123.47 18.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 175.16 170.57 38.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 63' ' ' VAL . 11.1 ttmt -104.93 152.86 22.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 31' ' ' VAL . 15.1 t -71.92 143.91 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 110.152 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.05 -17.98 11.32 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.44 117.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.164 -0.96 . . . . 0.0 110.387 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -100.89 132.67 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.117 -0.99 . . . . 0.0 109.852 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.18 -21.81 9.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.045 -1.034 . . . . 0.0 110.723 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 7.5 p -59.86 148.83 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.82 145.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.42 76.13 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 177.83 -45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.305 -0.872 . . . . 0.0 110.1 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 23.6 t0 -55.3 128.13 32.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.277 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -140.68 164.65 29.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 75' ' ' GLN . 85.1 t 56.44 164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.789 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 57.44 111.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.389 -0.819 . . . . 0.0 110.877 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.3 -159.78 27.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.91 -19.2 55.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 6.2 mt-30 -92.68 138.51 31.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -1.213 . . . . 0.0 110.421 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.58 177.03 0.36 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -135.5 -65.9 0.59 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.75 142.37 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -100.42 120.83 40.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.86 128.55 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.884 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.336 0.588 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.73 -107.26 3.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.4 tt0 -140.33 104.31 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -1.151 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.93 -39.53 2.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -54.66 157.48 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -1.093 . . . . 0.0 110.476 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 18' ' ' ILE . 5.1 mp -116.13 104.63 52.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 109.928 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 43.7 Cg_endo -71.18 136.74 29.95 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.585 1.308 . . . . 0.0 110.533 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -64.54 139.2 97.68 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.76 -24.13 13.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.61 1.321 . . . . 0.0 110.623 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -131.51 166.24 21.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 75' ' ' GLN . . . -75.06 174.92 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.299 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.3 179.36 39.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.1 m -133.42 137.32 45.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 110.156 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 41.9 t -69.67 118.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.69 -28.63 19.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.69 126.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.868 HD12 HD21 ' A' ' 44' ' ' LEU . 1.4 tt -81.48 150.34 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 -38.38 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.171 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.13 176.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.412 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.35 46.01 1.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.321 -0.862 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.746 ' HA ' HG11 ' A' ' 63' ' ' VAL . 1.4 tt0 59.82 155.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.26 28.22 42.09 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.61 124.73 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.164 . . . . 0.0 110.288 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 61' ' ' GLY . 25.8 m -69.64 149.93 47.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 57' ' ' ALA . 7.2 p -136.7 161.51 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 37' ' ' VAL . 3.7 ttmm -115.48 155.27 27.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.95 109.94 1.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.211 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 28.73 4.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -118.16 115.24 24.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -1.214 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 87.0 m -54.42 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 55' ' ' ILE . 20.5 m -69.07 -22.65 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.22 172.3 16.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.493 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 97.1 t -119.36 130.55 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.034 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 -177.8 3.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.331 0.586 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.7 103.46 14.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.675 ' O ' HG22 ' A' ' 43' ' ' VAL . 41.0 mm -68.85 91.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.553 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -77.24 131.41 38.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.434 -0.791 . . . . 0.0 110.238 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -50.2 156.41 1.4 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 -37.92 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.694 1.365 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -158.8 178.3 10.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.18 132.12 38.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 36' ' ' THR . . . 174.85 -135.44 3.09 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -154.41 150.13 27.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.272 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 33' ' ' GLU . 9.1 t -64.25 142.11 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.053 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -115.6 -18.38 10.91 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.843 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 3.4 tmtm? 179.24 89.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.6 p -79.8 117.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.974 . . . . 0.0 110.202 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.753 HD11 ' O ' ' A' ' 79' ' ' GLY . 2.7 pp -96.93 -25.71 15.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.79 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.293 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -132.16 160.19 36.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.34 153.58 43.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.917 . . . . 0.0 110.224 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 55.13 21.63 4.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.313 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.05 87.32 2.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.163 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.22 149.09 13.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 75' ' ' GLN . 13.2 p -153.0 164.12 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.114 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -106.15 -179.21 3.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.48 129.56 10.54 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 35.42 2.24 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -136.19 126.32 26.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -1.148 . . . . 0.0 110.14 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.753 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.91 151.17 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 20' ' ' ALA . 67.8 mt -118.58 -64.21 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -1.115 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 66' ' ' VAL . 1.8 pp -135.31 133.64 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.198 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -82.45 143.66 31.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.403 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.2 tt -164.82 161.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.547 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.222 0.534 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.95 -168.53 17.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.06 78.45 3.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -1.186 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.79 -20.88 1.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.53 170.49 9.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -1.166 . . . . 0.0 110.234 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.45 132.14 24.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 109.97 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.9 Cg_endo -74.36 131.71 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.51 1.268 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -55.48 137.27 69.66 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.4 113.93 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.582 1.306 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.5 mm? 49.45 48.95 20.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 -154.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 0.0 110.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.732 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 143.06 172.46 14.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.5 p -112.49 112.22 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.481 HG21 ' OD2' ' A' ' 72' ' ' ASP . 38.8 t -76.18 112.31 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.982 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.6 -9.25 12.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.715 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -168.46 151.24 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.983 -1.073 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.25 145.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 30' ' ' LEU . 2.2 mm? -107.39 -42.31 4.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.118 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 43' ' ' VAL . 7.6 p -71.76 165.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.204 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 31' ' ' VAL . 25.7 tttt -140.92 163.21 33.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HB3' HG13 ' A' ' 66' ' ' VAL . 9.3 pt-20 -68.46 135.42 51.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.0 22.69 68.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.21 130.02 55.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.7 m -75.43 118.56 18.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.058 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.5 p -98.19 151.49 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.66 156.07 21.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 109.99 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 121.42 14.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -5.67 44.55 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.496 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ALA . 1.5 tt0 -85.5 123.64 31.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.819 -1.401 . . . . 0.0 110.441 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.2 m -55.68 102.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.285 -0.884 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.4 m -81.48 -23.0 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -154.2 162.97 40.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.613 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.94 125.26 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.732 HD21 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -98.91 168.03 10.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 110.291 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.248 0.547 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.25 113.58 25.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' HB3' ' A' ' 44' ' ' LEU . 49.7 mt -81.25 94.2 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.324 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 3.7 m-20 -66.67 148.79 51.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.407 0.622 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -65.19 146.47 98.93 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.51 -0.744 . . . . 0.0 110.352 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.09 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.703 1.37 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.75 150.5 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.98 147.99 52.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.175 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.5 -164.22 37.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -125.65 142.3 51.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -1.107 . . . . 0.0 110.251 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 18.7 t -80.06 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.019 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.58 -15.11 13.1 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.569 -0.707 . . . . 0.0 109.851 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.09 131.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.104 -0.998 . . . . 0.0 110.163 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 33' ' ' GLU . 32.5 m -73.31 150.69 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 79' ' ' GLY . 0.5 OUTLIER -125.12 -58.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' OD2' ' A' ' 72' ' ' ASP . 41.3 t -84.54 154.94 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 71' ' ' ARG . 9.1 mmtt -135.33 166.01 24.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 4.4 mt-10 -63.79 80.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -176.88 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.481 ' OD2' HG21 ' A' ' 26' ' ' VAL . 15.8 p-10 -52.7 125.03 15.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.537 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -122.2 158.68 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.204 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 73' ' ' ALA . 26.7 m 36.6 42.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 121.285 0.564 . . . . 0.0 111.694 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.883 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -99.46 150.12 19.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.68 14.88 64.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.2 tt0 -99.34 150.25 22.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.287 . . . . 0.0 110.119 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.532 ' O ' HD13 ' A' ' 67' ' ' LEU . . . -66.47 106.28 1.57 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 2.7 mt -55.73 -79.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -1.156 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.5 mt -144.54 160.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -88.47 132.61 34.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.067 -1.02 . . . . 0.0 110.126 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.78 33.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.594 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.258 0.551 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.72 170.17 13.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.17 107.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.12 -24.73 5.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -94.64 158.2 15.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -1.143 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -124.54 111.64 27.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.8 Cg_endo -72.42 157.92 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.513 1.27 . . . . 0.0 110.793 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -95.77 112.49 59.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.92 -3.71 14.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.55 1.289 . . . . 0.0 111.28 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -142.18 33.2 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 110.725 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.89 -157.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.139 -0.975 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.84 -159.17 20.62 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.23 -146.83 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -1.176 . . . . 0.0 110.115 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 m -47.68 -31.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.049 -1.032 . . . . 0.0 111.147 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p 57.18 39.49 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -66.43 101.15 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 29' ' ' ILE . 5.5 tt -62.3 115.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.457 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 45' ' ' VAL . 28.4 mt -69.9 -26.75 64.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.944 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 31' ' ' VAL . 23.4 m -98.98 -158.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.177 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.84 -178.45 6.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -81.49 151.81 27.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 110.075 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.72 5.13 83.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.49 167.65 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.002 -1.293 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -103.75 156.53 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.327 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 38' ' ' LYS . 7.7 p -137.85 167.76 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -129.35 160.1 34.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 121.48 15.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.303 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.27 44.95 6.04 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.814 ' O ' HG13 ' A' ' 43' ' ' VAL . 3.4 tt0 -132.34 110.11 10.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 54' ' ' GLU . 93.8 m -53.07 114.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -124.72 -12.9 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.884 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.531 HD12 HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -132.45 166.35 22.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.848 -1.157 . . . . 0.0 110.909 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG13 HG23 ' A' ' 53' ' ' THR . 92.4 t -117.82 103.47 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 110.036 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -138.96 137.0 36.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.829 HG23 HG13 ' A' ' 45' ' ' VAL . 41.0 m . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 120.962 0.41 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 42' ' ' THR . 6.2 mt-10 -56.08 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.098 . . . . 0.0 110.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.9 mm -88.48 102.16 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -78.73 127.3 31.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.427 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.2 14.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 110.083 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -51.47 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.652 1.343 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.6 p -139.71 156.06 47.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 29.2 p-10 -62.28 166.51 4.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.75 -161.91 29.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -134.92 143.88 47.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -1.187 . . . . 0.0 109.936 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.48 134.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 110.329 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.83 -11.87 16.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.69 138.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 109.771 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 33' ' ' GLU . 34.1 m -86.44 160.55 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.36 -67.44 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' LYS . 13.3 p -62.42 169.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 110.489 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.2 mmmt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.158 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 28' ' ' LYS . 4.1 tt0 -53.88 134.23 42.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.903 . . . . 0.0 110.441 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 55.83 51.4 12.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.473 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.2 t0 -102.51 -26.35 13.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 61.82 142.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.397 -0.815 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.466 HG22 ' C ' ' A' ' 73' ' ' ALA . 14.8 m 34.53 89.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 121.417 0.627 . . . . 0.0 112.139 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.19 64.28 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.102 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -104.44 154.87 17.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.3 54.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.7 tt0 -118.24 163.41 16.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -1.165 . . . . 0.0 110.143 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.14 175.81 2.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 20' ' ' ALA . 65.7 mt -123.42 -43.03 2.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 81' ' ' ILE . 8.5 tt -175.67 143.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.084 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -98.4 126.35 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.69 113.29 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.525 -179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.119 0.485 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.56 -125.38 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.42 97.15 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -1.12 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.62 1.15 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -118.23 174.86 5.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.317 -1.108 . . . . 0.0 110.343 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' LEU . 15.6 mm -107.97 100.12 34.34 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.179 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.01 45.78 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.638 1.336 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.51 116.1 61.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.94 -8.03 22.19 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.46 1.242 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 22' ' ' LEU . 14.6 tp -150.03 126.13 10.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.999 -1.063 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB1' ' H ' ' A' ' 75' ' ' GLN . . . -58.74 178.35 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.751 ' C ' ' HB3' ' A' ' 73' ' ' ALA . . . 151.19 -149.52 21.33 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.066 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.547 ' N ' ' HB3' ' A' ' 73' ' ' ALA . 31.0 p -137.46 100.01 4.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.898 HG23 ' HB2' ' A' ' 73' ' ' ALA . 59.1 t -50.28 100.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.013 -1.055 . . . . 0.0 110.291 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 t -57.44 -41.02 79.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -173.12 156.64 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.721 HD12 HG21 ' A' ' 68' ' ' VAL . 3.6 tt -96.42 136.3 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.348 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 30' ' ' LEU . 1.2 mm? -103.43 -25.81 13.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 81' ' ' ILE . 9.2 p -87.15 153.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -123.29 149.21 45.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.208 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -69.85 136.12 50.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.64 24.13 59.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.35 143.43 51.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -1.09 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -85.67 116.8 24.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 43' ' ' VAL . 13.1 p -100.96 154.64 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 145.77 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -55.41 142.12 33.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.303 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.88 -34.59 5.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.22 123.56 20.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -1.201 . . . . 0.0 110.381 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 42' ' ' THR . 8.1 t -57.19 101.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.971 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.889 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 32.9 m -77.57 -17.39 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 110.449 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 55' ' ' ILE . 4.0 mt -152.21 155.61 38.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.077 -1.014 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.83 117.97 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.842 HD11 ' CB ' ' A' ' 73' ' ' ALA . 2.4 mm? -102.35 174.56 5.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.457 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.098 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.181 0.515 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.27 132.34 53.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.849 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.754 HD11 HD23 ' A' ' 46' ' ' LEU . 20.8 mt -107.02 99.68 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.45 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 10.6 p-10 -70.86 137.41 49.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.367 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.889 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -56.66 148.32 47.02 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.85 . . . . 0.0 110.068 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.49 -36.11 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.644 1.339 . . . . 0.0 110.504 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 2.6 m -157.31 158.27 35.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 139.23 46.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.18 38.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 139.43 49.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 31' ' ' VAL . 24.5 t -72.43 142.28 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.014 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -105.86 -18.18 14.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.794 . . . . 0.0 109.681 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 156.61 0.55 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -0.976 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 66' ' ' VAL . 35.8 m -134.63 100.06 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.055 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -84.08 -15.0 48.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 0.0 110.489 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.721 HG21 HD12 ' A' ' 29' ' ' ILE . 30.2 m -46.7 153.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 7.66 8.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.657 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 61.27 143.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.957 . . . . 0.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.7 mtp-105 52.53 39.03 27.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -154.53 42.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.898 ' HB2' HG23 ' A' ' 26' ' ' VAL . . . -82.12 -4.92 57.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.002 . . . . 0.0 110.439 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 24' ' ' GLY . 29.9 m -44.29 140.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.367 -0.833 . . . . 0.0 111.155 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.609 ' H ' ' HB1' ' A' ' 23' ' ' ALA . 20.2 tt0 54.12 100.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.454 -0.778 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -168.6 8.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.91 -24.69 27.28 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -79.11 130.69 35.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -1.075 . . . . 0.0 110.158 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.939 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -55.99 157.44 9.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 68' ' ' VAL . 32.3 mt -118.68 -64.96 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -1.179 . . . . 0.0 110.216 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.649 HD13 HG11 ' A' ' 31' ' ' VAL . 51.6 mt -126.65 156.36 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 146.55 25.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.006 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 6.5 tt -136.59 25.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.56 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.283 0.564 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.87 -122.0 2.88 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 -57.62 2.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -1.133 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.54 -5.69 89.21 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.522 ' OE1' HD21 ' A' ' 67' ' ' LEU . 42.2 mt-10 -78.1 135.24 37.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.311 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.48 109.84 34.66 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.351 -0.843 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.15 152.51 56.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.495 1.261 . . . . 0.0 110.641 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -100.76 122.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.87 -17.62 25.32 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.481 1.253 . . . . 0.0 110.43 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.95 138.67 42.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.96 141.24 28.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.106 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -134.39 158.64 23.51 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -121.11 104.83 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -1.132 . . . . 0.0 110.04 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 27' ' ' SER . 7.5 p -47.38 168.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -0.898 . . . . 0.0 110.902 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 26' ' ' VAL . 25.7 t -149.69 -42.19 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 109.878 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -160.24 119.42 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 44' ' ' LEU . 1.2 tt -81.76 151.73 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.76 -38.01 5.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.104 -0.997 . . . . 0.0 110.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.813 HG21 HG13 ' A' ' 43' ' ' VAL . 35.9 m -123.41 168.35 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.284 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -121.38 -162.58 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -82.99 140.56 32.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 110.28 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.82 49.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 172.38 7.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.093 -1.239 . . . . 0.0 110.41 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.6 m -116.93 133.58 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 61' ' ' GLY . 34.8 m -125.56 152.56 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 14.0 tttt -110.78 163.91 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.386 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 107.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.257 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.99 -0.72 31.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -90.25 127.26 36.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.334 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 3.4 m -54.13 135.6 43.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 31' ' ' VAL . 97.2 t -118.6 -38.17 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -147.94 159.34 43.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.792 . . . . 0.0 110.544 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.03 116.79 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.954 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.458 HD11 ' HA3' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -101.39 153.57 19.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.076 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.272 0.558 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.64 128.77 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.8 81.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.246 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 2.0 m120 -72.58 133.93 44.95 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.545 0.688 . . . . 0.0 110.654 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 43' ' ' VAL . . . -49.97 143.7 11.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 110.456 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.25 -32.44 6.63 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.655 1.345 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -145.08 162.25 37.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.1 p-10 -77.27 133.5 38.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 166.42 173.83 35.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -90.99 152.63 20.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -1.131 . . . . 0.0 110.153 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.18 128.67 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -109.25 -1.33 18.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.448 -0.783 . . . . 0.0 110.319 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -177.86 139.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.01 89.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.522 HD21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -52.31 -58.1 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.509 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.677 HG22 HG11 ' A' ' 74' ' ' VAL . 57.9 t -95.92 137.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -163.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 0.0 109.759 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HA ' HG21 ' A' ' 26' ' ' VAL . 8.3 tt0 -91.69 131.63 36.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 110.133 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 71.53 2.96 4.48 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.595 -0.69 . . . . 0.0 111.189 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.455 ' N ' HG11 ' A' ' 26' ' ' VAL . 4.6 m-20 -98.39 84.54 3.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.0 109.702 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.34 155.96 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.224 -0.922 . . . . 0.0 110.794 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HG22 ' A' ' 68' ' ' VAL . 26.4 m -142.51 158.75 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 110.077 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -100.77 152.27 20.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.943 . . . . 0.0 110.398 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.13 138.66 42.46 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.71 -7.37 11.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.91 150.26 38.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.918 -1.343 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.09 159.85 17.62 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 20' ' ' ALA . 57.5 mt -108.86 -49.68 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.865 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' C ' ' A' ' 80' ' ' LEU . 4.8 pt -154.46 150.58 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.835 . . . . 0.0 110.024 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 65' ' ' LYS . 37.2 tttt -108.36 139.42 43.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.938 . . . . 0.0 110.368 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 3.7 tt -148.85 44.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.611 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.581 ' HB1' ' CG ' ' A' ' 17' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.343 0.592 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.98 -110.59 1.03 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.0 mt-10 -139.45 125.44 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 110.13 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.86 -33.56 5.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -57.23 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.409 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG12 ' A' ' 83' ' ' ILE . 3.9 mp -138.84 110.75 7.99 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.079 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.76 137.01 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.539 1.284 . . . . 0.0 110.355 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.11 136.32 53.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.78 -24.55 13.21 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.462 1.243 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -134.05 139.9 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.32 178.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.977 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -176.83 155.84 19.28 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -99.74 121.31 41.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.362 -1.081 . . . . 0.0 109.979 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.42 136.37 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 110.366 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 45' ' ' VAL . 44.5 t -115.62 -31.86 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 109.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtmt -172.84 139.94 0.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.083 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.437 ' H ' HG22 ' A' ' 29' ' ' ILE . 8.2 tt -101.82 140.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 mt -116.29 -27.14 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.258 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.634 ' CG2' HG21 ' A' ' 63' ' ' VAL . 9.2 p -82.83 155.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.61 160.37 39.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.888 . . . . 0.0 110.248 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -68.07 122.17 17.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.99 -2.26 55.35 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 126.32 38.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.872 -1.37 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.8 m -64.55 124.03 20.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.7 p -99.46 145.27 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.88 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.47 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.937 . . . . 0.0 110.234 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.16 17.86 23.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -118.45 119.55 34.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.149 -1.207 . . . . 0.0 110.189 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 79.5 m -52.65 122.45 9.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.915 . . . . 0.0 110.011 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -114.33 -23.34 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 171.06 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.977 -1.077 . . . . 0.0 111.058 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 27' ' ' SER . 50.4 t -121.31 117.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 109.397 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 24' ' ' GLY . 3.2 tp -107.83 149.51 28.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.943 . . . . 0.0 110.815 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.819 . . . . 0.0 109.966 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 53.8 m . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.051 0.453 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -58.46 97.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 111.106 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 43' ' ' VAL . 26.7 mm -96.12 90.96 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.012 . . . . 0.0 109.5 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -62.63 138.85 58.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.582 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -54.06 167.81 0.5 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.387 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.53 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 48.6 Cg_endo -75.02 -35.85 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.822 1.433 . . . . 0.0 110.446 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -165.69 -159.41 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.9 147.51 26.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.85 -150.53 22.09 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -129.99 149.06 51.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.94 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 31' ' ' VAL . 38.6 t -80.5 110.18 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 110.379 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -78.4 -12.39 60.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.99 174.71 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 66' ' ' VAL . 34.7 m -123.64 91.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.742 HD13 ' HA3' ' A' ' 79' ' ' GLY . 1.1 mt -60.53 -30.18 69.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -103.81 142.74 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 110.545 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 -171.64 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 109.992 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.6 154.76 21.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.043 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 58.07 30.55 19.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.896 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.95 67.55 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 173.3 0.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.479 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t 53.55 86.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -131.21 28.09 4.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.155 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.38 132.98 11.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.11 44.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.31 150.01 21.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -1.202 . . . . 0.0 110.152 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.742 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -58.12 149.01 35.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.1 mt -96.57 -68.57 0.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 6.1 mt -126.85 146.86 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -88.06 118.93 27.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.491 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 18' ' ' ILE . 4.5 pt -146.0 153.36 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.506 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.716 ' HB1' ' OE2' ' A' ' 17' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.213 0.53 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.12 -106.23 0.48 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.0 148.47 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.96 58.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.716 ' OE2' ' HB1' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -111.65 166.14 11.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -1.095 . . . . 0.0 110.46 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.67 100.41 19.59 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.858 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.2 Cg_endo -71.18 121.31 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.742 1.391 . . . . 0.0 110.542 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -60.79 141.62 92.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -20.56 21.74 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.654 1.344 . . . . 0.0 110.387 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.84 151.43 29.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.66 174.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.304 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.03 153.37 11.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 46' ' ' LEU . 21.2 p -106.77 135.33 48.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -1.19 . . . . 0.0 110.22 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 68' ' ' VAL . 43.1 t -89.9 130.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -101.8 -23.18 14.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -169.63 165.43 10.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.5 tt -122.43 145.24 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -103.01 -54.55 2.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.822 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 HG13 ' A' ' 43' ' ' VAL . 29.2 m -71.53 -171.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.837 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.93 39.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 17.9 tt0 61.21 142.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.295 -0.878 . . . . 0.0 110.727 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.73 60.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -1.234 . . . . 0.0 109.886 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' VAL . 3.7 m -57.61 178.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 110.047 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 36' ' ' THR . 13.4 p -171.78 164.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' HG22 ' A' ' 37' ' ' VAL . 10.1 mtmm -122.69 177.45 5.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.28 125.93 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.464 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.51 -22.34 41.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 43' ' ' VAL . 49.0 tt0 -70.01 127.73 33.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 0.0 110.407 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.587 HG22 HD22 ' A' ' 30' ' ' LEU . 69.2 m -52.13 137.95 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.931 . . . . 0.0 110.011 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.878 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 93.7 t -123.49 -36.45 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -142.82 176.28 9.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.135 -0.978 . . . . 0.0 111.076 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 53' ' ' THR . 42.1 t -124.48 145.12 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -174.83 4.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.046 . . . . 0.0 110.523 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.47 HG23 ' N ' ' A' ' 54' ' ' GLU . 8.2 t . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' THR . 1.1 mt-10 -37.69 133.79 0.76 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.302 -0.874 . . . . 0.0 112.237 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.663 HG13 HD12 ' A' ' 46' ' ' LEU . 35.1 mm -125.69 106.71 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.643 -0.661 . . . . 0.0 109.411 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 76.3 m-20 -57.18 144.1 36.41 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.703 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.878 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -62.38 152.38 79.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.71 -33.77 7.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.693 1.365 . . . . 0.0 110.389 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -161.51 151.75 17.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.43 158.49 14.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 145.59 -144.23 12.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -140.33 158.17 44.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -1.158 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 52.5 t -85.19 119.98 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 84' ' ' GLY . 1.2 mm-40 -90.22 -10.49 44.15 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 109.598 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.1 mttm 179.86 163.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -123.72 95.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 -36.48 75.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.741 HG21 HD23 ' A' ' 80' ' ' LEU . 45.1 t -96.15 128.53 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 -170.9 2.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.109 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 134.7 34.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 52.14 42.17 30.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.7 t70 -104.25 -23.76 13.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.312 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 60.73 117.17 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.04 -177.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.0 . . . . 0.0 110.339 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.08 162.85 21.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.62 146.43 48.5 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.84 37.16 6.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.7 tt0 -146.51 132.05 18.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.74 114.74 4.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 68' ' ' VAL . 26.1 mt -70.19 -57.89 4.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.296 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.03 168.78 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.3 143.08 42.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.38 162.6 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.305 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 64' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.531 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.195 0.521 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.74 -133.16 4.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.35 132.35 46.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.43 24.75 59.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.21 159.34 32.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -1.188 . . . . 0.0 110.277 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 83' ' ' ILE . 67.7 mt -130.94 99.56 18.03 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.967 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.5 Cg_endo -73.53 130.28 14.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.734 1.386 . . . . 0.0 110.618 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.55 114.18 36.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -18.59 26.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.468 1.247 . . . . 0.0 110.665 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.0 mt -119.97 9.27 11.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' ' N ' ' A' ' 76' ' ' GLY . . . 51.68 -150.32 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 0.0 110.402 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 141.62 176.69 16.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -121.23 108.96 14.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -1.136 . . . . 0.0 110.009 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.3 136.35 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -40.21 3.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.248 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.69 139.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.5 tt -81.73 149.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -105.16 -45.57 4.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.152 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 HG23 ' A' ' 43' ' ' VAL . 24.4 m -101.91 -158.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -148.98 179.25 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 146.41 53.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.37 87.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.12 146.48 26.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.3 . . . . 0.0 110.163 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.7 m -97.83 107.26 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 61' ' ' GLY . 31.3 m -81.25 158.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.86 155.42 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.34 109.43 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.371 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.8 34.43 5.73 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -125.04 114.52 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.153 . . . . 0.0 110.084 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -49.16 113.77 0.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.221 -0.924 . . . . 0.0 110.412 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 31' ' ' VAL . 12.0 p -107.95 -26.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.838 . . . . 0.0 110.625 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.758 ' CD1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -142.78 175.44 9.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.137 -0.977 . . . . 0.0 111.163 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' THR . 57.5 t -116.17 142.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.948 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HB2' HG13 ' A' ' 55' ' ' ILE . 21.7 tp -134.72 159.22 41.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.015 . . . . 0.0 110.731 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 34.8 tt0 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.979 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 54' ' ' GLU . 54.6 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.814 0.34 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 53' ' ' THR . 7.4 mt-10 -59.9 105.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.717 -1.24 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 46' ' ' LEU . 26.2 mm -103.76 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 18.4 p-10 -69.81 135.38 49.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.638 -0.664 . . . . 0.0 110.726 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.43 175.3 0.13 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 110.175 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.761 ' O ' HG23 ' A' ' 59' ' ' THR . 49.0 Cg_endo -76.51 -48.99 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.762 1.401 . . . . 0.0 110.768 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -163.42 -167.66 1.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 124.86 26.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 37' ' ' VAL . . . -179.87 169.9 40.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -107.62 151.43 25.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.84 106.85 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.997 . . . . 0.0 110.453 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -84.33 -10.79 57.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt 178.19 157.3 0.43 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.119 -0.988 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' VAL . 19.2 m -112.39 94.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -70.37 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.498 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.48 166.12 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -118.5 -176.25 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.52 145.5 26.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 57.89 33.62 23.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.64 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' THR . . . -51.38 145.74 8.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.226 -0.922 . . . . 0.0 110.48 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.09 158.59 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 110.094 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -98.8 24.79 7.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.912 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . 77.52 172.1 37.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.19 34.33 88.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -128.47 130.03 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -1.117 . . . . 0.0 110.157 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.33 111.25 2.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.1 mt -67.9 -70.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.333 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.758 HD11 ' CD1' ' A' ' 44' ' ' LEU . 72.3 mt -132.5 160.61 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -102.35 117.92 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 83' ' ' ILE . 70.8 mt -118.88 38.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.221 0.534 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.4 -179.19 26.89 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.4 141.53 51.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -1.175 . . . . 0.0 110.231 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.59 -51.59 4.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.02 132.63 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.341 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.97 120.07 51.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 154.27 53.22 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.409 1.215 . . . . 0.0 110.672 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.76 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -107.5 94.52 11.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.54 -5.63 17.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.735 1.387 . . . . 0.0 111.056 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.09 3.24 35.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.064 -1.023 . . . . 0.0 110.8 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.11 178.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.936 -1.103 . . . . 0.0 110.188 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.51 172.06 31.51 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.635 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.6 p -101.14 112.73 25.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -1.123 . . . . 0.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 69' ' ' LYS . 96.8 t -80.63 97.51 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.857 . . . . 0.0 109.983 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -41.76 11.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.298 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.28 170.87 4.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' ILE . 20.4 tt -133.26 124.03 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 4.7 mp -68.78 -60.73 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 32' ' ' LYS . 21.3 t -131.52 -115.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.097 -1.002 . . . . 0.0 109.812 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.608 ' C ' HG21 ' A' ' 63' ' ' VAL . 3.9 tttp 53.96 50.45 16.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.401 -1.437 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -170.05 103.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -0.82 . . . . 0.0 109.803 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.6 22.11 61.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 140.04 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 110.12 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 m -76.95 88.28 3.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.7 m -67.04 -171.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 15.7 ttpp -147.64 155.87 42.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.053 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.15 93.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -0.958 . . . . 0.0 110.397 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.45 34.07 1.65 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.808 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -115.18 109.04 17.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 110.362 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.591 HG21 ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -52.22 109.8 0.42 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -130.02 -4.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 111.226 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.437 HD23 HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -131.05 164.21 25.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 110.658 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.811 HG13 ' CG2' ' A' ' 53' ' ' THR . 81.7 t -123.33 108.16 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 25' ' ' THR . 1.4 mm? -125.15 154.63 41.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.301 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.811 ' CG2' HG13 ' A' ' 45' ' ' VAL . 1.4 m . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 121.164 0.507 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.591 ' HG3' HG21 ' A' ' 42' ' ' THR . 2.9 mp0 -56.57 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 111.08 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -99.63 98.43 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.185 -0.947 . . . . 0.0 109.755 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.98 131.71 44.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.837 . . . . 0.0 110.136 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 156.07 2.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.39 -49.03 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.701 1.369 . . . . 0.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.5 p -138.97 -172.5 3.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 110.202 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.457 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 6.3 p-10 -101.56 152.44 20.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 150.69 159.88 9.04 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -85.69 121.09 27.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.129 . . . . 0.0 110.356 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.608 HG21 ' C ' ' A' ' 32' ' ' LYS . 27.4 t -54.34 159.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -118.39 -14.87 9.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.438 -0.789 . . . . 0.0 110.123 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 tttt 179.97 149.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.73 159.5 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 109.558 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -138.27 -68.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.538 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.676 HG11 HD23 ' A' ' 80' ' ' LEU . 23.7 m -48.55 155.12 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.175 -0.953 . . . . 0.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' O ' HG11 ' A' ' 26' ' ' VAL . 9.5 mtmt -124.31 148.46 47.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.237 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.0 72.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -176.79 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.39 145.22 11.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' C ' HG12 ' A' ' 74' ' ' VAL . . . -135.91 135.18 39.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.491 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.5 p 36.91 48.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.883 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.33 97.87 6.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.09 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.96 156.31 19.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.43 18.27 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.71 155.94 17.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -1.213 . . . . 0.0 110.241 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.97 161.9 23.53 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 20' ' ' ALA . 9.4 mt -109.18 -68.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.736 HG22 HG23 ' A' ' 83' ' ' ILE . 36.3 mm -140.8 148.42 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 91.28 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.736 HG23 HG22 ' A' ' 81' ' ' ILE . 46.6 pt -125.45 45.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.224 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.571 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.13 0.491 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.0 25.88 5.16 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 53.24 25.32 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -1.132 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.79 49.85 0.09 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.48 -176.94 5.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 110.187 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.51 91.51 49.67 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.115 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.41 134.55 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.704 1.371 . . . . 0.0 110.709 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.81 142.62 69.95 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.54 -32.35 9.89 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.609 1.32 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 23' ' ' ALA . 5.8 tt -118.73 157.16 28.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -61.1 176.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 110.546 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -153.52 146.85 15.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -68.32 -141.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -1.125 . . . . 0.0 110.584 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 27' ' ' SER . 19.1 m -38.47 -46.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.518 -0.739 . . . . 0.0 112.539 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER 61.01 40.82 14.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.748 -1.22 . . . . 0.0 110.016 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -54.95 108.39 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 29' ' ' ILE . 12.2 tt -62.05 120.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.475 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.506 HD23 ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -88.2 -18.23 29.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.175 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.629 HG11 HD13 ' A' ' 81' ' ' ILE . 14.0 p -91.27 169.77 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 31' ' ' VAL . 23.9 tttt -123.7 159.55 29.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.72 142.49 53.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.9 . . . . 0.0 110.171 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.45 73.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -110.69 154.72 23.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.102 -1.234 . . . . 0.0 109.874 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 1.4 m -96.73 110.67 23.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.308 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' GLY . 34.5 m -81.92 157.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 25.1 tttt -120.06 160.44 22.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.294 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . -69.12 99.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.02 46.92 0.85 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.5 tt0 -135.34 114.44 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -1.167 . . . . 0.0 109.809 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 42' ' ' THR . 12.6 t -55.25 105.12 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.575 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.1 m -104.52 0.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.942 -1.099 . . . . 0.0 110.227 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.81 156.82 42.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.952 -1.093 . . . . 0.0 110.472 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 30' ' ' LEU . 93.5 t -119.23 99.84 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.582 ' HB3' HD11 ' A' ' 55' ' ' ILE . 7.8 tt -105.83 151.0 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' N ' HD23 ' A' ' 46' ' ' LEU . 2.6 tt0 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.897 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.204 0.526 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.1 pt-20 -65.41 103.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 46' ' ' LEU . 48.6 mm -77.37 94.05 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 67.3 m-20 -77.31 133.16 38.85 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.629 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.77 170.09 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 49.9 Cg_endo -77.29 -54.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.762 1.401 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 58' ' ' PRO . 1.3 p -153.26 -166.12 2.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.361 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 52.3 t0 -78.56 123.59 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.395 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' HA3' HD11 ' A' ' 83' ' ' ILE . . . -173.42 -165.95 31.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.8 ttpt -133.27 153.48 51.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.131 -1.217 . . . . 0.0 110.384 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.709 HG22 ' CG2' ' A' ' 81' ' ' ILE . 37.9 t -80.19 125.14 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -88.64 -14.09 38.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.76 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.5 169.06 0.84 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.63 144.91 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -52.62 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 109.95 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 70' ' ' GLU . 11.3 p -53.05 154.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 18.0 mttt -94.28 -10.87 31.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -0.976 . . . . 0.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.797 ' H ' HG22 ' A' ' 68' ' ' VAL . 4.8 tt0 61.61 135.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.21 22.38 7.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.07 . . . . 0.0 109.949 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 69' ' ' LYS . 22.9 t70 -115.86 120.62 39.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 109.821 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -67.87 168.7 11.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 19.5 t 60.86 139.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.488 0.661 . . . . 0.0 110.648 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.04 43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.012 -1.055 . . . . 0.0 110.338 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.08 130.89 10.38 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.82 19.37 63.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 16.1 mt-30 -131.37 139.83 49.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -1.179 . . . . 0.0 110.14 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.75 140.85 29.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.1 mt -92.1 -47.71 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -1.188 . . . . 0.0 110.002 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.709 ' CG2' HG22 ' A' ' 63' ' ' VAL . 98.2 mt -137.2 151.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.2 ttmt -97.31 145.97 25.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.464 HD11 ' HA3' ' A' ' 61' ' ' GLY . 10.7 tt -147.46 159.08 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.615 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.96 -106.93 0.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -119.18 -49.36 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.159 . . . . 0.0 109.893 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' CA ' ' HG2' ' A' ' 82' ' ' LYS . . . -95.58 85.28 0.92 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.7 pm0 -157.96 150.78 22.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -1.079 . . . . 0.0 110.236 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 81' ' ' ILE . 78.5 mt -111.85 99.38 45.13 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.9 128.35 14.87 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.702 1.369 . . . . 0.0 110.472 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -69.84 138.05 87.82 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.079 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.46 -13.31 25.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.558 1.294 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.04 153.15 41.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.249 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.03 162.09 9.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.139 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.37 -165.04 34.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -150.55 149.23 29.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.295 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.879 HG21 HG13 ' A' ' 68' ' ' VAL . 90.0 t -88.69 132.89 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.57 -28.6 12.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 109.923 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.42 153.52 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.441 HG22 ' OE2' ' A' ' 70' ' ' GLU . 3.8 tt -112.46 149.56 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.478 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.696 HD13 HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -114.4 -36.0 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.009 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 43' ' ' VAL . 59.6 t -110.04 157.24 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.05 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -119.83 178.71 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -77.28 131.5 38.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.85 70.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.58 157.02 18.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.317 . . . . 0.0 110.421 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.69 174.7 8.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.919 . . . . 0.0 109.971 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 61' ' ' GLY . 11.4 p -157.61 166.28 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 110.212 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 37' ' ' VAL . 1.3 mtpm? -122.06 169.57 10.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -79.42 114.6 18.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.5 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -109.46 119.67 40.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -1.224 . . . . 0.0 110.006 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.696 HG22 HD13 ' A' ' 30' ' ' LEU . 88.6 m -53.19 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.374 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 41.5 t -64.73 -33.49 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 0.0 109.776 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -155.03 -177.74 6.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.627 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.94 125.67 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.053 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -100.74 177.67 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.195 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.242 0.544 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.79 112.69 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 46' ' ' LEU . 98.1 mt -82.61 89.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 70.1 m-80 -72.57 135.12 45.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.549 -0.719 . . . . 0.0 110.797 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.702 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -56.43 154.17 17.57 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.297 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 -46.19 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.746 1.393 . . . . 0.0 110.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.578 HG22 ' OD1' ' A' ' 60' ' ' ASP . 4.4 m -155.82 169.98 23.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.265 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.578 ' OD1' HG22 ' A' ' 59' ' ' THR . 9.5 p-10 -64.66 145.08 56.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 162.66 -156.47 28.17 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -132.2 150.96 52.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 66' ' ' VAL . 30.2 t -71.87 132.86 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -9.43 20.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.517 -0.739 . . . . 0.0 110.081 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 140.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.06 . . . . 0.0 109.837 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 63' ' ' VAL . 64.3 t -123.67 95.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.463 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.26 -18.07 59.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.103 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.879 HG13 HG21 ' A' ' 26' ' ' VAL . 39.6 t -69.67 143.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 110.342 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.99 15.87 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 110.349 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.1 tt0 61.97 135.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.324 -0.86 . . . . 0.0 110.586 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 32.75 17.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -127.59 116.85 20.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 25' ' ' THR . . . -64.52 146.21 54.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 80' ' ' LEU . 26.6 m -136.16 122.71 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 160.4 30.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.68 51.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 -2.76 30.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -97.79 123.73 41.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.363 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.5 137.68 48.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 20' ' ' ALA . 51.5 mt -107.43 -57.87 2.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -1.193 . . . . 0.0 110.352 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.57 HD13 HG11 ' A' ' 43' ' ' VAL . 16.4 tt -143.19 170.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.476 ' O ' HG23 ' A' ' 83' ' ' ILE . 8.0 tptp -143.02 172.26 12.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' LYS . 3.3 pt -153.39 131.89 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.668 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.242 0.544 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.39 -115.08 3.63 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -120.65 -35.01 3.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.65 15.42 11.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -97.09 124.24 41.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.255 . . . . 0.0 109.991 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.19 117.2 67.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.357 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.7 Cg_endo -73.89 134.33 19.68 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.386 1.203 . . . . 0.0 110.385 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -80.19 125.88 80.49 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.14 141.12 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.441 1.232 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.52 127.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.397 -0.814 . . . . 0.0 110.523 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.93 170.59 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 0.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.41 -177.8 47.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.2 m -133.99 147.16 50.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.85 134.52 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.1 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 p -110.16 -20.67 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.952 . . . . 0.0 110.141 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.93 122.8 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.311 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.494 ' O ' HD22 ' A' ' 30' ' ' LEU . 1.1 tt -83.39 144.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.082 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 29' ' ' ILE . 2.3 mm? -119.31 -24.8 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.917 . . . . 0.0 110.632 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.5 p -108.12 165.02 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.307 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -136.13 169.06 18.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 110.322 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -73.09 156.98 38.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 23.32 70.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.13 166.14 12.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -1.14 . . . . 0.0 110.075 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -109.11 128.12 54.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 61' ' ' GLY . 7.6 p -109.19 158.96 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' CG ' ' OD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -110.94 179.71 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.87 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . . . -90.1 124.55 34.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.098 -1.001 . . . . 0.0 110.33 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.33 29.55 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 43' ' ' VAL . 20.3 tt0 -113.82 122.31 46.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -1.174 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 24.2 m -56.6 109.91 0.7 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 57' ' ' ALA . 34.3 m -95.81 -21.14 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -147.93 173.94 12.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.992 -1.067 . . . . 0.0 111.348 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.491 HG23 HD23 ' A' ' 30' ' ' LEU . 45.7 t -126.2 113.33 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 109.251 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.35 165.46 11.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.01 -1.056 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.58 -0.7 . . . . 0.0 109.707 179.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 51.9 m . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 53' ' ' THR . 4.9 tt0 -60.94 102.11 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 111.076 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 43' ' ' VAL . 32.1 mm -103.94 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.941 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 31.3 m120 -73.89 135.28 43.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.42 0.628 . . . . 0.0 110.694 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -55.35 167.81 0.67 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.547 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.0 Cg_endo -74.09 -52.47 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.761 1.4 . . . . 0.0 110.523 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.28 170.27 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.098 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 39' ' ' ALA . 3.6 m-20 -57.88 139.01 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 169.4 172.35 35.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -109.86 150.06 28.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -1.14 . . . . 0.0 109.974 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 33' ' ' GLU . 31.5 t -77.81 124.42 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.39 -6.81 23.56 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 110.003 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -177.87 150.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 109.92 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.62 146.28 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -119.92 -69.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.65 HG21 HD23 ' A' ' 80' ' ' LEU . 33.5 m -75.46 158.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -129.69 -165.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 155.26 20.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 55.53 25.86 8.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.27 105.61 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.245 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 137.55 50.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.004 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.9 p -130.23 132.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.74 -177.45 6.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.304 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.07 125.72 7.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.29 0.69 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -154.15 128.71 9.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.419 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.01 130.55 36.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 20' ' ' ALA . 10.9 mt -92.21 -70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -1.099 . . . . 0.0 109.698 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.3 mm -134.64 145.04 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 0.0 109.833 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.72 137.96 31.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.182 -0.949 . . . . 0.0 110.493 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.95 146.2 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.305 0.574 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.5 -173.71 44.11 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 135.72 56.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -1.147 . . . . 0.0 110.17 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . 102.61 -19.12 48.76 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' OE2' ' CD ' ' A' ' 82' ' ' LYS . 1.1 mp0 -110.04 127.7 54.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.248 . . . . 0.0 110.508 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.7 mp -82.38 111.93 32.24 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.793 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.88 143.35 45.19 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.41 1.216 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 1.014 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -85.86 135.73 37.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.123 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.58 133.81 17.74 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.592 1.312 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.36 -166.87 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.55 137.88 38.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.254 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.77 169.13 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 132.58 54.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.32 141.32 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 110.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -113.18 -24.45 9.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.52 140.78 0.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.855 . . . . 0.0 110.088 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 29' ' ' ILE . 11.0 tt -100.06 134.45 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.343 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -85.48 -56.18 3.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 43' ' ' VAL . 19.5 m -81.02 -177.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.364 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -145.93 52.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.028 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.622 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER 59.85 157.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.08 55.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 4.2 p30 -106.93 147.92 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.233 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.9 m -108.75 123.3 48.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.275 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 61' ' ' GLY . 35.6 m -108.81 -175.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.086 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 3.0 ttpt -142.7 49.58 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . 54.75 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.76 -13.32 7.7 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.339 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.8 tt0 -77.59 119.94 21.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.05 -1.264 . . . . 0.0 110.555 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.3 m -61.71 103.3 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.035 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 31' ' ' VAL . 34.7 m -86.78 -21.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -151.18 176.84 10.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG23 HD23 ' A' ' 30' ' ' LEU . 67.8 t -134.26 117.98 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.07 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -99.23 157.4 16.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.248 0.547 . . . . 0.0 110.346 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 42' ' ' THR . 16.1 mt-10 -62.39 149.58 42.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 44' ' ' LEU . 64.6 mt -111.91 86.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.965 . . . . 0.0 110.613 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.2 m-20 -84.31 127.59 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.273 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.01 145.32 5.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 110.277 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -45.22 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.65 1.342 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.723 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 8.9 t -137.41 158.09 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 110.419 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 4.6 p30 -56.83 160.22 3.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 148.71 168.76 14.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 21.9 ttpt -109.53 139.56 44.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.7 t -64.66 135.45 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.03 . . . . 0.0 109.94 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.19 -17.66 16.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.83 156.06 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.008 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 81' ' ' ILE . 23.9 m -126.72 127.29 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.81 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.693 ' CD1' HG23 ' A' ' 68' ' ' VAL . 1.8 pp -104.79 -26.27 12.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.305 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 67' ' ' LEU . 84.3 t -98.97 150.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -164.87 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -79.75 151.38 30.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 110.148 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.52 39.11 27.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.79 -19.47 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.315 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.33 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.547 -0.721 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.96 145.33 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.392 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.4 171.53 8.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.24 119.83 18.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 44.51 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 125.35 27.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -54.78 139.49 39.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.014 HD11 ' HB2' ' A' ' 20' ' ' ALA . 8.6 mt -107.64 -61.01 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.203 -1.175 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.562 ' CD1' HG12 ' A' ' 66' ' ' VAL . 11.8 tt -143.56 151.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' CD ' ' OE2' ' A' ' 17' ' ' GLU . 4.5 ttpt -95.23 143.81 26.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.072 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.8 tt -136.07 151.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.888 -1.507 . . . . 0.0 109.573 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' N ' ' A' ' 79' ' ' GLY . . . . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.262 0.553 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.67 -106.74 1.08 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -129.82 158.89 38.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.009 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.06 39.79 92.55 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 13' ' ' ALA . 2.0 pp20? -135.15 161.33 35.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -1.117 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.622 ' N ' HD12 ' A' ' 18' ' ' ILE . 4.7 mp -118.14 102.69 50.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.9 Cg_endo -72.12 156.6 55.47 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.656 1.345 . . . . 0.0 110.527 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -86.23 138.64 34.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.316 -0.865 . . . . 0.0 110.081 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.88 -27.37 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.609 1.321 . . . . 0.0 110.506 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.78 165.69 23.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.08 156.34 21.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . -134.28 -177.42 14.93 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 1.5 m -122.99 -133.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -1.198 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' SER . 15.7 m -36.8 -46.32 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.472 -0.768 . . . . 0.0 112.276 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t 54.95 42.41 31.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 0.0 109.918 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -51.93 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 29' ' ' ILE . 13.6 tt -68.09 86.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.5 mm? -54.04 -41.87 68.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.002 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.9 p -62.03 164.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 31' ' ' VAL . 5.5 ttmt -123.57 169.31 11.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 110.27 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.73 134.39 34.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.51 19.13 57.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.62 179.42 4.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.924 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -122.12 140.25 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.75 175.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -125.46 161.2 27.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -63.38 127.93 33.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.89 . . . . 0.0 110.084 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.56 19.13 45.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.719 ' O ' HG13 ' A' ' 43' ' ' VAL . 37.1 tt0 -109.36 111.65 23.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.243 . . . . 0.0 109.992 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 54.2 m -51.08 116.09 1.84 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.541 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.027 HG23 HD12 ' A' ' 44' ' ' LEU . 30.2 m -115.44 -22.56 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.842 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.027 HD12 HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -131.16 154.77 48.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 28' ' ' LYS . 98.6 t -128.2 109.76 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.215 -0.928 . . . . 0.0 110.818 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.653 HD22 ' HA3' ' A' ' 24' ' ' GLY . 30.5 mt -98.33 147.33 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 0.0 109.953 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.716 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.1 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.247 0.546 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.4 OUTLIER -77.85 118.58 20.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 46' ' ' LEU . 30.7 mm -88.75 90.07 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.575 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.0 p-10 -73.45 132.36 42.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 110.064 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.37 1.93 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.362 -0.836 . . . . 0.0 110.665 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.88 -40.22 1.97 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.569 1.299 . . . . 0.0 110.644 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 79.4 m -156.09 153.4 29.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.255 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 24.7 t70 -55.79 140.94 40.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.45 177.8 39.73 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.19 142.29 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -1.141 . . . . 0.0 110.045 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 81' ' ' ILE . 41.9 t -71.8 129.73 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.95 -6.66 35.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 110.362 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -174.84 148.14 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 110.204 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 81' ' ' ILE . 7.1 p -105.14 144.49 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.97 -53.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 70' ' ' GLU . 92.5 t -53.46 128.21 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -80.15 1.75 26.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 68' ' ' VAL . 18.8 tt0 61.95 132.39 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.64 26.38 12.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.077 . . . . 0.0 110.136 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.1 t0 -126.41 120.63 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' THR . . . -54.18 142.95 24.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.963 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 72' ' ' ASP . 35.9 m -136.66 171.39 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.967 -1.083 . . . . 0.0 110.426 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -113.34 -179.23 3.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.79 140.78 15.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.22 20.62 10.9 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.2 mm-40 -125.97 143.85 50.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.164 . . . . 0.0 110.111 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.04 144.48 49.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 48.9 mt -104.85 -42.73 5.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 66' ' ' VAL . 1.9 tp -167.72 143.51 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -92.46 147.95 22.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.957 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.3 pt -133.76 158.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.467 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.28 0.562 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.33 59.6 0.53 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 53.65 79.03 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.23 -56.49 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -53.1 143.62 17.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.126 . . . . 0.0 110.362 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -113.33 131.87 22.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -73.34 144.7 37.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.524 1.276 . . . . 0.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -113.25 74.34 1.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.959 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.54 61.84 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.772 1.406 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 22' ' ' LEU . 1.7 mm? -113.01 -12.46 13.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.62 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 46' ' ' LEU . . . 55.01 -174.16 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.054 -1.029 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . 113.29 -162.48 12.35 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.483 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 10.4 p -130.46 101.0 5.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.254 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.547 ' H ' ' HB2' ' A' ' 73' ' ' ALA . 34.5 m -55.05 137.01 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.171 -0.956 . . . . 0.0 109.802 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -22.62 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.958 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -178.32 166.12 1.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.989 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.492 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -114.16 145.85 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.0 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 29' ' ' ILE . 3.3 mm? -117.59 -15.77 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.75 140.0 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 178.79 4.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.887 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.79 143.47 28.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 110.183 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.9 21.64 65.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.41 158.28 25.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -1.167 . . . . 0.0 110.118 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 134.56 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.06 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 2.0 ttpm? -138.64 146.91 42.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -58.9 103.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 -7.31 8.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -94.33 121.8 36.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.855 -1.379 . . . . 0.0 110.376 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.54 HG21 ' CG ' ' A' ' 54' ' ' GLU . 1.3 m -51.11 129.6 24.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.155 -0.966 . . . . 0.0 110.012 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 55' ' ' ILE . 31.1 m -124.91 -24.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 111.191 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.93 167.53 21.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.883 -1.136 . . . . 0.0 111.091 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 53' ' ' THR . 85.5 t -123.64 121.18 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 109.678 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 23' ' ' ALA . 8.8 tt -151.41 140.87 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.0 110.523 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' OG1' ' A' ' 25' ' ' THR . 4.4 pt-20 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.098 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 55' ' ' ILE . 24.9 p . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 120.798 0.333 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -52.14 104.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.632 -1.292 . . . . 0.0 110.79 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 43' ' ' VAL . 24.3 mm -94.01 90.96 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 37.8 p-10 -49.38 147.04 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.502 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 38' ' ' LYS . . . -57.79 151.68 41.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.979 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 59' ' ' THR . 45.1 Cg_endo -72.66 -27.85 14.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.164 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -170.62 -171.86 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.948 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -103.6 144.05 31.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.52 -155.23 26.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -127.49 144.35 51.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.093 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 81' ' ' ILE . 39.4 t -76.18 100.88 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 110.111 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.73 -15.37 63.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.743 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER 177.24 161.1 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 81' ' ' ILE . 92.5 t -131.51 129.44 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.587 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.1 pp -109.9 -28.04 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.979 . . . . 0.0 110.641 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 80' ' ' LEU . 35.4 m -78.84 -176.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.051 -1.031 . . . . 0.0 110.306 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.2 155.53 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -50.95 165.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER 74.09 -42.63 0.51 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.538 -0.726 . . . . 0.0 111.949 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.41 129.06 30.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' GLY . . . -165.12 -156.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.377 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 84.6 t 57.4 115.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.607 0.718 . . . . 0.0 111.196 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 51.88 93.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.622 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.05 -136.34 0.25 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.12 7.07 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -141.46 140.54 33.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.184 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.587 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.19 148.07 5.54 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 20' ' ' ALA . 4.1 mt -91.51 -70.76 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -1.107 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.698 HD13 HG22 ' A' ' 63' ' ' VAL . 2.7 pp -152.29 154.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 110.099 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.61 130.27 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.18 22.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.944 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 17' ' ' GLU . . . -64.56 -124.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -120.61 -25.85 5.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.15 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.79 64.93 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLY . 1.8 pm0 -129.59 166.95 18.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 83' ' ' ILE . 2.7 mp -118.47 104.55 47.51 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.92 138.23 30.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.587 1.309 . . . . 0.0 110.27 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -101.17 148.69 35.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 110.33 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.43 -24.09 19.63 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.679 1.358 . . . . 0.0 110.171 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.79 96.64 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 109.911 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' H ' ' A' ' 76' ' ' GLY . . . -49.95 -62.41 1.59 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.209 -0.932 . . . . 0.0 110.004 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' HD13 ' A' ' 46' ' ' LEU . . . 90.89 -170.02 34.34 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 80.34 8.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.33 114.48 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.3 m -111.58 -36.46 5.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 142.85 31.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -107.26 113.4 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 110.051 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 45' ' ' VAL . 2.8 mm? -79.33 -25.49 42.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.537 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 32' ' ' LYS . 8.6 p -90.3 161.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.421 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' HG22 ' A' ' 31' ' ' VAL . 3.5 ttpt -134.82 -167.89 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.901 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -94.66 133.73 38.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.048 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.41 -1.61 88.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.51 137.4 32.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.33 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -85.93 124.47 32.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.547 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 61' ' ' GLY . 25.5 m -102.55 -175.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.937 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 16.6 mmtt -139.45 164.72 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.8 98.8 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.86 19.31 6.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.687 ' O ' HG13 ' A' ' 43' ' ' VAL . 17.4 tt0 -106.18 118.94 37.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.1 -1.235 . . . . 0.0 109.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -49.08 128.12 15.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.972 -1.08 . . . . 0.0 110.659 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 41' ' ' GLN . 17.9 m -128.76 -31.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.717 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.57 161.34 27.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 53' ' ' THR . 41.4 t -132.07 126.36 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.264 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -134.07 167.36 20.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 54' ' ' GLU . 88.6 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.622 0.248 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 53' ' ' THR . 33.6 mt-10 -50.53 114.42 1.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.586 -1.321 . . . . 0.0 111.303 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 46' ' ' LEU . 13.7 mm -106.79 99.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.81 134.57 55.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.565 -0.709 . . . . 0.0 110.458 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -52.89 154.96 4.54 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.701 ' HG3' HG21 ' A' ' 18' ' ' ILE . 50.8 Cg_endo -77.04 -38.9 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.693 1.365 . . . . 0.0 110.539 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.73 149.68 28.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.4 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 2.6 p30 -65.49 153.1 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.647 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 151.68 161.54 10.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -84.3 142.52 30.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -1.084 . . . . 0.0 110.205 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.73 131.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.213 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -91.45 -15.32 29.05 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.457 -0.777 . . . . 0.0 109.801 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt 179.55 166.64 1.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.214 -0.929 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 66' ' ' VAL . 11.8 m -131.1 105.9 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 109.909 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.3 pp -96.29 -28.13 14.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.962 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.59 155.26 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -135.17 159.62 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.633 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.7 74.33 6.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.92 -36.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.818 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -51.96 107.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.29 124.63 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.689 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 57.43 113.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.702 -0.624 . . . . 0.0 110.78 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.4 tt0 -153.68 -77.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.988 -1.07 . . . . 0.0 111.298 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 23' ' ' ALA . . . 64.3 132.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.85 2.22 39.66 Favored Glycine 0 N--CA 1.491 2.306 0 O-C-N 121.09 -1.241 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -127.95 146.59 50.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.804 -1.41 . . . . 0.0 110.244 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.651 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -63.39 141.45 45.94 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 20' ' ' ALA . 23.0 mt -84.85 -48.86 8.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.325 -1.103 . . . . 0.0 110.002 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.438 HG23 ' C ' ' A' ' 80' ' ' LEU . 29.6 pt -149.07 152.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 110.173 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 157.87 36.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 18' ' ' ILE . 1.9 tt -162.88 149.78 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.16 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' ' CA ' ' A' ' 79' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.24 0.543 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.25 -155.49 6.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.13 127.94 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -1.108 . . . . 0.0 110.236 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.34 -57.23 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.75 162.12 19.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -1.205 . . . . 0.0 110.197 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 pt -133.19 135.56 25.82 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.0 Cg_endo -72.42 155.97 54.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.615 1.324 . . . . 0.0 110.688 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 75' ' ' GLN . . . -83.71 131.24 52.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.09 -19.9 17.21 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.54 1.284 . . . . 0.0 110.625 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -129.79 148.76 51.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' H ' HD13 ' A' ' 22' ' ' LEU . . . -85.44 166.11 16.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.546 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . 166.23 -179.89 40.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 46' ' ' LEU . 14.6 m -113.62 127.36 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.17 139.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 109.891 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 m -134.98 -39.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.7 148.46 45.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.37 151.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 HG22 ' A' ' 42' ' ' THR . 2.4 mp -129.37 -49.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.499 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 43' ' ' VAL . 9.3 p -51.45 143.76 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.272 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -103.85 157.84 16.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.006 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 63' ' ' VAL . 5.4 pt-20 -83.66 146.6 28.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.12 58.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.15 173.99 6.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.296 . . . . 0.0 110.052 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.5 m -106.47 110.22 22.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.086 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 ' CG1' ' A' ' 43' ' ' VAL . 14.9 p -87.45 145.07 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.86 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -100.9 152.66 20.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.206 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 130.68 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.59 21.39 29.13 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 43' ' ' VAL . 1.6 tt0 -116.44 121.77 42.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -1.212 . . . . 0.0 110.29 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.9 m -53.57 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 33.8 m -86.07 -21.7 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.77 171.27 16.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -136.74 140.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.586 ' HG ' HD11 ' A' ' 55' ' ' ILE . 11.8 mt -110.99 170.32 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 110.19 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.5 132.41 49.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 110.217 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 44' ' ' LEU . 85.8 mt -98.9 87.08 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.6 m-20 -74.09 129.37 37.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.555 -0.716 . . . . 0.0 110.35 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.716 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -48.55 138.99 11.43 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.436 -0.79 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.93 -37.61 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.595 1.313 . . . . 0.0 110.82 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -144.67 149.34 35.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 110.549 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.16 153.0 31.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.21 -166.55 39.75 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -127.61 143.03 51.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 33' ' ' GLU . 12.8 t -84.06 141.92 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -0.886 . . . . 0.0 110.274 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.4 -11.3 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.571 -0.706 . . . . 0.0 110.263 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 178.19 107.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 110.079 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -97.6 143.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.874 HD11 ' O ' ' A' ' 79' ' ' GLY . 1.4 pp -118.62 -23.91 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.053 -1.029 . . . . 0.0 110.544 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 80' ' ' LEU . 35.2 m -61.97 163.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 110.166 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 71' ' ' ARG . 13.7 mtmt -157.63 158.71 36.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.99 68.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -173.62 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.81 149.16 27.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.525 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -127.57 179.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.0 109.874 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' C ' ' A' ' 73' ' ' ALA . 29.2 m 36.22 68.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 65.9 mm-40 -75.44 -0.82 21.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -54.97 104.62 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.01 57.53 1.9 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.3 tt0 -163.24 138.33 6.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -1.127 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.874 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -52.13 136.45 34.45 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.856 ' O ' HG13 ' A' ' 68' ' ' VAL . 10.8 mt -102.15 -71.52 0.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.315 -1.109 . . . . 0.0 109.952 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.423 HG23 ' C ' ' A' ' 80' ' ' LEU . 26.4 pt -148.64 152.43 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -90.79 123.63 34.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.079 -1.013 . . . . 0.0 110.487 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.3 tt -129.74 142.22 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.507 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.266 0.555 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.26 156.02 21.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -54.06 134.59 43.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -1.168 . . . . 0.0 110.314 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 -23.07 37.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CG ' ' HD2' ' A' ' 82' ' ' LYS . 15.2 mt-10 -91.87 155.96 17.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.58 104.71 55.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.5 Cg_endo -73.4 164.11 35.99 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.567 1.298 . . . . 0.0 110.766 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -81.56 156.11 70.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.849 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.51 -36.97 3.45 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.716 1.377 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.26 -53.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.972 . . . . 0.0 110.325 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -167.62 179.19 4.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.378 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 177.43 160.46 24.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.8 p -115.96 90.83 3.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.174 . . . . 0.0 110.439 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.715 HG21 ' CG2' ' A' ' 68' ' ' VAL . 41.4 t -63.81 136.23 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 109.667 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.4 m -127.39 -30.67 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.013 -1.054 . . . . 0.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.83 159.12 41.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.604 ' CD1' HG11 ' A' ' 66' ' ' VAL . 6.2 tt -129.21 135.26 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.7 mm? -93.35 -40.2 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.942 . . . . 0.0 109.987 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 31' ' ' VAL . 35.6 m -91.02 -170.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 109.804 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -165.78 -45.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.655 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.0 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.15 31.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -54.71 115.32 2.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -1.17 . . . . 0.0 109.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 19.0 m -75.86 95.84 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.17 165.27 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 4.1 mttp -124.42 165.01 18.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.33 110.59 2.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.5 36.9 11.36 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.833 ' O ' HG13 ' A' ' 43' ' ' VAL . 5.5 tt0 -116.25 114.26 24.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -1.103 . . . . 0.0 110.073 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 54' ' ' GLU . 1.4 m -52.58 118.58 3.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 41' ' ' GLN . 35.3 m -124.16 -10.5 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.915 . . . . 0.0 110.943 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.39 160.37 42.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 110.738 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' THR . 89.2 t -109.68 117.19 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.617 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -150.37 134.89 17.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.408 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 110.115 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 120.942 0.401 . . . . 0.0 111.114 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.1 OUTLIER -71.44 98.93 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.892 -1.13 . . . . 0.0 110.552 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 53' ' ' THR . 29.5 mm -105.54 98.6 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 11.6 m-20 -74.31 133.34 42.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.649 -0.657 . . . . 0.0 110.123 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -47.84 166.21 0.21 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.369 -0.832 . . . . 0.0 110.468 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.9 Cg_endo -72.69 -32.89 8.92 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.734 1.386 . . . . 0.0 110.526 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 t -173.39 171.08 4.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.7 p-10 -65.09 131.71 47.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' THR . . . 170.17 -176.59 43.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.61 142.3 35.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -1.099 . . . . 0.0 110.208 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.13 109.49 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.56 -17.66 60.7 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.704 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 176.87 164.65 0.49 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.257 -0.902 . . . . 0.0 109.998 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 68' ' ' VAL . 48.8 t -123.99 88.51 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -42.03 70.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.022 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.746 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 p -80.92 147.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -146.38 174.9 10.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.65 76.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.298 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER 179.9 -51.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 110.131 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.66 138.83 40.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.872 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -158.56 158.82 34.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.536 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 23.1 m 36.73 49.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.257 0.551 . . . . 0.0 111.7 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -154.03 85.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -92.72 -172.97 41.13 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.84 -25.75 25.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -101.25 160.46 14.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -1.155 . . . . 0.0 110.301 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.66 171.2 5.81 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -131.84 -58.02 0.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.24 -1.153 . . . . 0.0 110.04 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 44' ' ' LEU . 2.7 mp -136.88 146.38 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.192 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 17' ' ' GLU . 2.5 tttm -106.15 131.91 52.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.875 . . . . 0.0 110.141 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.62 35.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB3' ' HD2' ' A' ' 2' ' ' LYS . 1.3 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.234 0.54 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -143.78 168.17 20.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.216 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.8 mt -137.15 154.99 50.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 110.268 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -121.02 120.57 35.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.43 38.03 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.071 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 59.06 159.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.2 t -137.76 68.86 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.158 -0.964 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -111.1 132.11 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.272 -0.893 . . . . 0.0 110.167 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.48 -29.27 3.65 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.03 -172.87 4.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -1.129 . . . . 0.0 110.205 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.32 -127.84 4.51 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -134.36 28.4 3.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -1.166 . . . . 0.0 110.179 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.43 122.18 11.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.908 . . . . 0.0 110.193 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.07 -131.78 3.77 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -125.25 106.48 9.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -1.151 . . . . 0.0 110.275 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.14 -31.23 4.98 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -52.44 168.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 110.629 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.34 105.03 34.08 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.817 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.0 Cg_endo -70.96 139.55 36.29 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.582 1.306 . . . . 0.0 110.762 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.737 ' HB1' ' HD2' ' A' ' 21' ' ' PRO . . . -69.55 174.3 3.16 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 0.0 110.297 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 20' ' ' ALA . 47.7 Cg_endo -74.18 -53.34 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.722 1.38 . . . . 0.0 110.384 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 22' ' ' LEU . 5.5 mt -151.84 -49.13 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.922 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -175.35 177.89 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 110.107 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 48' ' ' ALA . . . 177.42 -171.06 43.77 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -126.96 104.8 8.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -1.109 . . . . 0.0 110.32 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.651 HG22 HD11 ' A' ' 46' ' ' LEU . 64.4 t -55.95 155.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -128.14 -40.61 1.65 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.861 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -174.0 133.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.883 . . . . 0.0 110.036 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG22 ' A' ' 29' ' ' ILE . 15.3 tt -98.48 151.13 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 30' ' ' LEU . 3.9 mm? -106.42 -58.76 1.88 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -0.908 . . . . 0.0 110.327 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 33' ' ' GLU . 95.6 t -70.61 150.9 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 110.196 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 33' ' ' GLU . 1.3 mttt -118.17 42.59 2.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.975 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HA ' HG11 ' A' ' 63' ' ' VAL . 13.3 tm-20 59.77 145.68 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.616 0.722 . . . . 0.0 110.698 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.74 20.29 66.1 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.45 136.54 52.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.965 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.8 m -71.84 159.57 34.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 110.106 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 57' ' ' ALA . 9.2 p -147.01 165.57 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.216 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -122.64 177.1 5.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 110.114 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.96 103.33 5.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.242 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.77 -19.02 9.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.22 112.63 2.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.123 -1.222 . . . . 0.0 110.297 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 89.1 m -52.1 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.319 -0.863 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 HD23 ' A' ' 44' ' ' LEU . 59.8 t -57.77 -37.6 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.844 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.928 HD11 HD12 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -167.11 -160.01 0.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.577 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.564 ' O ' HD12 ' A' ' 46' ' ' LEU . 39.9 t -143.03 148.16 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.143 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.651 HD11 HG22 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -150.22 173.68 13.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.27 -0.894 . . . . 0.0 110.058 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -161.79 100.14 1.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.604 ' HB2' ' HA3' ' A' ' 24' ' ' GLY . . . -118.39 -52.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.338 -0.851 . . . . 0.0 109.771 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.88 49.57 0.92 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.853 . . . . 0.0 109.744 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.43 48.76 16.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 110.0 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 21.6 ttm -152.33 27.32 0.59 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -143.06 -81.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.157 -0.965 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER 51.92 -152.44 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.157 -0.964 . . . . 0.0 110.254 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER -54.25 109.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 110.211 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.928 HD12 HD11 ' A' ' 44' ' ' LEU . 48.1 mt -88.82 102.64 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 13.9 p-10 -75.99 138.21 40.77 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.602 0.715 . . . . 0.0 110.892 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.619 ' HB2' HG21 ' A' ' 37' ' ' VAL . . . -54.23 145.9 33.69 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.887 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.01 -37.05 3.79 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.593 1.312 . . . . 0.0 110.637 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.7 m -155.5 160.91 40.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.13 -0.981 . . . . 0.0 110.391 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.49 142.62 48.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -0.863 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.04 -164.33 37.71 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -132.03 148.47 52.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -1.133 . . . . 0.0 110.035 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.0 t -84.73 138.16 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.068 -1.02 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.51 -25.37 16.88 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.475 -0.766 . . . . 0.0 109.05 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG3' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 179.17 137.47 0.1 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.616 -0.678 . . . . 0.0 109.75 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.4 p -93.31 130.37 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 110.438 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -95.49 -50.79 4.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.047 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 69' ' ' LYS . 11.4 p -58.04 163.06 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 110.209 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 68' ' ' VAL . 7.9 ttmt -136.15 160.35 38.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.007 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HA ' HG11 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 58.07 28.85 16.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.286 -0.884 . . . . 0.0 110.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.535 ' O ' HG23 ' A' ' 26' ' ' VAL . 46.3 t0 -113.25 112.96 24.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.867 . . . . 0.0 109.824 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -105.09 177.33 4.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 110.602 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.922 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 33.6 m 36.84 56.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-O 121.294 0.569 . . . . 0.0 111.709 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.405 ' O ' ' CG ' ' A' ' 75' ' ' GLN . 0.5 OUTLIER -136.85 71.22 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.065 -1.022 . . . . 0.0 110.48 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -116.07 168.85 12.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 -29.61 12.13 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -102.77 152.51 21.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -1.059 . . . . 0.0 109.914 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.55 136.66 43.74 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.3 mt -88.83 -51.09 5.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -1.17 . . . . 0.0 110.058 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.99 139.97 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 110.099 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -93.5 134.81 35.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -145.78 147.15 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.151 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.247 0.546 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.44 40.47 3.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 85.73 5.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.214 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.81 -178.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.297 -0.877 . . . . 0.0 110.254 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.6 p -71.71 125.27 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 110.371 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.1 p -127.66 -70.25 0.71 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 110.134 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 p -137.44 148.18 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.254 -0.904 . . . . 0.0 110.127 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -133.73 131.62 39.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.158 -0.964 . . . . 0.0 110.316 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.46 155.14 24.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 51.38 84.1 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -1.11 . . . . 0.0 110.444 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.53 57.42 0.09 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -122.21 22.29 10.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -1.157 . . . . 0.0 110.303 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.71 -168.63 1.33 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 110.129 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.18 158.26 27.17 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.13 -28.05 66.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -1.09 . . . . 0.0 110.27 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.03 -24.14 25.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -80.41 150.51 29.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.291 -1.123 . . . . 0.0 110.471 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.9 100.1 53.2 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.956 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -72.42 164.67 34.92 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.676 1.356 . . . . 0.0 110.956 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.37 119.8 74.5 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.848 . . . . 0.0 109.984 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.94 0.03 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.45 1.237 . . . . 0.0 111.152 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.54 59.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.829 -1.169 . . . . 0.0 110.389 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.87 -167.88 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 0.0 110.568 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.77 156.65 7.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.463 ' C ' HD23 ' A' ' 46' ' ' LEU . 92.4 m -103.68 108.29 19.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -1.168 . . . . 0.0 110.29 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 72' ' ' ASP . 44.9 t -72.37 125.07 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.73 -46.25 3.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.092 -1.005 . . . . 0.0 110.569 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.16 152.8 13.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.088 -1.008 . . . . 0.0 110.137 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.427 HG22 ' HG ' ' A' ' 44' ' ' LEU . 21.5 pt -118.76 135.35 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.152 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.1 mp -92.29 -3.16 55.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 110.472 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 63' ' ' VAL . 12.0 p -93.8 151.64 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.79 153.3 44.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.054 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -68.18 131.55 45.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 110.132 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.77 16.72 67.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.95 158.7 19.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.16 -1.2 . . . . 0.0 109.968 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 59.2 m -105.37 129.21 53.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 110.421 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.3 m -113.75 174.09 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.309 -0.869 . . . . 0.0 110.122 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 6.1 mtpm? -128.52 152.6 48.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.884 . . . . 0.0 110.008 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -62.52 116.4 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.405 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.94 -24.98 9.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' HG13 ' A' ' 43' ' ' VAL . 8.6 tt0 -76.41 122.66 24.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -1.17 . . . . 0.0 110.253 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' N ' ' A' ' 55' ' ' ILE . 5.0 m -59.05 104.59 0.25 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.178 -0.951 . . . . 0.0 110.291 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 41' ' ' GLN . 23.8 m -91.0 -15.09 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 110.59 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -145.14 160.32 41.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.121 -0.987 . . . . 0.0 110.191 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.3 t -129.52 122.32 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 25' ' ' THR . 1.9 mt -113.89 172.91 6.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -139.54 129.32 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.237 -0.915 . . . . 0.0 110.373 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.95 139.83 22.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.9 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.82 39.73 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.11 -0.994 . . . . 0.0 110.077 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.5 tttt 52.96 46.82 26.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.358 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.73 -179.69 5.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -0.945 . . . . 0.0 110.323 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -105.3 136.66 44.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 110.145 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -126.29 74.68 1.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.408 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.2 OUTLIER -54.25 129.92 36.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.91 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.553 ' N ' HG23 ' A' ' 42' ' ' THR . 37.9 mm -101.71 90.35 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.238 -0.914 . . . . 0.0 110.36 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -65.38 141.42 58.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -52.58 150.58 9.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.166 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.31 -31.48 11.56 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.675 1.355 . . . . 0.0 110.497 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.631 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 7.3 t -174.69 166.25 3.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 110.185 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.04 123.47 18.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.214 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 175.16 170.57 38.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 63' ' ' VAL . 11.1 ttmt -104.93 152.86 22.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -1.078 . . . . 0.0 110.117 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.468 HG21 ' CG2' ' A' ' 31' ' ' VAL . 15.1 t -71.92 143.91 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 110.152 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.05 -17.98 11.32 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.593 -0.692 . . . . 0.0 109.665 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.44 117.49 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.164 -0.96 . . . . 0.0 110.387 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -100.89 132.67 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.117 -0.99 . . . . 0.0 109.852 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 68' ' ' VAL . 0.9 OUTLIER -116.18 -21.81 9.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.045 -1.034 . . . . 0.0 110.723 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 7.5 p -59.86 148.83 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.155 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.82 145.2 49.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.317 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.42 76.13 0.55 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.905 . . . . 0.0 110.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 177.83 -45.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.305 -0.872 . . . . 0.0 110.1 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 23.6 t0 -55.3 128.13 32.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.277 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -140.68 164.65 29.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 75' ' ' GLN . 85.1 t 56.44 164.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.789 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.475 ' N ' HG12 ' A' ' 74' ' ' VAL . 0.0 OUTLIER 57.44 111.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.389 -0.819 . . . . 0.0 110.877 179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.3 -159.78 27.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.91 -19.2 55.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 6.2 mt-30 -92.68 138.51 31.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -1.213 . . . . 0.0 110.421 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.58 177.03 0.36 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -135.5 -65.9 0.59 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.25 -1.147 . . . . 0.0 110.365 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.4 pt -136.75 142.37 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.137 -0.977 . . . . 0.0 110.331 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -100.42 120.83 40.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.1 mt -131.86 128.55 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.884 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.309 0.576 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.33 59.67 1.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 110.297 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -162.25 -50.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.165 -0.96 . . . . 0.0 110.309 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -117.48 124.13 48.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 0.0 110.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.8 -61.88 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 6' ' ' THR . 45.1 m -159.54 31.2 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.2 m -119.93 -20.45 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 54.83 77.56 0.2 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.1 -1.0 . . . . 0.0 110.107 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.53 -174.44 43.85 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.51 -55.13 2.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.0 110.228 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 135.69 0.14 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -88.04 88.4 7.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -1.18 . . . . 0.0 110.163 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.77 161.9 28.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.123 -0.986 . . . . 0.0 110.26 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.73 -107.26 3.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 16.4 tt0 -140.33 104.31 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -1.151 . . . . 0.0 110.31 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.93 -39.53 2.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 15' ' ' GLU . 1.3 pm0 -54.66 157.48 2.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -1.093 . . . . 0.0 110.476 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 18' ' ' ILE . 5.1 mp -116.13 104.63 52.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 0.0 109.928 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 43.7 Cg_endo -71.18 136.74 29.95 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.585 1.308 . . . . 0.0 110.533 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -64.54 139.2 97.68 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 0.0 110.242 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.76 -24.13 13.67 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.61 1.321 . . . . 0.0 110.623 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.1 mt -131.51 166.24 21.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 110.404 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 75' ' ' GLN . . . -75.06 174.92 8.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.342 -0.849 . . . . 0.0 110.299 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.3 179.36 39.09 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.1 m -133.42 137.32 45.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 110.156 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 41.9 t -69.67 118.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 110.303 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.69 -28.63 19.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 0.0 110.134 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.69 126.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.868 HD12 HD21 ' A' ' 44' ' ' LEU . 1.4 tt -81.48 150.34 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.78 -38.38 5.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.171 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.13 176.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.275 -0.891 . . . . 0.0 110.412 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -145.35 46.01 1.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.321 -0.862 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.746 ' HA ' HG11 ' A' ' 63' ' ' VAL . 1.4 tt0 59.82 155.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.305 -0.872 . . . . 0.0 110.366 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.26 28.22 42.09 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.61 124.73 45.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -1.164 . . . . 0.0 110.288 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 61' ' ' GLY . 25.8 m -69.64 149.93 47.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.598 HG21 ' HB2' ' A' ' 57' ' ' ALA . 7.2 p -136.7 161.51 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.318 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 37' ' ' VAL . 3.7 ttmm -115.48 155.27 27.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 110.018 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.95 109.94 1.07 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.25 -0.906 . . . . 0.0 110.211 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.17 28.73 4.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -118.16 115.24 24.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -1.214 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 87.0 m -54.42 94.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 55' ' ' ILE . 20.5 m -69.07 -22.65 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.876 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -161.22 172.3 16.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.493 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 97.1 t -119.36 130.55 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.034 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.03 -177.8 3.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' CG ' ' HB2' ' A' ' 50' ' ' LYS . 1.0 OUTLIER 52.82 -176.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.3 -62.6 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.318 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.95 -30.72 16.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.307 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 47' ' ' GLU . 37.4 mttt -69.87 -52.64 23.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.162 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 3.4 tpp -175.79 117.9 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.111 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.12 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.0 110.07 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.4 m -80.26 134.8 36.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.373 -0.829 . . . . 0.0 110.471 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -100.7 103.46 14.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.878 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.675 ' O ' HG22 ' A' ' 43' ' ' VAL . 41.0 mm -68.85 91.19 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 110.553 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 69.4 m-80 -77.24 131.41 38.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.434 -0.791 . . . . 0.0 110.238 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -50.2 156.41 1.4 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.43 -37.92 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.694 1.365 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -158.8 178.3 10.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.245 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.18 132.12 38.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 110.258 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 36' ' ' THR . . . 174.85 -135.44 3.09 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -154.41 150.13 27.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -1.172 . . . . 0.0 110.272 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 33' ' ' GLU . 9.1 t -64.25 142.11 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 110.053 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -115.6 -18.38 10.91 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.543 -0.723 . . . . 0.0 109.843 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 3.4 tmtm? 179.24 89.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 66' ' ' VAL . 12.6 p -79.8 117.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.974 . . . . 0.0 110.202 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.753 HD11 ' O ' ' A' ' 79' ' ' GLY . 2.7 pp -96.93 -25.71 15.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.387 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.79 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.293 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -132.16 160.19 36.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.184 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -67.34 153.58 43.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.917 . . . . 0.0 110.224 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.1 ttt85 55.13 21.63 4.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.313 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.05 87.32 2.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.163 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.22 149.09 13.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.352 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 75' ' ' GLN . 13.2 p -153.0 164.12 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 110.114 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -106.15 -179.21 3.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.26 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.48 129.56 10.54 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 35.42 2.24 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -136.19 126.32 26.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -1.148 . . . . 0.0 110.14 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.753 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.91 151.17 4.52 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 20' ' ' ALA . 67.8 mt -118.58 -64.21 1.31 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -1.115 . . . . 0.0 110.203 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 66' ' ' VAL . 1.8 pp -135.31 133.64 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 110.198 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -82.45 143.66 31.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.214 -0.929 . . . . 0.0 110.403 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.2 tt -164.82 161.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.547 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.242 0.544 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -74.86 -59.09 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.196 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 mt -111.7 -171.03 1.76 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 110.332 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 16.9 tptp -132.18 -54.33 0.97 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 109.904 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 4' ' ' LYS . 16.0 t 61.14 137.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.525 0.678 . . . . 0.0 110.571 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.5 p -99.14 37.36 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.073 -1.017 . . . . 0.0 110.018 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 7' ' ' VAL . 46.7 t -128.46 19.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.37 -0.831 . . . . 0.0 110.299 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.43 146.12 23.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 110.157 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.25 155.35 6.81 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.66 131.66 52.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -1.126 . . . . 0.0 110.202 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -124.59 -75.41 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.39 177.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -1.213 . . . . 0.0 110.106 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.54 -168.86 1.71 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 110.545 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.95 -168.53 17.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.06 78.45 3.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.184 -1.186 . . . . 0.0 110.282 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.79 -20.88 1.14 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.483 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -97.53 170.49 9.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -1.166 . . . . 0.0 110.234 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.45 132.14 24.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.304 -0.873 . . . . 0.0 109.97 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.9 Cg_endo -74.36 131.71 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.51 1.268 . . . . 0.0 110.639 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -55.48 137.27 69.66 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 0.0 110.192 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.4 113.93 3.78 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.582 1.306 . . . . 0.0 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 ' N ' HD22 ' A' ' 22' ' ' LEU . 4.5 mm? 49.45 48.95 20.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 -154.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.111 -0.993 . . . . 0.0 110.478 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.732 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 143.06 172.46 14.08 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.5 p -112.49 112.22 23.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 110.271 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.481 HG21 ' OD2' ' A' ' 72' ' ' ASP . 38.8 t -76.18 112.31 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.929 . . . . 0.0 109.982 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -114.6 -9.25 12.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.715 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -168.46 151.24 5.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.983 -1.073 . . . . 0.0 110.328 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -126.25 145.27 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 110.189 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 30' ' ' LEU . 2.2 mm? -107.39 -42.31 4.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.118 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 43' ' ' VAL . 7.6 p -71.76 165.19 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.204 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 31' ' ' VAL . 25.7 tttt -140.92 163.21 33.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HB3' HG13 ' A' ' 66' ' ' VAL . 9.3 pt-20 -68.46 135.42 51.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.0 22.69 68.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.21 130.02 55.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -1.147 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.7 m -75.43 118.56 18.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.142 -0.974 . . . . 0.0 110.058 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.5 p -98.19 151.49 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -110.66 156.07 21.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.341 -0.85 . . . . 0.0 109.99 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 121.42 14.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -5.67 44.55 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.496 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ALA . 1.5 tt0 -85.5 123.64 31.16 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.819 -1.401 . . . . 0.0 110.441 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.2 m -55.68 102.73 0.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.285 -0.884 . . . . 0.0 110.435 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.4 m -81.48 -23.0 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 110.191 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -154.2 162.97 40.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.034 -1.041 . . . . 0.0 110.613 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.94 125.26 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.732 HD21 ' HA3' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -98.91 168.03 10.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 110.174 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.04 82.14 1.98 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 110.291 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.07 -157.92 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 0.0 110.113 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.4 mtm -57.81 -23.05 50.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -67.19 -14.63 63.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.887 . . . . 0.0 110.408 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 57.3 105.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.074 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 57.16 74.31 0.42 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 0.0 110.018 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.2 m -96.23 132.08 42.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.248 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.25 113.58 25.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.899 . . . . 0.0 110.28 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.583 HD12 ' HB3' ' A' ' 44' ' ' LEU . 49.7 mt -81.25 94.2 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.324 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 3.7 m-20 -66.67 148.79 51.42 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.407 0.622 . . . . 0.0 110.83 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -65.19 146.47 98.93 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.51 -0.744 . . . . 0.0 110.352 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.09 -45.59 0.27 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.703 1.37 . . . . 0.0 110.373 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.75 150.5 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.156 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -64.98 147.99 52.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.175 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.5 -164.22 37.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -125.65 142.3 51.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -1.107 . . . . 0.0 110.251 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 18.7 t -80.06 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.927 . . . . 0.0 110.019 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -112.58 -15.11 13.1 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.569 -0.707 . . . . 0.0 109.851 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.09 131.15 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.104 -0.998 . . . . 0.0 110.163 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 33' ' ' GLU . 32.5 m -73.31 150.69 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.169 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD13 ' O ' ' A' ' 79' ' ' GLY . 0.5 OUTLIER -125.12 -58.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.334 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' OD2' ' A' ' 72' ' ' ASP . 41.3 t -84.54 154.94 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.288 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 71' ' ' ARG . 9.1 mmtt -135.33 166.01 24.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 4.4 mt-10 -63.79 80.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.14 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -176.88 -47.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.28 -0.887 . . . . 0.0 110.173 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.481 ' OD2' HG21 ' A' ' 26' ' ' VAL . 15.8 p-10 -52.7 125.03 15.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -0.936 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -122.2 158.68 28.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.927 . . . . 0.0 110.204 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG22 ' C ' ' A' ' 73' ' ' ALA . 26.7 m 36.6 42.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 121.285 0.564 . . . . 0.0 111.694 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.66 93.68 4.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.286 -0.883 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -99.46 150.12 19.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.68 14.88 64.56 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 13.2 tt0 -99.34 150.25 22.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.012 -1.287 . . . . 0.0 110.119 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.532 ' O ' HD13 ' A' ' 67' ' ' LEU . . . -66.47 106.28 1.57 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 2.7 mt -55.73 -79.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -1.156 . . . . 0.0 110.126 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.5 mt -144.54 160.18 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -88.47 132.61 34.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.067 -1.02 . . . . 0.0 110.126 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.78 33.36 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.909 . . . . 0.0 110.285 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.594 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.329 0.585 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -125.78 147.28 49.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.6 mp -114.03 -177.78 3.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.201 -0.937 . . . . 0.0 110.136 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 147.02 23.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 0.0 110.124 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.86 103.28 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.231 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.8 m -88.09 -25.42 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 8' ' ' ASN . 14.2 p -91.35 163.84 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 110.177 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' N ' HG22 ' A' ' 7' ' ' VAL . 8.4 t-20 -91.45 156.38 17.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 110.313 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -166.2 -157.8 10.47 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 9' ' ' GLY . . . 54.65 -160.99 0.15 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -1.195 . . . . 0.0 110.152 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' ALA . . . 110.45 74.81 0.79 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 tptt 55.24 -88.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.483 -1.01 . . . . 0.0 110.384 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' GLY . . . -158.3 152.82 24.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.911 -1.118 . . . . 0.0 110.253 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.72 170.17 13.54 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.17 107.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.12 -24.73 5.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -94.64 158.2 15.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -1.143 . . . . 0.0 110.199 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -124.54 111.64 27.83 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.033 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.8 Cg_endo -72.42 157.92 52.25 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.513 1.27 . . . . 0.0 110.793 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -95.77 112.49 59.38 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 110.167 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.92 -3.71 14.22 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.55 1.289 . . . . 0.0 111.28 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.3 pp -142.18 33.2 1.52 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.803 -1.186 . . . . 0.0 110.725 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.89 -157.55 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.139 -0.975 . . . . 0.0 110.684 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -174.84 -159.17 20.62 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.23 -146.83 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.201 -1.176 . . . . 0.0 110.115 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 m -47.68 -31.89 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.049 -1.032 . . . . 0.0 111.147 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p 57.18 39.49 28.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 109.988 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -66.43 101.15 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.838 . . . . 0.0 110.066 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 29' ' ' ILE . 5.5 tt -62.3 115.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.457 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.433 ' HG ' HG23 ' A' ' 45' ' ' VAL . 28.4 mt -69.9 -26.75 64.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.944 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 31' ' ' VAL . 23.4 m -98.98 -158.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.177 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.84 -178.45 6.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 110.145 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -81.49 151.81 27.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 110.075 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.72 5.13 83.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.49 167.65 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.002 -1.293 . . . . 0.0 109.999 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -103.75 156.53 17.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 110.327 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' N ' ' A' ' 38' ' ' LYS . 7.7 p -137.85 167.76 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -129.35 160.1 34.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.64 121.48 15.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 110.303 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.27 44.95 6.04 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.814 ' O ' HG13 ' A' ' 43' ' ' VAL . 3.4 tt0 -132.34 110.11 10.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 54' ' ' GLU . 93.8 m -53.07 114.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -0.886 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.814 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -124.72 -12.9 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.884 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 HD12 HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -132.45 166.35 22.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.848 -1.157 . . . . 0.0 110.909 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG13 HG23 ' A' ' 53' ' ' THR . 92.4 t -117.82 103.47 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.369 -0.832 . . . . 0.0 110.036 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.6 OUTLIER -138.96 137.0 36.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 110.085 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -127.23 106.87 9.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' A' ' 50' ' ' LYS . . . -144.81 71.14 1.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 59.04 -83.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.465 -0.772 . . . . 0.0 110.438 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -60.07 -38.34 82.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.994 . . . . 0.0 110.503 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 17.6 mmt -88.14 159.64 18.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.176 -0.953 . . . . 0.0 110.34 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -143.17 68.85 1.3 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.129 -0.982 . . . . 0.0 110.299 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.829 HG23 HG13 ' A' ' 45' ' ' VAL . 41.0 m 61.0 -74.74 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.712 -0.618 . . . . 0.0 111.188 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 42' ' ' THR . 6.2 mt-10 -56.08 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.944 -1.098 . . . . 0.0 110.639 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.9 mm -88.48 102.16 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 109.518 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -78.73 127.3 31.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.617 -0.677 . . . . 0.0 110.427 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.2 14.32 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.376 -0.827 . . . . 0.0 110.083 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.47 -51.47 0.25 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.652 1.343 . . . . 0.0 110.452 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.6 p -139.71 156.06 47.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 29.2 p-10 -62.28 166.51 4.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.231 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.75 -161.91 29.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -134.92 143.88 47.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -1.187 . . . . 0.0 109.936 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.48 134.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 110.329 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.83 -11.87 16.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 0.0 109.82 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.69 138.08 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.272 -0.892 . . . . 0.0 109.771 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 33' ' ' GLU . 34.1 m -86.44 160.55 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.14 -0.975 . . . . 0.0 110.552 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.36 -67.44 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG22 ' N ' ' A' ' 69' ' ' LYS . 13.3 p -62.42 169.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.399 -0.813 . . . . 0.0 110.489 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.526 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.2 mmmt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 110.158 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.463 ' CG ' ' HA ' ' A' ' 28' ' ' LYS . 4.1 tt0 -53.88 134.23 42.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.903 . . . . 0.0 110.441 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 55.83 51.4 12.35 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.127 -0.983 . . . . 0.0 110.473 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.2 t0 -102.51 -26.35 13.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.982 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 61.82 142.82 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.397 -0.815 . . . . 0.0 110.454 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.466 HG22 ' C ' ' A' ' 73' ' ' ALA . 14.8 m 34.53 89.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.361 0 CA-C-O 121.417 0.627 . . . . 0.0 112.139 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.19 64.28 1.58 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 110.102 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -104.44 154.87 17.51 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.6 -19.3 54.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.7 tt0 -118.24 163.41 16.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -1.165 . . . . 0.0 110.143 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.14 175.81 2.13 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 20' ' ' ALA . 65.7 mt -123.42 -43.03 2.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.29 -1.124 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 81' ' ' ILE . 8.5 tt -175.67 143.37 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.084 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -98.4 126.35 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 110.253 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.69 113.29 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.253 -0.904 . . . . 0.0 110.148 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.525 -179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.224 0.535 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -70.3 62.07 0.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 110.269 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.14 172.56 18.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.255 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpt -122.6 171.48 9.1 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.248 -0.908 . . . . 0.0 110.299 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 6' ' ' THR . 92.7 t -115.85 81.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 5' ' ' VAL . 15.1 t 37.99 30.53 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.232 0.539 . . . . 0.0 111.702 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 5' ' ' VAL . 27.7 t 49.17 61.23 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.263 -0.898 . . . . 0.0 110.441 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.49 -172.48 3.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.254 -0.904 . . . . 0.0 110.34 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.62 -138.16 14.03 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.81 -175.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.254 -1.145 . . . . 0.0 110.384 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.78 169.61 24.06 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.6 tttm -151.29 141.62 22.4 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -1.158 . . . . 0.0 110.308 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.24 169.81 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 110.228 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.56 -125.38 3.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.42 97.15 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.295 -1.12 . . . . 0.0 110.137 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.62 1.15 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -118.23 174.86 5.98 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.317 -1.108 . . . . 0.0 110.343 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 80' ' ' LEU . 15.6 mm -107.97 100.12 34.34 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.179 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.01 45.78 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.638 1.336 . . . . 0.0 110.459 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.51 116.1 61.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.161 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.94 -8.03 22.19 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.46 1.242 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 22' ' ' LEU . 14.6 tp -150.03 126.13 10.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.999 -1.063 . . . . 0.0 110.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.609 ' HB1' ' H ' ' A' ' 75' ' ' GLN . . . -58.74 178.35 0.11 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 110.115 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.751 ' C ' ' HB3' ' A' ' 73' ' ' ALA . . . 151.19 -149.52 21.33 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.066 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.547 ' N ' ' HB3' ' A' ' 73' ' ' ALA . 31.0 p -137.46 100.01 4.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.898 HG23 ' HB2' ' A' ' 73' ' ' ALA . 59.1 t -50.28 100.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.013 -1.055 . . . . 0.0 110.291 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 t -57.44 -41.02 79.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.205 -0.934 . . . . 0.0 110.344 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -173.12 156.64 3.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.721 HD12 HG21 ' A' ' 68' ' ' VAL . 3.6 tt -96.42 136.3 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 110.348 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 30' ' ' LEU . 1.2 mm? -103.43 -25.81 13.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG11 HD13 ' A' ' 81' ' ' ILE . 9.2 p -87.15 153.94 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.204 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tptp -123.29 149.21 45.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 110.208 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -69.85 136.12 50.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.119 -0.988 . . . . 0.0 110.196 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.64 24.13 59.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.35 143.43 51.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -1.09 . . . . 0.0 110.173 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.7 m -85.67 116.8 24.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 43' ' ' VAL . 13.1 p -100.96 154.64 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.942 . . . . 0.0 110.358 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 145.77 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.652 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -55.41 142.12 33.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.303 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.88 -34.59 5.09 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.22 123.56 20.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.159 -1.201 . . . . 0.0 110.381 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 42' ' ' THR . 8.1 t -57.19 101.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.971 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.889 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 32.9 m -77.57 -17.39 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 110.449 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 55' ' ' ILE . 4.0 mt -152.21 155.61 38.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.077 -1.014 . . . . 0.0 110.412 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.8 t -125.83 117.97 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 110.047 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.842 HD11 ' CB ' ' A' ' 73' ' ' ALA . 2.4 mm? -102.35 174.56 5.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 110.457 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.74 117.59 3.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.343 -0.848 . . . . 0.0 110.098 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.36 -80.34 0.56 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.408 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 13.0 ttp -85.38 56.95 4.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.313 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.53 38.33 27.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -139.35 105.57 5.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 110.199 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.59 109.11 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 110.213 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m -89.87 87.61 7.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.883 . . . . 0.0 110.36 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.27 132.34 53.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.849 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.754 HD11 HD23 ' A' ' 46' ' ' LEU . 20.8 mt -107.02 99.68 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.45 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 10.6 p-10 -70.86 137.41 49.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.682 -0.636 . . . . 0.0 110.367 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.889 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -56.66 148.32 47.02 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.85 . . . . 0.0 110.068 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.49 -36.11 5.53 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.644 1.339 . . . . 0.0 110.504 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 2.6 m -157.31 158.27 35.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.952 . . . . 0.0 110.284 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 139.23 46.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.24 -167.18 38.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 139.43 49.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -1.128 . . . . 0.0 110.006 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.451 HG21 ' CG2' ' A' ' 31' ' ' VAL . 24.5 t -72.43 142.28 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.077 -1.014 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -105.86 -18.18 14.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.43 -0.794 . . . . 0.0 109.681 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 179.36 156.61 0.55 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.138 -0.976 . . . . 0.0 110.217 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 66' ' ' VAL . 35.8 m -134.63 100.06 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.236 -0.915 . . . . 0.0 110.055 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 ' O ' ' A' ' 79' ' ' GLY . 0.9 OUTLIER -84.08 -15.0 48.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.124 -0.985 . . . . 0.0 110.489 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.721 HG21 HD12 ' A' ' 29' ' ' ILE . 30.2 m -46.7 153.82 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.218 -0.926 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.48 7.66 8.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.354 -0.841 . . . . 0.0 110.657 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 61.27 143.45 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.957 . . . . 0.0 110.608 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.7 mtp-105 52.53 39.03 27.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -154.53 42.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.538 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.898 ' HB2' HG23 ' A' ' 26' ' ' VAL . . . -82.12 -4.92 57.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.096 -1.002 . . . . 0.0 110.439 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 24' ' ' GLY . 29.9 m -44.29 140.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.367 -0.833 . . . . 0.0 111.155 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.609 ' H ' ' HB1' ' A' ' 23' ' ' ALA . 20.2 tt0 54.12 100.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.454 -0.778 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -168.6 8.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.91 -24.69 27.28 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -79.11 130.69 35.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -1.075 . . . . 0.0 110.158 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.939 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -55.99 157.44 9.38 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.579 ' O ' HG13 ' A' ' 68' ' ' VAL . 32.3 mt -118.68 -64.96 1.22 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -1.179 . . . . 0.0 110.216 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.649 HD13 HG11 ' A' ' 31' ' ' VAL . 51.6 mt -126.65 156.36 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.0 109.77 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 146.55 25.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.206 -0.934 . . . . 0.0 110.006 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 6.5 tt -136.59 25.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.56 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.269 0.557 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.96 17.09 24.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.397 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 3' ' ' LEU . 2.2 mm? 51.87 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.212 -0.93 . . . . 0.0 110.407 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -92.35 136.97 32.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.2 m -143.9 104.4 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 110.412 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 m -122.07 36.42 4.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.156 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.8 t 57.75 160.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.55 -0.719 . . . . 0.0 110.471 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.99 102.33 11.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.167 -0.958 . . . . 0.0 110.159 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.63 -152.4 0.19 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.16 -158.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 110.225 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.95 54.02 0.46 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.44 -54.78 4.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -1.153 . . . . 0.0 110.302 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.0 -155.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.87 -122.0 2.88 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.26 -57.62 2.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -1.133 . . . . 0.0 110.123 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.54 -5.69 89.21 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.522 ' OE1' HD21 ' A' ' 67' ' ' LEU . 42.2 mt-10 -78.1 135.24 37.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.97 -1.311 . . . . 0.0 110.375 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.48 109.84 34.66 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.351 -0.843 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.15 152.51 56.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.495 1.261 . . . . 0.0 110.641 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -100.76 122.32 49.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.87 -17.62 25.32 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.481 1.253 . . . . 0.0 110.43 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.95 138.67 42.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.214 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.96 141.24 28.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 110.106 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -134.39 158.64 23.51 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -121.11 104.83 10.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.276 -1.132 . . . . 0.0 110.04 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 27' ' ' SER . 7.5 p -47.38 168.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.263 -0.898 . . . . 0.0 110.902 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.542 ' N ' HG22 ' A' ' 26' ' ' VAL . 25.7 t -149.69 -42.19 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.521 -0.737 . . . . 0.0 109.878 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -160.24 119.42 2.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 44' ' ' LEU . 1.2 tt -81.76 151.73 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.215 -0.928 . . . . 0.0 110.026 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.76 -38.01 5.26 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.104 -0.997 . . . . 0.0 110.476 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.813 HG21 HG13 ' A' ' 43' ' ' VAL . 35.9 m -123.41 168.35 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.917 . . . . 0.0 110.284 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -121.38 -162.58 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -82.99 140.56 32.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 0.0 110.28 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.82 -19.82 49.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.63 172.38 7.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.093 -1.239 . . . . 0.0 110.41 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.6 m -116.93 133.58 55.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.354 -0.841 . . . . 0.0 110.058 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 61' ' ' GLY . 34.8 m -125.56 152.56 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 110.273 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 14.0 tttt -110.78 163.91 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 110.386 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.82 107.74 1.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.257 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.99 -0.72 31.6 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -90.25 127.26 36.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.334 . . . . 0.0 110.149 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 3.4 m -54.13 135.6 43.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.94 . . . . 0.0 110.342 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.813 HG13 HG21 ' A' ' 31' ' ' VAL . 97.2 t -118.6 -38.17 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -147.94 159.34 43.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.434 -0.792 . . . . 0.0 110.544 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.5 t -113.03 116.79 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.282 -0.886 . . . . 0.0 109.954 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.458 HD11 ' HA3' ' A' ' 24' ' ' GLY . 0.6 OUTLIER -101.39 153.57 19.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.403 -179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -106.77 141.02 38.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.306 -0.871 . . . . 0.0 110.076 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.64 -157.24 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.276 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.9 mtp -52.59 -26.98 14.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 0.0 110.289 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.53 -6.48 57.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.189 -0.945 . . . . 0.0 110.864 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.9 ttp 56.33 19.57 4.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.036 -1.04 . . . . 0.0 110.314 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.49 96.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 109.931 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 m -121.1 98.45 5.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 110.481 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -62.64 128.77 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -101.8 81.66 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.246 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 2.0 m120 -72.58 133.93 44.95 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.545 0.688 . . . . 0.0 110.654 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 43' ' ' VAL . . . -49.97 143.7 11.63 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.63 -0.669 . . . . 0.0 110.456 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.25 -32.44 6.63 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.655 1.345 . . . . 0.0 110.548 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 t -145.08 162.25 37.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.958 . . . . 0.0 110.3 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.1 p-10 -77.27 133.5 38.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.287 -0.883 . . . . 0.0 110.177 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 166.42 173.83 35.18 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -90.99 152.63 20.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -1.131 . . . . 0.0 110.153 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.18 128.67 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 0.0 110.045 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -109.25 -1.33 18.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.448 -0.783 . . . . 0.0 110.319 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -177.86 139.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.01 89.78 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.522 HD21 ' OE1' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -52.31 -58.1 7.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.91 . . . . 0.0 110.509 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.677 HG22 HG11 ' A' ' 74' ' ' VAL . 57.9 t -95.92 137.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.357 -0.84 . . . . 0.0 110.705 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 -163.45 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 0.0 109.759 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HA ' HG21 ' A' ' 26' ' ' VAL . 8.3 tt0 -91.69 131.63 36.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.962 . . . . 0.0 110.133 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' N ' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER 71.53 2.96 4.48 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.595 -0.69 . . . . 0.0 111.189 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.455 ' N ' HG11 ' A' ' 26' ' ' VAL . 4.6 m-20 -98.39 84.54 3.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.0 109.702 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.34 155.96 1.31 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.224 -0.922 . . . . 0.0 110.794 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.677 HG11 HG22 ' A' ' 68' ' ' VAL . 26.4 m -142.51 158.75 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 110.077 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -100.77 152.27 20.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.943 . . . . 0.0 110.398 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.13 138.66 42.46 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.71 -7.37 11.13 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -116.91 150.26 38.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.918 -1.343 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.09 159.85 17.62 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 20' ' ' ALA . 57.5 mt -108.86 -49.68 3.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -1.094 . . . . 0.0 109.865 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' C ' ' A' ' 80' ' ' LEU . 4.8 pt -154.46 150.58 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.835 . . . . 0.0 110.024 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 65' ' ' LYS . 37.2 tttt -108.36 139.42 43.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.198 -0.938 . . . . 0.0 110.368 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' A' ' 83' ' ' ILE . 3.7 tt -148.85 44.82 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.164 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 CA-C-O 117.945 -1.475 . . . . 0.0 109.611 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.176 0.512 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -156.22 143.59 19.19 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.44 54.06 0.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -156.59 120.93 4.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.302 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 6' ' ' THR . 12.5 p -54.07 170.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.264 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.519 ' N ' HG22 ' A' ' 5' ' ' VAL . 10.4 m 53.99 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.386 -0.821 . . . . 0.0 110.438 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.7 75.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.152 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -95.82 73.64 3.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 110.155 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.1 -146.6 13.18 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.09 178.91 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.231 -1.158 . . . . 0.0 110.392 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.27 34.16 1.09 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -125.86 24.11 7.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 110.226 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.581 ' HB1' ' CG ' ' A' ' 17' ' ' GLU . . . -123.9 157.72 33.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.34 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.98 -110.59 1.03 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 6.0 mt-10 -139.45 125.44 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -1.138 . . . . 0.0 110.13 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.86 -33.56 5.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.581 ' CG ' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -57.23 -175.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -1.137 . . . . 0.0 110.409 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.408 HD11 HG12 ' A' ' 83' ' ' ILE . 3.9 mp -138.84 110.75 7.99 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 110.079 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.76 137.01 26.47 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.539 1.284 . . . . 0.0 110.355 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.11 136.32 53.88 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.78 -24.55 13.21 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.462 1.243 . . . . 0.0 110.65 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -134.05 139.9 46.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.237 -0.914 . . . . 0.0 110.442 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.32 178.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.977 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 46' ' ' LEU . . . -176.83 155.84 19.28 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -99.74 121.31 41.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.362 -1.081 . . . . 0.0 109.979 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.42 136.37 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 110.366 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 45' ' ' VAL . 44.5 t -115.62 -31.86 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.0 109.805 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 mtmt -172.84 139.94 0.91 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.0 110.083 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.437 ' H ' HG22 ' A' ' 29' ' ' ILE . 8.2 tt -101.82 140.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.9 mt -116.29 -27.14 6.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.258 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.634 ' CG2' HG21 ' A' ' 63' ' ' VAL . 9.2 p -82.83 155.66 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.61 160.37 39.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.888 . . . . 0.0 110.248 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -68.07 122.17 17.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 0.0 110.245 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.99 -2.26 55.35 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.05 126.32 38.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.872 -1.37 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.8 m -64.55 124.03 20.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 37' ' ' VAL . 8.7 p -99.46 145.27 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.241 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 133.88 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.47 8.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.937 . . . . 0.0 110.234 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.16 17.86 23.65 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -118.45 119.55 34.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.149 -1.207 . . . . 0.0 110.189 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 79.5 m -52.65 122.45 9.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.915 . . . . 0.0 110.011 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 57' ' ' ALA . 15.4 m -114.33 -23.34 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 110.864 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 171.06 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.977 -1.077 . . . . 0.0 111.058 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 27' ' ' SER . 50.4 t -121.31 117.4 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 109.397 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.634 HD11 ' HA3' ' A' ' 24' ' ' GLY . 3.2 tp -107.83 149.51 28.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.943 . . . . 0.0 110.815 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -131.62 53.47 1.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.819 . . . . 0.0 109.966 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.74 -166.4 1.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.888 . . . . 0.0 110.41 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.4 mtt -63.35 -39.8 95.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.416 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -14.83 61.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 22.6 ttp 54.63 75.52 0.29 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.109 -0.995 . . . . 0.0 110.122 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.4 tp10 -92.27 -34.51 14.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.268 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 53.8 m 56.81 -83.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.585 -0.697 . . . . 0.0 111.002 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' GLU . 29.0 mt-10 -58.46 97.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.096 . . . . 0.0 111.106 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 43' ' ' VAL . 26.7 mm -96.12 90.96 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.012 . . . . 0.0 109.5 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -62.63 138.85 58.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.62 -0.675 . . . . 0.0 110.686 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.582 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -54.06 167.81 0.5 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.455 -0.778 . . . . 0.0 110.387 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.53 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 48.6 Cg_endo -75.02 -35.85 2.88 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.822 1.433 . . . . 0.0 110.446 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -165.69 -159.41 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -100.9 147.51 26.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 110.439 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.85 -150.53 22.09 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -129.99 149.06 51.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.35 -1.088 . . . . 0.0 109.94 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.634 HG21 ' CG2' ' A' ' 31' ' ' VAL . 38.6 t -80.5 110.18 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -0.951 . . . . 0.0 110.379 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -78.4 -12.39 60.0 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.507 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.99 174.71 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -0.91 . . . . 0.0 109.519 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 66' ' ' VAL . 34.7 m -123.64 91.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.107 -0.995 . . . . 0.0 110.228 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.742 HD13 ' HA3' ' A' ' 79' ' ' GLY . 1.1 mt -60.53 -30.18 69.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 p -103.81 142.74 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.889 . . . . 0.0 110.545 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 -171.64 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 109.992 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.6 154.76 21.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.043 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 58.07 30.55 19.45 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.266 -0.896 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.95 67.55 0.66 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 173.3 0.52 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.871 . . . . 0.0 110.479 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 75.8 t 53.55 86.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.33 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -131.21 28.09 4.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.155 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.38 132.98 11.44 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.48 -21.11 44.69 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -97.31 150.01 21.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -1.202 . . . . 0.0 110.152 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.742 ' HA3' HD13 ' A' ' 67' ' ' LEU . . . -58.12 149.01 35.58 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.1 mt -96.57 -68.57 0.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 6.1 mt -126.85 146.86 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.923 . . . . 0.0 110.206 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -88.06 118.93 27.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.491 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 18' ' ' ILE . 4.5 pt -146.0 153.36 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.172 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.506 -179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.998 0.427 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 62.94 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.716 -0.615 . . . . 0.0 110.664 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -117.15 121.66 41.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.052 . . . . 0.0 109.98 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.609 ' HB3' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -90.51 176.41 6.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.923 . . . . 0.0 110.183 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -60.38 -32.6 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.609 HG22 ' HB3' ' A' ' 4' ' ' LYS . 5.1 t -60.1 167.53 2.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 110.199 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 52.2 t -119.52 109.99 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.188 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -59.54 -166.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.119 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.02 -31.15 0.31 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.42 -46.79 83.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.197 -1.178 . . . . 0.0 110.388 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.78 -66.35 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.73 176.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -1.145 . . . . 0.0 110.153 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.716 ' HB1' ' OE2' ' A' ' 17' ' ' GLU . . . -107.39 162.29 14.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.175 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.12 -106.23 0.48 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -135.0 148.47 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -1.152 . . . . 0.0 109.952 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.21 36.96 58.12 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.716 ' OE2' ' HB1' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -111.65 166.14 11.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -1.095 . . . . 0.0 110.46 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.67 100.41 19.59 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.828 . . . . 0.0 109.858 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.2 Cg_endo -71.18 121.31 7.69 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.742 1.391 . . . . 0.0 110.542 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -60.79 141.62 92.67 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.02 -20.56 21.74 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.654 1.344 . . . . 0.0 110.387 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD13 ' HD3' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -153.84 151.43 29.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.246 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.66 174.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.907 . . . . 0.0 110.304 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.03 153.37 11.14 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 46' ' ' LEU . 21.2 p -106.77 135.33 48.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -1.19 . . . . 0.0 110.22 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG21 ' CG1' ' A' ' 68' ' ' VAL . 43.1 t -89.9 130.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.427 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.1 m -101.8 -23.18 14.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -169.63 165.43 10.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.319 -0.863 . . . . 0.0 110.179 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.5 tt -122.43 145.24 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 42' ' ' THR . 0.3 OUTLIER -103.01 -54.55 2.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.319 -0.863 . . . . 0.0 109.822 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG11 HG13 ' A' ' 43' ' ' VAL . 29.2 m -71.53 -171.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.146 -0.971 . . . . 0.0 109.837 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.93 39.17 0.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.089 -1.007 . . . . 0.0 110.569 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 63' ' ' VAL . 17.9 tt0 61.21 142.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.295 -0.878 . . . . 0.0 110.727 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.4 16.73 60.99 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.88 126.03 54.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.102 -1.234 . . . . 0.0 109.886 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 37' ' ' VAL . 3.7 m -57.61 178.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 110.047 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 36' ' ' THR . 13.4 p -171.78 164.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 110.213 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' N ' HG22 ' A' ' 37' ' ' VAL . 10.1 mtmm -122.69 177.45 5.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.005 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.28 125.93 32.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.464 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.51 -22.34 41.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 43' ' ' VAL . 49.0 tt0 -70.01 127.73 33.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -1.191 . . . . 0.0 110.407 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.587 HG22 HD22 ' A' ' 30' ' ' LEU . 69.2 m -52.13 137.95 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.211 -0.931 . . . . 0.0 110.011 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.878 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 93.7 t -123.49 -36.45 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.29 -0.881 . . . . 0.0 110.28 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -142.82 176.28 9.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.135 -0.978 . . . . 0.0 111.076 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 53' ' ' THR . 42.1 t -124.48 145.12 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.355 -0.841 . . . . 0.0 109.534 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 HG13 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -174.83 4.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.027 -1.046 . . . . 0.0 110.523 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -168.13 109.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.087 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 51' ' ' MET . . . -168.3 -165.32 0.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.101 -0.999 . . . . 0.0 110.394 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -35.34 80.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 110.441 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.727 ' HD3' HD13 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -117.99 12.98 13.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.713 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.658 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -120.11 153.23 36.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.791 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' C ' HG22 ' A' ' 53' ' ' THR . 0.0 OUTLIER -149.48 92.74 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 0.0 111.088 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.553 HG22 ' C ' ' A' ' 52' ' ' GLU . 8.2 t 36.5 -127.61 0.15 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.989 -0.444 . . . . 0.0 111.989 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 53' ' ' THR . 1.1 mt-10 -37.69 133.79 0.76 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.302 -0.874 . . . . 0.0 112.237 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.663 HG13 HD12 ' A' ' 46' ' ' LEU . 35.1 mm -125.69 106.71 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.643 -0.661 . . . . 0.0 109.411 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 76.3 m-20 -57.18 144.1 36.41 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.36 0.6 . . . . 0.0 110.703 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.878 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -62.38 152.38 79.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.71 -33.77 7.81 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.693 1.365 . . . . 0.0 110.389 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.1 t -161.51 151.75 17.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.279 -0.888 . . . . 0.0 110.203 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.43 158.49 14.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 145.59 -144.23 12.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -140.33 158.17 44.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -1.158 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 33' ' ' GLU . 52.5 t -85.19 119.98 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.53 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 84' ' ' GLY . 1.2 mm-40 -90.22 -10.49 44.15 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 109.598 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.1 mttm 179.86 163.6 1.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.1 t -123.72 95.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.0 110.195 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 -36.48 75.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 110.008 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.741 HG21 HD23 ' A' ' 80' ' ' LEU . 45.1 t -96.15 128.53 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 110.204 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 -170.9 2.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.109 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.09 134.7 34.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.253 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 52.14 42.17 30.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 1.7 t70 -104.25 -23.76 13.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.312 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 72' ' ' ASP . . . 60.73 117.17 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.29 -0.881 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 m -124.04 -177.84 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.099 -1.0 . . . . 0.0 110.339 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -123.08 162.85 21.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.62 146.43 48.5 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.84 37.16 6.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.7 tt0 -146.51 132.05 18.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 110.174 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.74 114.74 4.23 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.741 HD23 HG21 ' A' ' 68' ' ' VAL . 26.1 mt -70.19 -57.89 4.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -1.143 . . . . 0.0 110.296 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 pt -139.03 168.78 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.3 143.08 42.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.235 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 pt -140.38 162.6 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.184 -0.947 . . . . 0.0 110.305 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 64' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.261 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.531 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.203 0.525 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -81.41 173.0 12.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.51 -173.11 4.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 110.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.63 63.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.084 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.65 90.0 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.182 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -153.85 38.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.37 -0.831 . . . . 0.0 110.065 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.55 101.19 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -122.23 -61.08 1.51 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.322 -0.861 . . . . 0.0 110.145 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.09 -166.58 15.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 52.95 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -1.152 . . . . 0.0 110.172 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.97 -45.12 1.35 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 124.32 12.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -1.113 . . . . 0.0 110.259 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -175.27 -150.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.877 . . . . 0.0 110.198 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.74 -133.16 4.18 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -101.35 132.35 46.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -1.172 . . . . 0.0 110.313 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.43 24.75 59.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.21 159.34 32.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -1.188 . . . . 0.0 110.277 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 83' ' ' ILE . 67.7 mt -130.94 99.56 18.03 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 0.0 109.967 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.5 Cg_endo -73.53 130.28 14.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.734 1.386 . . . . 0.0 110.618 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.55 114.18 36.11 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.4 -18.59 26.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.468 1.247 . . . . 0.0 110.665 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.0 mt -119.97 9.27 11.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.711 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HB2' ' N ' ' A' ' 76' ' ' GLY . . . 51.68 -150.32 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 0.0 110.402 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 48' ' ' ALA . . . 141.62 176.69 16.1 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 73' ' ' ALA . 0.5 OUTLIER -121.23 108.96 14.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -1.136 . . . . 0.0 110.009 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 t -62.3 136.35 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -40.21 3.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 110.248 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.69 139.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' HG22 ' A' ' 29' ' ' ILE . 10.5 tt -81.73 149.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -0.877 . . . . 0.0 110.119 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -105.16 -45.57 4.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.152 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG21 HG23 ' A' ' 43' ' ' VAL . 24.4 m -101.91 -158.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 0.0 110.356 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -148.98 179.25 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.5 146.41 53.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.49 -2.37 87.33 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.12 146.48 26.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.989 -1.3 . . . . 0.0 110.163 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.7 m -97.83 107.26 19.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 61' ' ' GLY . 31.3 m -81.25 158.45 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.072 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.86 155.42 38.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 110.114 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.34 109.43 1.0 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.371 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.8 34.43 5.73 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -125.04 114.52 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.153 . . . . 0.0 110.084 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -49.16 113.77 0.87 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.221 -0.924 . . . . 0.0 110.412 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 31' ' ' VAL . 12.0 p -107.95 -26.97 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.838 . . . . 0.0 110.625 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.758 ' CD1' HD11 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -142.78 175.44 9.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.137 -0.977 . . . . 0.0 111.163 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' THR . 57.5 t -116.17 142.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.451 -0.781 . . . . 0.0 109.948 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.45 ' HB2' HG13 ' A' ' 55' ' ' ILE . 21.7 tp -134.72 159.22 41.98 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.075 -1.015 . . . . 0.0 110.731 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' N ' ' HG ' ' A' ' 46' ' ' LEU . 34.8 tt0 -154.47 72.6 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.406 -0.809 . . . . 0.0 109.979 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB2' ' HA2' ' A' ' 24' ' ' GLY . . . -114.04 69.7 0.71 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 5.5 ttp 59.0 16.64 4.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.303 -0.873 . . . . 0.0 110.562 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -126.89 -11.55 5.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.101 -0.999 . . . . 0.0 110.783 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.7 ttt 53.56 23.85 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.038 -1.038 . . . . 0.0 110.411 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.1 -40.94 64.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 109.616 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 54' ' ' GLU . 54.6 m 52.1 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.558 -0.714 . . . . 0.0 110.773 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' HG22 ' A' ' 53' ' ' THR . 7.4 mt-10 -59.9 105.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.717 -1.24 . . . . 0.0 110.949 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.45 HG13 ' HB2' ' A' ' 46' ' ' LEU . 26.2 mm -103.76 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 18.4 p-10 -69.81 135.38 49.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.638 -0.664 . . . . 0.0 110.726 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.735 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.43 175.3 0.13 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.455 -0.778 . . . . 0.0 110.175 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.761 ' O ' HG23 ' A' ' 59' ' ' THR . 49.0 Cg_endo -76.51 -48.99 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.762 1.401 . . . . 0.0 110.768 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -163.42 -167.66 1.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 124.86 26.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.275 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 37' ' ' VAL . . . -179.87 169.9 40.91 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -107.62 151.43 25.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.84 106.85 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.997 . . . . 0.0 110.453 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -84.33 -10.79 57.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 109.706 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt 178.19 157.3 0.43 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.119 -0.988 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' VAL . 19.2 m -112.39 94.34 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -70.37 0.12 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.952 . . . . 0.0 110.498 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.48 166.12 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.501 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -118.5 -176.25 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.52 145.5 26.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 110.017 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 57.89 33.62 23.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 0.0 110.327 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -120.64 87.19 2.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.105 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 25' ' ' THR . . . -51.38 145.74 8.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.226 -0.922 . . . . 0.0 110.48 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.09 158.59 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 110.094 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -98.8 24.79 7.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.24 -0.912 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 23' ' ' ALA . . . 77.52 172.1 37.48 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.19 34.33 88.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -128.47 130.03 46.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -1.117 . . . . 0.0 110.157 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.33 111.25 2.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.1 mt -67.9 -70.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.333 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.758 HD11 ' CD1' ' A' ' 44' ' ' LEU . 72.3 mt -132.5 160.61 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.408 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -102.35 117.92 35.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 110.268 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 83' ' ' ILE . 70.8 mt -118.88 38.43 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 110.175 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.561 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.219 0.533 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -137.9 49.06 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 110.153 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -102.4 -28.56 12.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.357 -0.84 . . . . 0.0 110.124 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm 54.91 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.769 . . . . 0.0 110.307 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 3' ' ' LEU . 29.4 m -137.02 28.67 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.938 -1.101 . . . . 0.0 110.05 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.548 ' O ' HD23 ' A' ' 3' ' ' LEU . 3.1 m -100.39 145.54 28.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.285 -0.884 . . . . 0.0 110.174 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.84 147.5 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -155.63 90.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 110.364 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.6 127.68 4.06 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 165.96 17.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.109 . . . . 0.0 110.107 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.49 -95.28 0.22 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -131.52 121.21 24.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.307 -1.113 . . . . 0.0 110.223 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.54 155.89 6.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.242 -0.911 . . . . 0.0 110.16 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.4 -179.19 26.89 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -58.4 141.53 51.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -1.175 . . . . 0.0 110.231 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.59 -51.59 4.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.02 132.63 47.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 110.341 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.97 120.07 51.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.955 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.91 154.27 53.22 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.409 1.215 . . . . 0.0 110.672 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.76 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -107.5 94.52 11.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.12 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.54 -5.63 17.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.735 1.387 . . . . 0.0 111.056 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 49' ' ' MET . 0.7 OUTLIER -103.09 3.24 35.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.064 -1.023 . . . . 0.0 110.8 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.11 178.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.936 -1.103 . . . . 0.0 110.188 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.51 172.06 31.51 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.635 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.6 p -101.14 112.73 25.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -1.123 . . . . 0.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 69' ' ' LYS . 96.8 t -80.63 97.51 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.857 . . . . 0.0 109.983 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.5 -41.76 11.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.298 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.28 170.87 4.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 110.262 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' ILE . 20.4 tt -133.26 124.03 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 110.127 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 43' ' ' VAL . 4.7 mp -68.78 -60.73 2.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.371 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 32' ' ' LYS . 21.3 t -131.52 -115.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.097 -1.002 . . . . 0.0 109.812 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.608 ' C ' HG21 ' A' ' 63' ' ' VAL . 3.9 tttp 53.96 50.45 16.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.401 -1.437 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -170.05 103.41 0.3 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.388 -0.82 . . . . 0.0 109.803 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.6 22.11 61.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 140.04 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -1.125 . . . . 0.0 110.12 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 m -76.95 88.28 3.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.075 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 61' ' ' GLY . 27.7 m -67.04 -171.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 110.172 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 15.7 ttpp -147.64 155.87 42.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.053 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.15 93.39 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.167 -0.958 . . . . 0.0 110.397 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.45 34.07 1.65 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.808 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -115.18 109.04 17.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -1.163 . . . . 0.0 110.362 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.591 HG21 ' HG3' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -52.22 109.8 0.42 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.346 -0.846 . . . . 0.0 110.02 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.0 m -130.02 -4.81 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 111.226 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.437 HD23 HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -131.05 164.21 25.91 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.82 -1.175 . . . . 0.0 110.658 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.811 HG13 ' CG2' ' A' ' 53' ' ' THR . 81.7 t -123.33 108.16 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 25' ' ' THR . 1.4 mm? -125.15 154.63 41.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 5.0 tt0 -144.12 69.24 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.217 -0.927 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' GLU . . . -179.32 139.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.201 -0.937 . . . . 0.0 110.423 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.411 ' HB3' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 54.5 78.32 0.17 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.328 -0.858 . . . . 0.0 110.865 179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 tptt 51.64 61.71 3.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.27 -0.894 . . . . 0.0 111.015 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.443 ' HG2' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -149.26 95.4 2.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 109.737 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 mt-10 -87.14 53.88 2.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.812 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.811 ' CG2' HG13 ' A' ' 45' ' ' VAL . 1.4 m 65.7 -64.99 0.18 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.37 -0.831 . . . . 0.0 111.046 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.591 ' HG3' HG21 ' A' ' 42' ' ' THR . 2.9 mp0 -56.57 98.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 111.08 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -99.63 98.43 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.185 -0.947 . . . . 0.0 109.755 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.98 131.71 44.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.36 -0.837 . . . . 0.0 110.136 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 156.07 2.77 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.26 -0.9 . . . . 0.0 110.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.39 -49.03 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.701 1.369 . . . . 0.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.5 p -138.97 -172.5 3.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.309 -0.87 . . . . 0.0 110.202 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.457 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 6.3 p-10 -101.56 152.44 20.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 150.69 159.88 9.04 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -85.69 121.09 27.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -1.129 . . . . 0.0 110.356 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.608 HG21 ' C ' ' A' ' 32' ' ' LYS . 27.4 t -54.34 159.46 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.294 -0.879 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -118.39 -14.87 9.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.438 -0.789 . . . . 0.0 110.123 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 tttt 179.97 149.26 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.04 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.2 t -94.73 159.5 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.825 . . . . 0.0 109.558 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -138.27 -68.52 0.45 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.538 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.676 HG11 HD23 ' A' ' 80' ' ' LEU . 23.7 m -48.55 155.12 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.175 -0.953 . . . . 0.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' O ' HG11 ' A' ' 26' ' ' VAL . 9.5 mtmt -124.31 148.46 47.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 0.0 110.237 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.0 72.69 0.18 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -0.905 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -176.79 -37.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.128 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.39 145.22 11.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' C ' HG12 ' A' ' 74' ' ' VAL . . . -135.91 135.18 39.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.491 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 74' ' ' VAL . 14.5 p 36.91 48.02 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.883 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.33 97.87 6.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.09 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -99.96 156.31 19.65 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.43 18.27 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.71 155.94 17.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -1.213 . . . . 0.0 110.241 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.97 161.9 23.53 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.76 HD11 ' HB2' ' A' ' 20' ' ' ALA . 9.4 mt -109.18 -68.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 110.258 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.736 HG22 HG23 ' A' ' 83' ' ' ILE . 36.3 mm -140.8 148.42 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.49 91.28 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.736 HG23 HG22 ' A' ' 81' ' ' ILE . 46.6 pt -125.45 45.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.913 . . . . 0.0 110.224 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.571 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.24 0.543 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.39 156.27 19.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.21 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.6 tp -98.45 -25.62 14.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.01 105.42 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.247 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 5' ' ' VAL . 13.9 p -137.27 132.43 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 p -149.42 129.41 13.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 110.15 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.868 HG21 ' O ' ' A' ' 11' ' ' GLY . 34.3 m -79.45 148.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.167 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -102.52 43.99 1.04 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.055 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.51 32.31 1.64 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.75 47.18 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -1.147 . . . . 0.0 110.275 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.868 ' O ' HG21 ' A' ' 7' ' ' VAL . . . 96.98 121.68 4.17 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -162.56 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -1.155 . . . . 0.0 110.467 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . 55.12 -166.24 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.153 -0.967 . . . . 0.0 109.964 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -127.0 25.88 5.16 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 53.24 25.32 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.275 -1.132 . . . . 0.0 110.284 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -178.79 49.85 0.09 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.48 -176.94 5.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -1.128 . . . . 0.0 110.187 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.51 91.51 49.67 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.115 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.41 134.55 24.8 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.704 1.371 . . . . 0.0 110.709 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.81 142.62 69.95 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.087 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.54 -32.35 9.89 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.609 1.32 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 23' ' ' ALA . 5.8 tt -118.73 157.16 28.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.254 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.734 ' O ' HD23 ' A' ' 22' ' ' LEU . . . -61.1 176.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.345 -0.847 . . . . 0.0 110.546 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -153.52 146.85 15.59 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -68.32 -141.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.288 -1.125 . . . . 0.0 110.584 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 27' ' ' SER . 19.1 m -38.47 -46.26 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.518 -0.739 . . . . 0.0 112.539 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER 61.01 40.82 14.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.748 -1.22 . . . . 0.0 110.016 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -54.95 108.39 0.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.946 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 29' ' ' ILE . 12.2 tt -62.05 120.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 110.475 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD23 ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -88.2 -18.23 29.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.881 . . . . 0.0 110.175 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.629 HG11 HD13 ' A' ' 81' ' ' ILE . 14.0 p -91.27 169.77 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 110.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 31' ' ' VAL . 23.9 tttt -123.7 159.55 29.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.144 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.72 142.49 53.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -0.9 . . . . 0.0 110.171 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.45 73.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -110.69 154.72 23.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.102 -1.234 . . . . 0.0 109.874 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 62' ' ' LYS . 1.4 m -96.73 110.67 23.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.259 -0.9 . . . . 0.0 110.308 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' GLY . 34.5 m -81.92 157.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.036 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 25.1 tttt -120.06 160.44 22.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 110.294 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 59' ' ' THR . . . -69.12 99.58 1.14 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.02 46.92 0.85 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.5 tt0 -135.34 114.44 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -1.167 . . . . 0.0 109.809 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 42' ' ' THR . 12.6 t -55.25 105.12 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.575 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 41' ' ' GLN . 27.1 m -104.52 0.79 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.942 -1.099 . . . . 0.0 110.227 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -148.81 156.82 42.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.952 -1.093 . . . . 0.0 110.472 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.506 ' CG2' HD23 ' A' ' 30' ' ' LEU . 93.5 t -119.23 99.84 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.582 ' HB3' HD11 ' A' ' 55' ' ' ILE . 7.8 tt -105.83 151.0 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 2.6 tt0 -124.55 159.16 31.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 109.897 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' GLU . . . -176.42 -69.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.105 -0.997 . . . . 0.0 110.749 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.69 52.41 2.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.9 mttm 49.19 38.35 13.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.171 -0.956 . . . . 0.0 110.583 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.93 134.34 6.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 110.247 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.52 128.34 36.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.217 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.8 m -102.97 107.64 18.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.138 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 2.1 pt-20 -65.41 103.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.19 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 ' HB3' ' A' ' 46' ' ' LEU . 48.6 mm -77.37 94.05 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.203 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 67.3 m-20 -77.31 133.16 38.85 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.629 . . . . 0.0 110.745 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.77 170.09 0.2 Allowed Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.381 -0.824 . . . . 0.0 110.454 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 49.9 Cg_endo -77.29 -54.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.762 1.401 . . . . 0.0 110.812 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 58' ' ' PRO . 1.3 p -153.26 -166.12 2.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.361 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 52.3 t0 -78.56 123.59 27.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 110.395 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' HA3' HD11 ' A' ' 83' ' ' ILE . . . -173.42 -165.95 31.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 2.8 ttpt -133.27 153.48 51.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.131 -1.217 . . . . 0.0 110.384 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.709 HG22 ' CG2' ' A' ' 81' ' ' ILE . 37.9 t -80.19 125.14 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.878 . . . . 0.0 110.354 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -88.64 -14.09 38.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.76 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.5 169.06 0.84 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.63 144.91 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.88 -52.62 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.274 -0.891 . . . . 0.0 109.95 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.797 HG22 ' H ' ' A' ' 70' ' ' GLU . 11.3 p -53.05 154.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' GLU . 18.0 mttt -94.28 -10.87 31.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.138 -0.976 . . . . 0.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.797 ' H ' HG22 ' A' ' 68' ' ' VAL . 4.8 tt0 61.61 135.79 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.21 22.38 7.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.987 -1.07 . . . . 0.0 109.949 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.404 ' CB ' ' HB2' ' A' ' 69' ' ' LYS . 22.9 t70 -115.86 120.62 39.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.358 -0.839 . . . . 0.0 109.821 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' VAL . . . -67.87 168.7 11.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.281 -0.887 . . . . 0.0 110.28 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 19.5 t 60.86 139.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.488 0.661 . . . . 0.0 110.648 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.04 43.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.012 -1.055 . . . . 0.0 110.338 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.08 130.89 10.38 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.82 19.37 63.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 16.1 mt-30 -131.37 139.83 49.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -1.179 . . . . 0.0 110.14 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.75 140.85 29.69 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.1 mt -92.1 -47.71 7.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -1.188 . . . . 0.0 110.002 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.709 ' CG2' HG22 ' A' ' 63' ' ' VAL . 98.2 mt -137.2 151.84 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.2 ttmt -97.31 145.97 25.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.464 HD11 ' HA3' ' A' ' 61' ' ' GLY . 10.7 tt -147.46 159.08 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 110.293 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.615 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.254 0.55 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -119.47 -50.47 2.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.282 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.3 tt -68.57 147.59 51.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.877 . . . . 0.0 110.286 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.2 -155.94 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 110.019 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -134.41 86.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 110.135 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.653 HG23 HG13 ' A' ' 7' ' ' VAL . 7.0 t -161.78 -40.55 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 110.398 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.653 HG13 HG23 ' A' ' 6' ' ' THR . 34.0 m -118.44 178.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.372 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -160.45 -50.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.11 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.63 -156.44 15.82 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.13 -60.63 1.68 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 110.119 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.39 132.25 0.56 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -74.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -1.108 . . . . 0.0 110.252 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . . . 53.73 79.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.918 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.96 -106.93 0.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -119.18 -49.36 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.159 . . . . 0.0 109.893 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' CA ' ' HG2' ' A' ' 82' ' ' LYS . . . -95.58 85.28 0.92 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 3.7 pm0 -157.96 150.78 22.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -1.079 . . . . 0.0 110.236 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 81' ' ' ILE . 78.5 mt -111.85 99.38 45.13 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.859 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.9 128.35 14.87 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.702 1.369 . . . . 0.0 110.472 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.704 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -69.84 138.05 87.82 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.079 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.46 -13.31 25.16 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.558 1.294 . . . . 0.0 110.676 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.04 153.15 41.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 110.249 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.03 162.09 9.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.139 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.37 -165.04 34.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -150.55 149.23 29.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.295 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.879 HG21 HG13 ' A' ' 68' ' ' VAL . 90.0 t -88.69 132.89 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.224 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.57 -28.6 12.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 109.923 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -171.42 153.52 3.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -0.819 . . . . 0.0 109.805 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.441 HG22 ' OE2' ' A' ' 70' ' ' GLU . 3.8 tt -112.46 149.56 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.478 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.696 HD13 HG22 ' A' ' 42' ' ' THR . 0.5 OUTLIER -114.4 -36.0 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.009 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 43' ' ' VAL . 59.6 t -110.04 157.24 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.05 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -119.83 178.71 4.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -77.28 131.5 38.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 110.127 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.85 70.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.58 157.02 18.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.962 -1.317 . . . . 0.0 110.421 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.69 174.7 8.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.229 -0.919 . . . . 0.0 109.971 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 61' ' ' GLY . 11.4 p -157.61 166.28 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 110.212 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' N ' HG22 ' A' ' 37' ' ' VAL . 1.3 mtpm? -122.06 169.57 10.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -79.42 114.6 18.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.26 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.23 19.5 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -109.46 119.67 40.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.12 -1.224 . . . . 0.0 110.006 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.696 HG22 HD13 ' A' ' 30' ' ' LEU . 88.6 m -53.19 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.374 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 57' ' ' ALA . 41.5 t -64.73 -33.49 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -0.905 . . . . 0.0 109.776 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -155.03 -177.74 6.74 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.627 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.94 125.67 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.847 . . . . 0.0 110.053 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -100.74 177.67 4.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.21 97.51 1.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.195 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.5 -51.47 2.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.3 mmt -96.78 42.41 1.09 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.15 -0.969 . . . . 0.0 110.219 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm 53.23 38.17 26.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 110.206 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.4 ttm -138.99 117.83 12.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -56.91 102.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.177 -0.952 . . . . 0.0 110.258 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.5 m -91.49 129.8 37.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 110.321 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.79 112.69 22.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.167 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 46' ' ' LEU . 98.1 mt -82.61 89.59 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 70.1 m-80 -72.57 135.12 45.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.549 -0.719 . . . . 0.0 110.797 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.702 ' HB2' ' CG2' ' A' ' 43' ' ' VAL . . . -56.43 154.17 17.57 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.41 -0.806 . . . . 0.0 110.297 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 -46.19 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.746 1.393 . . . . 0.0 110.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.578 HG22 ' OD1' ' A' ' 60' ' ' ASP . 4.4 m -155.82 169.98 23.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.265 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.578 ' OD1' HG22 ' A' ' 59' ' ' THR . 9.5 p-10 -64.66 145.08 56.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.271 -0.893 . . . . 0.0 110.171 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.533 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 162.66 -156.47 28.17 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -132.2 150.96 52.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.253 -1.145 . . . . 0.0 110.168 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 66' ' ' VAL . 30.2 t -71.87 132.86 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 0.0 110.317 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.59 -9.43 20.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.517 -0.739 . . . . 0.0 110.081 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 140.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.003 -1.06 . . . . 0.0 109.837 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 63' ' ' VAL . 64.3 t -123.67 95.68 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.129 -0.982 . . . . 0.0 110.463 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.26 -18.07 59.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.177 -0.952 . . . . 0.0 110.103 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.879 HG13 HG21 ' A' ' 26' ' ' VAL . 39.6 t -69.67 143.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -0.971 . . . . 0.0 110.342 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.99 15.87 10.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 110.349 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 68' ' ' VAL . 1.1 tt0 61.97 135.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.324 -0.86 . . . . 0.0 110.586 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.55 32.75 17.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.293 -0.879 . . . . 0.0 110.4 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -127.59 116.85 20.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.335 -0.853 . . . . 0.0 110.006 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 25' ' ' THR . . . -64.52 146.21 54.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 80' ' ' LEU . 26.6 m -136.16 122.71 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 110.058 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.91 160.4 30.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.2 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.68 51.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 109.64 -2.76 30.63 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -97.79 123.73 41.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.882 -1.363 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.5 137.68 48.74 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 20' ' ' ALA . 51.5 mt -107.43 -57.87 2.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -1.193 . . . . 0.0 110.352 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.57 HD13 HG11 ' A' ' 43' ' ' VAL . 16.4 tt -143.19 170.1 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.476 ' O ' HG23 ' A' ' 83' ' ' ILE . 8.0 tptp -143.02 172.26 12.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' LYS . 3.3 pt -153.39 131.89 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.668 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.213 0.53 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -61.84 -50.95 70.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.161 -0.962 . . . . 0.0 110.27 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 3' ' ' LEU . 1.3 mm? -90.53 -25.01 20.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.326 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.8 tttt 59.94 155.11 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.347 -0.845 . . . . 0.0 110.267 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.0 p -60.64 123.73 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.159 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p -83.77 144.72 29.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.267 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.17 136.7 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 110.142 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -164.05 37.36 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.211 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.79 179.88 37.63 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 150.67 24.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -1.135 . . . . 0.0 110.186 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.76 -74.51 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -57.66 -58.86 6.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.318 -1.107 . . . . 0.0 110.272 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.86 138.85 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.237 -0.915 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.39 -115.08 3.63 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -120.65 -35.01 3.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -1.173 . . . . 0.0 110.22 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.65 15.42 11.5 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -97.09 124.24 41.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.255 . . . . 0.0 109.991 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 mt -82.19 117.2 67.51 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.313 -0.867 . . . . 0.0 110.357 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.7 Cg_endo -73.89 134.33 19.68 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 O-C-N 123.386 1.203 . . . . 0.0 110.385 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -80.19 125.88 80.49 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.235 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.14 141.12 28.95 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.441 1.232 . . . . 0.0 110.389 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.52 127.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.397 -0.814 . . . . 0.0 110.523 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.93 170.59 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 0.0 110.159 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.41 -177.8 47.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.2 m -133.99 147.16 50.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.13 . . . . 0.0 110.365 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -85.85 134.52 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.307 -0.871 . . . . 0.0 110.1 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 p -110.16 -20.67 12.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.176 -0.952 . . . . 0.0 110.141 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.93 122.8 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.311 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.494 ' O ' HD22 ' A' ' 30' ' ' LEU . 1.1 tt -83.39 144.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.082 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 29' ' ' ILE . 2.3 mm? -119.31 -24.8 6.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.232 -0.917 . . . . 0.0 110.632 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.5 p -108.12 165.02 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.307 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -136.13 169.06 18.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 0.0 110.322 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -73.09 156.98 38.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 23.32 70.76 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.13 166.14 12.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -1.14 . . . . 0.0 110.075 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.7 m -109.11 128.12 54.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 110.143 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 61' ' ' GLY . 7.6 p -109.19 158.96 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.402 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' CG ' ' OD2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -110.94 179.71 3.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.87 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . . . -90.1 124.55 34.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.098 -1.001 . . . . 0.0 110.33 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.88 26.33 29.55 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' HG13 ' A' ' 43' ' ' VAL . 20.3 tt0 -113.82 122.31 46.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -1.174 . . . . 0.0 110.316 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 24.2 m -56.6 109.91 0.7 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 0.0 110.191 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.808 HG11 ' HB2' ' A' ' 57' ' ' ALA . 34.3 m -95.81 -21.14 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.479 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -147.93 173.94 12.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.992 -1.067 . . . . 0.0 111.348 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.491 HG23 HD23 ' A' ' 30' ' ' LEU . 45.7 t -126.2 113.33 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.513 -0.742 . . . . 0.0 109.251 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.35 165.46 11.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.01 -1.056 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -144.67 80.05 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.58 -0.7 . . . . 0.0 109.707 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.23 -163.49 0.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 110.264 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.95 52.59 2.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 110.053 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -168.91 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.342 -0.849 . . . . 0.0 110.009 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.0 OUTLIER 174.44 -73.41 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.188 -0.945 . . . . 0.0 110.445 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.7 mm-40 54.08 -92.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.897 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 51.9 m 51.67 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.12 -0.987 . . . . 0.0 111.082 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' HG22 ' A' ' 53' ' ' THR . 4.9 tt0 -60.94 102.11 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 111.076 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 43' ' ' VAL . 32.1 mm -103.94 89.23 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.941 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 31.3 m120 -73.89 135.28 43.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.42 0.628 . . . . 0.0 110.694 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -55.35 167.81 0.67 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.852 . . . . 0.0 110.253 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.547 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.0 Cg_endo -74.09 -52.47 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.761 1.4 . . . . 0.0 110.523 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -160.28 170.27 21.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.188 -0.945 . . . . 0.0 110.098 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 39' ' ' ALA . 3.6 m-20 -57.88 139.01 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.255 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.659 ' O ' HG12 ' A' ' 37' ' ' VAL . . . 169.4 172.35 35.97 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -109.86 150.06 28.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -1.14 . . . . 0.0 109.974 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 33' ' ' GLU . 31.5 t -77.81 124.42 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.159 -0.963 . . . . 0.0 110.368 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.39 -6.81 23.56 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 110.003 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -177.87 150.52 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 109.92 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.62 146.28 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 110.396 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -119.92 -69.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 110.179 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.65 HG21 HD23 ' A' ' 80' ' ' LEU . 33.5 m -75.46 158.78 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.051 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -129.69 -165.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.129 -0.982 . . . . 0.0 110.224 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 155.26 20.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 110.185 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 55.53 25.86 8.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.22 -0.925 . . . . 0.0 110.125 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.27 105.61 11.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 110.245 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 137.55 50.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.91 . . . . 0.0 110.004 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 74' ' ' VAL . 14.9 p -130.23 132.31 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.74 -177.45 6.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.218 -0.926 . . . . 0.0 110.304 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.07 125.72 7.24 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.29 0.69 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -154.15 128.71 9.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.419 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.01 130.55 36.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 20' ' ' ALA . 10.9 mt -92.21 -70.05 0.71 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.331 -1.099 . . . . 0.0 109.698 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.3 mm -134.64 145.04 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 0.0 109.833 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.72 137.96 31.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.182 -0.949 . . . . 0.0 110.493 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.95 146.2 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.234 0.54 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' C ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER 52.74 -166.35 0.06 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.964 . . . . 0.0 110.233 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.548 HD23 ' C ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -168.18 51.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 110.3 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.67 96.98 3.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.0 110.291 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.885 HG12 HG23 ' A' ' 6' ' ' THR . 32.2 t -108.47 147.8 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.322 -0.861 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.885 HG23 HG12 ' A' ' 5' ' ' VAL . 48.6 p 44.26 -153.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.544 -0.723 . . . . 0.0 110.881 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 7' ' ' VAL . 27.0 m -123.23 58.7 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.895 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -132.24 126.01 32.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.338 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.03 111.24 0.55 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.21 42.48 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -1.109 . . . . 0.0 110.134 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.26 92.55 0.76 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.11 75.24 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -1.162 . . . . 0.0 110.152 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.29 154.12 20.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 110.154 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.5 -173.71 44.11 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.48 135.72 56.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -1.147 . . . . 0.0 110.17 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' LYS . . . 102.61 -19.12 48.76 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' OE2' ' CD ' ' A' ' 82' ' ' LYS . 1.1 mp0 -110.04 127.7 54.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.079 -1.248 . . . . 0.0 110.508 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.7 mp -82.38 111.93 32.24 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.793 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.88 143.35 45.19 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.41 1.216 . . . . 0.0 110.582 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 1.014 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -85.86 135.73 37.39 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 110.123 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.58 133.81 17.74 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.592 1.312 . . . . 0.0 110.542 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.36 -166.87 0.07 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.242 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.55 137.88 38.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.254 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.77 169.13 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 132.58 54.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -1.168 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -67.32 141.32 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 110.358 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 m -113.18 -24.45 9.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 110.063 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -175.52 140.78 0.49 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.855 . . . . 0.0 110.088 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 29' ' ' ILE . 11.0 tt -100.06 134.45 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.0 110.343 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -85.48 -56.18 3.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 43' ' ' VAL . 19.5 m -81.02 -177.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.364 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -145.93 52.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.028 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.622 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER 59.85 157.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.268 -0.895 . . . . 0.0 109.99 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.08 55.51 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 4.2 p30 -106.93 147.92 29.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -1.092 . . . . 0.0 110.233 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.9 m -108.75 123.3 48.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.275 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 61' ' ' GLY . 35.6 m -108.81 -175.83 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.086 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 3.0 ttpt -142.7 49.58 1.49 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . 54.75 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.76 -13.32 7.7 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.339 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.8 tt0 -77.59 119.94 21.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.05 -1.264 . . . . 0.0 110.555 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 1.3 m -61.71 103.3 0.32 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.22 -0.925 . . . . 0.0 110.035 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.675 ' HA ' HG13 ' A' ' 31' ' ' VAL . 34.7 m -86.78 -21.5 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 110.256 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.709 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -151.18 176.84 10.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.395 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG23 HD23 ' A' ' 30' ' ' LEU . 67.8 t -134.26 117.98 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.425 -0.797 . . . . 0.0 110.07 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -99.23 157.4 16.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.206 -0.934 . . . . 0.0 110.238 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -155.1 115.11 3.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.07 120.54 20.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 110.149 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.5 52.13 10.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.158 -0.964 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.25 55.03 10.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.825 . . . . 0.0 110.781 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.94 -34.62 5.69 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 0.0 110.399 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 55.33 100.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.252 -0.905 . . . . 0.0 110.209 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.6 m -130.21 107.33 9.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.281 -0.887 . . . . 0.0 110.346 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 42' ' ' THR . 16.1 mt-10 -62.39 149.58 42.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.997 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 44' ' ' LEU . 64.6 mt -111.91 86.1 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.965 . . . . 0.0 110.613 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.2 m-20 -84.31 127.59 34.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.583 -0.698 . . . . 0.0 110.273 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.01 145.32 5.03 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.582 -0.699 . . . . 0.0 110.277 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.65 -45.22 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.65 1.342 . . . . 0.0 110.639 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.723 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 8.9 t -137.41 158.09 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 110.419 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 4.6 p30 -56.83 160.22 3.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 148.71 168.76 14.84 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 21.9 ttpt -109.53 139.56 44.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 33' ' ' GLU . 16.7 t -64.66 135.45 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.03 . . . . 0.0 109.94 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.19 -17.66 16.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.949 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.83 156.06 0.6 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.008 . . . . 0.0 110.388 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 81' ' ' ILE . 23.9 m -126.72 127.29 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.341 -0.849 . . . . 0.0 109.81 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.693 ' CD1' HG23 ' A' ' 68' ' ' VAL . 1.8 pp -104.79 -26.27 12.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.305 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 67' ' ' LEU . 84.3 t -98.97 150.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.73 -164.87 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 110.163 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -79.75 151.38 30.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 110.148 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.52 39.11 27.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.242 -0.911 . . . . 0.0 110.287 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.79 -19.47 15.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.315 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.33 111.12 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.547 -0.721 . . . . 0.0 110.904 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.96 145.33 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.18 -0.95 . . . . 0.0 110.392 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.4 171.53 8.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.24 119.83 18.59 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.62 44.51 2.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.0 125.35 27.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.34 -1.094 . . . . 0.0 110.021 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -54.78 139.49 39.77 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.014 HD11 ' HB2' ' A' ' 20' ' ' ALA . 8.6 mt -107.64 -61.01 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.203 -1.175 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.562 ' CD1' HG12 ' A' ' 66' ' ' VAL . 11.8 tt -143.56 151.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.886 . . . . 0.0 110.276 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' CD ' ' OE2' ' A' ' 17' ' ' GLU . 4.5 ttpt -95.23 143.81 26.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.072 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.8 tt -136.07 151.95 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.888 -1.507 . . . . 0.0 109.573 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.286 0.565 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -100.94 120.34 40.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 0.0 110.197 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.17 166.78 0.35 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.925 . . . . 0.0 110.11 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.85 24.51 1.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -106.37 119.66 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.153 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.9 p -69.4 105.11 2.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.33 -0.856 . . . . 0.0 110.314 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 7' ' ' VAL . 14.9 p -165.22 58.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 110.247 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -140.89 -170.15 2.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.335 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -58.66 -46.23 93.61 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 9' ' ' GLY . . . 55.71 -174.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.203 -1.175 . . . . 0.0 110.247 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.17 -61.36 5.82 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 56.36 70.93 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.287 -1.125 . . . . 0.0 110.481 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' HB2' ' N ' ' A' ' 79' ' ' GLY . . . 50.5 -164.27 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.312 -0.868 . . . . 0.0 110.537 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.67 -106.74 1.08 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -129.82 158.89 38.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -1.168 . . . . 0.0 110.009 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.06 39.79 92.55 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CD ' ' HB1' ' A' ' 13' ' ' ALA . 2.0 pp20? -135.15 161.33 35.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.301 -1.117 . . . . 0.0 110.335 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.622 ' N ' HD12 ' A' ' 18' ' ' ILE . 4.7 mp -118.14 102.69 50.55 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.274 -0.891 . . . . 0.0 109.826 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 45.9 Cg_endo -72.12 156.6 55.47 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.656 1.345 . . . . 0.0 110.527 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -86.23 138.64 34.36 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.316 -0.865 . . . . 0.0 110.081 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.88 -27.37 12.37 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.609 1.321 . . . . 0.0 110.506 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.78 165.69 23.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.08 156.34 21.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.913 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.653 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . -134.28 -177.42 14.93 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 1.5 m -122.99 -133.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.163 -1.198 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 27' ' ' SER . 15.7 m -36.8 -46.32 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.472 -0.768 . . . . 0.0 112.276 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.479 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.3 t 54.95 42.41 31.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.999 -1.063 . . . . 0.0 109.918 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG3' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -51.93 94.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.18 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 29' ' ' ILE . 13.6 tt -68.09 86.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.5 mm? -54.04 -41.87 68.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.002 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 32' ' ' LYS . 9.9 p -62.03 164.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.986 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' N ' HG22 ' A' ' 31' ' ' VAL . 5.5 ttmt -123.57 169.31 11.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 110.27 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.73 134.39 34.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.105 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.51 19.13 57.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.62 179.42 4.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -1.156 . . . . 0.0 109.924 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -122.12 140.25 52.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.125 -0.984 . . . . 0.0 110.49 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.75 175.15 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.346 -0.846 . . . . 0.0 109.817 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -125.46 161.2 27.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.107 -0.996 . . . . 0.0 110.367 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -63.38 127.93 33.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.89 . . . . 0.0 110.084 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 90.56 19.13 45.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.719 ' O ' HG13 ' A' ' 43' ' ' VAL . 37.1 tt0 -109.36 111.65 23.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.086 -1.243 . . . . 0.0 109.992 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 54.2 m -51.08 116.09 1.84 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.541 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.027 HG23 HD12 ' A' ' 44' ' ' LEU . 30.2 m -115.44 -22.56 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.842 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.027 HD12 HG23 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -131.16 154.77 48.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.201 -0.937 . . . . 0.0 110.385 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 28' ' ' LYS . 98.6 t -128.2 109.76 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.215 -0.928 . . . . 0.0 110.818 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.653 HD22 ' HA3' ' A' ' 24' ' ' GLY . 30.5 mt -98.33 147.33 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.183 -0.948 . . . . 0.0 109.953 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -127.65 59.61 1.45 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.69 110.72 5.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 109.909 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.32 43.64 26.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 110.044 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt 52.94 47.83 23.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.144 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 9.6 mtt -94.39 -18.8 21.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 0.0 110.506 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 53.17 88.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.047 -1.033 . . . . 0.0 109.912 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.1 m -120.32 114.72 22.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.903 . . . . 0.0 110.436 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.4 OUTLIER -77.85 118.58 20.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 HD12 ' A' ' 46' ' ' LEU . 30.7 mm -88.75 90.07 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.575 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 7.0 p-10 -73.45 132.36 42.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.535 -0.728 . . . . 0.0 110.064 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.97 148.37 1.93 Allowed Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.362 -0.836 . . . . 0.0 110.665 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.88 -40.22 1.97 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.569 1.299 . . . . 0.0 110.644 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 39' ' ' ALA . 79.4 m -156.09 153.4 29.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.16 -0.963 . . . . 0.0 110.255 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 24.7 t70 -55.79 140.94 40.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.45 177.8 39.73 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.19 142.29 41.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -1.141 . . . . 0.0 110.045 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 81' ' ' ILE . 41.9 t -71.8 129.73 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 110.117 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -96.95 -6.66 35.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 110.362 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -174.84 148.14 1.05 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.099 -1.001 . . . . 0.0 110.204 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 81' ' ' ILE . 7.1 p -105.14 144.49 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.97 -53.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.138 -0.976 . . . . 0.0 110.158 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 70' ' ' GLU . 92.5 t -53.46 128.21 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.22 -0.925 . . . . 0.0 110.061 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -80.15 1.75 26.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.916 . . . . 0.0 110.918 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 68' ' ' VAL . 18.8 tt0 61.95 132.39 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' HA ' ' HB ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER 57.64 26.38 12.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.077 . . . . 0.0 110.136 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.571 ' O ' HG13 ' A' ' 74' ' ' VAL . 2.1 t0 -126.41 120.63 30.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.143 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' THR . . . -54.18 142.95 24.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.946 . . . . 0.0 109.963 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 72' ' ' ASP . 35.9 m -136.66 171.39 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.967 -1.083 . . . . 0.0 110.426 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -113.34 -179.23 3.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.79 140.78 15.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.22 20.62 10.9 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 2.2 mm-40 -125.97 143.85 50.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.164 . . . . 0.0 110.111 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 13' ' ' ALA . . . -62.04 144.48 49.08 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 68' ' ' VAL . 48.9 mt -104.85 -42.73 5.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.258 -1.142 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 66' ' ' VAL . 1.9 tp -167.72 143.51 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 0.0 110.125 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -92.46 147.95 22.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.957 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.3 pt -133.76 158.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 110.207 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 CA-C-O 117.979 -1.456 . . . . 0.0 109.467 -179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.257 0.551 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -62.27 -170.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 110.319 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.708 ' O ' HD23 ' A' ' 3' ' ' LEU . 6.3 tt -140.01 101.92 4.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -119.83 -66.53 1.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.346 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 5' ' ' VAL . 31.6 m -137.67 132.23 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 110.303 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m 52.93 82.33 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 110.309 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.4 148.68 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.215 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -50.38 96.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.146 -0.971 . . . . 0.0 110.522 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.7 40.82 0.04 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.66 104.53 5.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -1.112 . . . . 0.0 110.244 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.95 -69.02 0.57 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? 54.0 -160.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.284 -1.127 . . . . 0.0 110.066 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.9 -161.45 0.35 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.988 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.33 59.6 0.53 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 53.65 79.03 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -1.162 . . . . 0.0 110.255 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.23 -56.49 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -53.1 143.62 17.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -1.126 . . . . 0.0 110.362 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 80' ' ' LEU . 4.3 mp -113.33 131.87 22.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.137 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.9 Cg_endo -73.34 144.7 37.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.524 1.276 . . . . 0.0 110.577 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.945 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -113.25 74.34 1.98 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.959 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.54 61.84 2.84 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.772 1.406 . . . . 0.0 110.569 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 22' ' ' LEU . 1.7 mm? -113.01 -12.46 13.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.62 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' O ' HD21 ' A' ' 46' ' ' LEU . . . 55.01 -174.16 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.054 -1.029 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.665 ' O ' ' HB1' ' A' ' 73' ' ' ALA . . . 113.29 -162.48 12.35 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.483 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 10.4 p -130.46 101.0 5.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.069 -1.254 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.547 ' H ' ' HB2' ' A' ' 73' ' ' ALA . 34.5 m -55.05 137.01 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.171 -0.956 . . . . 0.0 109.802 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 -22.62 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.958 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HA ' ' CG ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -178.32 166.12 1.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.217 -0.927 . . . . 0.0 109.989 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.492 ' O ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -114.16 145.85 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.0 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 29' ' ' ILE . 3.3 mm? -117.59 -15.77 10.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.137 -0.977 . . . . 0.0 110.429 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.75 140.0 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.22 178.79 4.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.887 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HA ' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -85.79 143.47 28.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 110.183 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.9 21.64 65.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.41 158.28 25.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -1.167 . . . . 0.0 110.118 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 134.56 46.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.06 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 2.0 ttpm? -138.64 146.91 42.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 59' ' ' THR . . . -58.9 103.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 -7.31 8.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.686 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -94.33 121.8 36.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.855 -1.379 . . . . 0.0 110.376 -179.833 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.54 HG21 ' CG ' ' A' ' 54' ' ' GLU . 1.3 m -51.11 129.6 24.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.155 -0.966 . . . . 0.0 110.012 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 55' ' ' ILE . 31.1 m -124.91 -24.72 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 111.191 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.93 167.53 21.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.883 -1.136 . . . . 0.0 111.091 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 53' ' ' THR . 85.5 t -123.64 121.18 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 109.678 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.517 HD21 ' O ' ' A' ' 23' ' ' ALA . 8.8 tt -151.41 140.87 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.0 110.523 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' CG ' ' OG1' ' A' ' 25' ' ' THR . 4.4 pt-20 -119.56 154.41 33.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 110.098 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.93 73.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.967 . . . . 0.0 110.489 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.96 26.35 2.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 110.376 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' GLU . 6.2 tttt -160.73 29.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 53' ' ' THR . 3.5 mtt 57.04 -85.67 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.536 -0.727 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.537 ' OE1' HD11 ' A' ' 55' ' ' ILE . 1.1 mt-10 62.86 -77.15 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.208 -0.932 . . . . 0.0 110.617 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 55' ' ' ILE . 24.9 p 44.77 -92.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.655 -0.653 . . . . 0.0 111.109 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' CG ' HG21 ' A' ' 42' ' ' THR . 0.8 OUTLIER -52.14 104.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.632 -1.292 . . . . 0.0 110.79 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 43' ' ' VAL . 24.3 mm -94.01 90.96 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.122 -0.986 . . . . 0.0 109.625 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 56' ' ' ASN . 37.8 p-10 -49.38 147.04 3.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.427 -0.796 . . . . 0.0 110.502 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 38' ' ' LYS . . . -57.79 151.68 41.36 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.134 -0.979 . . . . 0.0 109.979 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.789 ' O ' HG23 ' A' ' 59' ' ' THR . 45.1 Cg_endo -72.66 -27.85 14.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.164 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -170.62 -171.86 1.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.345 -0.847 . . . . 0.0 109.948 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -103.6 144.05 31.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 110.137 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.52 -155.23 26.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -127.49 144.35 51.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.341 -1.093 . . . . 0.0 110.02 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 81' ' ' ILE . 39.4 t -76.18 100.88 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 110.111 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -67.73 -15.37 63.61 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.33 -0.856 . . . . 0.0 109.743 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER 177.24 161.1 0.45 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.133 -0.979 . . . . 0.0 110.051 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 81' ' ' ILE . 92.5 t -131.51 129.44 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.943 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.587 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.1 pp -109.9 -28.04 8.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.133 -0.979 . . . . 0.0 110.641 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 80' ' ' LEU . 35.4 m -78.84 -176.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.051 -1.031 . . . . 0.0 110.306 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.2 155.53 20.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.18 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -50.95 165.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.186 -0.946 . . . . 0.0 110.518 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER 74.09 -42.63 0.51 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.538 -0.726 . . . . 0.0 111.949 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -53.41 129.06 30.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.574 -1.329 . . . . 0.0 110.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 24' ' ' GLY . . . -165.12 -156.83 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.377 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 73' ' ' ALA . 84.6 t 57.4 115.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.607 0.718 . . . . 0.0 111.196 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 51.88 93.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.622 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.05 -136.34 0.25 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.12 7.07 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -141.46 140.54 33.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.184 . . . . 0.0 110.015 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.587 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -49.19 148.07 5.54 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 20' ' ' ALA . 4.1 mt -91.51 -70.76 0.67 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.318 -1.107 . . . . 0.0 110.268 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.698 HD13 HG22 ' A' ' 63' ' ' VAL . 2.7 pp -152.29 154.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 110.099 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HB3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.61 130.27 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.18 22.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 110.294 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.944 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.278 0.561 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 tttt 52.97 53.91 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 -60.13 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.91 . . . . 0.0 110.089 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.88 130.67 5.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -96.31 125.69 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.559 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.6 p -123.18 169.97 10.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.4 t 60.05 151.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.426 -0.796 . . . . 0.0 110.406 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 53.35 75.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.06 -108.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.5 170.61 7.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -1.127 . . . . 0.0 110.292 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.09 -154.59 6.25 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -115.1 37.85 3.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -1.118 . . . . 0.0 110.256 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.5 113.51 25.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.304 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 17' ' ' GLU . . . -64.56 -124.06 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -120.61 -25.85 5.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.15 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.79 64.93 0.59 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 14' ' ' GLY . 1.8 pm0 -129.59 166.95 18.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -1.15 . . . . 0.0 110.221 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.783 HD11 HG21 ' A' ' 83' ' ' ILE . 2.7 mp -118.47 104.55 47.51 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 44.2 Cg_endo -71.92 138.23 30.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.587 1.309 . . . . 0.0 110.27 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.875 ' HB2' HD11 ' A' ' 80' ' ' LEU . . . -101.17 148.69 35.48 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 110.33 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.43 -24.09 19.63 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.679 1.358 . . . . 0.0 110.171 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 mt -154.79 96.64 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.0 109.911 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.535 ' HB2' ' H ' ' A' ' 76' ' ' GLY . . . -49.95 -62.41 1.59 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.209 -0.932 . . . . 0.0 110.004 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' HD13 ' A' ' 46' ' ' LEU . . . 90.89 -170.02 34.34 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.22 80.34 8.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.33 114.48 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 109.66 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.3 m -111.58 -36.46 5.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.731 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.91 142.85 31.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.068 -1.02 . . . . 0.0 110.843 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -107.26 113.4 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 110.051 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 45' ' ' VAL . 2.8 mm? -79.33 -25.49 42.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 110.537 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 32' ' ' LYS . 8.6 p -90.3 161.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.421 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' HG22 ' A' ' 31' ' ' VAL . 3.5 ttpt -134.82 -167.89 2.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.901 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -94.66 133.73 38.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.143 -0.973 . . . . 0.0 110.048 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.41 -1.61 88.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.51 137.4 32.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.33 . . . . 0.0 110.148 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.0 m -85.93 124.47 32.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 110.547 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 61' ' ' GLY . 25.5 m -102.55 -175.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.937 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HA ' ' CB ' ' A' ' 60' ' ' ASP . 16.6 mmtt -139.45 164.72 29.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 0.0 110.291 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.8 98.8 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 112.86 19.31 6.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.687 ' O ' HG13 ' A' ' 43' ' ' VAL . 17.4 tt0 -106.18 118.94 37.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.1 -1.235 . . . . 0.0 109.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -49.08 128.12 15.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.972 -1.08 . . . . 0.0 110.659 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 41' ' ' GLN . 17.9 m -128.76 -31.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.863 . . . . 0.0 110.717 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.57 161.34 27.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 0.0 110.733 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 53' ' ' THR . 41.4 t -132.07 126.36 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 110.264 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -134.07 167.36 20.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 0.0 110.701 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -130.4 88.2 2.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 47' ' ' GLU . . . -179.87 155.16 0.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -0.923 . . . . 0.0 109.694 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.2 mmt 51.56 90.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' GLU . 21.9 mtmt 56.58 26.19 10.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.827 . . . . 0.0 110.4 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' THR . 0.8 OUTLIER 65.58 -63.28 0.21 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.707 -0.62 . . . . 0.0 110.935 179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' LYS . 1.1 tp10 67.76 -65.15 0.25 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.24 -0.913 . . . . 0.0 109.88 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 54' ' ' GLU . 88.6 m 52.45 -103.46 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.197 -0.939 . . . . 0.0 110.585 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 53' ' ' THR . 33.6 mt-10 -50.53 114.42 1.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.586 -1.321 . . . . 0.0 111.303 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.67 HD11 HD21 ' A' ' 46' ' ' LEU . 13.7 mm -106.79 99.9 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.81 134.57 55.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.565 -0.709 . . . . 0.0 110.458 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -52.89 154.96 4.54 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.701 ' HG3' HG21 ' A' ' 18' ' ' ILE . 50.8 Cg_endo -77.04 -38.9 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.693 1.365 . . . . 0.0 110.539 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.73 149.68 28.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.4 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 38' ' ' LYS . 2.6 p30 -65.49 153.1 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.078 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.647 ' O ' HG22 ' A' ' 37' ' ' VAL . . . 151.68 161.54 10.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -84.3 142.52 30.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.357 -1.084 . . . . 0.0 110.205 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.73 131.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 110.213 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -91.45 -15.32 29.05 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.457 -0.777 . . . . 0.0 109.801 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt 179.55 166.64 1.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.214 -0.929 . . . . 0.0 110.201 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 66' ' ' VAL . 11.8 m -131.1 105.9 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 109.909 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 79' ' ' GLY . 3.3 pp -96.29 -28.13 14.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.962 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.59 155.26 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.88 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -135.17 159.62 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.633 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.7 74.33 6.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 110.205 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.92 -36.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.307 -0.87 . . . . 0.0 109.818 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -51.96 107.84 0.23 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.29 124.63 47.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.689 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 57.43 113.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.702 -0.624 . . . . 0.0 110.78 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.4 tt0 -153.68 -77.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.988 -1.07 . . . . 0.0 111.298 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.535 ' H ' ' HB2' ' A' ' 23' ' ' ALA . . . 64.3 132.76 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 105.85 2.22 39.66 Favored Glycine 0 N--CA 1.491 2.306 0 O-C-N 121.09 -1.241 . . . . 0.0 110.295 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -127.95 146.59 50.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.804 -1.41 . . . . 0.0 110.244 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.651 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -63.39 141.45 45.94 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.875 HD11 ' HB2' ' A' ' 20' ' ' ALA . 23.0 mt -84.85 -48.86 8.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.325 -1.103 . . . . 0.0 110.002 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.438 HG23 ' C ' ' A' ' 80' ' ' LEU . 29.6 pt -149.07 152.7 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 110.173 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.26 157.87 36.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 18' ' ' ILE . 1.9 tt -162.88 149.78 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.248 -0.908 . . . . 0.0 110.16 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.251 0.548 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 146.92 49.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.905 . . . . 0.0 110.174 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.68 171.88 10.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.19 179.59 7.12 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.222 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 m -98.45 145.81 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 110.257 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -64.29 127.51 31.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.266 -0.897 . . . . 0.0 110.136 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 9' ' ' GLY . 86.3 t -117.1 -77.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.269 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t30 51.35 35.35 13.68 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.939 . . . . 0.0 110.477 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.606 ' H ' HG12 ' A' ' 7' ' ' VAL . . . 134.98 166.26 11.05 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.17 41.98 32.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -1.066 . . . . 0.0 110.366 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.84 157.18 8.37 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.38 164.92 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.384 -1.068 . . . . 0.0 110.411 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' ' CA ' ' A' ' 79' ' ' GLY . . . -92.53 -155.95 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.065 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.25 -155.49 6.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -72.13 127.94 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -1.108 . . . . 0.0 110.236 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.34 -57.23 1.03 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -65.75 162.12 19.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.151 -1.205 . . . . 0.0 110.197 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 pt -133.19 135.56 25.82 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.902 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 47.0 Cg_endo -72.42 155.97 54.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.615 1.324 . . . . 0.0 110.688 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 75' ' ' GLN . . . -83.71 131.24 52.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.09 -19.9 17.21 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.54 1.284 . . . . 0.0 110.625 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.565 HD13 ' H ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -129.79 148.76 51.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 -179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' H ' HD13 ' A' ' 22' ' ' LEU . . . -85.44 166.11 16.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 0.0 110.169 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.546 ' HA3' HD22 ' A' ' 46' ' ' LEU . . . 166.23 -179.89 40.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 46' ' ' LEU . 14.6 m -113.62 127.36 56.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.17 139.57 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 109.891 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.8 m -134.98 -39.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.7 148.46 45.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.652 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.37 151.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD13 HG22 ' A' ' 42' ' ' THR . 2.4 mp -129.37 -49.45 1.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.499 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 43' ' ' VAL . 9.3 p -51.45 143.76 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.172 -0.955 . . . . 0.0 110.272 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -103.85 157.84 16.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 110.006 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' HG11 ' A' ' 63' ' ' VAL . 5.4 pt-20 -83.66 146.6 28.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.12 58.0 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.15 173.99 6.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.296 . . . . 0.0 110.052 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.5 m -106.47 110.22 22.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.086 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 ' CG1' ' A' ' 43' ' ' VAL . 14.9 p -87.45 145.07 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.86 . . . . 0.0 110.134 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -100.9 152.66 20.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.26 -0.9 . . . . 0.0 110.206 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 130.68 44.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.59 21.39 29.13 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 43' ' ' VAL . 1.6 tt0 -116.44 121.77 42.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.14 -1.212 . . . . 0.0 110.29 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 69.9 m -53.57 100.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.0 110.372 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.716 ' CG1' ' HB2' ' A' ' 57' ' ' ALA . 33.8 m -86.07 -21.7 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.731 ' HB3' HD12 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -149.77 171.27 16.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.5 t -136.74 140.24 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.271 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.586 ' HG ' HD11 ' A' ' 55' ' ' ILE . 11.8 mt -110.99 170.32 8.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 110.19 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -152.59 127.09 9.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.142 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.21 -156.45 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.276 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 6.2 tpt -92.73 39.82 1.04 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.396 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -153.04 -47.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 110.099 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.27 -173.93 1.6 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.332 -0.855 . . . . 0.0 110.193 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -106.68 138.4 42.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.878 . . . . 0.0 110.148 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.2 m -109.16 150.23 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.091 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -103.5 132.41 49.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 110.217 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.731 HD12 ' HB3' ' A' ' 44' ' ' LEU . 85.8 mt -98.9 87.08 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.6 m-20 -74.09 129.37 37.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.555 -0.716 . . . . 0.0 110.35 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.716 ' HB2' ' CG1' ' A' ' 43' ' ' VAL . . . -48.55 138.99 11.43 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.436 -0.79 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.93 -37.61 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.595 1.313 . . . . 0.0 110.82 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -144.67 149.34 35.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 110.549 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -62.16 153.0 31.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.085 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.21 -166.55 39.75 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -127.61 143.03 51.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -1.096 . . . . 0.0 110.25 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 33' ' ' GLU . 12.8 t -84.06 141.92 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.282 -0.886 . . . . 0.0 110.274 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.4 -11.3 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.571 -0.706 . . . . 0.0 110.263 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER 178.19 107.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.007 -1.058 . . . . 0.0 110.079 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.0 m -97.6 143.91 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.0 110.022 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.874 HD11 ' O ' ' A' ' 79' ' ' GLY . 1.4 pp -118.62 -23.91 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.053 -1.029 . . . . 0.0 110.544 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 80' ' ' LEU . 35.2 m -61.97 163.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 110.166 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 71' ' ' ARG . 13.7 mtmt -157.63 158.71 36.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.32 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.99 68.1 0.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -173.62 -42.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.172 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.81 149.16 27.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.298 -0.876 . . . . 0.0 110.38 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -127.57 179.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.0 109.874 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' C ' ' A' ' 73' ' ' ALA . 29.2 m 36.22 68.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 CA-C-O 121.351 0.596 . . . . 0.0 111.725 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 65.9 mm-40 -75.44 -0.82 21.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -54.97 104.62 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.01 57.53 1.9 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 1.3 tt0 -163.24 138.33 6.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.285 -1.127 . . . . 0.0 110.15 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.874 ' O ' HD11 ' A' ' 67' ' ' LEU . . . -52.13 136.45 34.45 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.856 ' O ' HG13 ' A' ' 68' ' ' VAL . 10.8 mt -102.15 -71.52 0.72 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.315 -1.109 . . . . 0.0 109.952 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.423 HG23 ' C ' ' A' ' 80' ' ' LEU . 26.4 pt -148.64 152.43 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -90.79 123.63 34.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.079 -1.013 . . . . 0.0 110.487 -179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.3 tt -129.74 142.22 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.221 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.002 -1.443 . . . . 0.0 109.507 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.242 0.544 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.72 43.08 3.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.231 -0.918 . . . . 0.0 110.281 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mt -66.51 93.87 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.141 -0.974 . . . . 0.0 110.156 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 5' ' ' VAL . 9.2 pttt -69.66 -25.83 64.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 110.35 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 ' N ' ' HG3' ' A' ' 4' ' ' LYS . 9.0 p -58.47 152.74 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.955 . . . . 0.0 110.15 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 p -89.21 161.72 16.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 110.246 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.01 117.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -100.14 83.32 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 110.266 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.07 -133.2 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.93 -168.39 0.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.256 -1.143 . . . . 0.0 110.235 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.71 -78.05 0.38 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.13 156.94 40.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -1.148 . . . . 0.0 110.076 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.69 -165.75 1.27 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.26 156.02 21.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -54.06 134.59 43.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -1.168 . . . . 0.0 110.314 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.51 -23.07 37.47 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' CG ' ' HD2' ' A' ' 82' ' ' LYS . 15.2 mt-10 -91.87 155.96 17.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.58 104.71 55.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.22 -0.925 . . . . 0.0 110.1 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' GLN . 46.5 Cg_endo -73.4 164.11 35.99 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.567 1.298 . . . . 0.0 110.766 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' HA2' ' A' ' 76' ' ' GLY . . . -81.56 156.11 70.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.341 -0.849 . . . . 0.0 110.335 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.51 -36.97 3.45 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.716 1.377 . . . . 0.0 110.738 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.26 -53.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.972 . . . . 0.0 110.325 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -167.62 179.19 4.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.378 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' A' ' 46' ' ' LEU . . . 177.43 160.46 24.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.8 p -115.96 90.83 3.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -1.174 . . . . 0.0 110.439 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.715 HG21 ' CG2' ' A' ' 68' ' ' VAL . 41.4 t -63.81 136.23 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 109.667 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 52.4 m -127.39 -30.67 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.013 -1.054 . . . . 0.0 110.972 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.83 159.12 41.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.999 -1.063 . . . . 0.0 110.5 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.604 ' CD1' HG11 ' A' ' 66' ' ' VAL . 6.2 tt -129.21 135.26 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.398 -0.814 . . . . 0.0 110.108 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 30' ' ' LEU . 2.7 mm? -93.35 -40.2 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.942 . . . . 0.0 109.987 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 31' ' ' VAL . 35.6 m -91.02 -170.05 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 109.804 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -165.78 -45.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.655 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 179.0 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 0.0 110.208 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -24.15 31.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -54.71 115.32 2.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -1.17 . . . . 0.0 109.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 19.0 m -75.86 95.84 3.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 0.0 110.296 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.17 165.27 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASP . 4.1 mttp -124.42 165.01 18.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 110.153 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.33 110.59 2.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.5 36.9 11.36 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.833 ' O ' HG13 ' A' ' 43' ' ' VAL . 5.5 tt0 -116.25 114.26 24.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.324 -1.103 . . . . 0.0 110.073 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.48 HG21 ' HG3' ' A' ' 54' ' ' GLU . 1.4 m -52.58 118.58 3.72 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.833 HG13 ' O ' ' A' ' 41' ' ' GLN . 35.3 m -124.16 -10.5 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.915 . . . . 0.0 110.943 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -146.39 160.37 42.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.96 -1.087 . . . . 0.0 110.738 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 53' ' ' THR . 89.2 t -109.68 117.19 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 109.617 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.438 HD21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -150.37 134.89 17.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.408 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -117.47 104.0 10.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 110.115 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.02 -160.24 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.361 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.2 ttm -76.26 -29.03 57.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.221 -0.925 . . . . 0.0 110.348 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -113.26 11.52 18.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.695 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 5.0 mtt -135.68 168.94 18.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.047 -1.033 . . . . 0.0 109.976 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 tt0 -154.1 73.37 0.93 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.04 -1.038 . . . . 0.0 110.978 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 45' ' ' VAL . 0.8 OUTLIER 66.84 -59.96 0.36 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.265 -0.897 . . . . 0.0 111.114 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 42' ' ' THR . 0.1 OUTLIER -71.44 98.93 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.892 -1.13 . . . . 0.0 110.552 -179.481 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 53' ' ' THR . 29.5 mm -105.54 98.6 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 0.0 110.122 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 11.6 m-20 -74.31 133.34 42.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.649 -0.657 . . . . 0.0 110.123 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.566 ' HB2' HG11 ' A' ' 43' ' ' VAL . . . -47.84 166.21 0.21 Allowed Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.369 -0.832 . . . . 0.0 110.468 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 46.9 Cg_endo -72.69 -32.89 8.92 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.734 1.386 . . . . 0.0 110.526 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.6 t -173.39 171.08 4.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.209 -0.932 . . . . 0.0 110.052 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 5.7 p-10 -65.09 131.71 47.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' THR . . . 170.17 -176.59 43.82 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -105.61 142.3 35.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -1.099 . . . . 0.0 110.208 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.13 109.49 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.231 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.56 -17.66 60.7 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 109.704 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt 176.87 164.65 0.49 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.257 -0.902 . . . . 0.0 109.998 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 68' ' ' VAL . 48.8 t -123.99 88.51 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.54 -42.03 70.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.022 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.746 ' O ' HG12 ' A' ' 66' ' ' VAL . 14.7 p -80.92 147.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.896 . . . . 0.0 110.239 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -146.38 174.9 10.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -65.65 76.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 0.0 110.298 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER 179.9 -51.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 110.131 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -54.66 138.83 40.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.872 . . . . 0.0 110.169 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' C ' HG22 ' A' ' 74' ' ' VAL . . . -158.56 158.82 34.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.536 ' HA ' ' HB1' ' A' ' 23' ' ' ALA . 23.1 m 36.73 49.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.257 0.551 . . . . 0.0 111.7 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -154.03 85.75 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 20' ' ' ALA . . . -92.72 -172.97 41.13 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.84 -25.75 25.31 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -101.25 160.46 14.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.237 -1.155 . . . . 0.0 110.301 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.66 171.2 5.81 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -131.84 -58.02 0.97 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.24 -1.153 . . . . 0.0 110.04 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.412 HD11 HD22 ' A' ' 44' ' ' LEU . 2.7 mp -136.88 146.38 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 110.192 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 17' ' ' GLU . 2.5 tttm -106.15 131.91 52.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.301 -0.875 . . . . 0.0 110.141 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -135.62 35.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.905 . . . . . . . . 0 0 . 1 stop_ save_